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Abstract 
 
Diagnosis of Alzheimer’s disease is encouraged as a first step towards people planning 
for their future with the condition. Despite the proposed benefits of diagnosis, it is also 
widely recognised that Alzheimer’s disease can expose people to stigma. Therefore, this 
thesis explores the relationship between stigma and future outlook, from the perspective 
of people affected by early and late-onset Alzheimer’s disease. In order to recognise the 
physicality of the condition and how psychological and social factors influence 
experiences, a biopsychosocial perspective is employed throughout.   
People with Alzheimer’s disease (n=15 people with late-onset, 7 people with early-
onset) and their supporters (n=22) completed questionnaires about perceived stigma. 
This was followed by 14 interviews with a subsample of participants, which explored 
stigma and future outlook in more depth. Perceived stigma reporting across participants 
was low in the questionnaires; whereas interviews revealed higher levels of stigma with 
people discussing mixed, unpredictable reactions from a range of sources. Participants 
expressed awareness of the unpredictable nature of their futures with the condition. The 
subsequent lack of control was managed through focusing on ‘one day at a time’ and 
avoiding looking too far ahead.  
Across reflections on stigma and future outlook there was a deliberate focus on positive 
experiences for people affected by early and late-onset Alzheimer’s disease. The similar 
management of experiences across participants minimised possible age-based 
differences. These findings are supported by socioemotional selectivity theory, which 
suggests people are motivated to maintain positive emotional states when facing ‘time-
limiting’ conditions irrespective of age. The research suggests people’s experiences of 
stigma and future outlook interact, with stigma-driven assumptions about the future 
affecting how people manage their daily lives. The avoidance of looking ahead suggests 
that policy which encourages future planning should consider its utility and explore 
ways of helping people to manage both exposure to stigma, and planning for the future, 
whilst focusing on daily living.  
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Chapter 1- Introduction 
 
Introduction 
 
The diagnosis of Alzheimer’s disease has both positive and negative implications for 
people with the condition and their supporters. This thesis seeks to explore how the 
consequences of diagnosis interact with each other, namely considering the relationship 
between exposure to stigma and future outlook. The subjective experiences of people 
affected by Alzheimer’s disease are considered from a biopsychosocial perspective, 
viewed as a non-linear ‘journey’. The perspective aims to reflect how biomedical and 
psychosocial understandings of Alzheimer’s disease complement each other, and allow 
for a more holistic understanding of experiences.  
The thesis offers several new insights into the lives of people affected by Alzheimer’s 
disease; firstly understandings of stigma are built on by considering individual 
perceptions of stigma as opposed to public understanding of the condition.  Prior to this 
research there has been limited focus on individuals’ perceptions in this area, which in 
part reflects an assumed lack of awareness. The thesis explores how people manage 
stigma and subsequently envisage their futures with Alzheimer’s disease, given that 
many of the stigma-driven assumptions suggest limited, negative futures.   
Across experiences, possible age-based similarities and differences are explored. The 
majority of previous research into experiences of Alzheimer’s disease considers people 
with early and late-onset Alzheimer’s disease separately. Although such separation 
provides important understandings of how the condition may impact people at different 
stages of their life course, it does not always give room for shared experiences to 
emerge or differences to be seen within the same study.  
The discussion throughout the thesis recognises the physicality of the condition whilst 
reflecting how a wide range of psychological and societal factors impact on overall 
experiences. The following chapter provides the background and context to this thesis, 
beginning with the collaborative partnership between the Scottish Dementia Clinical 
Research Network and the University of Stirling, which led to this PhD. Following on 
from this is discussion of the importance of learning from people with dementia and 
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listening to their experiences, before outlining how a biopsychosocial perspective 
facilitates such focus.  Throughout the introduction there will be reference to relevant 
statistics which reflect the importance of increasing research and knowledge in the field 
of dementia. It is important to note that these numbers reflect people and that for each 
person a wider web of people may be affected by the condition in various ways. The 
background context for researching experiences of stigma and future outlook is 
introduced, before a more in-depth discussion of the literature available in these areas 
within chapters 2 and 3. The terminology used throughout is outlined and explained. 
This is particularly necessary as the thesis brings together research from biology, 
psychology, and sociology, in order to better understand the experiences of people 
living with Alzheimer’s disease. The different disciplines often use alternative terms 
synonymously, therefore clarification of terms is provided. The core aims of the 
research are outlined, including the research questions formulated to address these aims. 
Finally, an overview of the thesis structure with a summary of the content of each 
chapter is given. 
 
Collaborative PhD  
 
This PhD originates from collaboration between the University of Stirling and the 
Scottish Dementia Clinical Research Network (SDCRN). The Scottish Dementia 
Clinical Research Network (SDCRN) began in 2008, promoting dementia research 
across Scotland (SDCRN, 2010). The aims of the network are supported by Scotland’s 
National Dementia Strategy, with commitment to research opportunities for people with 
dementia following diagnosis (Scottish Government, 2010; 2013). The strategy 
highlights the overlap between interest in diagnosis rates and research by referring to 
research opportunities within the government’s commitment to meet HEAT targets and 
increase rates of diagnosis (Scottish Government, 2013). This overlap may reflect how 
a biomedical focus towards dementia can influence care policy and practice (Innes and 
Manthorpe, 2012).  
The role of the network has evolved with the increasing amount of dementia research 
being undertaken in Scotland, and in 2015 the SDCRN joined with Join Dementia 
Research to form a UK wide register for people interested in research participation 
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(SDCRN, 2015a). Research registers such as this, aim to bridge the gap between people 
affected by dementia and research studies (Avent et al., 2013).  
Part of the PhD collaboration included working as a Clinical Studies Officer within the 
SDCRN for one day a week. This job role enabled regular contact with people with 
dementia and their families, as well as a range of health care professionals. This helped 
to focus the research topics, and keep the needs of those affected by the condition at the 
forefront of the research process. Through working across disciplines, the scope for 
applicability and dissemination of findings increased. Additionally, the complementary 
nature of seemingly separate disciplines such as psychiatry and sociology emerged, and 
shaped the overall thesis and research.  
 
Moving towards a biopsychosocial model of Alzheimer’s disease 
 
Internationally there is an increasing awareness of Alzheimer’s disease and other types 
of dementia (Matthews et al., 2013). Alzheimer’s disease has been identified as a 
neurodegenerative disease, with significant pathological changes which separate the 
condition from the norms of an ageing body (Braak et al., 1996). As such it is often 
considered within a biomedical perspective as an illness that can be diagnosed, and 
potentially treated (Bond, 1992). There is currently no cure for the condition, which 
adds to the motivation to focus efforts on helping people manage their daily lives 
(O’Sullivan et al., 2014).  
According to the figures published in 2014, around 500,000 people in the UK are living 
with Alzheimer’s disease (Alzheimer’s Research UK, 2014). It is the most common 
type of dementia, and is associated with a range of symptoms including memory loss 
and communication difficulties (Alzheimer’s Research UK, 2014). In Scotland, 
statistics estimate around 67,000 people have a diagnosis of dementia (Prince et al., 
2014) with around 50% diagnosed with Alzheimer’s disease (Alzheimer’s Scotland, 
2013). Importantly, these statistics reflect the estimated prevalence of the condition, but 
they do not capture the complexity of experiences each individual within these statistics 
faces. The statistics may inadvertently lead to an ‘us’ and ‘them’ view of Alzheimer’s 
disease. However, as Benbow and Jolley (2012) reiterate, dementia is non-
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discriminatory and is likely to affect many of us over the coming years. Further the 
condition is not experienced in isolation, but can be seen to impact the individual 
(Caddell and Clare, 2011), friends and family (Brodaty and Donkin, 2009), and society 
more widely (Wimo et al., 2013).  
National policy such as Scotland’s Dementia Strategy (Scottish Government, 2010) 
reflects the increasing incidence of Alzheimer’s disease, and the wide range of 
consequences the condition can have for both the individual and society (Pimouguet et 
al., 2015). However, the voices of people affected by the condition remain 
underrepresented in research (McKeown et al., 2010; Batsch and Mittleman, 2012). 
Pervasive negative beliefs are suggested to underlie the dearth of research which 
prioritises dementia, or engages people affected by the condition (Benbow and Jolley, 
2012). Therefore, this research seeks to provide people affected by Alzheimer’s disease 
the opportunity to have their experiences heard.  
The biomedical model considers the person by observing the physical and 
psychological changes associated with the condition (Wade and Halligan, 2004). The 
journey of Alzheimer’s disease is seen to be marked by progressive neurological 
changes from mild to severe, with increasing ‘care’ needs (Cuijpers and van Lente, 
2015). This perspective of Alzheimer’s disease is limited by its lack of consideration for 
how the condition is experienced, taking into account social meanings of health and 
illness (Innes, 2009; Olafsdottir, 2013). Further, the cultural notion of “a pill for every 
ill” (Conrad and Barker, 2010:75) focuses efforts on cures rather than on long term 
needs of people affected by the condition. This may fuel therapeutic nihilism and loss 
of hope (Chaufan et al. 2012). This view is supported by O’Sullivan et al. (2014) who 
argue that there is still too heavy an emphasis on medical science and dementia. They 
propose that this leads to a narrowed vision of the future, which does not recognise or 
facilitate ways of living positively.  
The evolution of the biomedical model to incorporate psychosocial components was 
proposed by Engel (1977). The rationale for this progression was to better link medicine 
and science, moving away from linear causality (Smith, 2002). The biopsychosocial 
model looks at the philosophy of illness from a molecular to a societal level, whilst 
practically exploring people’s experiences of illness (Borrell-Carrio et al., 2004). The 
model is based on a General Systems Theory (Engel, 1980) which theoretically 
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suggests the levels of biological, psychological and social processes should not be given 
functional priority and are all integral to the experience of health and illness (Alvarez et 
al., 2012). Since its conception, the biopsychosocial perspective has been widely 
accepted within health psychology and medical science (Hatala, 2012). However, there 
remain concerns that the model cannot be applied easily to practice, and consequently 
Alvarez et al., (2012) suggest that it should be used as a perspective rather than as an 
empirical theory.  
The holistic perspective of the biopsychosocial model allows for a journey of 
Alzheimer’s disease which is continually being modified and adjusted, rather than 
viewed as a fixed linear process.  The biopsychosocial model has been discussed by 
several researchers in relation to experiences of dementia (Boustani et al., 2007; Clare 
et al., 2011; Downs et al., 2008; Spector and Orrell, 2010). In particular, the framework 
is discussed as being an important move forward in our understanding of dementia; 
since a consistent relationship between biological markers of Alzheimer’s disease and 
the symptoms experienced is yet to be established (Downs et al., 2008), so a 
biopsychosocial perspective is helpful since it incorporates psychological and social 
aspects of the condition that affect how it is experienced. 
It is important to recognise that moving towards a biopsychosocial model should not 
discount the benefits of the biomedical perspective (Innes and Manthorpe, 2012).For 
instance, considering ways of alleviating symptoms of the condition, and possible 
factors which may exacerbate or contribute to the physiological experiences. Rather, it 
looks to consider how psychosocial factors can shape people’s experiences. Given the 
increasing prevalence of people developing and living with Alzheimer’s disease (Hebert 
et al., 2003), there is an ever present pressure to understand how best to support people 
in managing their experiences. Specifically, this research focuses on stigma and future 
outlook.   
 
Background context: Stigma and Future Outlook 
 
Coinciding with the increasing incidence and awareness of Alzheimer’s disease is a 
drive towards early diagnosis within UK policy and practice (Department of Health, 
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2013). This is encouraged in allowing people to plan for their future (Luengo-
Fernandez et al., 2010). Due to the advances in biomedical research, there are a growing 
number of techniques in place which aim to support diagnosis (Dubois et al., 2014; 
Nordberg, 2015; Viola et al., 2015). However, this perspective favours a biomedical 
approach, with a deterministic linear progression from diagnosis to end of life based on 
worsening symptoms (Bond and Corner, 2001). This thesis aligns with an alternative 
stance, depicting a non-linear journey of illness experiences based on the influence of 
psychosocial factors (Engel, 1977). The conceptualisation of Alzheimer’s disease as a 
‘journey’ is being increasingly used within research literature such as Chrisp et al. 
(2012), and policy such as Scotland’s Dementia Strategy (Scottish Government, 2013), 
suggesting a positive move forward towards engaging in the complex nature of 
experiences.  
Given the increased drive towards early diagnosis of Alzheimer’s disease, it is 
important to recognise the associated strengths and limitations (Alzheimer’s 
Association, 2011), as discussed in the following section. Importantly, diagnosis of 
Alzheimer’s disease exposes people to negative attitudes and beliefs (Garand et al., 
2009). This is known as stigma (Goffman, 1963) and relates to both the diagnostic label 
and assumptions about how a person will be affected by the condition (Aminzadeh et 
al., 2007; Langdon et al., 2007). Such exposure can lead to a variety of negative 
consequences for people with the condition and those close to them (Garand et al., 
2009). These will be discussed in greater depth within chapter 2.  
One of the driving forces behind encouraging early diagnosis for people affected by the 
condition is in providing the opportunity to plan for the future (Bamford et al., 2004). 
However, there has been limited research which considers whether this is happening in 
practice. Undeniably people with Alzheimer’s disease are likely to experience decline 
over time, where additional support is needed (O’Sullivan et al., 2014). However, the 
‘end point’ focus has led to less emphasis on facilitating people to live with the 
condition (O’Sullivan et al., 2014). Therefore, although this thesis is contextualised by 
early diagnosis and the biomedical focus on care, it does not aim to focus on the debates 
surrounding whether to diagnose the condition (Brunet et al., 2012; Pimouguet et al., 
2015), or the use of advance care planning (Robinson et al., 2012). Rather, it focuses on 
how people plan for a future with a stigmatised condition. 
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Explanation of terminology 
 
Throughout the thesis, a range of specific terminology will be used. The following 
section clarifies the use of these terms. The term ‘person with Alzheimer’s disease’ has 
been used throughout this thesis to refer to people with the condition. This is a 
deliberate move away from biomedical literature which uses ‘patient’ more frequently, 
similarly ‘condition’ is used over ‘illness’ where appropriate. Further, previous 
literature highlights how the terms ‘Alzheimer’s disease’ and ‘dementia’ are often used 
synonymously (Langdon et al., 2007). For example, ‘people with Alzheimer’s disease’ 
has been used to describe study participants when further detail highlights that the 
participant group included people with different diagnoses such as, mild cognitive 
impairment (Beard and Fox, 2008), or mixed dementia (Burgener and Berger, 2008). 
Different types of dementia are associated with different symptoms (Knopman et al., 
2003; Gure et al., 2010; Chiu et al., 2006). This could impact on experiences of stigma 
and consequently future outlook (O’Sullivan et al., 2014).  Within this thesis only 
people with Alzheimer’s disease have been included. Further, ‘people with dementia’ is 
only  used when referring to people with different types of dementia together, or when 
the type of dementia has not been noted in the research being discussed. 
As well as moving away from terms such as ‘patient’, it is important to consider how 
those who help support people with Alzheimer’s disease conceptualise their role. 
Common terms used throughout dementia research and health and illness literature 
include ‘carer’ or ‘caregiver’ (Molyneaux et al., 2011). However, interviews conducted 
by O’Connor (2007) highlighted that people did not see themselves as a ‘carer’, with 
additional literature suggesting that the dislike for the term was widespread and that it 
should therefore be avoided (Molyneaux et al., 2011). This thesis uses the term 
‘supporter’ as an alternative. This term has been suggested as more reflective of their 
role in the person with Alzheimer’s disease’s life (Carers and Confidentiality, 2013). 
Further, it reinforces the move away from the focus on ‘care’, which is often focused on 
in ‘living with dementia’ literature (O’Sullivan et al., 2014), and is potentially 
associated with dependency (Guberman et al., 2003). Many supporters may see their 
role as an extension of their previous relationship (O’Connor, 2007). However, it is 
important to recognise that taking on such a role can have a range of positive and 
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negative effects (Shim et al., 2012). Therefore, supporters’ experiences will be 
considered separately as well as together with the person they support.  
Alzheimer’s disease affects both older and younger people (Alzheimer’s Research UK, 
2014). Throughout this thesis, early-onset Alzheimer’s disease refers to people who are 
diagnosed before 65 years old, and late-onset refers to people diagnosed after 65 years 
old. The age range is arbitrary (Woods and Clare, 2015), but mirrors the age categories 
used within clinical settings (Koedam et al., 2010). Previous research tends either to 
separate people with Alzheimer’s disease into the two age categories in different 
research studies, or to include both age categories within the same study without 
recognition that age may be influential. For instance, research such as Caddell and 
Clare (2013) and Keady et al. (2009) included participants with early and late-onset 
dementia without discussion over whether age influenced experiences. Different 
experiences have been reported between the two age groups (Tolhurst et al., 2014). 
Therefore, this research sought to consider the experiences of people with early and 
late-onset Alzheimer’s disease in the same study, whilst considering whether age is a 
causal factor in the study outcomes.  
Finally, literature related to terminal illnesses has been included within the thesis. The 
literature has been used to consider how people manage conditions which limit their 
sense of time left in life. Alzheimer’s disease is defined as a terminal illness, although 
this characterisation is still fairly under-recognised (Davies et al., 2014; Thune-Boyle et 
al., 2010). Literature which considers the most appropriate terminology in this area is 
limited, and various terms have been used (Nicholl, 2007). A commonly used term 
within this literature is ‘life limiting’ conditions.  However, this may suggest that 
people are no longer as capable or able to continue ‘normally’. For the purpose of this 
thesis, ‘time-limiting’ condition has been used as an appropriate alternative when 
needed. This has been chosen due to the main theoretical framework considering 
perceptions of time (Lockenhoff and Carstensen, 2004). Additionally, the focus on time 
sought to move away from unintended associations with capabilities and quality of life 
associated with the term ‘life limiting’ (Entwistle and Watt, 2013).  
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Research Aims  
 
The aim of this research is to explore people’s experiences of living with Alzheimer’s 
disease, focusing on perceptions of stigma and future outlook, and whether age may 
influence these experiences. The design and study protocol sought to be as inclusive as 
possible, and encourage the indirect benefits of being involved in non-therapeutic 
research (Higgins, 2013).  Based on an extensive review of the literature, novel areas of 
research were highlighted and developed into research questions which formed the 
basis of this study. The application of the findings to current policy and practice 
emphasise how stigma and looking to the future are worth considering together. This is 
shown by the current drive for diagnosis of Alzheimer’s disease to enable people to 
plan for the future, despite the subsequent exposure to stigma. The thesis explored four 
key research questions which sought to add to what is already known in the literature, 
and provide new insights for future research.  
 
1. Do people with Alzheimer’s disease and their supporters experience stigma? 
2. How do people with Alzheimer’s disease and their supporters view and plan for 
the future? 
3. Is there an association between levels of perceived stigma and how a person 
views and plans for the future: for both people with Alzheimer’s disease and their 
supporters? 
4. Are there differences in experiences, in terms of both stigma and future outlook, 
for people experiencing early-onset Alzheimer’s disease and late-onset Alzheimer’s 
disease? 
 
Thesis Overview 
 
This thesis initially reviews the background research literature which has influenced 
this study. The background context is provided across two literature review chapters, 
which identify areas of research to be explored in the subsequent study. This is 
followed by chapters 4 and 5 on research methodology, including reflections on method 
in practice. The heart of the thesis is in the research findings, which are presented 
across three chapters (6, 7, and 8) reflecting three of the four research questions. The 
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fourth research question has been addressed throughout the three chapters, considering 
age as a variable across the findings. Finally, in chapter 9 the research findings are 
brought together with the previous literature to consider how the research contributes to 
current understanding and directions for the future.  
Chapter 1: Introduction 
The introduction chapter presents the background context for the PhD, and for 
researching the subjective experiences of people affected by Alzheimer’s disease. 
Relevant statistics and policy are drawn upon to highlight the importance of adding to 
this field. The terminology to be used throughout the thesis is explained and justified, 
particularly in cases where multiple terms could be used synonymously. Finally, the 
aims of the thesis are presented before the structural overview.  
Chapter 2: Developing Alzheimer’s disease: Exposure to stigma 
This chapter is the first of two literature review chapters. The methods behind the 
review are outlined, including specific search strategies used to collect literature for 
synthesis. The chapter moves on to focus on how the diagnosis of Alzheimer’s disease 
may expose people to stigma. The process of stigmatisation is discussed, before 
highlighting the consequences of this for how people experience their condition and 
their prospective futures.  
Chapter 3: Living with Alzheimer’s disease: Managing stigma and future outlook 
The second literature review chapter focuses on how people affected by Alzheimer’s 
disease manage the negative consequences associated with stigma. Namely, how people 
remain positive in the face of adversity, and manage their futures following diagnosis. 
Socioemotional selectivity theory (Carstensen, 1991) is discussed as the overarching 
theoretical framework for this thesis. Further, a range of biopsychosocial literature has 
been synthesised to consider future outlook and how it may be influenced when facing 
conditions such as Alzheimer’s disease.  
Chapter 4: Methodology 
The methodology chapter considers the epistemological positioning of this research. It 
focuses on how a mixed method design, made up of questionnaires and semi-structured 
interviews, is most suitable for answering the proposed research questions. This is 
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followed by considering the use of research registers, and sampling of participants. The 
inclusion and exclusion criteria are outlined, and discussed with reference to possible 
ethical and practical concerns. Finally, reflections on the sampling and recruitment 
process are provided.  
Chapter 5: Methods 
The methods chapter expands on the discussions of chapter 4, discussing how the study 
design was utilised. The specific research measures are explained, with reference to 
appropriate literature. Further, a detailed protocol is provided, which seeks to make the 
research process transparent. Reflections on data collection are discussed, before 
outlining the data analysis process.  
Chapter 6: Do people with Alzheimer’s disease and their supporters experience 
stigma? 
The first of three findings chapters considers the data collected from questionnaires and 
interviews, relating to participants’ experiences of stigma. Reporting of stigma is 
compared between people with Alzheimer’s disease and their supporters, as well as 
across age groups. There was a clear discrepancy between the degree of stigma reported 
in questionnaires and interviews, which has been discussed with reference to 
methodological and theoretical considerations. The findings reflect that people affected 
by Alzheimer’s disease are exposed to stigma from a range of sources. People with 
Alzheimer’s disease reported higher stigma than their supporters, in keeping with 
previous research in this area. Age-based differences emerged for the different types of 
stigma reported, although age itself was not statistically significant.   
Chapter 7: How do people with Alzheimer’s disease and their supporters view and plan 
for the future? 
This chapter focuses on the second research question. The findings emerging from 
thematic analysis of the interview data are discussed across the journey of Alzheimer’s 
disease, from initial adjustment through to considering one’s future with the condition. 
In general people felt unable to look too far ahead, due to the emotional strain this could 
cause. As an alternative, people chose to focus on one day at time and accepted that the 
future was outwith their control. The experiences shared across interviews suggested 
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minimal age-related differences in future outlook and subsequent strategies for 
managing the unpredictable nature of Alzheimer’s disease.    
Chapter 8: Is there an association between levels of perceived stigma and how a person 
views and plans for the future: for both people with Alzheimer’s disease and their 
supporters 
The final findings chapter focuses on the association between stigma and future 
outlook. The findings presented in chapter 6 and 7 are brought together with previous 
literature, to highlight how people affected by early and late-onset Alzheimer’s disease 
manage exposure to stigma and its impact on future outlook. The interviews highlight a 
focus on being ‘the lucky one’ and seeing one’s situation as unique and unpredictable, 
to facilitate separation from the group-stigma attached to ‘people with Alzheimer’s 
disease’ and the corresponding feared futures.  
Chapter 9: Discussion and Conclusions 
The concluding chapter brings together research presented across the thesis, 
summarising the key findings and how they contribute to the wider field of dementia. 
People affected by early and late-onset Alzheimer’s disease report a range of negative 
experiences in relation to stigma. As such, people separate themselves from the group-
identity and the negative responses of others, and focused on remaining positive as 
much as possible. People avoided situations which involved confronting their fears of 
the future, instead focusing on one day at a time. Future directions of research arising 
from the study findings are presented including, exploring ways of helping people to 
manage both exposure to stigma and planning for the future, whilst focusing on daily 
living. Finally, the experiences of people affected by Alzheimer’s disease and how best 
to support the needs highlighted from this research are discussed, namely maintaining 
positive emotional states.  
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Chapters 2: Developing Alzheimer’s disease: Exposure to stigma 
 
The following two chapters present the literature reviews which have informed this 
study, from initial conception through to data analysis and discussion. The first chapter 
focuses on how diagnosis of the condition can expose people to stigma, and the possible 
consequences of this. This is contextualised within a biopsychosocial perspective, 
moving beyond the biomedical model to consider how social constructions of health 
and illness can influence experiences. Literature which demonstrates how Alzheimer’s 
disease is currently understood is synthesised, with theoretical and research-based 
examples. The chapter goes on to acknowledge areas which have informed the 
subsequent research questions. Firstly, that people with Alzheimer’s disease and their 
supporters may be exposed to and perceive stigma. Secondly, age may influence 
experiences of stigma, although the direction of this influence is unclear.  
The second literature review (chapter 3) considers how people manage the 
consequences associated with stigma outlined in chapter 2. Literature related to 
managing stigma and future outlook is explored with a particular focus on 
socioemotional selectivity theory (Carstensen, 1991). This provides an overarching 
framework to understand people’s experiences of early and late-onset Alzheimer’s 
disease. The theories discussed help to inform investigation of responses to stigma and 
looking to the future, by focusing on the preservation of positive emotional states.  
Areas to explore outlined from the literature in chapter 3 include a possible association 
between stigma and future planning, as well as potential age-based similarities in 
managing experiences. The literature review concludes with the research aims and 
questions for this study. 
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Search strategy 
 
The origins of this thesis began with the question “How do people with dementia and 
their carers look to their futures.” With this question as a baseline, mind maps were 
generated which considered the wealth of topic areas which could be explored. 
Dementia was conceptualised as a journey from pre-diagnosis, through to diagnosis, 
learning to live with the condition, and end of life care. The experiences of the person 
with dementia and their supporter were viewed as separate but shared. The complex 
journey was narrowed following synthesis of the literature and presentation of ideas to 
academic audiences, as well as people affected by dementia. The conceptualisation of 
this has been presented in Figure 1. Two core topics central to this thesis are stigma and 
future outlook. Possible age-based similarities and differences in experiences relating to 
these topics were also explored. 
 
Figure 1. Visual conceptualisation of the journey of dementia for both the person 
with the condition and their supporter. 
 
The following literature review chapters have synthesised the literature in relation to the 
aforementioned topic areas. These topics individually are broad and complex; therefore 
it was important to narrow down the literature for review. A narrative review was 
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chosen over a systematic review in keeping with the exploratory nature of the research 
and the need for broader literature (Bryman, 2012).The primary purpose of the literature 
review is to provide a comprehensive background on the topics this thesis aims to 
explore, identifying gaps in knowledge and determining research questions (Cronin et 
al., 2008). Although the search prioritised peer-reviewed journal articles, a range of 
sources has been accessed due to the overall need to gain a thorough overview of the 
topic. One of the main limitations of a narrative review, in comparison to a systematic 
review, is the reduced clarity of process (Cronin et al., 2008) and increased possibility 
of researcher bias (Cipriani and Geddes, 2003). The following sections seek to 
demonstrate clarity of process. The majority of literature fits within the psychological 
discipline, with biological and sociological literature being introduced to complement 
the main discussion, and reflect the biopsychosocial perspective introduced in the 
previous chapter.    
The literature search used a variety of databases, as well as snowball strategies, where 
literature cited in a relevant article was sourced and read. The combination of ‘protocol 
defined’ searches and ‘snowballing techniques’ can be a more effective method of 
searching than relying on search terms alone (Greenhalgh and Peacock, 2005). This 
process allowed for a wide range of literature to be sought, as well as permitting 
literature which might not have fitted with the original search terms. For example, 
‘future planning and dementia’ searches often produced more policy and economic-
focused literature, rather than psychosocial experiences. Whereas, citations obtained 
from papers which were relevant revealed more appropriate search terms for this topic 
including, ‘imagined futures’. This increased the scope of applicable literature in this 
area.  
As the field of dementia research spans many different disciplines, it was important to 
be aware that different terms are often used when referring to the same underlying idea. 
For instance, ‘mental time travel’ is more reflective of neurobiological literature for 
future outlook, with ‘imagined futures’ used more in psychosocial contexts. In addition, 
using a combination of search techniques is particularly useful when the amount of 
literature relating to the topic is small (Horsley et al., 2011). Where the gaps in the 
literature were broad, literature from similar fields was introduced as a source of 
comparison. For example, literature on social constructions of health or illness, and 
experiences of mental health and ‘life-limiting’ conditions was included.  
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Initial literature searches were carried out between October 2012 and June 2013, during 
the development of the research topic and possible research questions. Further literature 
searches were undertaken the following year in July 2014 alongside the data collection. 
These reviews sought to update the previous review with a more specific focus on 
future outlook emerging from the study visits and interviews. A third round of literature 
searches took place between January and April 2015, bringing together the literature 
reviews previously written with up to date literature relevant to the emerging thesis 
findings to develop the final literature review chapters. Overall, literature searches were 
carried out throughout the development of the study from considering research 
questions, through to understanding the data produced from the research and 
considering the application of findings to policy and practice. Searches ranged from 
general to more specific terms. Table 1 on page 26 provides primary and secondary 
search terms used during the literature searches and subsequent review process. 
A variety of search engines were used including: Google Scholar, Stirgate (University 
of Stirling resource platform including: Cochrane Database of Systematic Reviews, 
PsychiatryOnline, ScienceDirect, and Social Sciences Citation Index), Dementia 
Catalogue (Alzheimer’s Society library database), and PsychInfo. A range of literature 
was included for review, such as research-led articles, discussion papers, literature 
reviews, and reflective pieces relating to working with people with dementia. The 
relevance of papers to ageing, stigma, and future outlook was assessed by the researcher 
through critical reading (Saunders and Rojon, 2011) of the broader literature on 
experiences of dementia, social constructions of health and illness, and attitudes 
towards mental health. Bryman (2012) suggests there is always an element of judging 
research based on what the researcher finds relevant and interesting. In addition, policy 
literature such as the national dementia strategies was included to provide additional 
context to people’s circumstances. 
Abstracts were read with articles that contained information relevant to ageing, stigma, 
and future outlook being read in more detail. Although the study was focusing on 
Alzheimer’s disease, dementia was included as a search term due to the synonymous 
use of the term in previous literature (Langdon et al., 2007). Further, articles which 
related to one of the three topics, but looking at a different type of dementia, were 
considered in more detail as a source of comparison.  The primary focus of this thesis is 
how the individual experiences stigma and future outlook. Alternative perspectives 
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have been noted for their relevance, but not focused on in detail. For instance, there is 
general consensus that people with dementia are affected by stigma (Batsch and 
Mittleman, 2012). Therefore, the thesis is not looking to establish whether it is a 
stigmatised condition, but whether the stigma is perceived by those affected by 
Alzheimer’s disease. Similarly, research that explores healthcare professionals’ 
attitudes towards stigma and public attitudes was noted in terms of contextualising 
attitudes, but was not the main research focus as by its nature this type of research tends 
to miss the voices of people with dementia, and this thesis sought to keep people with 
Alzheimer’s disease at the centre of the work. In addition, research which focused on 
residential settings, and areas such as minority groups, were used in the context of 
reading for background knowledge but not looked at in as much detail due to the nature 
of the participant sample (see chapter 4) and the type of research being carried out. 
Instead, the research aimed to understand the experiences of people living with 
Alzheimer’s disease in the community in Scotland, in terms of stigma and future 
outlook. Therefore, literature which focused on these areas was prioritised. 
Table 1 illustrates some of the search terms used relating to dementia, stigma, future 
outlook, and ageing. Search terms were added across the research process based on 
emerging themes from the data collection and analysis. This was particularly the case 
for papers which relate to ‘future outlook’ as there was limited literature available on 
this topic when starting the study. Similarly, the theories which have been discussed in 
the subsequent review emerged from common themes in the interviews, and through 
exploring the possible reasons behind people’s responses.  
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 Example Search Terms 
Topic Area Primary  Secondary 
Ageing and 
Dementia 
‘Older Adult’ 
‘Young Onset’ 
‘Early Onset’ 
‘Late Onset’  
‘Age associated’ 
Stigma and 
Dementia 
‘Stigma’  
‘Stereotypes’ 
‘Discrimination’ 
‘Attitudes’ 
‘Courtesy Stigma’ 
‘Family Stigma’ 
‘Self-Stigmatisation’ 
Future Outlook 
and Dementia 
‘Future Planning’ 
‘Future Outlook’ 
‘Advance Care Planning’ 
‘End of Life Care’ 
‘Anticipated Future’ 
‘Mental time-travel’ 
‘Future time orientation’ 
Experiences of 
Dementia 
‘Experiences of dementia’ 
 ‘Living with dementia’ 
‘psychosocial factors’ 
Surrounding 
Literature 
‘Stigma and mental illness/health’ 
‘Experiences of mental illness/health 
‘Social constructions of 
health/illness/dementia’ 
Table 1. Examples of search terms used for synthesising literature relating to 
experiences of Alzheimer’s disease 
 
The field of dementia research is growing rapidly, with national policy focused on 
increasing the numbers of people with dementia involved in research (Department of 
Health, 2012). As a result, the literature review sought to present the latest knowledge 
available relating to stigma, future outlook, and ageing, for people affected by 
Alzheimer’s disease. Initial searches were not limited by date, although Alzheimer’s 
disease was not recognised as an illness until the 1970’s (Fox, 1989), which would 
affect the research available prior to this. As literature was synthesised the latest 
research on each topic was sought to look for possible changes over time. Restrictions 
of 10 years, to 5 years were then included, depending on the scope and specificity of the 
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search. Overall, the literature searches produced a wide range of research papers which 
have been synthesised across the following two chapters.  
Finally, as discussed in the previous chapter, this thesis has adopted a biopsychosocial 
perspective. This is not without critiques, with some suggesting that the model does not 
give clear guidelines about the relative emphasis on the biological, psychological, and 
sociological domains, with relevant implications for literature reviewed, and 
methodology chosen (Benning, 2015; Ghaemi, 2009). It should be noted that this is not 
an issue exclusive to the biopsychosocial model. Lilienfield et al. (2015) argue that the 
term biomedical model often faces similar ambiguity. The lack of clear guidelines to the 
integration for the different domains is discussed as being a result of the 
biopsychosocial model being developed as a solution to the biomedical model, rather 
than being based on theoretical understandings (Benning, 2015). Despite the lack of 
clarity between the emphases of each domain, the benefit of this freedom is in allowing 
researchers to focus on their particular areas of interest and expertise. My emphasis 
throughout the literature review has been a greater focus on the psychological literature, 
due to interest in how psychological frameworks explain the individual’s experience of 
stigma (Modified Labelling Theory: Link, 1987) and future outlook (Socioemotional 
Selectivity Theory: Carstensen et al., 1999), contextualised with biological and 
sociological literature where appropriate. 
Developing Alzheimer’s disease: Exposure to stigma 
 
The remainder of this chapter explores the literature currently available around how 
developing Alzheimer’s disease can expose people to stigma. This process begins as 
people start to develop the condition, and recognise that symptoms may be impacting 
on their everyday life. This recognition of symptoms and subsequent help seeking is 
complex. It can be initiated by the person developing the condition, or from the 
awareness of those around them. This review has not focused on why people seek help; 
rather it acknowledges that one of the barriers to help seeking and diagnosis can be fear 
of stigma (Clement et al., 2015; Mackenzie, 2006).  In order to understand how a 
diagnosis of a condition such as Alzheimer’s disease can lead to negative attitudes of 
others, a biopsychosocial perspective has been adopted. This recognises that diagnosing 
conditions such as Alzheimer’s disease is more than acknowledging a set of symptoms. 
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The experience of these symptoms and the way people respond to the condition are 
socially constructed. 
 
Diagnosis of Alzheimer’s disease 
 
Diagnosis rates for dementia have increased over time and have been seen to correlate 
with the introduction of national dementia strategies which promote early diagnosis 
(Mukadam et al., 2014). According to Pratt and Wilkinson (2003) the diagnosis process 
is one of the most fundamental components in people’s experience of dementia. It can 
be seen as the point in which someone adopts the identity of ‘person with Alzheimer’s 
disease’ (Manthorpe et al., 2010) or ‘supporter’ (Ducharme et al., 2011). Literature 
which considers people’s experiences of diagnosis will be synthesised before focusing 
on the two core topics this thesis explores: perceptions of stigma and future outlook.  
Although much of the discussion will focus on people’s journey following a diagnosis, 
it is important to note how people experience their diagnosis and the potential 
consequences this may have on learning to live with Alzheimer’s disease. This is 
particularly important when applying findings back to policy and practice, as much of 
the discussion surrounding stigma and future outlook is embedded within ‘positives and 
negatives of early diagnosis’ debates (Fox et al., 2013). 
A range of emotions and experiences have been reported in the diagnosis of 
Alzheimer’s disease literature, although the area is still discussed as under-researched 
given the importance of understanding people’s experiences (Lee et al., 2014). A 
systematic review by Bamford et al. (2004) summarises commonly cited reasons for 
and against diagnosis including: facilitating planning and maximising opportunities for 
intervention, as well as risk of distress and stigma. 
Stigma is a commonly cited reason for avoiding diagnosis and taking on the identity of 
a ‘person with Alzheimer’s disease’ (Bunn et al., 2012), therefore suggesting caution 
regarding the drive for early diagnosis. Conversely, a proposed strength of diagnosis is 
the opportunity to plan for the future (Derksen et al., 2006). As noted previously the 
thesis does not aim to look at these two aspects distinctly, but to consider how they 
influence each other. For instance, much of current ‘future planning’ research focuses 
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on ‘care needs’, or considers the end points of the journey of Alzheimer’s disease, 
without the much needed recognition of the on-going journey following diagnosis.  
Diagnosis may be where people take on the label of ‘Alzheimer’s disease’ (Manthorpe 
et al., 2010). However, their journey with the condition begins prior to this (Chrisp et 
al., 2012). A number of processes can be worked through by the person with dementia 
and their supporter, separately and together, before seeking a diagnosis (Keady and 
Nolan, 2003). Examples include, people covering up for minor ‘slips’ in memory, and 
normalising experiences until a point where the frequency and amount of change 
becomes harder to trivialise. The hurdles people experience prior to diagnosis highlight 
how pre-diagnosis can be associated with fear of being diagnosed with a condition like 
Alzheimer’s disease (de Vugt and Verhey, 2013).  
Reactions to diagnosis can understandably be negative with experiences of shock, grief, 
distress, and denial reported in the literature (Bamford et al., 2004). Research which 
explores these experiences over time has suggested that these feelings can fluctuate and 
reduce (Vernooij-Dassen et al., 2006) as people adapt to both the label of the condition 
(Beard and Fox, 2008) and living with the symptoms (MacRae, 2008). Further, 
although a diagnosis can reduce uncertainty relating to symptoms experienced, the 
future is viewed as unpredictable and can be a threatening prospect for the person with 
Alzheimer’s disease and for their families (de Vugt and Verhey, 2013). The 
perspectives discussed are influenced by both biomedical understandings and societal 
assumptions about the condition, and may reproduce the stigma surrounding the 
condition by focusing on care needs. 
A review of diagnostic-disclosure literature highlights that despite the negative 
experiences, the majority of people wish to know their diagnosis (Robinson et al., 
2011). The preference for diagnosis can be contextualised by the work of Keady et al. 
(2009), who discuss how seeking and receiving a diagnosis can enable people to find 
‘balance’. As such, they are able to move forward with the journey of Alzheimer’s 
disease, striving to keep balance as part of a dynamic process of decision making 
(Keady et al., 2009).  
In light of this, understanding more about how people live with their condition post-
diagnosis may help to influence the type of support provided to people with 
Alzheimer’s disease. In particular, how people manage the potential exposure to stigma 
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following diagnosis of Alzheimer’s, and whether this influences future outlook and 
their engagement with future planning. The following chapter will focus on exposure to 
stigma, before considering the consequences of stigma and how people learn to manage 
their experiences. The following section synthesises literature relating to the process of 
stigmatisation, to illustrate how Alzheimer’s disease and stigma have been connected.  
 
Process of stigmatisation 
 
There is general agreement relating to the meaning of stigma, however there are various 
definitions depending on the perspective being taken (Benbow and Jolley, 2012). For 
the purpose of this thesis, the definition given by Goffman (1963) has been used as a 
starting point. He defines stigma as “an attribute that is deeply discrediting” (p.13). This 
is based on prevailing social norms (Olafsdottir, 2013). A distinction is made between 
“discredited and discreditable” attributes (Goffman, 1963:14), which refers to whether 
the mark by which the person is stigmatised is immediately obvious to those around 
them (discredited), or is concealable or not recognised as quickly (discreditable). This 
level of visibility is suggested to impact on how intrusive a condition is on a person’s 
everyday life, and their ability to manage (Kelly and Field, 1996). For example, Kelly 
and Field (1996) suggest that people with discredited attributes will experience greater 
challenges to their social identity, than people with discreditable attributes. The 
literature remains unclear regarding how people who experience symptoms which 
fluctuate in their level of intrusiveness manage their everyday lives. Specifically, the 
discredited/discreditable distinction does not consider experiences of stigma for people 
with Alzheimer’s disease, where symptoms can be unpredictable in terms of their 
visibility (Phillips et al., 2012; Hellstrom and Torres, 2013).  
The different elements of stigma and lack of agreement on an operational definition, 
make it a challenging concept to understand and research (Benbow and Jolley, 2012), 
despite general agreement towards its meaning. There are various models which seek to 
explain the complex process of stigmatization, particularly in the field of mental health 
(Olafsdottir, 2013). For example, Modified Label Theory (Link, 1987) was proposed to 
address the increasing need to acknowledge both the physiology of mental illness, and 
the social construction of labelling. The theory focuses on the behaviour of others in 
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labelling mental illness, whilst also acknowledging that stigma is made up of an 
individual’s perception of others stigmatising them (Link and Phelan, 2012). The 
consequences are discussed based on how able a person is to continue ‘normally’ in 
society (Link and Phelan, 2012). The inherent involvement of people in the 
environment giving negative responses, as well as how the individual perceives and 
manages this, moves away from earlier models of stigma, which viewed labelling as a 
direct result of mental illness (Link and Phelan, 2012).  
When considering differences in people’s experiences of stigma, three different types of 
stigma are noted by Earnshaw and Chaudoir (2009): anticipated, enacted, and 
internalised. These will be discussed in more detail to highlight the different aspects of 
stigma, and how they may differentially influence future outlook. Within these three 
types, a distinction between prejudice and discrimination is noted. Prejudice refers to a 
group or its members being evaluated negatively, without considering who they are as 
individuals (Taylor et al., 2006). Discrimination is the behavioural consequence of 
prejudice, where the person or group is then treated adversely (Benbow and Jolley, 
2012).  Anticipated stigma defines people’s expectations of experiencing prejudice and 
discrimination. This may be particularly prevalent within the earlier stages of people’s 
journey with Alzheimer’s disease. Recognition of symptoms and deciding whether to 
act on this is tied in with fears about what the diagnosis may mean, and the anticipated 
stigma attached (Vernooij-Dassen et al., 2005; Aminzadeh et al., 2007; Garand et al., 
2009). Further, the presence of anticipated stigma highlights how future outlook is also 
relevant prior to diagnosis.  
Enacted stigma refers to whether people believe others have been prejudiced and 
discriminatory towards them (Earnshaw and Chaudoir, 2009). This may be more 
relevant following diagnosis, where people are learning to live with Alzheimer’s 
disease, and managing how people may react. Thirdly, internalised stigma focuses on 
whether a person endorses the negative feelings and beliefs associated with the 
stigmatised attribute towards themselves (Earnshaw and Chaudoir, 2009). This is also 
referred to as self-stigmatisation (Byrne, 2000). Importantly, the internalisation of 
stigma-driven assumptions such as ‘no future’ following diagnosis (Devlin et al., 2007) 
could influence a person’s future outlook.   
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For people with Alzheimer’s disease, internalised stigma includes a person’s previous 
understanding of the condition as well as awareness of the changes they have 
experienced. For example, O’Sullivan et al. (2014) noted how participants who 
previously held prejudiced beliefs about people with dementia, had since found it 
harder to disclose their own diagnosis. Importantly, one of the myths of dementia is that 
people with the condition do not have awareness of their situation (Mendez and 
Cumming, 2003; Baste and Ghate, 2015). However, there is increasing literature 
highlighting that this is not the case, and that ‘awareness’ fluctuates along a continuum 
influenced by biopsychosocial factors (Clare et al., 2012). Despite this increasing 
knowledge of ‘awareness’, there remains a disproportionately small amount of literature 
which considers stigma from the perspective of those affected, with the majority of 
research focusing on how others view people with Alzheimer’s disease (Burgener and 
Berger, 2008).  
The approaches described thus far encompass a socio-cognitive approach to stigma 
(Corrigan, 2000). Alternative approaches which could be applied to people’s 
experiences of Alzheimer’s disease include sociocultural frameworks, where stigma 
develops through social injustice (Corrigan, 2000). Sociocultural models provide 
greater detail about the social and environmental elements of stigma than is possible 
when a socio-cognitive approach is taken, and offer an approach for understanding 
additional coping strategies to cognitive reactions (Yang et al., 2007).  The work 
previously outlined by Link and Phelan (2001) has made important contributions in the 
shift towards sociocultural aspects of stigma by including a structural component to 
their model of stigma, whilst still maintaining an individual focus (Kleinmen and Hall-
Clifford, 2009). Although a sociocultural approach provides useful insights for policy 
and practice, particularly in challenging public attitudes, Corrigan (2000) notes that 
socio-cognitive approaches are a promising alternative framework within psychology 
and mental health, and are particularly appropriate for exploring the individual’s 
perceptions of stigma, as focused on within this thesis.  
 
The majority of the research discussed so far has focused on either public understanding 
of Alzheimer’s disease, or the person with the condition. However, it is important to 
recognise that close family and friends can also be exposed to stigma relating to their 
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association with Alzheimer’s disease. Goffman (1963) termed the spreading of stigma 
from the stigmatised individual to their close connections as ‘courtesy stigma’. 
Alternative terminology, such as ‘family stigma’ has also been used (Larson and 
Corrigan, 2008). Supporters have been documented as experiencing stigma based on 
their association with the person with dementia (Phelan, 2005), as well as stigma 
attached to their role (Werner et al., 2010). The extent of this stigma is unclear; Werner 
and Heinik (2008) reported that courtesy stigma has been largely unexplored in relation 
to supporters of people with Alzheimer’s disease. There is some research which 
suggests courtesy stigma may be explained through assumptions about the origins of the 
stigmatised attribute. For example, Phelan (2005) found that people were more likely to 
stigmatise the sibling of a person with a stigmatised condition, if they believed it was 
genetic in origin. Similarly, Burgener and Berger (2008) discussed how the perceived 
genetic causes of dementia led to greater stigmatisation of people with dementia. 
Notably, this may suggest differences in stigma applying to people with early and late-
onset Alzheimer’s disease, as early-onset Alzheimer’s disease is hypothesised by some 
to have a greater genetic influence than late-onset (Alzheimer’s Association, 2004). 
This discussion reiterates that Alzheimer’s disease is not experienced in isolation, with 
stigma felt by the person with the condition and those close to them. It is important to 
consider how people’s experiences interact, as the reactions of close family and friends 
to the diagnosis of Alzheimer’s disease are seen to be much more important to people 
living with the condition, than the reaction of others (Benbow and Jolley, 2012). 
Therefore, when researching stigma it is important to explore both the person with 
Alzheimer’s disease and their supporters’ perspective of stigma. 
The research literature presented considers people with Alzheimer’s disease and their 
supporters as a fairly homogenous group. However, as Link and Phelan (2012) 
highlight, people’s perception of stigma is made up of both individual and societal 
attitudes. The literature discussed highlights that the process of stigmatisation involves 
both the individual with the stigmatising attribute, and people within their social 
environment responding to this (Link and Phelan, 2012). This suggests that how people 
manage their experiences can shape their perceptions of stigma and vice versa. When 
exploring how people with Alzheimer’s disease perceive stigma, the underlying 
assumption is that they are identifying themselves as somebody affected by the 
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condition. However, taking on such an identity involves exposure to the stigma attached 
to the group as discussed within the following section.  
Research grounded in social psychology suggests that when diagnosed with a 
stigmatising attribute, people may separate themselves from the stigma through seeing 
others with the condition as worse off than themselves. This phenomenon is known as 
personal/group discrimination discrepancy (Taylor et al., 1990). By individuals framing 
their situation as better than others, they may also be able to disassociate themselves 
from the group norm, thereby protecting themselves from the negative consequences of 
stigma, which will be discussed in more detail later in the chapter.   
Personal/group discrimination discrepancy (Taylor et al., 1990) was developed to 
explain the emergent finding that people perceived a higher level of discrimination 
towards their group (such as people with Alzheimer’s disease) compared to themselves 
as an individual within the group (Taylor et al. 1990). Early research by Taylor et al. 
(1990) suggests several reasons for personal/group discrimination discrepancy, 
including attempting to minimise personal discrimination, an exaggeration of the 
amount of stigma directed at the overall group, and cognitive information-processing 
mechanisms. These findings are important to recognise when exploring how people 
with Alzheimer’s disease and their supporters experience stigma. The theory suggests 
that if Alzheimer’s disease is viewed as a stigmatised condition, individuals will report 
personal stigma as lower, than if they are discussing experiences of other people in the 
same group. Therefore, when measuring or exploring stigma, it is important to note that 
the nature of reporting may be influenced by how much people engage with the group 
identity. The following section will draw attention to some of the stigma attached to the 
group, to illustrate why people may find it beneficial to separate themselves from the 
group identity.  
 
Components of stigma and Alzheimer’s disease 
 
A range of stigma in the form of negative attitudes and inaccurate beliefs has been 
reported in the literature towards people affected by Alzheimer’s disease. Mendez and 
Cummings (2003) describe several myths including, Alzheimer’s disease is 
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synonymous with dementia; dementia is an inevitable part of ageing; and that people 
with dementia cannot have insight into their condition. These myths have been seen 
within the general public, as well as amongst healthcare professionals (Baste and Ghate, 
2015). Similar attitudes can be seen from public survey data in Ireland with responses 
including, once someone has dementia the person you knew will eventually disappear; 
and that people with dementia are like children and should be cared for as such 
(McParland et al., 2012). Similar examples appeared in focus groups in Scotland, with 
people with dementia viewed as having little awareness and whose ‘life is nil’ (Devlin 
et al., 2007:52). In addition, people noted that the public assumed the condition would 
be obvious or visible (Devlin et al., 2007). The myths highlight that the stigma is not 
just attached to the diagnostic label, but to the assumed experiences people will have 
post-diagnosis. They present an image of dementia as being something that cannot be 
lived with, which potentially leads to the skewed focus on end of life. Further, they fuel 
the catastrophizing discourse of dementia as a ‘living death’ (Sweeting and Gilhooly, 
1997; Peel, 2014). As Behuniak (2011) argues, the stigma attached to Alzheimer’s 
disease is dehumanising and based on fear, describing how the socially constructed 
image of the condition has alarming parallels to that of zombies (Behuniak, 2011). The 
stigma-driven assumptions therefore do not recognise the continuing futures of people 
living with Alzheimer’s disease which this thesis will explore.  
As noted within the introduction, the thesis explores people’s experiences of 
Alzheimer’s disease over other types of dementia. As well as the challenge of 
synonymous use of the terms ‘Alzheimer’s disease’ and ‘dementia’, there is debate 
among researchers as to whether the terms used influenced the extent of stigma. For 
example, Aminzadeh et al. (2007) found that people expressed greater distress about a 
diagnosis of Alzheimer’s disease, compared to vascular dementia. This is despite a 
similar illness trajectory (Kalaria and Ballard, 1999). Similarly, Robinson et al. (2011) 
suggests that ‘Alzheimer’s disease’ holds more negative connotations than ‘dementia’, 
which may in turn affect adjustment to diagnosis. Conversely, Langdon et al. (2007) 
found that both ‘Alzheimer’s disease’ and ‘dementia’ produced negative reactions, but 
particularly ‘dementia’ in its association to the word ‘demented’. This association is 
mirrored by Gilmour and Brannelly (2010) who used examples from fictional literature 
to reflect the underlying meaning, such as the ‘Dementors’ from J.K.Rowling’s Harry 
Potter novels. These are negative, soulless characters, which make a person ‘demented’. 
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This is described as ‘a fate worse than death’; a description also discussed in dementia 
literature (Innes, 2002). The literature presented does not lead to clear conclusions 
related to which terms will be viewed more negatively, adding to the complexity of 
exploring stigma and Alzheimer’s disease. 
Understanding the stigma attached to the label of dementia or Alzheimer’s disease 
poses a challenge for health care professionals, among others. For instance, Moore and 
Cahill (2013) found that general practitioners (GPs) were avoidant of these terms, 
preferring to use ‘memory problems’. Part of this avoidance was explained as concern 
over scaring the person with the condition, reflecting fear. However, although 
avoidance of the word dementia may be them trying to protect people, arguably it 
continues to fuel the stigma (Milne, 2010). Further, the use of ‘memory problems’ as a 
synonym for Alzheimer’s disease may add to the confusion around what to expect, and 
how it differs from the ‘norm’. This may be particularly true for older people, given the 
uncertainty between what constitutes age-related memory loss or dementia (Leung et 
al., 2011). Additionally, previous research indicated that reducing dementia to memory 
problems can make it harder for people to manage. For example, Ikels (1998) found 
evidence of supporters blaming the person with dementia for behaviours that they had 
not understood were symptoms of the condition. Similarly, Stokes et al. (2014) reported 
that supporters found it harder to adjust to the full impact of dementia when symptoms 
other than memory loss were present. This was explained through being inconsistent 
with previous expectations about dementia equating to memory loss.  
 
Alternatively, there may be people with Alzheimer’s disease who benefit from using the 
term ‘memory problems’ when defining their condition. Garand et al. (2009) discuss 
how people may adjust better to their diagnosis if they see it as ‘an expected part of 
ageing’, thereby not differing from the norm. As such, age-based differences may be 
expected for people with Alzheimer’s disease based on whether memory loss is 
normalised. Disentangling understandings relating to ‘normal ageing’ and Alzheimer’s 
disease has significant implications for older people with and without the condition, as 
well as younger people with Alzheimer’s disease. Therefore, ageing, stigma, and 
Alzheimer’s disease will be discussed in the following section. 
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Age-associated influences on stigma and Alzheimer’s disease 
 
Understanding what is perceived to be ‘normal’ influences whether people are likely to 
seek help or advice (Feldman et al., 2015; Werner et al., 2014; Mukadam et al., 2013). 
Neuro-degeneration is an expected part of ageing; but this in itself does not result in 
Alzheimer’s disease. In previous research, such as Sonnen et al. (2011), significant 
beta-amyloid build up was seen in 25%-50% of cognitively ‘normal’ brains, despite the 
fact beta-amyloid is associated with Alzheimer’s disease (Stern, 2002). The findings of 
Sonnen et al. (2011) emphasise the separation between age, neuro-degeneration and the 
development of dementia.  Despite the neurological distinctions set out by Sonnen et al. 
(2011), the boundary between physiological ageing and early stages of dementia 
remains unclear (Derouesne, 2002).  
 
The lack of clear boundary is further complicated by the presence of early-onset 
Alzheimer’s disease. There is evidence to suggest younger people may take longer to 
diagnose as the condition is considered less likely (Van Vliet et al., 2013).  However, 
older people may also face time delays based on the lack of clarity in age-related 
memory loss for healthcare providers trying to diagnose symptoms (Derouesne, 2002). 
Further, therapeutic nihilism whereby GPs and healthcare professionals may be more 
reluctant to diagnose an ‘untreatable condition’ may also differ by age group of the 
person seeking diagnosis (Rossor et al., 2010; Pinner and Bouman, 2003; Bradford et 
al., 2009). The complexity of the relationship between disclosure and age has been 
explored by Heal and Husband (2010), who found that age was a significant factor in 
disclosure. Younger people were more likely to be told their diagnosis (Heal and 
Husband, 2010). However, this could be linked to the diagnostician and type of 
dementia over age itself (Van Vliet et al., 2013). These findings suggest a need to 
explore in more depth whether age is a causal factor, or whether the expected 
differences by age are caused by other variables. 
 
The differences in hypothesised age-based experiences discussed are embedded within 
societal attitudes towards ageing.  From a biological perspective, ageing is a progressive 
build-up of changes to the body over time, which increases a person’s probability of 
disease, and death (Vina et al., 2007).  This perspective emphasises the inevitability of 
ageing, based on its universal, intrinsic, progressive, and deleterious nature (Strehler, 
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1977). The biological postulates suggest that ageing should not be a distinguishing 
feature between people, as it is a process that is continuous and happens to everyone 
across the life course. This would suggest that ageing, removed from its social context, 
would not be a cause of stigmatisation. However, focusing on the biological perspective 
alone does not give a comprehensive picture of how people experience their ageing and 
therefore how age may influence stigma.   
 
Based on a synthesis of age-related literature, several possible directions of effects have 
been noted in relation to stigma. People with late-onset Alzheimer’s disease may 
experience greater amounts of stigma than people with early-onset Alzheimer’s disease. 
Alternatively, people with early-onset Alzheimer’s disease may experience greater 
amounts of stigma than people with late-onset Alzheimer’s disease. A final 
consideration is that the age of onset of Alzheimer’s disease will not significantly 
influence the amount of stigma people experience. The literature supporting these three 
possibilities is discussed across the following section.  
 
Firstly, people with late-onset Alzheimer’s disease have been suggested to experience 
greater amounts of stigma due to the ‘double stigma’ of being an older adult and having 
Alzheimer’s disease (Nolan et al., 2006). There is a wealth of research evidence to 
illustrate discrimination of people based on their age, with particularly acute stigma 
attached to older people (Richeson and Shelton, 2006). Thornton (2002) considered the 
myths of ageing, and how they contributed to ageism. Older adults have been 
stereotyped as being frail, ill, and dependent (Thornton, 2002). More recently, Erber 
and Szuchman (2015) revisited the myths of ageing and illustrated how there is minimal 
change over time to those highlighted by Thornton (2002), stressing how ingrained such 
views are in western society. Myths such as older people are poor drivers, and fully 
reliant on others (Erber and Szuchman, 2015) emphasise that older people are seen as 
an inferior group within society, who lose skills and abilities. This discussion is not 
intended to go through these myths and critique them; rather, the focus is how such 
assumptions impact on society and the person, particularly when these stereotypes can 
then accumulate with the stereotypes of Alzheimer’s disease (Jolley and Moniz-Cook, 
2009). As such, Scodellaro and Pin (2013) proposed that people affected by early-onset 
Alzheimer’s disease experience less stigma than people affected by late-onset 
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Alzheimer’s disease, as they do not have the additional stigma of being an older adult 
such as that described by Thornton (2002). 
 
Alternatively, Chaston (2010) argued that people with early-onset Alzheimer’s disease 
may experience more stigma than people with late-onset Alzheimer’s disease. This is 
suggested to result from having a condition which is associated with older adults (Van 
der Flier and Sscheltens, 2005), leading to ‘inverse ageism’ (Chaston, 2010).  This 
hypothesis is supported by theories such as Neugarten (1976), which consider how age-
based norms influence experiences (Ferraro, 2013), and suggests that people will 
experience more adverse reactions to situations which take place ‘off time’ to their age-
expected trajectory (Heckhausen et al., 1989). Therefore, the theory suggests people 
with early-onset Alzheimer’s disease will be more affected by their diagnosis than older 
adults due to the ‘untimely’ nature of the condition.  
Similarly, biographical disruption (Bury, 1982) research may suggest a difference in 
age groups based on experiences contrasting with the common cultural paradigms of 
conditions like Alzheimer’s disease. Bury’s (1982) work with people with rheumatoid 
arthritis highlighted slower diagnosis, increased uncertainty and feelings of premature 
ageing in younger participants. Experiences may resemble those of living with 
Alzheimer’s disease, particularly with the awareness that there is limited medical 
knowledge, and no cure for the condition. However, the literature search did not find 
papers which have explored people with early and late-onset Alzheimer’s disease in 
relation to biographical disruption, although researchers have suggested its applicability 
to experiences of dementia (Tolhurst and Kingston, 2013). A more recent paper by 
Boerner and Wang (2010) provides additional support for the expectation that younger 
people will be more affected by changes in health, by looking at vision loss among 
older and younger adults. The study highlighted that vision loss had more negative 
consequences for younger adults than older adults, and this was explained through the 
‘untimely’ nature of the condition for the younger population (Boerner and Wang, 
2010). It should also be noted that the concept of biographical disruption has been 
criticised for too strong a focus on biographical identity with insufficient attention to 
the biological and physical aspects of living with a chronic illness (Kelly and Field, 
1998; Williams, 2000). 
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Although much of the biographical disruption literature suggests younger people may 
be more affected by onset of a chronic illness than older people (Pound et al., 1998; 
Sanders et al., 2002), conflicting research is also available to suggest older people may 
be more affected by change even if the disruption is expected (Larsson and Jeppsson-
Grassman, 2012). The somewhat conflicting nature of the discussions of age and 
chronic illness within the biographical disruption literature further supports the 
inclusion of both younger and older people within research into conditions such as 
Alzheimer’s disease, as this will allow for more direct age-based comparisons of the 
same condition. A socio-cognitive framework could therefore extend what is known 
about stigma across age groups to explore how people with dementia and their 
supporters describe, experience and manage stigma at different ages.  
Interestingly, Boener and Wang (2010) highlighted that, although there were age-
differences in the impact of vision loss for older and younger adults, this was not 
evident across all aspects of functioning. This finding suggests that age-based 
differences may not affect all aspects of people’s experiences of adjusting to ‘age-
associated conditions’. For example, health psychology literature has highlighted how 
age-based differences may be minimised when people face a ‘life-limiting’ condition 
(Carstensen and Fredrickson, 1998; Sullivan-Singh et al., 2015). This lack of difference 
has been explained through people employing similar methods for managing 
experiences irrespective of age; thereby suggesting that age is not the causal factor 
(Fung and Carstensen, 2004; Lockenhoff and Carstensen, 2004). These findings will be 
explored in more detail in chapter 3 in relation to Socioemotional Selectivity Theory 
(Carstensen, 1991) and managing exposure to stigma and future outlook. Collectively, 
the research evidence depicts a complex relationship between Alzheimer’s disease, 
ageing, and experiences of stigma. The relationship will be explored further by 
considering experiences of people affected by early- and late-onset Alzheimer’s disease 
within the same study.   
 
Consequences of stigma for people with Alzheimer’s disease and their supporters 
 
Although there is a wealth of literature relating to stigma, there are several gaps which 
are yet to be addressed. The rationale for understanding more about stigma can be seen 
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through the possible consequences people who are stigmatised may be exposed to. 
These consequences can impact on both the person with Alzheimer’s disease, and their 
supporter in both everyday experiences and looking to the future. The second literature 
review (chapter 3) will consider whether exposure to stigma and its consequences can 
be managed effectively, thereby outweighing some of the potential risks of diagnosis 
and offering an opportunity for supporting people to look to the future.  
A meta-analysis of studies which looked at discrimination effects on health concluded 
that perceived discrimination negatively impacted on a person’s mental and physical 
well-being (Pascoe and Richman, 2009).  Stigma has been seen to decrease well-being 
of people with dementia (Milne, 2010), including loss of confidence and subsequent 
withdrawal from activities (O’Sullivan et al., 2014). Further, people affected by 
dementia have discussed fears of disclosing their condition due to fear of stigma (Reed 
and Bluethmann, 2008). Fear of disclosure could increase the social isolation of people 
affected with dementia (Nolan et al., 2006). Importantly, stigma relating to Alzheimer’s 
disease and other dementias can increase the symptoms and negative outcomes of the 
condition for people affected (Bamford et al., 2014).  
Supporters of people with Alzheimer’s disease have also been reported to experience 
various consequences of stigma including anticipatory grief defined as “the process of 
experiencing normal phases of bereavement in advance of the loss of a significant 
person” (Garand et al. 2012:159), based on the belief that the person with Alzheimer’s 
disease will be lost (Garand et al., 2012). Anticipatory grief has been seen in supporters 
of people with dementia at a range of time points, due to the recognition of loss and 
expected losses. The literature surrounding the consequences of anticipatory grief is 
conflicting. For example, Garand et al. (2012) discuss how, although anticipatory grief 
can have negative effects on supporters’ psychological and physical health, it has also 
been noted that expression of anticipatory grief can reduce ‘caregiver burden’. 
Whereas, researchers such as Holley and Mast (2009) report that anticipatory grief is 
significantly associated with ‘caregiver burden’. This finding is more reflective of 
literature from other health conditions, such as Cora et al. (2012) who found that 
anticipatory grief led to worsened supporter stress for people living with terminal 
cancer.  Feelings of loss and anticipatory grief have also been shown in studies 
surrounding insight, affecting all family members, not just the primary supporter (Allen 
et al., 2009). The highest levels of anticipatory grief were seen in the early stages of 
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Alzheimer’s disease in the Garand et al. (2012) study; this could be due to facing the 
unknown, and predicting the future based on stereotypical knowledge, further 
highlighting the possible link with stigma and societal understandings of Alzheimer’s 
disease. Anticipatory grief may decrease over time due to adaption to everyday living 
with the disease and discovering how best to manage, however, this was not explicitly 
researched in the study. 
Additional consequences of stigma for supporters include, experiences of shame and 
guilt (Werner et al., 2010), highlighting the similarities in consequences for the person 
with Alzheimer’s disease and their supporter. Additionally, feelings of shame and 
embarrassment have been reported by older people with forgetfulness due to fear of 
dementia (Ballard, 2010). Taken together, the findings highlight the breadth of people 
the stigma attached to dementia, and its consequences, impacts upon.  
An additional consequence of stigma is suggested to be reduced rates of diagnosis 
(O’Sullivan et al., 2014). As the previous discussions highlight, this resistance to 
diagnosis may be from the person with condition themselves, their families, or 
healthcare professionals. However, Benbow and Jolley (2012) propose that non-
disclosure is denying people the opportunity to plan for their future, even if well-
intentioned. These findings reiterate the overlapping relationships between stigma and 
future planning, following the diagnosis of Alzheimer’s disease. There is also a need to 
consider how stigma may influence future outlook more generally, moving beyond a 
focus on planning. Frazier et al. (2003) found that a diagnosis of Alzheimer’s disease 
and the attached stigma can create a feared future-self.  These fears included loss of 
independence and becoming dependent on others. This suggests that internalisation of 
stigma-driven assumptions of Alzheimer’s disease may affect how people adjust to 
living with the condition and imagine themselves in the future.  
These conclusions are supported by recent research of Kristiansen et al. (2015) who 
considered how people with Alzheimer’s disease view the future. Two very different 
case studies are reported. The participant in the first case study focused on the present, 
and deliberately avoided thinking about the future. This was suggested to positively 
influence their quality of life. The other participant focused on their fears relating to the 
future, which led to increased feelings of despair (Kristiansen et al., 2015). The findings 
suggest that when stigma-driven fears are highly salient, people will find looking to the 
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future very distressing (Kristiansen et al., 2015). Further, they suggest that diagnosis of 
Alzheimer’s disease may not necessarily lead to people planning for the future.  This 
will be considered in more detail in chapter 3. The difference in experiences between 
the two case studies emphasises the need to recognise that people with Alzheimer’s 
disease do not represent a homogenous group, and that subjective experiences are made 
up of a complex interplay between biological and psychosocial factors. In addition, 
understanding more about how people can positively manage their experiences may 
provide insight for helping others who express greater fear of the future.  
 
Conclusions and key gaps in the research literature 
 
Overall, this chapter has outlined that there are many myths and negative beliefs 
relating to Alzheimer’s disease. The process of stigmatisation is complex; across the 
research literature it is evident that there is no inherent attribute which leads to stigma 
(Olafsdottir, 2013). Various predictors relating to the extent to which people will be 
stigmatised against have been suggested. These include the origin of the condition, the 
visibility or intrusiveness of symptoms, and accumulation of multiple or conflicting 
stereotypes such as age-based expectations. Within this study, several stigma-based 
assumptions about Alzheimer’s disease have been challenged to get a sense of how 
people experience the condition. This includes listening to the voices of those affected 
by Alzheimer’s disease, and acknowledging that their future is not solely ‘care’ 
focused.  
Current literature generally separates the experiences of people with early and late-
onset Alzheimer’s disease, with conflicting hypotheses relating to the challenges they 
may face. However, minimal research has been done which explicitly considers the two 
age groups within the same study, particularly from a biopsychosocial perspective. 
Therefore, it is unclear whether the findings reported about the two age groups are 
reflective of age, or other possible variables. This supports the inclusion of both age 
groups within one study for this research. 
  
45 | P a g e  
 
Chapter 3- Living with Alzheimer’s disease: Managing stigma and looking to the 
future  
 
Within the UK there is a strong drive to increase the rates of early diagnosis of 
dementia, as demonstrated by Alzheimer’s Society (2015c) ‘Right to Know’ campaign. 
As outlined in chapter one, part of this drive is to encourage early interventions and 
future planning for people affected by the condition (Luengo-Fernandez et al., 2010). 
However, one of the consequences of diagnosis, as discussed in chapter 2, is exposure 
to stigma (Milne, 2010). The reasons behind the stigmatisation of Alzheimer’s disease 
have not been linked to any one particular attribute (Olafsdottir, 2013); rather there are 
a range of complex processes which appear to underpin people’s experiences. Given the 
complexities discussed, several similarities and differences in experiences of stigma 
have been hypothesised based on possible subcategories within the group, such as age 
of onset. Importantly, a range of negative consequences have been associated with 
exposure to stigma for people with Alzheimer’s disease and their supporters. 
This chapter reviews how people affected by Alzheimer’s disease manage the 
consequences of stigma, with a particular focus on how it may influence their future 
outlook. Firstly, the key theoretical framework for the research, socioemotional 
selectivity theory (Carstensen, 1991), is introduced before applying the findings to 
managing stigma and the resultant fears about the future. There is minimal research 
which has used this theory in the field of Alzheimer’s disease, however, there is 
literature across disciplines suggesting the theory may facilitate understanding of how 
people manage negative experiences and look to the future as a person with a ‘time-
limiting’ condition. This therefore involves a novel approach to how people with 
Alzheimer’s disease manage their condition. 
The limited theoretical frameworks available for understanding future outlook and 
Alzheimer’s disease are likely to reflect how current literature focuses more on end of 
life care (Dening et al., 2011; Robinson et al., 2010; Dickinson et al., 2013). Further, it 
is suggested that the increased presence of advance care planning literature compared to 
everyday future planning may inadvertently fuel the stigma, by suggesting that a 
diagnosis of the condition is equivalent to a lost future (de Medeiros, 2010; O’Sullivan 
et al., 2014). This thesis has adopted an alternative perspective to future outlook, in 
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which ‘care’ is one of many parts of a complex set of experiences across the journey of 
Alzheimer’s disease. Finally, research will be synthesised to consider whether people 
with Alzheimer’s disease are planning for the future, as recommended by the drive for 
early diagnosis.  
 
Socioemotional selectivity theory: Stigma and Future Outlook  
 
Given the negative beliefs attached to Alzheimer’s disease highlighted in chapter 2, it is 
important to consider how people may learn to manage their exposure to stigma. 
Synthesis of research literature has led to a focus on how particular cognitive processes 
may shape the way people manage the physiology of their condition, as well as how 
society responds to them. Socioemotional selectivity theory (Carstensen, 1991) is one 
of several ‘social-cognitive approaches’ towards ageing (Christopher, 2014), and has 
been chosen as the theoretical framework for much of this research due to its 
understandings of health and ageing, as well as its applicability within a 
biopsychosocial perspective. One of the underlying assumptions of the theory is that 
human behaviour is guided by pursuit of goals (Carstensen et al., 1999). ‘Knowledge 
seeking’ goals refer to engaging in social interactions for the primary purpose of 
acquiring information. Conversely, ‘emotion seeking’ goals refer to pursuing 
interactions to regulate emotional states. When people are motivated by their ‘emotion 
seeking’ goals they are more likely to avoid negativity and focus on positive interaction 
(Carstensen et al., 1999). These two goal states are not mutually exclusive, but hold 
different consequences in time. ‘Knowledge focused’ goals are underpinned by a focus 
on future pursuits, acquiring information to affect future outcomes. Whereas, ‘emotion 
focused’ goals are about emotion regulation in the present, in keeping with a ‘day at a 
time perspective’.   
Changing perspectives of time, from expansive to restricted, leads to greater numbers of 
‘emotion focused’ goals (Carstensen et al., 1999).  This has been suggested to occur for 
older people and people with ‘time-limiting’ conditions (Carstensen et al., 1999). 
Traditional developmental theories have a tendency to separate people into age 
categories, which make it difficult to consider the possible overlap in experiences 
across groups. Socioemotional selectivity theory provides an alternative view, where 
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age-based differences in people’s everyday experiences are a result of different 
motivational goals, rather than age being a causal factor (Lockenhoff and Carstensen, 
2004). The use of this theory was considered important for recognising that both older 
and younger people can develop Alzheimer’s disease (Alzheimer’s Scotland, 2011). 
According to the theory, both older people and people who are experiencing ‘time-
limiting’ conditions will have similar responses to stigma and views of the future. This 
is due to a restricted sense of time and pursuit of ‘emotion focused’ goals. In 
comparison, younger people without health conditions are seen to view time as 
expansive, and therefore are more orientated towards ‘knowledge focused’ goals 
(Carstensen et al., 1999).  
The theory suggests that people with a ‘time-limiting’ condition, in this case 
Alzheimer’s disease, are more likely to prioritise positive emotional states. This 
phenomenon led to literature which questions how people can maintain a positive 
emotional state whilst faced with negative circumstances (Sharot, 2011). For example, 
how people manage negative attitudes and beliefs towards Alzheimer’s disease, and 
look to a future which is stigmatised as solely ‘care’. Socioemotional selectivity theory 
suggests that in order to remain positive, the smaller things in life become appreciated 
(Hicks et al., 2012). Most importantly the relationships with those around us are 
prioritised, due to the pursuit of emotionally engaging experiences (Carstensen, 1991). 
This may explain findings of Benbow and Jolley (2012) noted in chapter 2, where 
family and friends’ reactions to Alzheimer’s disease had a greater impact on how 
people adjusted to their diagnosis. Emotion-focused goals lead to social networks 
getting smaller; this is viewed as an active, deliberate process (Carstensen et al., 1999).  
Further, Steeman et al. (2013) found a shift in values for people with early-stage 
dementia from ‘being valued for what you do’ to ‘being valued for who you are’, which 
mirrors the knowledge to emotion-focused trajectory suggested by socioemotional 
selectivity theory. 
Expanding on this, one of the explanations for how people maintain positivity in the 
face of adversity is through a positivity bias in processing (Walker et al., 2003). 
Exploration of the positivity bias stems from the ‘paradox of ageing’ that while physical 
health declines as a person ages, their psychological health and well-being is often 
maintained or improved (Diener and Suh, 1998). The presence of a positivity bias, 
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whereby people are more likely to process and remember positive over negative 
information, can be seen as a universal bias in human cognition (Mezulis et al., 2004).  
Research suggests that as people get older, they show a preference for processing 
positive memories, and show better recall of positive stimuli, relative to their younger 
counterparts (Mather and Carstensen, 2005). Similarly, Berntsen et al. (2011) found that 
positive events were seen as more central to older people’s life story and identity. The 
centrality of the positive event increased over time, whereas for negative events this 
decreased (Berntsen et al., 2011). Negative events have also been seen to fade faster 
from a person’s memory than positive events (Walker et al., 2003). Exploration of 
autobiographic memories across age groups has suggested that older adults are more 
likely to focus on positive memories of events, as well as use positive reappraisal of 
negative encounters (Mather and Carstensen, 2005; Folkman et al., 1987). The findings 
discussed highlight how the neurological mechanisms of memory are malleable to 
psychosocial factors, and importantly can be self-protective (Green et al., 2005). Within 
psychology literature, this self-protective quality of memory is described as ‘mnemic 
neglect’ (Sedikides and Gregg, 2003). This term describes how people are less likely to 
recall information which is negative towards them (Green and Sedikides, 2004). This 
supports previous research which highlights a shift towards positive memory recall as 
people age, or face ‘time-limiting’ conditions. Further, Green et al. (2005) suggest that 
this self-protective forgetting is more likely when the negative information refers to 
something that a person is unable to change about themselves. This could suggest that 
people with Alzheimer’s disease and their supporters are more likely to experience 
mnemic neglect as the condition cannot be cured.  
Together, these findings have important implications for how people may report the 
positive and negative experiences associated with Alzheimer’s disease. For instance, 
taken alone these results may also suggest age-based differences in experiences for 
people with Alzheimer’s disease, with older people reporting more positive 
experiences. However, if considered alongside socioemotional selectivity theory, 
similar reporting may be the case, due to the similarity in viewed time for people with 
‘time-limiting’ conditions.  
Although these findings may suggest people are able to manage their experiences of 
stigma through changing what they attend to, such findings have not been directly 
49 | P a g e  
 
explored in the experiences of people with Alzheimer’s disease. The increased interest 
in whether the self-protective mechanisms of memory are applicable to people with 
memory difficulties has been highlighted by on-going research looking specifically at 
mnemic neglect in people with Alzheimer’s disease and dementia (UK Clinical 
Research Network, 2015).The current gap in applying findings to this population is 
largely due to the mechanisms such as the positivity bias being an active process which 
requires cognitive resources (Reed and Carstensen, 2012). Therefore it is unclear 
whether people with Alzheimer’s disease are able to apply the bias.  The available 
evidence surrounding this is inconclusive, with evidence to both support and refute the 
positivity bias in people with Alzheimer’s disease (Mark, 2012).  
Several hypotheses can be suggested based on whether people are able to make use of 
the positivity bias, and shift their motivational goals as set out by socioemotional 
selectivity theory. If Alzheimer’s disease stops people being able to use the positivity 
bias, experiences of younger and older people with the condition would be expected to 
be similar, such as both groups reporting high levels of stigma. If the positivity bias is 
not influenced by Alzheimer’s disease, older adults are likely to report less stigma than 
younger adults. Alternatively, both older and younger people could be influenced by the 
positivity bias, due to increased motivation to focus on positive events while facing a 
‘time-limiting’ condition. This would result in similar experiences, but with lower 
reporting of negative events such as stigma. The presence or absence of the positivity 
bias to manage stigma also results in different hypotheses for supporters’ experiences. 
If the bias is seen to affect people with Alzheimer’s disease and older people, 
differences between younger and older supporters may be seen. However, this 
difference would rely on the assumption that younger supporters continued to see time 
as expansive. Alternatively, the complex relationship between people with Alzheimer’s 
disease and their supporters may result in a shared perception of time, leading to both 
being influenced by the positivity bias.  
The research presented thus far highlights the possible applicability of socioemotional 
selectivity theory to people’s experiences of Alzheimer’s disease in terms of 
perceptions of stigma. It also draws attention to the change in people’s motivational 
goals which not only impact on interpretation of events, but also affect how people 
manage their future. When time is seen as restricted, people are more likely to focus on 
each day at a time, optimising resources to focus on meaningful experiences over 
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gathering knowledge for the future (Lockenhoff and Carstensen, 2004). Therefore, the 
theory would suggest that people affected by Alzheimer’s disease are likely to avoid 
looking to the future. This raises important questions for the debate surrounding 
diagnosis and opportunity to plan ahead. However, several challenges to the 
applicability of the theory should be noted. For example, socioemotional selectivity 
theory is based on the assumption that a person feels that their time is restricted, 
whether that be by age or health condition. However, people with Alzheimer’s disease 
experience differences in levels of awareness about their condition (Clare, 2004). This 
is further complicated by the fact that this awareness is not stationary, but continually 
fluctuating along a continuum with marked individual as well as group differences 
(Phinney, 2002). Such difficulties make it a very difficult area to research as it is 
unclear how time will be viewed; however, the available literature supports further 
research in this area. 
 
Biopsychosocial perspective on looking to the future 
 
In order to understand more about whether people with Alzheimer’s disease are able to 
look ahead and plan for the future, the process of looking to the future will be 
discussed. These findings will then be applied to what is currently known about 
Alzheimer’s disease. The physical process of looking to the future has been most 
widely considered within neurobiological literature. The phrase ‘mental time travel’ has 
been used to explain the experience of thinking of oneself across time (Tulving, 2005). 
Importantly for considering the experiences of people with Alzheimer’s disease, the 
neural mechanisms behind remembering the past have been linked to imagining future 
events (Addis et al., 2007). This is indicative of a specific core brain system (Buckner 
and Carroll, 2007) which influences ability to ‘mentally time travel’. This is particularly 
true for episodic memory (Abram et al., 2014), the type of memory focused on events, 
rather than facts which is referred to as semantic memory (Squire et al., 1993).  
The simulation of future events requires a system which can flexibly bring together 
details of past events (Schacter et al., 2007). As this requires a piecing together of 
information, rather than a replay of the past, studies have shown that people find it 
easier to imagine a future where simulated events have familiarity (De Vito et al., 
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2012). As such, it may be more difficult for people with Alzheimer’s disease to look 
ahead if they have not had previous experience of the condition, or if their current 
experiences are very different to past circumstances. The research on the neurological 
mechanisms of memory suggests that there is significant overlap between how people 
remember the past and how they imagine the future (Addis et al., 2007). This has 
recently been looked at more specifically in research including older adults, and people 
with Alzheimer’s disease. Schacter et al. (2013) reviewed studies which looked at older 
adults’ memory capacities, and found that the ability to imagine future events is 
correlated with memory deficits. They reported that increasing memory deficits were 
associated with greater difficulties with such imagination. This can be explained 
through the additional complexity of recombining stored information, which needs to be 
easy to retrieve (Schacter and Addis, 2007).   
Similarly, people with Alzheimer’s disease have been shown to have marked 
impairments in simulating future events (Addis et al. 2009). This is unsurprising given 
the importance of core networks in facilitating this, as well as the increased cognitive 
load associated with such activity (Schacter et al., 2013). The reviewed evidence 
appears to suggest that people affected by Alzheimer’s disease are not able to imagine 
the future. However, it is unclear whether the ability to ‘mentally time travel’ influences 
people’s ability to plan ahead. This would pose a significant challenge to earlier 
discussions on diagnosis and future planning.   
More recently, there has been increasing insight into the psychosocial experience of 
imagining the future (Schacter et al., 2012). This has the potential to increase our 
overall understanding of people’s experiences, when combined with the neurobiological 
perspective. A study conducted by Szpunar and Schacter (2013) found that if people 
repeatedly simulated a personal event in their future, it increased the subjective 
plausibility of that event taking place. For instance, if a person repeatedly imagined a 
job promotion in their future, it led to them believing this was more likely to happen. 
This was found for both negative and positive events. Similar responses can be seen in 
terms of discussions around topics such as death, where there is often a fear that 
discussion will make death more imminent (Kirshbaum et al., 2011). These findings 
could have a significant impact on those affected by Alzheimer’s disease. Imagining a 
future which is stereotypically very negative, and involves an increasing need for care 
(Chenoweth et al., 2009) may make this possible future feel more likely. This could 
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have a significant emotional impact (Kristiansen et al., 2015). Overall, these findings 
suggest that even if people affected by Alzheimer’s disease are cognitively able to look 
to the future, they may deliberately avoid it, therefore not utilising the future planning 
focus promoted through diagnosis. The following section will consider the factors 
associated with future outlook in more depth to understand the processes involved and 
possible influences of Alzheimer’s disease.  
 
Are people affected by Alzheimer’s disease looking to the future? 
 
The search strategy presented in chapter 2 highlighted that there are many terms used 
when referring to future outlook. These terms are often used interchangeably 
(Aspinwall, 2005), but do not all cover the same aspects of future outlook. For example, 
central to economic theories of decision-making is the notion of a plan (Hey, 2005). 
Research in this field has explored whether and how far people plan ahead, to 
understand decision-making processes in more detail (Hey and Knoll, 2007). Similarly, 
future planning or ‘future-orientated thinking’ has been extensively explored in 
psychological literature, focusing on achievement-orientated behaviour (Aspinwall, 
2005). Planning is proposed to be a central skill within human behaviour (Friedman and 
Scholnick, 1997). It has been suggested that planning for the future in relation to an 
event such as an exam, may differ from planning for future care needs (Aspinwall, 
2005). Further, as well as types of planning there are individual differences in whether 
people choose to plan ahead (Hey and Knoll, 2007). The way people look ahead is also 
likely to be influenced by social structures (Settersen, 1999) and expectations about 
how people should approach their futures (Trommsdorff, 1983). In the context of 
people living with Alzheimer’s disease, this includes policy focus such as Scotland’s 
Dementia Strategy’s (Scottish Government, 2013) commitment to supporting people to 
plan for future needs.  
It has been suggested that people will not plan if they believe the outcome is not 
amenable to personal control (Skinner, 1997); however this relationship is complex. 
Making the decision to plan involves recognising the need for a plan, and believing that 
making a plan will be advantageous (Skinner, 1997). In essence, the majority of 
research has focused on how people view the future when seeking to achieve particular 
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goals or outcomes. Looking to the future is more complex than this, incorporating 
planning, goals, hopes, expectations, and predictions (Aspinwall, 2005). For example, 
in chapter 2 it was noted that people may anticipate stigma towards Alzheimer’s disease 
and therefore fear seeking or disclosing a diagnosis. As such, the way people view the 
future impacts on everyday-life decisions as well as more specific events, highlighting 
how multiple systems may shape future outlook (Beal, 2011).  
Several theories have emerged which consider future outlook within them. For instance, 
the model of possible selves (Markus and Nurius, 1986) suggests that how we view 
ourselves guides how we look to the future. Possible selves evolve across the life course 
and can include both hoped-for and feared-for possible selves (Whitbourne, 2005). 
Similar concepts of hoped-for selves have been discussed within sociological literature 
in relation to aspirations and expectations (Beal, 2011), which focus on idealistic future 
attainment (Messersmith and Schulenberg, 2008). A longitudinal study by Frazier et al. 
(2000) found that hoped-for selves and feared-selves were largely continuous over time, 
although health-related selves became increasingly prevalent with age. In relation to 
Alzheimer’s disease, Frazier et al. (2003) discuss how the condition can impact on 
feared-for future selves including loss of independence, and becoming dependent on 
others. The research discussed suggests that internalisation of stigma-driven 
assumptions and fears of Alzheimer’s disease may affect how people adjust to living 
with the condition and see themselves in the future.  
The complexity of future outlook may explain the limited research in the field of 
dementia. As the neurobiological research highlighted, the processes involved in 
‘mental time travel’ raise questions about whether people affected by Alzheimer’s 
disease are able to think ahead. However, the intricacy of future outlook suggests it is 
unlikely to be an ‘all or nothing’ phenomenon. Research into future outlook in the 
context of lifespan development and stressful events has suggested several insights into 
how people look to the future and manage adversity. For instance, the role of 
‘controllability’ of the stressor may influence the extent to which the stressor impacts 
on future outlook, with people showing greater reluctance to look ahead if the outcomes 
are seen as uncontrollable (Skinner, 1997). A lack of control does not necessarily mean 
that people do not look ahead, but that factors such as hope become increasingly 
important in facilitating the process (Bruininks and Malle, 2005). In addition, whether 
events are long-lasting can influence future outlook relative to events which take place 
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in a shorter time period, with ‘going with the flow’ being associated with better 
outcomes for longer-lasting events (Aspinwall et al., 2005).  
As noted throughout the previous chapters, much of the driving force behind early-
diagnosis of Alzheimer’s disease is in enabling people to plan for the future (Social 
Care Institute of Excellence, 2013). However, evidence across disciplines presented so 
far in the review suggests that this may not be happening for people affected by 
Alzheimer’s disease. Small and Rhodes (2001) found that people who were seriously ill 
were reluctant to think about future needs, and preferred to focus on a ‘day at a time’ 
approach. Similarly, Brown and Graaf (2013) observed that people facing high levels of 
vulnerability and uncertainty due to progression of cancer, were more likely to focus on 
the day-to-day present than the future. This was particularly evident when people did 
not feel they had control over the outcome of their condition, as noted previously 
(Skinner, 1997). When control is taken away, it is more adaptive to focus on situations 
that you can have mastery over (Brown and Graaf, 2013). Further, hope can play a key 
role in time-orientation. Future time was a place where hopes could be directed 
towards, and where negative futures could be ‘bracketed away’ (Brown and Graaf, 
2013). 
For the people in Brown and Graaf’s (2013) research, there was a ‘certainty and 
inevitability of death’ but the time-frame in which this would occur was unclear. This 
level of uncertainty in time-frame is often mirrored in the experiences of people 
affected by Alzheimer’s disease, as the trajectory of the condition is hard to predict 
(Doody et al., 2010). One of the ways of managing the unpredictable timescale is to 
focus on the near future, and ’bracket away’ the negative outcomes which may lie 
further ahead. Such strategies may be particularly useful in cases such as Alzheimer’s 
disease where the progression of the condition leads to an inevitable difficult future in 
terms of a decline in independence and increased care needs (Jalbert et al., 2008; 
Feldman et al., 2005).  It is worth reiterating at this point that despite this progressive 
decline, quality of life does not always follow the same path, and people across the 
journey of dementia can still experience high quality of life (Trigg et al. 2010; Conde-
Sala et al., 2014).  
In keeping with socioemotional selectivity theory, Brown and Graaf (2013) found that 
if people were able to reimagine their futures and focus on the emotional experiences in 
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daily living, they were better able to adapt to their condition (Brown and Graaf, 2013). 
However, the ability of people with Alzheimer’s disease to reimagine futures may be 
dependent on neurological mechanisms, and a person’s ability to understand the 
implications of their diagnosis (Schacter et al., 2013). Overall, these findings highlight 
that looking to the future is not one-dimensional. The level of active and passive 
engagement in such practice changes over time, and may be affected by the level of 
both physiological and psychosocial resources a person has available. 
In addition, it is important to recognise that although deliberate avoidance of negative 
information and focusing on the present day may be adaptive for people, it may have 
unintended negative consequences.  Lockenhoff and Carstensen (2004) note that as 
people face health conditions which restrict their perception of time, the subsequent 
shift in motivational goals affects health choices. Evidence suggests that older people or 
people facing ‘time-limiting’ conditions may avoid negative information, as their 
primary motivation is to maintain positive emotional states (Lockenhoff and 
Carstensen, 2004). A consequence of this is that people may avoid information that 
although unpleasant may be necessary to consider for future planning. For instance, 
people may be more likely to avoid advance care planning, power of attorney, and 
deciding on preferences for community or institutional care. However, it is not clear 
whether making such plans will lead to better outcomes overall for people with 
Alzheimer’s disease. Robinson et al. (2012) argued that the current evidence for 
advance care planning positively influencing future care and wishes is variable.  
The previous sections have focused on literature largely from the neurobiological and 
psychological literature. Mische (2009) argues that ‘imagined futures’ is a generally 
neglected topic in sociology; however, Mische’s (2009) discussion goes on to highlight 
how considering future projections may allow for increased knowledge and 
understanding about the ways in which people think and behave. How people think 
about the future and when they plan ahead are questions of particular interest to this 
thesis, which aligns more closely with psychological literature (Aspinwall et al., 2005; 
Frazier et al., 2000; Schacter et al., 2012). 
In addition, Mische (2009) highlights that the work in this area mostly uses 
questionnaire and interview methods to consider future outlook, further supporting a 
similar design for this thesis. Despite the lack of sociological focus specific to imagined 
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futures (Mische, 2009), there is relevant literature related to how people experience 
illness and their futures living with chronic conditions. Nettleton (2013), for example, 
explains that chronic illness can impact on daily life, social relationships, identity and 
sense of self. The impact of chronic illness is explored in more depth within 
sociological theory.  
Biographical disruption (Bury, 1982) is one theory from a more sociological 
perspective which explores chronic illness in the context of self and identity. Early 
writings using the theory focus on the experiences of people living with rheumatoid 
arthritis; however, there are theoretical overlaps with other conditions. Biographical 
disruption describes chronic illness as being a critical disruptive event in people’s lives, 
whereby the underpinnings of everyday life are unsettled leading to awareness of pain, 
suffering, and potential death (Bury, 1982).  This potentially paints a very bleak picture, 
and has potential dissonance with the current focus on ‘living well’ with conditions 
such as Alzheimer’s disease (Department of Health, 2009). However, the discussions of 
Bury (1982) and others (Charmaz, 1983, 1995; Robinson, 1988) highlight that, when 
faced with critical situations a person is required to re-think their biography and sense 
of self, and re-examine views of the future (Bury, 1982; Charmaz, 1983, 1995; 
Robinson, 1988). Alternatively it may be that people do not wish to engage with the 
potential for negative changes and instead actively minimise their thoughts about 
change, the future, and the consequences of Alzheimer’s disease on their lives. 
Focusing on the present to deliberately avoid thinking about the future is suggested to 
be dissonant with Bury’s (1982) notion that an unexpected event disrupts a ‘taken for 
granted’ life course (Larsson and Jeppsoon-Grassman, 2012). Active avoidance of the 
future may thus suggest awareness that the event or change is a possibility (Larsson and 
Jeppsson-Grassman, 2012).  
Recent research by Larsson and Jeppsson-Grassman (2012) raises additional concerns 
over the applicability of biographical disruption to conditions that involve repeated 
disruption. For example, the symptoms of Alzheimer’s disease are progressive and 
likely to be continually disruptive. Further, much of the work on biographical disruption 
focuses on the onset of a condition, but as Larsson and Jeppson-Grassman (2012) 
highlight, for some conditions the risks of worsening symptoms can increase over time. 
Williams et al. (2009) similarly argue that biographical disruption may not be as 
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relevant when focusing on future illness trajectories, due to the continual biographical 
revisions needed over time.   
Based on critical reading and appraisal of the literature presented across the two 
literature review chapters, Socioemotional Selectivity Theory (Carstensen, 1991) has 
been chosen over alternative theories discussed. This decision is based on 
Socioemotional Selectivity Theory’s relevance to younger and older people living with 
a chronic illness, in particular the possibility of similar experiences not captured in 
previous literature, and due to the gaps currently not addressed in relation to the theory 
and people with Alzheimer’s disease (Mark, 2012). Other perspectives such as 
biographical disruption are one of several ‘lenses’ that could have been used to explore 
experiences, although this may have been more beneficial if a life-history perspective 
had been taken, exploring the impact of stigma on the self and future self. Although an 
interesting angle, this was not the primary aim of the research. Instead, this thesis 
focuses on perceptions of stigma and the associations between stigma and the ways in 
which people view and plan for the future. The complexity of these two issues suggests 
that multiple approaches could be taken to explore them. This thesis, using a 
psychological lens and framed within a biopsychosocial perspective, as discussed in 
chapter 1, has led to the decision of a mixed-method approach, capturing a ‘snap shot’ 
of people’s experiences living with Alzheimer’s disease in relation to stigma and future 
outlook. Alzheimer’s disease is viewed as a physical condition impacting on physical 
and psychological health, with psychological and societal factors altering the 
experience of this.   
This review serves to emphasise the complexity of looking to the future for people with 
Alzheimer’s disease. It may be that in order to be able to take on practical future 
planning, a person has to go against the instinctive preference to avoid negative 
experiences. The avoidance of negative information also gives maximum resources to 
focus on emotionally meaningful activities and interactions with loved ones 
(Lockenhoff and Carstensen, 2004). Such findings support the proposition that across 
age groups, people with Alzheimer’s disease and their supporters are likely to be 
reluctant to plan ahead, instead choosing to focus on their emotional goals. This would 
suggest a greater focus on living in the present moment, thereby supporting the need to 
shift focus from end of life care to the journey between diagnosis and this point.  
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The literature reviewed suggests people are not planning for the future to the extent that 
current policy promotes. However, the consequences of this avoidance are unclear in 
terms of the benefits of future planning.  Neurobiological literature previously discussed 
may suggest that people have limited future outlook due to decreased ability to 
‘mentally time travel’. However, this does not explain the variation seen, or the 
challenges supporters face in looking to the future (Sampson et al., 2010). It appears 
that the way people look to the future is influenced by the way people manage their 
experiences.  
 
 Managing experiences of Alzheimer’s disease: Stigma and Future outlook 
 
The literature presented across this chapter illustrates that despite the good intentions 
behind diagnosis as an opportunity to plan ahead, there appears to be limited 
engagement with this process. The discussion highlighted that much of this is due to the 
way people manage challenging experiences, with a focus on maintaining positive 
emotional states as much as possible. This has been seen to influence how people 
manage experiences of stigma as well as feared futures. 
In relation to stigma and ageing, socioemotional selectivity theory (Carstensen, 1991) 
can be seen as a bridge between debates over experiences of early-onset or late-onset 
Alzheimer’s disease. Seemingly, the literature discussed in chapter 2, such as Chaston 
(2010) and Scodellaro and Pin (2013), suggested that the experience of stigma were 
likely to be skewed towards either older or younger people. However, based on the 
understandings of socioemotional selectivity theory there may in fact be similar levels 
of stigma reported, due to the shared experience of the condition. Further, the principles 
of the theory may support the idea that regardless of the public stigmatisation of 
Alzheimer’s disease, the focus is shifted in favour of actively narrowing social 
networks to those who provide positive emotional support. This pruning of networks 
can be used as a way of separating from people who have treated them negatively. In 
keeping with this, previous research has highlighted that the response of family and 
friends is much more important to those affected, than that of the public (Benbow and 
Jolley, 2012).  
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Finally, possible age-based differences in looking to the future appear to be dependent 
on how people with Alzheimer’s disease and their supporters view time. The limited 
literature available suggests that there may be cognitive challenges in looking ahead; 
however, general avoidance may be reflecting management of the situation over 
cognitive inability. The change in motivational goals leading to a ‘day at a time’ 
approach also reiterates the continued futures of people with Alzheimer’s disease, rather 
than focusing on a distant future.  
 
Conclusions and key gaps in the literature 
 
For both the person with Alzheimer’s disease and their supporter, focusing on the 
negative changes that are experienced as a result of the condition may restrict positive 
outcomes. This is the case for negative reactions of others, through to changes in 
possible futures. The positivity bias allows people to focus on positive circumstances as 
much as possible, and promotes avoidance of situations where their emotional state may 
be threatened. Despite the conflicting evidence relating to age-based differences in 
experiences of Alzheimer’s disease, the reviewed literature suggests that these 
differences may be mitigated through shared methods of managing challenging 
situations. This is both for looking to the future and experiencing stigma.  
Across chapters 2 and 3, the strengths and limitations of research presented have been 
discussed. Before moving on to the research questions and methodology, the key 
studies that have informed this thesis are noted. Burgener and Berger (2008) are highly 
relevant to the stigma focus as their research suggests a need to consider the perception 
of stigma by the person with Alzheimer’s disease, moving beyond a passive experience 
to an acknowledgement of insight of stigma. Their research validated the questionnaire 
being used in this thesis, as a tool for measuring stigma in people with Alzheimer’s 
disease. Further, the questionnaire has been developed with Modified Labelling Theory 
(Link, 1987) as its underlying framework. Two other illustrative papers in relation to 
stigma and age were Chaston (2010), and Scodellaro and Pin (2013). It should be noted 
that both of these papers are secondary literature, bringing together previous research in 
their respective areas (Machi and McEvoy, 2012), and summarising the key challenges 
in the field relating to younger people with Alzheimer’s disease (Chaston, 2010), or age 
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more generally (Scodellaro and Pin, 2013). Their discussions highlight the conflicting 
findings surrounding age, stigma, and Alzheimer’s disease, which this thesis aims to 
explore in more detail by considering similarities and differences across both age 
groups.  
In terms of the future outlook research, Carstensen (1991) and the subsequent research 
into Socioemotional Selectivity Theory were key to the way future outlook was 
conceptualised in this thesis. The theoretical literature explores how people of all ages 
manage an experience like Alzheimer’s disease, where time becomes more restricted. 
However, as Mark’s (2012) discussion piece has emphasised, this has not been 
researched in relation to Alzheimer’s disease due to the possible neurological issues in 
terms of being able to view time as restricted, or imagine the future. As discussed 
earlier in chapter 3, there are several lenses through which stigma and future outlook 
could be viewed with the biopsychosocial perspective allowing for flexibility in terms 
of how much each domain is represented (see chapter 1), including topics such as ‘the 
self ‘and ‘identity’, which other theories into experiences of chronic illness such as 
biographical disruption (Bury, 1982) would prioritise. Instead, this thesis aimed to 
explore how negative experiences such as stigma could be associated with future 
outlook from a psychological perspective.  
For the purpose of this study, several areas of research have been identified in relation 
to experiences of Alzheimer’s disease. Current literature separates the experiences of 
people with early and late-onset Alzheimer’s disease. However, research which 
considers management of ‘time-limiting conditions’ suggests there may be overlooked 
similarities. Current policy focuses on how the exposure to stigma through diagnosis is 
potentially justifiable due to the increased ability to plan. However, the research 
literature reviewed emphasises that people may not be taking advantage of this. In 
addition, greater research is needed to understand planning and looking to the future 
across the journey of Alzheimer’s disease rather than an end point. Understanding more 
about subjective experiences of Alzheimer’s disease can therefore influence how people 
can be best supported to manage their circumstances. Accordingly, the aims and 
research questions have been formulated as follows. 
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Aims and Research Questions 
 
Overall this research study aimed to explore people’s experiences of living with 
Alzheimer’s disease, with a particular focus on stigma and future outlook, as well as 
whether age plays an important role in outcomes. Experiences have been viewed from a 
biopsychosocial perspective, and aimed to recognise the distinct and entwined 
experiences of people with Alzheimer’s disease and their supporters. This aim has been 
broken down into four research questions: 
1. Do people with Alzheimer’s disease and their supporters experience stigma? 
2. How do people with Alzheimer’s disease and their supporters view and plan for 
the future? 
3. Is there an association between levels of perceived stigma and how a person 
views and plans for the future: for both people with Alzheimer’s disease and 
their supporters? 
4. Are there differences in experiences, in terms of both stigma and future outlook, 
for people experiencing early-onset Alzheimer’s disease and late-onset 
Alzheimer’s disease? 
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Chapter 4- Methodology 
 
The following chapter presents the methodology for this study. An overview of the 
study will be provided, before a discussion of where the research places itself within 
research paradigms. Ethical and practical considerations have been noted throughout 
the discussions on research design, inclusion criteria, and sampling methods. This is 
followed by reflections on recruiting people affected by Alzheimer’s disease to the 
study.  Throughout, the decisions made were based on how best to answer the research 
questions generated in the previous chapter.  
Ethical approval for this study was granted by NHS Research Ethics Committee (West 
of Scotland, REC 5, Appendix 1). This was followed by site-specific approval across 
five NHS health boards. Research register access was granted by the Scottish Dementia 
Clinical Research Network, and full risk assessment (Appendix 2) was approved by the 
School of Applied Social Science, University of Stirling, before research visits 
commenced. People with Alzheimer’s disease and their supporters were sampled using 
purposive sequential sampling from the Scottish Dementia Clinical Research Network 
research register, supplemented by two NHS referrals. All participants had capacity to 
consent, with the model of process consent (Dewing, 2007) applied throughout the 
study.  A mixed method design was chosen to include the most appropriate measures to 
address the research questions. People with Alzheimer’s disease (n=22: 7 people with 
early-onset, 15 people with late-onset) and their supporters (n=22) completed 
questionnaires which looked at perceived stigma. Additional questionnaires explored 
variables which may influence stigma, including quality of life, insight, and activities of 
daily living. A subsample of participants took part in semi-structured interviews (n=14: 
12 paired, 2 supporter only), exploring experiences of stigma in more depth, and future 
outlook.  A full discussion of measures will be provided in chapter 5. All study visits 
took place in people’s homes, and included additional time for sharing a cup of tea and 
informal conversation. Analysis of questionnaires included a range of statistical tests, 
supported by SPSS software. Interview data were analysed using thematic analysis, 
supported by NVivo software. The findings will be presented across chapters 6, 7, and 
8, reflecting the first three research questions respectively. The fourth research question, 
exploring age-based influences, has been amalgamated into the three chapters.  
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Epistemology and Ontology 
 
In order to choose a research design, a researcher should be aware of their 
epistemological and ontological position, placing themselves within a particular 
paradigm. In this context a paradigm is synonymous with a worldview, which is based 
on assumptions and beliefs about knowledge (Creswell and Plano Clark, 2011). Mixed 
method designs have become known as the third methodological movement 
(Tashakkori and Teddlie, 2003). They are defined as a type of research which combines 
elements of quantitative and qualitative approaches, for increased breadth and depth of 
understanding (Johnson et al., 2007). There is ongoing debate as to whether mixed 
methods designs are compatible as they may be considered to be combining opposing 
paradigms (Guba and Lincoln, 1994).  
 
Several paradigm options have been suggested to resolve the possible conflict of mixed 
methods bridging incompatible concepts. For instance, a paradigmatic stance can be 
taken, which refers to research that does not declare a particular paradigm (Tashakkori 
and Teddlie, 2003). However, Hall (2012) argues that research is implicitly or explicitly 
positioned within a research paradigm, regardless of whether this is declared. 
Alternatively, Gorard (2007) observes that paradigms themselves are too restrictive, and 
argues that there should not be a divide in quantitative and qualitative methods. 
Similarly, Johnson et al. (2007) suggest that mixed methods do not necessarily need a 
detailed philosophical and methodological position. Rather, the variation in 
philosophical commitments should be embraced. This promotes a reintegration of 
qualitative and quantitative methods (Hammersley, 2004).  A single paradigm approach 
which encompasses both quantitative and qualitative methods is discussed by 
Tashakkori and Teddlie (2003), who prioritise the research question over a particular 
method or philosophical stance (Creswell and Plano Clark, 2011).  Therefore, although 
this research identifies itself as a mixed method design, it does not seek to debate one 
paradigm against another, or argue for superiority of either method. Instead, the focus is 
on producing a wide range of data using multiple methods, to reflect people’s 
experiences of living with Alzheimer’s disease. This stance is also reflected in the 
analysis section through presentation of data by research questions, rather than 
quantitative versus qualitative data.  
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Research Design 
 
As discussed in the literature (chapters 2 and 3), there have been few studies looking 
into the experiences of people with Alzheimer’s disease and their supporters, in terms 
of perceived stigma and future outlook.  The majority of the research discussed uses 
either a quantitative or qualitative approach. However, by using only one of these 
approaches, several questions remain unanswered. The third methodological movement, 
mixed method design, enables some of these limitations to be addressed, whilst 
providing a unique perspective overall (Tashakkori and Teddlie, 2003). The increasing 
drive to support the inclusion of people with dementia also encourages methods which 
allow for diversity and flexibility in how people are asked to express their views 
(Wilkinson, 2002). A mixed method design may be the most suitable approach to allow 
for this diversity, particularly in an area of research which has supportive evidence 
across research paradigms.  
 
Mixed methods as defined by Creswell and Plano Clark (2011) focuses on collection 
and analysis of data from quantitative and qualitative measures in a single study, with 
the aim of providing a richer understanding than is possible from either approach alone. 
This is not to say that having a quantitative or qualitative design alone would be a 
weaker study than when the two are combined, rather they lead to different outcomes. 
This further reinforces the suggestion of Tashakkori and Teddlie (2003), prioritising the 
research questions. One of the advantages of choosing a mixed method approach is that 
the limitations of individual measures can be partially addressed. Such as, the lack of 
clarity for why people give a particular answer on a questionnaire, or the difficulty in 
generalising interview data. Further, including both questionnaires and semi-structured 
interviews gives people the opportunity to have their voices heard in different ways.  
 
Mixed method research is described by Johnson and Onwuegbuzie (2004) as being a 
promising research design for methodologies more in line with what researchers use in 
practice. Mixed method designs are reiterated as having the ability to minimise 
weaknesses of single research studies and maximise strengths (Brown et al., 2015), 
however, this arguably takes away from the strengths of mixed method research in its 
own right, suggesting it is a compensatory research paradigm (Tashakkori and Teddlie, 
2003). There is increasing use of mixed method research (De Lisle, 2011) and a move 
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away from the different paradigms debate (Sale et al., 2011). Although this it is not 
without critics (Bazeley, 2004; Sale et al., 2002), the increased use highlights the 
progression of mixed-method research in social science. Importantly for this thesis, 
Johnson and Onwuegbuzie (2004) emphasise that mixed method research designs are 
needed as the ‘research world’ is increasingly complex and multidisciplinary. A mixed 
method research design is suggested to facilitate communication and collaboration, and 
fits well with the collaborative nature of this PhD between the SDCRN and University. 
 
Similarly, a mixed-method research design is supported by the biopsychosocial 
perspective which, as outlined in chapter 1, represents understandings of the physical 
experience of illness as something objective that can be measured, with a need to 
consider how such experience is perceived and interpreted by the individual based on 
various psychological factors and societal inputs. This type of research design allows 
for use of quantitative scales which are more reflective of the clinical environment and 
the way stigma would be measured in practice environments, combined with more in-
depth interviews which give room for understanding more about the social context and 
psychological experience of stigma and future outlook.  
 
Mixed method design, as with quantitative or qualitative design, can be approached in 
many ways. Bryman (2006) brings together various researchers’ work to highlight five 
key dimensions of mixed method decision making. Firstly, will the data be collected 
simultaneously or sequentially? Secondly, does quantitative or qualitative data have 
priority, or are they equal? Thirdly, what is the purpose of combining the data? For 
instance, is data being combined for triangulation, exploration, or explanation? The 
final two stages outlined by Bryman (2006) question where in the research process the 
multi-strategy takes place, and whether there is more than one data strand; although if 
there is only one strand its classification of mixed-method or multi-method is debatable 
(Bryman, 2006). Figure 2 presents a ‘decision tree’ outlined by Creswell (2003), which 
incorporates the dimensions previously noted, and aims to guide researchers through the 
different options available to them.  The decision tree shows the various pathways 
towards mixed method designs. Sequential timing was chosen for this study, separating 
the questionnaires and interviews into visit one and visit two. As not all participants 
could be interviewed, this allowed preliminary analysis of questionnaires before 
selecting people for interview. Further, separate visits enabled a relationship to build up 
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between researcher and participants, allowing for greater familiarity at interview 
(McKillop and Wilkinson, 2004). Equal weighting was given to qualitative and 
quantitative measures, reflecting the underlying assumption that neither method is 
superior, but contributes differently to the outcome. The data across measures were then 
combined for the final analysis based on the research questions. This allowed for a 
more comprehensive understanding of people’s experiences, as well as possible 
similarities and differences in findings to be observed. Therefore, the research strategy 
employed was a sequential exploratory design, as described by Creswell (2003). 
 
Figure 2. Decision tree for mixed methods design, as discussed by Creswell (2003) 
 
Of note, a typical exploratory design collects qualitative data first, followed by 
quantitative data collection; this is useful when little is known about the topic area 
(Andrew and Halcomb, 2009). Whereas, a sequential explanatory design typically 
collects quantitative data and uses the qualitative data to confirm and expand on the 
findings (Ivankova et al., 2006). Based on the sequencing of the two study visits in this 
thesis it could be argued that the design is a sequential explanatory design, however, 
these designs typical prioritise the quantitative data. Instead, this thesis aimed to give 
equal weight to the two methods, with more of the research questions reflecting an 
exploratory approach. For example, how people look to the future, and whether there is 
an association between peoples experience of stigma and future outlook. Therefore, the 
sequential exploratory design best describes the overall design of this study while not 
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privileging one set of data over another. Onwuegbuzie and Teddlie (2003) suggest that 
instead of framing research in terms of quantitative and qualitative, we should 
reconceptualise these as exploratory and confirmatory methods (Onwuegbuzie and 
Teddlie, 2003). This conceptualisation may make it easier to highlight how the 
sequential methods have been used. However, for clarity and transparency the terms 
quantitative and qualitative have been used in the thesis. 
The combination of methods is a topic of considerable debate in the literature 
surrounding mixed method research designs (Bryman, 2006, 2007; Fielding, 2012; 
Olsen, 2004; Onwuegbuzie and Leech, 2007). One key aspect of this debate is how the 
quantitative and qualitative data are combined. Quantitative and qualitative research can 
be combined during the formulation of research questions, sampling, data collection 
and data analysis (Bryman, 2006). The degree of freedom within this process may help 
explain why it is difficult to establish clear, consistent guidelines for mixed-method 
research. Several justifications are outlined by Greene et al. (1989) for the combination 
of methods that are applicable to this thesis. Firstly, ‘development’ is applicable where 
the aim was to use scores from the quantitative data to inform sampling for the 
qualitative data collection. As noted in the reflections at the end of this chapter, the 
ability to do this was limited due to the lack of dispersion between scores, and the 
numbers of people with early-onset Alzheimer’s disease taking part in the research. 
Secondly, ‘triangulation and complementarity’ are used together to explore how the 
results from the two methods fit together, elaborating on the initial findings and 
exploring consistency. Discussion of the quantitative and qualitative findings is 
presented in chapters 6 and 8. Thirdly, the combination of mixed methods is justified 
through ‘expansion’ where the breadth of knowledge is increased by using multiple 
methods (Greene et al., 1989). Expansion is demonstrated within this thesis by 
considering stigma and future outlook separately and together as part of a possible 
association.  
Finally, it is important to recognise the limitations of mixed-method designs in order to 
try to minimise the impact of these. Many of the criticisms presented in the literature 
focus on the ‘paradigm debate’ where quantitative and qualitative methodologies are 
seen as incompatible (Doyle et al., 2009). However, this debate does not recognise the 
similarities between paradigms, where both methods are seeking to describe data, 
construct arguments and speculate over outcomes (Sechrest and Sidiini, 1995). 
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Focusing on the differences between paradigms is argued by Onwuegbuzie and Leech 
(2005) to be counterproductive in progressing social science research.  Several practical 
challenges which if not addressed can limit mixed-method research have been noted by 
Bryman (2007). For example, writing for different audiences can result in the weighting 
of the two methods changing during write up or dissemination. It is also important to 
reflect on preferences for quantitative or qualitative methodology and to make sure this 
is not creating bias in how the data is combined or reported. For instance, if a 
researcher’s background is more quantitative they may have more faith and confidence 
in this aspect of the mixed-method work, due to this greater familiarity and expertise 
(Bryman, 2006). It is therefore important to reflect on background and skills to make 
sure that if equal weight is being given to the two methods, the confidence in them is 
equal. In this thesis, this potential bias is part alleviated from collaboration with a 
multidisciplinary team of qualitative and quantitative researchers, therefore enabling 
both sets of skills to develop in parallel. Bryman (2006) also suggests that challenges 
may arise when data is generated at different speeds, leading to one aspect being 
analysed separately to another. However, this is alleviated by having a sequential design 
from the beginning of the research process.  
Overall, mixed-method research design has been chosen for this thesis as a way of 
exploring stigma and future outlook in a way that can create in-depth information as 
well as numerical data. As with all research designs there are limitations, however, as 
outlined in the previous paragraph efforts have been made to alleviate these as much as 
possible.  
 
Power and Sample Size 
 
When determining the most appropriate sample size to include for a mixed method 
study, both statistical power and data saturation need to be considered. As the study 
design included the collection of quantitative data, a sample size calculation (Brant, 
2013) was used to make sure that the number of people completing questionnaires was 
sufficient to generate suitable power for the study results. Power analysis considers the 
likelihood of a type I or II error, which indicate false-positives and false-negatives 
respectively (Halpern et al., 2002). Further, conducting a study without appropriate 
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power size could have ethical implications for the people involved (Halpern et al., 
2002). Saturation in this context refers to the state where increasing the number of 
participants does not add anything new to the data or theory (Bowen, 2008). There is 
not a calculator for saturation, although several factors have been identified to help 
researchers decide the ideal number of participants. These include the breadth of the 
topic, where with increasing breadth the time taken to research saturation increases 
(Morse, 2000). The nature of the topic is also important, as it may affect the 
accessibility of information. Highly emotive data may be more difficult to gather, and 
therefore requires a greater sample size to try and get a full picture (Morse, 2000). In 
addition, previous literature was considered to estimate the ideal sample size for both 
questionnaires and interviews.  
There remain challenges in operationalising data saturation and establishing a sample 
size, as ideally the sample size would be dependent on the information coming out of 
interviews, with more interviews being conducted until there was no further information 
being added about a particular topic (Mason, 2010). However, this raises challenges in 
time-limited research or research where a clear protocol is needed from the outset 
which determines the number of participants being included (Green and Thorogood, 
2004). The challenge for PhD research is argued to be that the pre-meditated focus on 
numbers of people detracts from the focus on true data saturation and qualitative 
enquiry (Mason, 2010). The issue of data saturation is suggested to be neglected due to 
the difficulty in defining it, and a lack of ‘one size fits all’ option (Fusch and Ness, 
2015). However, Guest et al. (2006) suggest the aim should be to have no new data, 
themes, or codes, with the ability to replicate the study. The process of data analysis and 
reflections on the interviews which will shape data-saturation are presented in chapter 
5.For calculating statistical power and sample size, a power level, alpha level, and 
expected population means and standard deviations are input. In this case a power level 
of 0.80 was chosen, which reflects a large effect size. This was based on the potential 
sample size being relatively small, and the focus on an effect that is consistent or large 
enough to be observed by ‘naked eye’ (Sullivan and Fenn, 2012). An alpha level of 0.05 
was selected in line with typical significance levels (Erdfelder et al., 1996).  This is 
followed by population mean values and expected standard deviation values. These 
values are based on the dependent variable within the questionnaires, in this case, 
perceived stigma. At the time of calculating sample size, there was very limited 
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research surrounding perceived stigma and people with Alzheimer’s disease. Further, 
the literature had not used the Stigma Impact Scale or equivalent to measure perceived 
stigma in people with early-onset Alzheimer’s disease or their supporters. As such there 
was minimal or no data to provide mean values of the different groups within this study. 
The literature search was widened to include stigma and ‘age associated conditions’. 
For example, research which looked at comparisons of perceived stigma between 
younger and older people for conditions such as HIV. However, there was not any 
research which focused on experiencing stigma of a condition, where age may have a 
significant effect.  
As Table 2 highlights, the only values in the literature at the time of sample selection, 
allowed a comparison between people with late-onset Alzheimer’s disease, and 
supporters of people with late-onset Alzheimer’s disease. Based on the values collected 
from two previous papers (Burgener and Berger, 2008; Liu, 2011), sample size 
calculations showed a minimum of 15 people was necessary in each group for a power 
of 0.80.  For this study, the proposed sample size for questionnaires was increased to 20 
participants per group. This allowed for greater data collection, as well as attrition.  The 
direction of results was not stated within the research questions, as there were several 
possible outcomes and insufficient literature to assume a given direction due to the 
opposing hypotheses. For instance, Chaston (2010) suggested people with early-onset 
Alzheimer’s disease would experience greater stigma than people with late-onset 
Alzheimer’s disease. Whereas, Scodellaro and Pinn (2013) suggest the opposite 
direction of effect, hypothesising that people with late-onset Alzheimer’s disease will 
experience more stigma. 
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  People with 
early- onset 
dementia 
People with 
late- onset 
dementia 
Supporters of 
people with 
early-onset 
dementia 
Supporters of 
people with 
late-onset 
dementia 
Predicted mean 
SIS scores 
Data unavailable 42.7 Data unavailable 29.58  
Predicted SD for 
SIS scores 
Assume ~9/10 9 Assume ~9/10 10.8 
Ideal power 0.8 
Minimum 
number for 
power 
  15   15 
Ideal number for 
this study 
20 20 20 20 
 
Table 2. Illustrated sample size calculation, based on the information available in 
the literature at the time of calculation. 
 
On the assumption that 80 people would participate in the questionnaires, completing 
interviews with every participant would not have been feasible. This is due to the time 
constraints of the data collection period, and the need for multiple visits. To address 
this, all of those who completed questionnaires were asked if they were happy to be 
contacted at a later date regarding a possible interview. Participants were reminded that 
not everybody would be able to complete interviews, but that if they were not contacted 
at this point they would still be contacted when the overall study was complete. It was 
also reiterated to all those involved that selection was not based on ‘right or wrong’ 
answers to questionnaires. This was to reduce possible anxiety over their answers. As 
one of the main outcomes of the study was experiences of stigma, and the consequences 
it could have on future outlook, the scores of the Stigma Impact Scale were to be used 
for interview selection. In accordance with mixed method design protocol, it was 
anticipated that extreme and deviant cases would be selected from each group (Patton, 
1990). This was to highlight the breadth of experiences, and allow for greater 
exploration of the factors which affected people’s perceptions and experiences of 
stigma.  
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If the extreme and deviant scores from each group were selected, it would provide a 
minimum sample of 8 people for interview. This mirrors the number of people affected 
by Alzheimer’s disease in previous research, such as Pipon-Young (2011). However, as 
future outlook is a largely unexplored area, a greater number of participants may be 
needed. This is supported by Morse’s (2000) discussions on topic breadth. Therefore, 
16 interviews were proposed to generate novel data, and increase the likelihood of data 
saturation. Of these 16, 8 were to be people with Alzheimer’s disease (4 people with 
early-onset, 4 people with late-onset) and 8 supporters of people with Alzheimer’s 
disease (4 supporters of people with early-onset, and 4 supporters of people with late-
onset).This is supported by Guest et al. (2006), who suggested that saturation generally 
occurred within twelve interviews, depending on the data set.   Further, similar sample 
sizes for semi-structured interviews can be seen in dementia research literature (Clare, 
2003; Harman and Clare, 2006; Robinson et al., 2005).  
As well as considering the number of interviews, dementia research literature calls for 
flexibility over whether interviews are with people with dementia and their supporters 
together or separately (Wilkinson, 2002). Therefore the total sample size for interviews 
was based on people’s preferences about who was present for the interviews. This 
suggests a minimum of 16 participants for interviews, and a maximum of 32 people. 
Further, the actual number of interviews remained flexible to the questionnaire data, in 
order to be responsive to the data collected and the variance between individual scores. 
The following section looks at how the discussed sample sizes worked in practice, 
taking into account inclusion and exclusion criteria for study participation. Reflections 
on the sampling methods and participation rates will be presented.  
 
Use of research registers for recruiting people with Alzheimer’s disease 
 
Recruiting people with Alzheimer’s disease to research is notably difficult, with 
Alzheimer’s Society (2015) reporting that despite around 700, 000 people experiencing 
dementia in the UK, researchers have difficulty recruiting more than 50 people to a 
study. People with dementia can be viewed as a ‘hard to reach population’ for research 
purposes. Shaghaghi et al. (2011) describe ‘hard to reach’ populations as subgroups of 
people who are difficult to involve in research. There are many different examples of 
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‘hard to reach groups’. Noteworthy for people with Alzheimer’s disease, is the 
difficulty in sampling from stigmatised groups (Sadler et al., 2010), and those living in 
difficult social or economic situations (Shaghaghi et al., 2011).  When compared to 
research participation for conditions such as cancer, public engagement in dementia 
research is low (Department of Health, 2012). One such approach for improving 
participation rates has been the use of research registers, which aim to bridge the gap 
between people affected by dementia and research studies (Avent et al., 2013).  
Sampling from a register has the potential to increase acceptance rate, due to people 
already having expressed interest in research (Avent et al., 2013). In addition, if people 
have previously expressed an interest in dementia-related research, they may be more 
willing to share their potentially difficult experiences. This would help to address 
concerns of reaching data saturation where topics are highly emotive, as outlined in the 
previous section.  
Research registers also allow researchers the opportunity to screen for potential 
participants based on the pre-set inclusion or exclusion criteria. This may save time, and 
reduce the likelihood of people being contacted about research that they are not suitable 
for, which could be unethical.  Despite the benefits of using this sampling method, there 
are some limitations which are important to acknowledge. Previous research such as 
Avent et al. (2013), suggests that as research registers appeal to people who are 
motivated to help themselves and others living with the condition, results may be 
biased. However, this does not mean that those who avoid participation in research do 
not wish to help themselves or others. Rather, that the negatives appear to outweigh the 
benefits for some. It is useful to know what reasons people have for engaging in 
research, but it is also important to consider who declines. This may help to better 
understand who may be missing from the research, and could therefore have 
implications for generalising findings (Brintnall-Karabelas et al., 2011).   
As discussed previously, Alzheimer’s disease can expose people to a range of stigma. 
Therefore, motivation to identify with the condition and participate in research may be 
low (Sadler et al., 2010). Other reasons explored in research literature for declining 
research participation have included specific protocol features, and inconvenience in 
timing or circumstances (Brintnall-Karabelas et al., 2011). Additionally, competing 
commitments, clarity of benefits, and previous negative experiences of healthcare 
and/or research have all been cited as reasons to avoid research participation (Taylor et 
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al., 2007). Taking these findings into account, it was important to make sure that 
people’s experiences of participating in this study were as positive as possible. This 
meant spending extra time with participants for informal conversations, and sharing a 
cup of tea, as will be highlighted in the study protocol (chapter 5).  
Inclusion and Exclusion criteria for study participation 
 
Participants for this study were recruited from the Scottish Dementia Clinical Research 
Network (SDCRN) research register, supplemented by two additional NHS referrals. 
Other organisations were also approached and adopted the study, but were unable to be 
included due to time limitations. This will be discussed more within reflections on 
sampling. As discussed in chapter 1, the SDCRN research register holds the details of 
people with  various types of dementia and their ‘carers’, who have expressed interest 
in dementia research participation. Following NHS ethical approval, the ensuing 
inclusion and exclusion criteria were provided to the SDCRN to filter potential 
participants from their research register.  This process resulted in a list of potentially 
eligible participants who could then be sampled and contacted.  As highlighted in the 
introduction (chapter 1), this PhD has been part funded by the SDCRN. To avoid any 
conflict of interest or bias when sampling, the study went through review by the 
network, in accordance with SDCRN study adoption protocol. Further, the register was 
not accessed by the researcher. 
The study focused on people with Alzheimer’s disease over other types of dementia. 
There were several reasons for this inclusion. Firstly, Alzheimer’s disease is the most 
common type of early and late-onset dementia (Alzheimer’s Society, 2014). Given that 
people with dementia are already viewed as a ‘hard to reach population’, selecting 
people with the most prevalent type was likely to increase sample size. In addition, as 
noted within the introduction (chapter 1) it was also important to separate ‘Alzheimer’s 
disease’ from ‘dementia’ which is made up of several types of neurodegenerative 
conditions.  Different types of dementia are associated with different symptoms 
(Knopman et al., 2003; Gure et al., 2010; Chiu et al., 2006). For example, one of the 
subtypes of dementia is known as frontotemporal dementia. This subtype is associated 
with reduced inhibition, which can lead to socially inappropriate behaviours and 
impulsivity (Alzheimer’s Society, 2013b). Such symptoms could potentially intrude 
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more on a person’s life and social interactions, making the attributes more discrediting, 
and therefore potentially affecting stigma experiences (Goffman, 1963; Kelly and Field, 
1996).   Based on these conclusions, people with other types of dementia were not 
included in the study.  
Diagnosis of Alzheimer’s disease could have been given either before or after the age of 
65. Age at diagnosis, as opposed to current age, was used for categorisation of early or 
late-onset Alzheimer’s disease, in line with clinical diagnosis (Koedam et al., 2010).   A 
minimum age of participants was set at aged 18, as different ethical considerations are 
associated with people younger than this. The maximum age of participants was not 
specified. Previous studies have capped the age limit at around 75 years old, however, 
as age was of particular interest to this study this may have been too restrictive. The 
probability of having many people within the ‘oldest old’ category of 85 years old and 
onwards was predicted to be low (Brumback-Peltz et al., 2011), due to an increased 
likelihood of people with dementia in this age range having mixed dementia pathology 
(James et al., 2012). In spite of this, over half of the people with Alzheimer’s disease in 
this study were over the age of 75, with nearly 30% within the ‘oldest old’ category. 
Full characteristics of the sample are presented later in the chapter. Importantly, had an 
age cap been in place the majority of people with late-onset Alzheimer’s disease in this 
study would not have had the opportunity to participate, thereby losing valuable insight 
into their experiences.  
All of the participants in this study had to be able to give informed consent themselves. 
Other studies have used proxy consent, whereby the supporter consents on behalf of the 
person with Alzheimer’s disease if they are unable to consent themselves. However, 
this was not done for this study as the person with Alzheimer’s disease was being asked 
to complete several self-report measures. Therefore, they would need to feel able and 
comfortable doing so.  When deliberating capacity to consent, there is a need for 
judgement and considering each person individually. There is insufficient evidence to 
relate cognitive capacity and ability (Warner et al., 2008). Situational factors and the 
complexity of the decision to be made have both been shown to influence capacity to 
consent (Dewing, 2007). For example, making a decision regarding taking part in a new 
drug trial has different considerations for a person with dementia, in comparison to 
completing a survey. 
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Mild to moderate stages of Alzheimer’s disease have been associated with a greater 
level of capacity to consent. This is due to relative preservation in ability to reason and 
decide (Karlawish, 2008), as well as increased insight (Rankin et al., 2005). Therefore, 
this ‘staging’ was used as a filter for the SDCRN. To fit with the design of the register, 
MMSE scores were used to indicate ‘mild to moderate’ Alzheimer’s disease. MMSE is 
a type of cognitive assessment regularly used within clinical practice to stage 
Alzheimer’s disease and other types of dementia. A possible score range for mild-
moderate Alzheimer’s disease is 10-26 (Alzheimer’s Society, 2012). Although MMSE 
scores were used for the filtering of participants, they were not used in the analysis or 
updated during this study. This will be discussed within study measures (chapter 5).  
All participants needed to be able to speak and understand English to take part in the 
study. The measures used such as the Stigma Impact Scale had not been validated in 
other languages, and it was not within the study scope to be able to do this. Secondly, 
given the complexity of the biopsychosocial underpinnings of Alzheimer’s disease, 
cultural differences are to be expected (Sayegh and Knight, 2013; Johl et al., 2014). 
Finally, limitations such as time and money were not viable for including people who 
did not speak English. Importantly, this reinforces that much of the psychosocial 
discussion is focused on social constructions within British society. 
The SDCRN research register holds less information about the supporters of people 
with dementia. Therefore, there were minimal inclusion or exclusion criteria 
specifically for supporters. However, as several of the study measures required 
perspectives of both the person with Alzheimer’s disease and their supporter, several 
considerations were noted. Supporters needed to have regular contact with the person 
with Alzheimer’s disease. This was important as courtesy stigma or family stigma is 
hypothesised on the basis of a clear connection with the person with Alzheimer’s 
disease (Larson and Corrigan, 2008). Close contact did not necessarily mean that the 
person with Alzheimer’s disease and their supporter needed to live together. Previous 
research which considers the reliability of proxy-ratings have not found clear links 
between hours of contact, or living with the person with Alzheimer’s disease (Huang et 
al., 2008). However, the person with Alzheimer’s disease could not be living within a 
care home, due to the difference in ethical procedures for researching within these 
settings (Luff et al., 2011). As such, ‘regular contact’ was not operationalised in terms 
of time, however, all carers had identified themselves on the research register as a study 
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partner. In practice, 18 of the research pairs were spouses, and 3 were adult-child 
supporters, who identified themselves as the main informants for the person with 
Alzheimer’s disease.   
Finally, the location of participants was restricted. In 2014, the Scottish Dementia 
Clinical Research Network register included 1401 people with dementia, and 1427 
supporters of people with dementia (SDCRN, 2015b). For the purpose of this research, 
the location of participants was restricted to five NHS health boards: NHS Forth Valley, 
Lothian, Grampian, Tayside, and Greater Glasgow and Clyde. The numbers of potential 
participants available by health board area is presented in Appendix 3.  These health 
boards were chosen based on the numbers of potential participants on the research 
register, as well as the feasibility of travelling to home visits.  Originally, NHS 
Lanarkshire was included due to proximity; however, administration within this area 
was particularly slow. Therefore it was discounted to prevent significant delay. 
 
Sampling Methods 
 
The outlined inclusion and exclusion criteria resulted in a list of potential participants 
from the SDCRN research register to contact. The use of research registers, and the 
mixed method design across separate visits, is best classified as purposive sequential 
sampling. This type of sampling allows for participant selection before and during the 
study, in-keeping with the sequential research design (Teddlie and Yu, 2007).  For 
instance, people completed questionnaires before being selected for interviews. The 
flexibility of purposive sampling also allows for multiple sampling techniques to be 
adopted within it. For example, selections of extreme and deviant scores of the Stigma 
Impact Scale for people with late-onset Alzheimer’s disease, and opportunistic 
sampling of people with early-onset Alzheimer’s disease. This was necessary due to the 
challenges faced in recruiting equal numbers of people with early and late-onset 
Alzheimer’s disease. This is discussed in more depth within reflections of sampling 
later in the chapter. Figure 3 illustrates the sample selection process for questionnaires 
and interviews, for people with early and late-onset Alzheimer’s disease and their 
supporters.  
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Figure 3. Illustration of the participant selection process for questionnaire and 
interview based data collection. 
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The SDCRN research register provided details of 120 eligible people with late-onset 
Alzheimer’s disease, and 17 people with early-onset Alzheimer’s disease. All of the 
possible participants with early-onset Alzheimer’s disease were contacted, with an 
additional two contacts made from NHS referrals. Of the 19 people with early-onset 
Alzheimer’s disease and their supporters, 7 pairs agreed to participate in the research. 
Therefore, all participants were invited to interview. As the number of people with late-
onset Alzheimer’s disease available for contact was higher, additional sampling was 
needed. 
Out of the 120 potential participants with late-onset Alzheimer’s disease, 73 were 
contacted for participation. Selection from the list for contact was opportunistic, with 
potential participants being contacted until a feasible amount of data had been collected. 
The 73 participants contacted were then analysed against the remainder of potential 
participants for possible selection bias, taking account of the variables available from 
the register including age, socioeconomic status, years living with Alzheimer’s disease, 
and MMSE scores. Discriminant analysis of the 120 people with late-onset Alzheimer’s 
disease suggested that none of these variables significantly predicted whether 
participants were contacted. This suggests that the sample chosen was representative of 
the observable characteristics from the overall sample available (Wilks λ = .921, Chi-
square = 8.767, df = 4, Canonical correlation = .280, p = 0.067).  
People with late-onset Alzheimer’s disease were selected for interview using deviant 
and extreme cases, as discussed earlier (Patton, 1990). It was also noted that interview 
selection must be sensitive to the data.  There was minimal dispersion of Stigma Impact 
Scale scores for people with late-onset Alzheimer’s disease and their supporters. 
Therefore, discrepancy between paired scores was also included, for example, the 
person with late-onset Alzheimer’s disease whose perceived stigma score was most 
different to their supporter.  
A discriminant analysis compared people with late-onset Alzheimer’s disease who 
completed questionnaires and people with late-onset Alzheimer’s disease who 
completed both questionnaires and interviews. Scores were compared across eight 
variables: age, socioeconomic status (SIMD), time living with diagnosis, gender, and 
questionnaire scores (Stigma Impact Scale, DEM-QOL, MARS-MFS score for the 
person with Alzheimer’s disease and the discrepancy with supporters). The overall Chi-
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square test was non-significant (N= 15, Wilks λ = .524, Chi-square = 5.822, df = 8, 
Canonical correlation = .690, p = 0.667).  This suggests there was no evidence of 
differences between the people with late-onset Alzheimer’s disease selected for 
interview and those who were not, based on the variables available. 
Similarly, for the nine comparable variables available for supporters of people with 
late-onset Alzheimer’s disease (age, socioeconomic status, time living with diagnosis, 
gender, and questionnaire scores (Stigma Impact Scale, MARS-MFS for supporter and 
discrepancy with person with Alzheimer’s disease, Zarit Burden Interview, and Bristol 
Activities of Daily Living) no significant differences were found between those selected 
for interview and those not (N=15 Wilks λ = .249, Chi-square = 11.809, df =9, 
Canonical correlation = .866, p = 0.224). The lack of significant differences suggests 
the interviewed sample were reflective of the sample of people with late-onset 
Alzheimer’s disease participating in the study. As all those affected by early-onset 
Alzheimer’s disease were offered interviews, and all but one pair agreed, discriminant 
analysis was not conducted for this group. 
 
Study Participants 
 
The summary characteristics of people who took part in this study are shown in Table 3. 
More detailed explanation for why each characteristic was reported is provided in the 
following chapter on study measures. Overall 22 people with Alzheimer’s disease and 
22 supporters were recruited, of which 26 took part in interviews. Twelve were paired 
interviews, and two were supporter only. Despite the challenges recruiting people to the 
study at the beginning, the retention of people across the study was high, with all but 
one pair of participants invited to interview agreeing, giving a retention rate of 93%. 
The final section will reflect on the sampling and recruitment process, and the possible 
implications of the challenges faced. 
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 Number of 
participants- 
Questionnaires 
Number of 
participants- 
Interviews 
Mean 
age in 
years 
/Range 
Mean 
time 
with 
diagnosis 
in years 
/Range 
Mean 
socioeconomic 
status by 
SIMD decile 
/Range 
Gender 
Male Female 
People with 
Alzheimer’s 
disease 
22 12 76.05 5 7.23 16 6 
Early-onset 7 5 63.29 
52-69 
3.57 
1-8 
6.71 
3-10 
7 0 
Late-onset 15 7 82.00 
73-91 
5.67 
1-11 
7.46 
3-10 
9 6 
Supporters 22 14 68.45 5 7.41 5 17 
Early-onset 7 6 59.43 
47-67 
3.57 
1-8 
6.71 
3-10 
0 7 
Late-onset 15 8 72.67 
53-88 
5.67 
1-11 
7.73 
3-10 
5 17 
Total 
sample 
44 26    21 23 
 
Table 3. Summary table for sample characteristics of people with Alzheimer’s 
disease and their supporters included in the study.  
 
Reflections on study recruitment 
 
The study aimed to recruit a sample of 80 people for the questionnaires (20 people with 
early-onset Alzheimer’s disease; 20 people with late-onset Alzheimer’s disease; and 
their 40 supporters), and a minimum of 16 interviews. However, achieving these 
numbers was not possible within the time of the study. This was particularly true for 
recruiting people with early-onset Alzheimer’s disease and their supporters. The initial 
contact list of people with early-onset Alzheimer’s disease provided by the SDCRN 
detailed 17 people. As a result, Alzheimer’s Scotland and The Scottish Dementia 
Working Group were both approached for additional recruitment, and adopted the 
study. However, time restrictions of the PhD meant it was not feasible to pursue these 
routes. Overall, the difference in numbers of people available led to the different 
sampling methods for people affected by early and late-onset Alzheimer’s disease, as 
previously displayed in figure 3.  
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The reduced sample size impacts on the overall power of comparisons, indicating that 
there is an increased chance of type I or type II errors. As highlighted in table 2, the 
minimum number of participants for ideal power was 15, based on the population 
norms available at the time of power calculations. This means that valid comparisons 
could be calculated between people with Alzheimer’s disease and their supporters 
(n=22 per group), but that age-based comparisons should be interpreted more 
cautiously. This is not to say that the results would be invalid, rather that they should be 
interpreted cautiously. 
The reduced sample size and its impact on internal validity is in part counteracted by 
the inclusion of semi-structured interviews. Based on the study design, the same 
participants were able to expand on their experiences and potentially corroborate the 
questionnaire data. Therefore, the risks of error may be reduced, based on the increased 
validity from triangulating data (Zohrabi, 2013) as can be seen in chapter 6. 
Importantly, researchers such as Slonim-Nevo and Nevo (2009) and Moffatt et al. 
(2006) highlight that mixed-method data can produce conflicting findings and that this 
should not invalidate the results; rather, they discuss how the presence of conflicting 
results reflects a strength of a mixed-method approach in capturing a level of 
complexity that may have been missed in a single-method study.   
Of the 92 people with Alzheimer’s disease contacted to take part in the study, 90 from 
the SDCRN research register and 2 from NHS referral, 22 were recruited. This gives a 
response rate of 22.2%. It is difficult to draw conclusions from the response rate alone. 
Galea and Tracy (2007) discuss how many studies fail to report response rates through 
concerns over low response rates being indicative of study inferiority. However, the 
lack of transparency in response rates does not allow for more in depth consideration of 
why people may choose to be involved in research. There may also be differences 
between people that are difficult to reach, and people who decline taking part in 
research (Patel et al., 2003). Although these considerations can influence 
generalizability, it also demonstrates the need for providing as much detail as possible 
about a study sample. The reduced generalizability should also not take away from the 
subjective experiences and voices of those who were involved.   
Due to the challenges faced in recruiting people with Alzheimer’s disease, possible 
variables which may have affected study uptake were explored. The discriminant 
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analysis compared those who were contacted and agreed to take part, with those who 
did not respond or declined. The variables age, number of years since diagnosis, and 
socioeconomic status were included as possible predictors. These variables were 
available without any additional information needed from people who declined. The 
analysis included 92 people with Alzheimer’s disease (73 people with late-onset 
Alzheimer’s disease, 19 people with early-onset Alzheimer’s disease).  The overall chi-
square test was non-significant (Wilks λ = .963, Chi-square = 3.302, df = 3, Canonical 
correlation = 0.191, p = 0.347). The results of the discriminant analysis suggested that 
age (p=0.321), socioeconomic status (p=0.103) and length of time since diagnosis 
(p=0.707) did not predict whether people with Alzheimer’s disease agreed to take part 
in the study. Due to the minimal information available about supporters on the SDCRN 
research register, discriminant analysis could not be done with their data. This may 
have yielded useful insight, given that supporters are often considered ‘gatekeepers’ to 
such activities (Beattie et al., 2004). 
The discussion highlights that there were clear challenges in recruiting people with 
Alzheimer’s disease. In many respects this is surprising given that participants have 
previously signed up to the SDCRN research register, thereby expressing their interest 
in taking part in research studies. Having worked within the SDCRN, there are several 
factors that I would suggest may impact on this. This is speculative, as participants who 
turned down the study were not asked to explain as this would violate their right to 
decline without giving a reason (APA, 2010). Firstly, participants contacted may 
already be involved in research studies and therefore feel they could not commit to an 
additional study. Galea and Tracey (2007) support this assumption, discussing how 
participation rates in studies have been declining and this may in part be due to the 
people being offered more research options. Further, the types of study offered by the 
SDCRN include pharmaceutical intervention studies as well as psychosocial 
interventions, and observational studies. Although pharmaceutical interventions may be 
prioritised by participants given the potential for more direct benefits, they are 
associated with higher risk, and it is unknown how prospective participants may weigh 
this up. Finally, prior to recruitment, it was acknowledged that the way the study was 
framed may impact on recruitment, in particular whether stigma was mentioned. 
Therefore, the study was called ‘Experiences of Alzheimer’s disease: Looking to the 
future’ on all information sheets. As noted within chapter 2, there is considerable 
84 | P a g e  
 
stigma attached to the terms ‘Alzheimer’s disease’ and ‘dementia’ with some people 
being reluctant to identify themselves as having the condition. This is less likely to be 
the case for people who have chosen to be part of a dementia research register. 
Despite the challenges of recruitment, the retention rate for the study was high. A 
retention rate of 93% is particularly positive given the difficulty in recruiting and 
retaining participants in health-related research (Provencher et al., 2014). As with 
response rate, there are limited guidelines on the classification of high or low retention 
rates. This is potentially due to concerns over invalidating results. Research has 
considered strategies which contribute to studies with higher retention rates. A review 
by Provencher et al. (2014) suggested several strategies which had positive effects on 
retention rates, many of which were used in this study and will be discussed in more 
details within the study measures and protocol (chapter 5). These included conducting 
face-to-face interviews, and using simple language. Materials were also adapted to 
potential needs, for example including large font due to the increased likelihood of 
visual difficulties (Van Boxtel et al., 2000). Further, it was important to remain flexible 
about the time and location of the study, with in-home interviews generally being 
preferred (Provencher et al., 2014). 
In addition to considering the numbers of people within the sample, it is important to be 
aware of the sample characteristics. As discussed in the previous section, Avent et al. 
(2013) note several positives to using recruitment registers to reach a target population, 
such as increased motivation, and self-identifying as potential participants. However, it 
is important to be aware of the possible biases within such a sample, and the challenges 
dementia research faces in general recruiting a representative sample (Rockwood and 
Gauthier, 2005). For instance, it may be that people who experience high levels of 
stigma are more reluctant to get involved in research. This might lead to lower levels of 
stigma being reported by participants than are present within the general population of 
people with dementia. Conversely, people who experience significantly more stigma 
may have increased motivation to be involved in research and support change, thereby 
leading to findings of higher than expected stigma. Such skewing of results based on 
the sample population could also be the case for future outlook and age-based 
experiences. A representative sample is ideal (Ritchie et al., 2015), however, not to 
have this should not invalidate the research; rather, it means the conclusions drawn 
should include awareness of the sample used and its limitations.  
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Possible sample qualities to be aware of include the socio-economic status of 
participants. Socio-economic status was measured by Scottish Index of Multiple 
Deprivation (SIMD) scores. Participants’ decile scores ranged from 3-10, which 
highlights that people within the least deprived areas were included, as shown by an 
SIMD of 10, however, the levels of highest deprivation (SIMD of 1-2) were not 
included. The importance of this finding is discussed within study measures in chapter 
5, noting the potential impact of socioeconomic status on outcomes. In addition, the 
population sample was entirely based in Scotland. This has implications in terms of the 
policy frameworks impacting on the support and care available to people with 
Alzheimer’s disease, such as Scotland’s policy for one year of post-diagnostic support 
(Scottish Government, 2013).Gender has been considered as there were no female 
participants with early-onset Alzheimer’s disease in this study, and only 27% of 
participants with late-onset Alzheimer’s disease were female. This is surprising given 
that gender-based statistics of Alzheimer’s disease would predict more women than 
men with the condition. For instance, Knapp and Prince (2007) report that that 67% of 
women are diagnosed with Alzheimer’s disease, compared to 55% of men. A possible 
reason for the disproportionate number of men in the study could be based on the 
gender prevalence on the SDCRN research register. There were more males (n=285) 
with Alzheimer’s disease on the register than females (n=279). Despite these 
differences, gender was not expected to have significant implications for stigma results 
(Corrigan et al., 2003; Prenda and Lachman, 2001), but it worth noting when 
considering possible generalisation of findings.  
Finally, one of the limitations to the study was the time delays between questionnaire 
and interview visits. The delay meant that for some pairs, the person with Alzheimer’s 
disease was no longer able to engage fully in the interview. In these circumstances, 
interviews with the supporter still took place. This was the case for Katie (SE3) and 
Toby (PE3), and Millie (PL12) and Holly (SL12). Further, on some occasions the 
person with Alzheimer’s disease was present but did not contribute to the interview 
questions. However, they were included in general conversation so as not to feel 
excluded. This was the case for Michael (SL2) and Grace (PL2), Poppy (SL1) and 
David (PL1), and Sophie (SL15) and Angus (PL15). The remaining interviews included 
both the person with Alzheimer's disease and their supporter. Despite this limitation, the 
interviews conducted reached data saturation, as discussed earlier in chapter 4.  
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The time-delay between visits 1 and 2 was up to six months for some participants, due 
to the delay in getting more people with early-onset Alzheimer’s disease participating in 
the research. Interviews were delayed due to the sequential design and the aim of 
having a larger sample of questionnaires for extreme and deviant case sampling as set 
out in the sampling method plan. The delay is likely to have led to increased likelihood 
of participants no longer feeling able to participate in the interview; although the 
unpredictable nature and progression of Alzheimer’s disease means that there is not a 
clear way of predicting the speed or likelihood of decline over a study period. It could 
be argued that a qualitative-quantitative sequence would have worked better for these 
participants, with interviews first followed by questionnaires, as interviews are likely to 
be harder and involve the ability to think in a more open-ended way. However, this 
would have changed the thesis in that questionnaires after interviews would not have 
given participants as much opportunity to expand on their questionnaire answers. In 
addition, questionnaires following interviews would not have allowed for 
deviant/extreme sampling from the quantitative data. Further, having the questionnaire 
visits first allowed a relationship to build up with participants, and if an interview had 
been carried out first, participants might not have been as open with their discussion. 
Therefore, the discussion outlines the support for a questionnaire to interview sequential 
design. 
 
Conclusions 
 
Overall, this chapter has provided an outline of the decision-making process and 
methodology behind this research study. These decisions have been made based on how 
best to answer the research questions derived from the literature reviews presented in 
chapters two and three. Supportive evidence has been used to increase the validity of 
the decisions made. Based on these decisions, the following chapter illustrates how the 
design was implemented for data collection. This will focus on the study measures, as 
well as reflect on conducting the research study.  
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Chapter 5-Methods Chapter 
 
This chapter will expand on the methodological framework presented in chapter 4. The 
measures used for data collection are discussed with reference to relevant literature, 
before a step by step protocol, including reflections on the research process. Finally, the 
data analysis procedure is described, with an introduction to the findings chapters which 
follow. Throughout the data collection, the experience of participants was prioritized. 
This is particularly important for research where people may not directly benefit from 
the study outcomes (Berghmans and Muelen, 1995; Higgins, 2013).  
 
Study Measures 
 
The following section outlines the measures used to answer the research questions of 
this study. The decision-making process for each measure is provided based on 
theoretical, methodological, and ethical considerations. For measures that were adapted 
or created specifically for this study examples are provided in the Appendices (4a and 
4b). A summary of the study measures and when they were used is provided in Figure 
4. These will be discussed in turn.  
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Figure 4. Summary of study measures and protocol. 
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Demographic information of people with Alzheimer’s disease was taken from the 
SDCRN register. By using register data, the number of questions people completed was 
minimised, prioritising the core study measures. The research register does not hold as 
much information about supporters, therefore a demographic information questionnaire 
was provided for them to complete. Demographic data allows for a range of information 
to be gained about people, which can be compared to other people in the study, as well 
as to other studies with similar research aims and objectives. Further, the variables 
noted have been suggested to influence experiences of Alzheimer’s disease and should 
therefore be measured for possible effects on the study outcomes. Measures included: 
age, socioeconomic status, and time of diagnosis. The reasons for which are outlined 
below.  
As outlined across the previous chapters, age may influence experiences of stigma and 
future outlook, although the direction of effects is unclear. Therefore, age of people 
with Alzheimer’s disease was recorded and categorised people as having early-onset or 
late-onset Alzheimer’s disease. People who had been diagnosed with Alzheimer’s 
disease before the age of 65, who at the time of study were older than 65 years old, 
were included in the early-onset Alzheimer’s disease category.  
The date people with Alzheimer’s disease began taking cholinesterase inhibitors was 
used as a consistent measure for dating diagnosis, and is provided on the register. 
Although time of diagnosis was not controlled for it was measured as a possible factor 
in experiences. For example, as discussed in the chapter 3, the literature highlights that 
positive memories are more likely to be retained over time than negative memories 
(Mather and Carstensen, 2005). Therefore, this could affect the reporting of negative 
experiences such as stigma over time. Additionally, research suggests that the 
experience of stigma is stronger at the point of diagnosis, with people adjusting over 
time, further implicating the amount of stigma people report (Vernooij-Dassen et al., 
2005).  
The final demographic variable included for analysis was socioeconomic status, which 
was measured using neighbourhood deprivation scores. Fischer et al. (2009) highlighted 
that there are large amounts of consistent evidence to support the view that low 
socioeconomic status increases the prevalence of dementia. Further, socioeconomic 
status has been linked to attitudes and behaviour, including future planning. For 
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instance, Wardle and Steptoe (2003) compared various attitudes, beliefs and behaviours 
around healthy living, and found lower socioeconomic status was associated with less 
future planning and thinking less about ways of staying healthy.  Various measures of 
socioeconomic status can be seen across research. Neighbourhood deprivation can be 
particularly important among older people as they have an increased risk associated 
with the effects of the neighbourhood, and they are less likely to be able to move from 
an area (Lang et al., 2008). These data are available by postcode using the Scottish 
Index of Multiple Deprivation (SIMD, Scottish Government, 2013b). The Scottish 
Government provides a full database of postcodes, with overall deprivation, quintiles, 
deciles and vigintiles, population estimates and health board classifications (Scottish 
Government, 2013b). The database is open access and can be downloaded to personal 
computers, which allows for specific postcodes to be input with the database generating 
all of the necessary SIMD information to be exported. Decile scores were chosen over 
quintile scores used by Fischer et al. (2009) as they allow for greater diversity, giving a 
more robust sense of socioeconomic status. Although both education and income levels 
have also been used in research as markers of socioeconomic status (Fischer et al., 
2009), they were not seen as appropriate across all participants, due to the increased 
likelihood of being retired, and reliance on memory for education levels. Additional 
data collection methods are discussed below in relation to individual research questions.  
 
Research Question Measures- Do people with Alzheimer’s disease and their supporters 
experience stigma? 
 
Perceived stigma was measured using the Stigma Impact Scale (Burgener and Berger, 
2008), and thematic analysis of interview data. The scale was conceptualised based on 
Modified Labelling Theory (Link, 1987), as discussed in chapter 2, and has been widely 
used within the psychological literature to explore stigma in mental and physical health 
from a biopsychosocial perspective since its development by Fife and Wright (2000). It 
was adapted for use with people with Alzheimer’s disease by Burgener and Berger 
(2008). The questionnaire is made up of 24 questions, which are answered on a Likert 
scale from strongly disagree (scoring 1), disagree (scoring 2), agree (scoring 3), and 
strongly agree (scoring 4). Questions could also be scored as non-applicable (scoring 
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0).  This gives an overall score range of 0-96. In their original study Burgener and 
Berger (2008), as well as Liu (2011), reported the mean Stigma Impact Scale scores. 
However, more recently and in line with the original scale (Fife and Wright, 2000), 
subcategory scores have also been reported (Burgener and Berger, 2013). This reflects a 
more comprehensive view of stigma. Presenting mean scores on their own risks a 
skewed view, particularly when the different subcategories are not equally weighted.  
The scale is made up of four subcategories: social rejection, financial instability, 
internalised shame, and social isolation. Cronbach’s alphas for the four subcategories 
based on populations of people with HIV and cancer, ranged from 0.85 to 0.90 
(Burgener and Berger, 2008). For people with Alzheimer’s disease, Cronbach’s alphas 
ranged from 0.56 to 0.82. Although 0.70 and above is generally considered to be 
reliable (Santos, 1999), the low range due to the financial instability subcategory (0.56) 
is discussed as acceptable when considered as part of the total scale, which has an 
overall Cronbach alpha of 0.87 (Burgener and Berger, 2008). In addition, Burgener and 
Berger (2008) discuss how ‘financial instability’ may be less relevant to the age range 
of people living with dementia, in comparison to the study populations using the Fife 
and Wright (2000) scale. However, Burgener and Berger’s (2008) discussion does not 
acknowledge people with early-onset Alzheimer’s disease, which may complicate age-
based comparisons in this thesis. The evidence available from Burgener and Berger 
(2008) suggests that this scale is suitable for use with people with Alzheimer’s disease, 
and it has since been used with this population by others (Burgener et al., 2013; 
Chapman, 2011; Liu, 2008; Riley, 2012). 
Examples of subcategory questions include: ‘Some family members have rejected me 
because of my condition’, which represents social rejection, and ‘I have experienced 
financial hardship that has affected how I feel about myself’, which represents financial 
instability. Questions were the same for the supporter’s questionnaire with wording 
changed to reflect their role, for example, ‘I do not feel I can be open with others about 
my family member’s condition’, which represents internalised shame, and ‘Changes in 
the appearance of my family member with Alzheimer’s disease have affected my social 
relationships’, which represents social isolation. The order of questions matched the 
Burgener and Berger (2008) scales. Adaptations specific to this study included 
changing the word ‘impairment’ to ‘condition’, and ‘neurological impairment’ to 
‘Alzheimer’s disease’. This was to move away from the medical perspective, and 
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clarify focus on people with Alzheimer’s disease over other types of dementia. The 
layout was also modified to be clear and accessible to people with Alzheimer’s disease, 
including increased font size and spacing of words. This is due to the higher likelihood 
of visual difficulties (Van Boxtel et al., 2000). Copies of the adapted questionnaires, 
with corresponding subcategories can be found in Appendix 4(a -c). 
The use of questionnaires with people with dementia has been explored by a range of 
research. For instance, Small and Perry (2005) found that communication was more 
successful between people with Alzheimer’s disease and their supporter, when closed-
ended questions (yes-no) were used compared to open-ended questions, particularly if 
the answer required episodic memory. Conversely, Moore and Hollett (2003) noted that 
there is supportive evidence for use of both open and closed-ended questions. The 
evidence supports the use of a research design which includes a variety of ways of 
gathering information, depending on what best suits the needs of the person with 
dementia. As such, a mixed-method design including quantitative and qualitative 
methods of different structures with open and closed ended questions has been used in 
this thesis. 
 
Further, the use of a stigma questionnaire allowed for comparisons of scores with 
similar studies, as well as between participants. It also included a restricted time-frame 
which spanned two weeks. As such, it provided an indication of the current situation for 
people with Alzheimer's disease and their supporters in relation to perceived stigma. 
However, to get a more comprehensive understanding of people’s experiences of 
stigma, a broader time-frame was also considered useful. Therefore, the interview topic 
guide included questions such as ‘How do you feel about others’ reactions to yourself 
and/or your diagnosis of Alzheimer’s disease?’ A full interview topic guide and 
schedule can be found in Appendix 5 and 6. Open ended questions relating to stigma 
experiences gave people the opportunity to expand on their questionnaire answers, 
particularly if more than one response was appropriate. For example, the questionnaire 
requires either a positive, negative, or non-applicable response. Comparatively, 
interviews allowed people to disclose examples of both.  
 
In order to draw conclusions from measures of stigma, possible factors which may 
influence differences in scores beyond stigma alone were considered. Research 
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literature suggests that stigma is made up of multiple layers, and can be influenced by a 
variety of factors including quality of life and people’s level of insight into their 
situation and people’s reactions to it. Assumptions include that people diagnosed with 
Alzheimer’s disease cannot have a high quality of life (see Bond et al., 2002), and that 
they will not have insight into their situation (see Baste and Ghate, 2015) therefore will 
not perceive stigma.   
 
Evidence from mental health literature indicates that lower insight could reduce the 
negative consequences of stigma (Boyer al., 2012), however, there is not sufficient 
evidence within the field of dementia to support this. Insight was therefore measured 
using the MARS-MFS (Clare et al., 2002). The questionnaire was completed by people 
with Alzheimer’s disease, reporting on how able they felt in managing a particular 
memory-based scenario. For example, ‘You have an appointment and need to 
remember to go along’. How frequently would you be able to manage this situation? 
Response cards were given to participants with 5 possible answers, never, rarely, 
sometimes, often, and always.  The same scenarios are answered by the supporter in 
relation to the abilities of the person with Alzheimer’s disease. This provides scores 
which reflected both the person with Alzheimer’s disease and the supporter’s view, as 
well as a discrepancy score which could be used to suggest an overall picture of 
functioning. The use of separate scores as well as a discrepancy moves away from the 
cognitive focus (Clare and Wilson, 2006) and is more encompassing of the subjective 
experience of the person with Alzheimer’s disease. Scores of the MARS-MFS were 
included in analysis of Stigma Impact Scale scores to see if they influenced the overall 
outcome.  
 
Additionally, quality of life measures were included as a possible covariate to perceived 
stigma. Research literature suggests that people who report increased stigma are more 
likely to experience poor quality of life in comparison to people who report lower levels 
of stigma (Mashiach-Eizenberg et al., 2013; Burgener et al., 2013). The DEM-QOL 
(Smith et al., 2005) and Zarit Burden Interview- short form (Bedard et al., 2001) were 
used to assess quality of life and how it may affect stigma scores for people with 
Alzheimer’s disease and their supporters respectively.  The DEM-QOL was developed 
specifically for using with people with dementia (Smith et al., 2005). It is made up of 
29 questions, which focus on a person’s experiences over the past week in terms of 
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emotions, memory, and everyday life. Example questions include, ‘In the last week how 
worried have you been about your physical health?’.  The use of the DEM-QOL for 
people with Alzheimer’s disease is supported by the Royal College of Psychiatrists 
(2012). The proxy measure of the DEM-QOL was not used with the supporter, as the 
study aimed to include the supporter’s quality of life, rather than their view of the 
person with Alzheimer’s disease. Therefore, The Zarit Burden Interview- short form 
(Bedard et al., 2001) measured quality of life for supporters, to see if it influenced their 
perceived stigma scores. The original scale made up of 22 questions is one of the most 
consistently used scales in similar research (Bedard et al., 2001). The short form is 
made up of 12 questions, with a correlation of 0.92 and 0.97 with the original version 
(Bedard et al., 2001).  Example questions include ‘Do you feel stressed between caring 
for your relative and trying to meet other responsibilities (work/family)?’ A shorter 
version was developed to reduce the number of questions supporters had to answer, 
particularly as quality of life was not the primary outcome measure. Other quality of 
life measures were considered for supporters, such as the Short Form Health Survey 
(Ware and Sherbourne, 1992). However, these measures are not specific to experiences 
of dementia, and the Zarit Burden Interview is more in-line with supporter outcomes, 
such as well-being (Royal College of Psychiatrists, 2012). Further, a significant 
correlation between burden and quality of life has been found across health literature 
(Isaac et al., 2011; Rha et al., 2015; Santos et al., 2014). Consequently, the Zarit Burden 
Interview has been used as a proxy measure for quality of life in this thesis. 
 
The final questionnaire used was completed by supporters, and refers to the daily 
functioning of the person with Alzheimer’s disease. Many studies use memory 
assessments as an indicator of functioning. These require the person with Alzheimer’s 
disease to answer questions which rely on memory, such as remembering and recalling 
a fictional name and address. The most commonly used assessments being the MMSE 
and ACE-R or ACE III (Simard, 1998; Mioshi et al., 2006; Sheehan, 2012). These 
assessments provide a cognitive functioning score which is often used to classify 
somebody as having mild, moderate or advanced stage of dementia. Although this can 
be useful from a clinical perspective, it does not provide insight into a person’s lived 
experiences with the condition. Further, completion of memory assessments can expose 
people to feelings of failure and unnecessary harm (Mograbi et al., 2012). As noted in 
chapter 4, the SDCRN research register used MMSE scores to filter potential 
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participants for this study. However, this was not used as a study measure, as there was 
variation in when people completed the MMSE. As an alternative that is more reflective 
of lived experiences, the Bristol Activities of Daily Living (Bucks et al., 1996) was 
chosen. The questions reflect the focus on people’s daily experiences moving beyond 
cognitive ability. During study visits, many participants expressed their frustration over 
cognitive tests, and how they did not feel they reflected daily living. This does not mean 
that cognitive assessment does not have its place, but that it needs greater 
contextualising to understand overall experiences.  
 
 
Research Question Measures- How do people with Alzheimer’s disease and their 
supporters view and plan for the future? 
 
Looking to the future was explored through semi-structured interviews. As discussed in 
the literature reviews (chapters 2 and 3), there has been limited research into future 
outlook which considers the journey between diagnosis and end of life care. As such, a 
more exploratory method was needed. Interview topic guides were formulated based on 
the gaps in the research literature and areas of interest identified within the literature 
review (see Appendix 5). These guides were provided to participants prior to interview, 
as well as during visits. This gave people the time and opportunity to consider the topics 
and how much information they wanted to share about them. The interview schedule 
which accompanied this had more specific questions including, ‘How do you view the 
future with Alzheimer’s disease?’ and ‘Have your thoughts about the future changed 
since having Alzheimer’s disease?’ These questions were used to facilitate discussion 
(see Appendix 6).  
 
 
Research Question Measures- Is there an association between levels of perceived 
stigma and how a person views and plans for the future: for both people with 
Alzheimer’s disease and their supporters? 
 
The remaining research questions were explored within the analysis using the data 
collected across research measures. As discussed within the literature reviews (chapters 
2 and 3), diagnosis of Alzheimer’s disease exposes people to stigma. Despite this, 
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diagnosis is encouraged to allow people to plan for the future. Therefore, the findings 
relating to both stigma and future outlook were considered together, to understand more 
about how people look ahead and whether experiences of stigma impact on this.  
 
Research Question Measures- Are there differences in experiences, in terms of both 
stigma and future outlook, for people experiencing early-onset Alzheimer’s disease and 
late-onset Alzheimer’s disease? 
 
Age differences were not explicitly asked about at interview, to reduce the likelihood of 
leading questions or eliciting stereotypes. Rather, during analysis the similarities and 
differences in experiences between age groups were explored. Although age differences 
were not raised by the researcher, age was repeatedly brought up by participants at 
interview, relating to the support services available and when comparing their 
experiences to others. This has been explored in more depth within the findings 
chapters.  
 
Overall, people with Alzheimer’s disease and their supporters completed a range of 
measures to explore the four research questions identified through the literature review. 
Demographic information was collected from all participants, either from the SDCRN 
research register or through a demographic information sheet. All participants 
completed the Stigma Impact Scale and measures of quality of life and insight, as 
previous literature has indicated these could influence stigma reporting. Semi-structured 
interviews allowed people with Alzheimer’s disease and their supporters to expand on 
their questionnaire responses, as well as explore future outlook in more depth. The 
subsequent section provides a discussion on quality assessment of measures before 
moving on to a more structured description of how these measures were used, following 
people through their study visits, through to the end of data collection and the 
beginnings of data analysis. 
 
Selection of measures: Quality assessment 
 
Establishing research rigour is a fundamental aspect of demonstrating strength of 
outcomes in research (Brown et al., 2015). Combining methods can be time-consuming 
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and is often done in research where a team of researchers are involved (Tariq and 
Woodman, 2013). However, the key benefit of a solo researcher as part of a PhD study 
is a consistent approach. The literature surrounding ‘research rigour’ considers 
quantitative, qualitative, and mixed method research, and how they differ in their 
approach to establishing quality (Seale and Silverman, 1997). Quantitative research is 
described by Seale and Silverman (1997) as focusing more on representative data; 
whereas, qualitative research favours authenticity and the need to accurately capture 
experiences (Seale and Silverman, 1997). Although Seale and Silverman make note of 
mixed-method research, Brown et al. (2015) argue that there remains little consensus 
for establishing rigour in mixed-method research designs.  
Despite this lack of consensus, there is general agreement that the quantitative and 
qualitative methods used within a mixed-method study can be evaluated, with 
‘reliability and validity’ applied to quantitative elements and ‘dependability and 
conformability’ applied to qualitative elements (Bryman et al., 2008). The different 
terms can lead to an assumption that reliability and validity cannot be applied to 
qualitative research; however, Tobin and Begley (2004) highlight that qualitative 
research should still consider these concepts as to reject them could reject rigour and the 
applicability of the scientific process to qualitative methods.   
Interestingly, although there is a tendency to apply reliability and validity to 
quantitative methods a recent paper by Lilienfeld et al. (2015) suggests that researchers 
should be more cautious of using the terms ‘reliable’ and ‘valid’, since the nature of 
science as ‘work in progress’ leads to an inability for findings to be conclusively 
validated or invalidated. Further, the concepts are not unitary; instead they are made up 
of different types of reliability and validity, such as internal and external validity, and 
test-retest reliability. Finally, the reliability and validity of research is not inherent to 
the test itself but conditional on the specific sample (Lilienfeld et al., 2015).  The 
following discusses rigour in relation to the mixed-method research carried out in this 
thesis. 
Reliability of the questionnaire data will be considered through comparison with other 
studies using the same scale in a similar research population. For instance, the Stigma 
Impact Scale scores available for the studies, previously used in power calculations 
(Burgener and Berger, 2008; Liu, 2008; Riley, 2012) will be discussed in relation to the 
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findings of this study in chapter 6. For the interview data, reliability is reflected as 
‘dependability’ (Tobin and Begley, 2004) where a clear ‘auditing trail’ has been kept 
throughout the research process. For instance, interviews were transcribed by the 
researcher, and examples were discussed and reviewed with the supervisory team to 
confirm a logical and clearly documented process for coding and thematic analysis (as 
discussed in chapter 5).  
The validity of questionnaire measures has been discussed in the previous section on 
study measures. Of note, the questionnaires chosen were all previously used in the 
dementia field, and have been adapted for their use with people with Alzheimer’s 
disease and their supporters (Burgener and Berger, 2008; Clare et al., 2002; Sheehan, 
2012). This increases the trustworthiness of scales, which also requires trust in past 
researchers to accurately document their use. According to Golafshani (2003), the 
involvement of several researchers can reduce the validity of a test, and this further 
supports having a consistent, single, researcher administering the questionnaires. All 
questionnaires given to the person with Alzheimer’s disease were read aloud and 
recorded by the researcher. In addition, the questionnaires had all been practiced in 
order to be prepared and consistent when administering them.  
Validity in relation to interview data can be viewed as ‘trustworthiness’ (Tobin and 
Begley, 2004) and incorporates dependability and conformability as previously outlined 
by Bryman et al. (2008). As with reliability discussions, dependability relates to 
providing an ‘auditing trail’ with reflexivity central to this (Tobin and Begley, 2004). 
Throughout the research process, supervision with PhD supervisors allowed for 
continued reflections on the research from initial conception to study visits, analysis, 
and overall write up of the thesis. In addition, separate field notes were made on study 
visits for personal reflections on the visits, as well as study data and summary of visits. 
As well as being reflexive of the research process, experiences of working with people 
with dementia as a Clinical Studies Officer for the SDCRN impacted on the research 
visits. For instance, through SDCRN work, sharing a cup of tea with people with 
dementia and their families to help build relationships was strongly beneficial 
(Ashworth, 2014). In addition, working with people with dementia and recognising the 
importance of familiarity led to small changes such as including a photograph of the 
researcher on all written correspondence, as well as keeping notes about general likes 
and dislikes of participants, allowing for familiar topics of conversation and trust to 
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build. Throughout study visits it was important to participants that the researcher had 
worked with people with dementia previously, as this supported the idea that the 
situation was understood, and that it would not be the first time such stories had been 
heard. This is likely to reduce the risk of people feeling they may ‘shock’ the 
researcher, and therefore withholding important information. Further reflections on 
study visits have been discussed following the study protocol.  
Reflexivity is a concept regularly noted in qualitative research as a way of validating 
research, but less so in quantitative research (Walker et al., 2013). Further, the use of 
reflexivity in quantitative methods may be counterintuitive given the discrepancy 
between objective measures and subjective experience (Ryan and Golden, 2006). 
Despite this, when conducting research with people with dementia, the researcher needs 
to overcome barriers to communication, such as cultural differences, gender, social 
class (Ryan and Golden, 2006), as well as potential symptom-related communication 
difficulties (Alzheimer’s Association, 2015). In order to do this, reflexivity is needed 
across the research process. Reflections on study measures and protocol are discussed at 
the end of chapter 5, before data analysis. Other aspects of reflection are noted in the 
following discussion. 
In addition to reflexivity, confirmability is noted by Bryman et al. (2008) and Tobin and 
Begley (2004) as being an important aspect of trustworthiness and validity of research. 
Confirmability requires researchers to demonstrate that the findings presented are 
clearly evident in the data (Tobin and Begley, 2004). Within this is a need to be aware 
of personal biases and how they may affect the findings (Bryman et al. 2008). As with 
the previous discussions, regular supervision and clear documentation of thought 
processes helped to maintain awareness of such biases and establish agreement that the 
findings were accurately reflecting the data. This included field work diaries, mind-
maps of analysis and potential themes, recorded supervisions and discussion 
summaries. These processes are not without critiques, with some arguing that the nature 
of validity and reliability being tested ‘post-hoc’ means that it may be too late to do 
anything to alleviate error (Morse et al., 2002). However, being aware of these 
challenges from the outset of research should help to alleviate this as much as possible.  
Finally, triangulation is worth noting within quality assessment given its importance in 
mixed method research. Triangulation is often used to address the differences between 
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qualitative and quantitative methods (Tobin and Begley, 2004). However, Olsen (2004) 
argues that triangulation goes beyond validation, and leads to a wider understanding of 
the topic area. In order to achieve this, the findings from questionnaire data and 
interview data will be combined with reference to the research questions in chapters 6 
and 8. As will be discussed in the analysis section, there was an a priori set of codes 
based on the type of questions being asked in the questionnaires and the interview 
schedule (see appendix 6). In addition to this, open coding was used, allowing for 
previously unexplored areas to emerge. Following the quantitative and qualitative 
analysis, conducted separately, the data was brought together by research question and 
is presented across three findings chapters. 
In the following section the study protocol will be outlined to provide a step-by-step 
guide to researchers for how the mixed method study was carried out, before reflections 
in practice, and an overview of data analysis. The level of detail within the protocol is 
an aspect of establishing quality and trust through transparency (Bryman et al., 2008). 
Transparency has been established in this thesis across the two methods chapters, as 
well as through supervision with PhD supervisors, and consultation with a statistician 
with regard to the data analysis intentions and outcomes to reduce the risk of statistical 
errors (Bridge and Sawilowsky, 1999). The quantitative and qualitative data has been 
analysed separately to preserve the integrity of each type of data (Tariq and Woodman, 
2013), before bringing them together based on the research questions, to give an overall 
enhanced understanding of the research phenomenon (Tariq and Woodman, 2013).  
 
 Study protocol 
 
People with Alzheimer’s disease and their supporters were invited to take part in a 
study which explored people’s experiences of living with Alzheimer’s disease. A 
particular focus on attitudes of others, and looking to the future was highlighted. All 
written correspondence with participants contained contact information, and a 
photograph of the researcher to make it easier for people to place the information they 
were receiving with the study. This was particularly important for participants in this 
study, as being part of the SDCRN research register meant that some participants had 
contact from several researchers over the study period. Having clearly identifiable 
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information helped to ease some of the confusion of this, and further added to the 
personalisation of research. The first visits included study information and consent. 
People with Alzheimer’s disease completed the Stigma Impact Scale, MARS-MFS, and 
DEM-QOL with the researcher, whilst supporters completed Stigma Impact Scale, 
MARS-MFS, Zarit Burden Interview, Bristol Activities of Daily Living, and the 
demographic information questionnaire.  
 
Second visits were organised with those selected for interview (see Figure 3). The visits 
were kept informal and open, with the topic guide providing a broad structure for 
experiences to be shared. On completion of the study, all participants were debriefed 
verbally and by letter, including useful contacts such as Alzheimer Scotland (Appendix 
11). A summary of results was sent to all participants following analysis and write up of 
results (Appendix 12). Although the primary purpose of study visits was the completion 
of research measures outlined previously, it was important to make the research 
experience as positive as possible for participants. This is particularly important in non-
therapeutic research, where people may not directly benefit from the study outcomes 
(Berghmans and Muelen, 1995; Higgins, 2013). Further, there is an increased likelihood 
of social isolation amongst this participant group (Alzheimer’s Australia, 2014). 
Therefore, to help people feel that their voices were being heard, additional time was 
added to all visits to allow for general conversation. Taking time to share a cup of tea 
aimed to alleviate some of the social isolation, which has been suggested to impact on 
cognitive functioning (Cacioppo and Hawkley, 2009). In addition, sharing in cultural 
practices such as tea drinking encourages positive relationships to form (Ashworth, 
2014). The aim was to make sure people were left in a positive frame of mind, which is 
particularly important when the study involves emotive topics. The protocol is 
discussed in more detail, with inclusion of the practical and ethical considerations 
which influenced the process. 
 
Initial contact 
 
All potential participants were sent an initial contact letter (see Appendix 7) and phoned 
using the telephone number listed on the SDCRN research register. Letters were sent 
out in hand-addressed envelopes to add personalisation and encourage uptake 
(Choudhury et al., 2012). The letter informed people that they were eligible for a study 
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looking into experiences of Alzheimer’s disease. If they wished to know more about the 
study they could reply using stamped-addressed envelope, phone or email. For those 
who agreed to learn more about what the study involved (see chapter 4 for study 
uptake), information sheets were sent out (Appendix 8a/b). The time, date and location 
of visits were kept as flexible as possible to meet people’s needs. A couple of 
restrictions included, no more than 2 visits in any one day, to reduce researcher fatigue, 
and allow time for processing visits without too much overlap. Additionally, Friday 
afternoon visits were not offered as it was felt that this could leave people with less 
contact opportunity after the visits, should it be needed.  
 
Participants were offered multiple visits to reduce the pressure of completing the study 
in one go. Three possible visits per participant were included in the study design; this 
was deemed enough to make sure there was plenty of time to answer research questions 
and spend time with participants. Finally, people were offered visits in their homes or at 
the University of Stirling. All participants preferred to be seen in their own home. For 
supporters who did not live with the person with Alzheimer’s disease, visits were 
completed at the person with Alzheimer’s disease’s home based on the pair’s 
preferences. 
 
Visit one  
 
Before the first visit, participants were called within 48 hours to confirm that the time 
and date were still suitable. Everyday life can be unpredictable and it was important to 
give people the opportunity to change their visit if they wished. Upon arrival, people 
with Alzheimer’s disease and their supporters were engaged in general conversation 
before focusing more specifically on their current situation. The first visits were not 
audio recorded, although a summary was written after visits. These were particularly 
useful to review before interview visits, by re-familiarising the researcher with the 
situation. They also provided conversational cues which could reinforce feelings of 
familiarity, such as dogs’ names or favourite hobbies.  
 
The purpose of the study was discussed in more detail with both the person with 
Alzheimer’s disease and their supporter, what the study involved, and the ability to 
pause or stop the study at any time without negative consequences was made clear 
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throughout. This discussion fed into the consent process. As noted within inclusion 
criteria (chapter 4), people with Alzheimer’s disease had to have capacity to consent to 
take part in the study. Proxy consent was not deemed appropriate given the measures 
being used. Capacity is not necessarily fixed or predictable based on one factor. It is 
based on a continuum (Cacchione, 2011) and can vary based on daily performance, and 
situational factors such as time of day (McKeown et al., 2010), mood and tiredness 
(Wilkinson, 2002). Therefore despite the list of potential participants provided by the 
SDCRN being of people with capacity, the overall decision was not made without 
further context, and discussion with both the person with Alzheimer’s disease and their 
supporter. 
 
Once it was established that somebody had capacity to give their consent, the secondary 
consideration was that consent was given based on an informed decision. Informed 
consent is defined as the provision of voluntary authorisation given by an individual 
who has the capacity to understand the research protocol, and decide whether to 
participate in research (Black et al., 2008). For people with Alzheimer’s disease it was 
important to make sure they agreed to consent throughout the process. This was 
addressed by applying the model of process consent (Dewing, 2007). This model 
challenges the cultural stereotypes of dementia, which suggest people are not able to 
give consent. Dewing (2007) outlines how consent can be more inclusive and 
appropriate to the needs of people with dementia, and comprises 5 key stages, 
background and preparation, establishing a basis for capacity and other abilities, initial 
consent, on-going consent monitoring, and feedback and support. In essence this brings 
together skills of communication and working together with people with dementia to 
understand how their subjective experiences may influence their ability to consent. A 
copy of the consent form used can be found in Appendix 9. 
After obtaining consent from both the person with Alzheimer’s disease and their 
supporter, questionnaires were given to both. Supporters completed the demographic 
information, the Stigma Impact Scale, the MARS-MFS, the Zarit Burden Interview, and 
the Bristol Activities of Daily Living. The researcher was available throughout to 
answer any questions. The person with Alzheimer’s disease completed the Stigma 
Impact Scale, MARS-MFS, and the DEM-QOL. The questionnaires were completed 
with the researcher reading the questions aloud, and each questionnaire came with a 
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laminated response card for people to refer to. Participants’ energy levels and 
engagement with the questions was monitored throughout, with people regularly being 
asked whether they were happy to continue.  
 
Completion of all questionnaires took around 30 minutes, although all visits were a 
minimum of an hour long to give sufficient time to get to know people, and complete 
measures without them feeling under pressure or rushed. After the questionnaires had 
been completed, the next stage was explained again to all participants. Particular focus 
was on whether people were happy to be contacted about a second visit. It was 
important that everybody understood that they may not be interviewed, but that they 
would hear from the researcher before the end of the study for a more formal debrief 
regardless. Finally, before leaving any of the visits, it was important to recognise that 
much of the discussion could elicit negative memories and emotions for people. It was 
therefore vital to make sure that people felt positive before ending the visit, and knew 
who they could contact if needed. This was another reason to exclude people who could 
not be seen as a pair, as this supportive relationship was important for the wellbeing of 
both the person with Alzheimer’s disease and their supporter.  
 
Visit two 
 
Following the selection of people for interview, participants were contacted and asked 
whether they were still interested in taking part in the second stage of the research. As 
with visit one, time and dates were left as flexible as possible to meet participants’ 
preferences, and confirmed within 48 hours of the visit. A topic guide (Appendix 5) was 
sent out to participants so that they would have an overview of what the interview 
involved, and feel more control over the discussion. All interviews were audio recorded 
to allow the researcher to stay engaged in the conversation and avoid note-taking. As 
with visit one, summaries of the visits were made afterwards to keep note of any 
additional information. These were included in transcript summaries to provide as much 
context to the interview data as possible.   
 
Visits began by recapping what had been happening in people’s lives between visit one 
and visit two. It was important to take the time to let people settle into the interview and 
feel comfortable sharing their stories, particularly as many of the interview topics were 
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emotive and involved sharing personal experiences. As with the first visit, it was 
important that people felt they were being listened to beyond just question answers. 
Having summary notes of previous visits helped to facilitated general discussion and 
emphasised the focus on overall experiences as well as research-specific outcomes. 
Interviews followed a general structure, although they were deliberately left open to the 
subjective experiences of people with Alzheimer’s disease and their supporters. For 
some participants, following the schedule more rigidly was their preferred style, 
whereas others discussed topics through elaborate stories. Remaining responsive to 
individual preferences in communication allowed people to share information in the 
ways that suited them most.  
 
As with the first visits, around one hour was allocated for discussion, however this was 
left flexible to the preferences of participants. As part of ethical practice it was 
important to be aware of fatigue, and both verbal and non-verbal communication of 
wishes to pause the study. For this reason multiple visits were planned into the research 
design. When conducting the research, interviews lasted a minimum of 1 hour, up to 2.5 
hours. For the longer interviews, participants were regularly asked if they wished to 
pause or stop the interview. However, the response was always a preference to continue 
unless the researcher had to leave. This in part reflects the relaxed atmosphere of 
interviews, aiming to learn more about people whilst addressing the study aims. 
Further, it reinforced how for many people the study visit was a significant amount of 
social contact, relative to their normal routine, and as such was encouraged.  
 
When designing the study it was decided that formal compensation would not be issued. 
Monetary incentives can lead people to feel under pressure to participate, or to continue 
in a study when they may wish to withdraw (The Research Ethics Guidebook, 2013). 
Therefore, a thank you gesture was deemed the most appropriate way of acknowledging 
people’s involvement whilst not adding unintended pressure. All interview visits 
included a token gesture of strawberries and gluten-free biscuits. These were chosen as 
foods which should be inclusive of a range of different diets and food preferences.  
 
At the end of the interview, the schedule was looked over to check that all of the topics 
had been picked up, although they did not require equal time spent on each. The final 
processes of the study were explained to people. This included who could be contacted 
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if they had any questions, and when they could next expect to hear more about the 
study. A verbal debrief was given, which included an overview of the study, as well as 
a more general debrief to make sure people were left in a positive frame of mind. 
People were then sent written debrief letters by post, which included additional contacts 
for support should it be needed.  Finally, a summary of results was sent to participants 
once the study had been completed and written up. Research such as Law et al. (2014) 
highlighted that people felt strongly about having clear feedback of results. Further, if 
people participated in research where results were not fed back they felt less inclined to 
participate in future projects (Law et al., 2014). A copy of the debrief letter, useful 
contacts, and summary of results is available in Appendices 10, 11 and 12 respectively.  
 
Reflections on study measures and protocol 
 
The following section reflects on the experiences of data collection, from consent 
through to final visits. The consent process was not always straightforward. For 
instance, Harris
1
 (person with late-onset Alzheimer’s disease, PL3) was very eager to 
take part in the study, and showed clear understanding of what was involved. However, 
when the consent form was presented to Harris he showed significant distress. It was 
explained to Harris that we could share a cup of tea, and I could come back at a later 
date if he wished to consent another time. Whilst sharing a cup of tea, Harris repeatedly 
asked to start the questionnaires. When asked about his previous discomfort over the 
consent form, he disclosed fear of being unable to spell his name. Once he had seen his 
name written down he eagerly signed and continued with the study. Scenarios such as 
this emphasise the complexity of conducting research with people with dementia, and 
supports the use of process consent (Dewing, 2007).   
 
Including additional time for sharing a cup of tea and getting to know participants 
enabled a relationship to build up. The benefits of engaging with participants through 
sharing a cup of tea has been discussed in more detail by Ashworth (2014), which 
highlights the importance of cultural practices in facilitating research visits. It was 
                                                          
1
 Harris is a pseudonym for PL3. See Table 5 for full list of participants and their pseudonyms. 
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important for participants to have time to get used to the researcher and the study 
protocol, as well as helping people feel valued as participants.  
 
As noted within the discussion of study measures, multiple questionnaires were 
included in the first study visit. The Stigma Impact Scale was used as a quantitative 
measure of perceived stigma. This scale has previously been adapted and validated for 
use with people with Alzheimer’s disease (Burgener and Berger, 2008), and was 
therefore chosen to capture people’s experiences. However, it should be noted that at 
the time of study design there were no alternative scales (following literature review) to 
measure perceived stigma, validated in this population. There is limited previous 
research with the scale, and the research available does not provide detailed critique of 
its use (Chapman, 2011; Liu, 2008; Riley, 2012). As will be discussed in more detail 
within the results (chapter 6), the scale is missing areas such as the negative attitudes of 
healthcare professionals, which were important to the participants within this study. 
Despite the potential challenges of the scale, first study visits, which included 
questionnaires, demonstrated several positives which support the use of the Stigma 
Impact Scale for exploring stigma. In terms of time feasibility, more people could be 
involved in visit 1 than visit 2, leading to a wider range of data being available. In 
addition, the less intrusive nature of the questionnaires compared to interviews 
(Benjamin Darling, 2006) enabled relationships to build up with participants in order to 
develop trust and openness for the second visits. This is particularly beneficial when 
conducting interviews on emotive topics. Therefore, in addition to providing relevant 
data, visit 1 supported an ethical approach to introducing stigma before exploring the 
topic in-depth at visit 2. 
 
During the study visits the time-referencing of questionnaires emerged as an interesting 
aspect of the tools that was potentially important. For instance, the DEM-QOL (Smith 
et al., 2005) asks participants to describe their emotions over the past week. When 
documenting the development of the scale, Smith et al. (2005) highlight that the 
appropriateness of the time-frame question was assessed. However, they go on to note 
that pre-testing indicated variation in the ability of people with dementia to use this 
specified time. It was concluded that although data from some people with dementia 
may be unreliable, it was still important to keep a time reference for people with 
dementia who were able to use it (Smith et al. 2005). The DEM-QOL specifies a period 
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of a week as being a practical time reference for people with mild dementia, and the 
time reference is indicated in each question to maintain its salience.  
Other scales which have been adapted for use with people with dementia use longer 
time references, including the Stigma Impact Scale (Burgener and Berger, 2008), which 
measures perceived stigma, and asks participants to describe their experiences from the 
past three to four weeks. Similarly, scales used by a supporter to rate a person with 
dementia’s daily activities, such as the Bristol Activities of Daily Living scale (Bucks et 
al., 1996), have a two-week time reference. Of interest, is whether people are using this 
time reference, and if variation in its use amongst participants is a problem. Scales such 
as the Bristol Activities of Daily Living (Bucks et al., 1996) includes items which relate 
to time orientation, such as how aware a person is of the date/time of day. Such 
symptomatology suggests that considering how people place themselves in time may 
influence the way they answer questionnaires with a specific time reference.  
Despite acknowledging the reliability concerns of including a time reference, Smith et 
al. (2005) kept it in the questionnaire design. Other questionnaires used for people with 
dementia have not included such time restrictions, such as the Memory Functioning 
Awareness scale (Clare, 2002). However, when discussing the development of such 
measures, Clare et al. (2011) do not mention whether this exclusion was a deliberate 
choice. The importance of time reference is largely dependent on what questions are 
being asked. For example, if a cross sectional study looking at people’s experiences of 
stigma was conducted, different participants’ use of the time reference might not affect 
reliability. However, if a longitudinal study wanted to look at whether the experiences 
of stigma have changed over time for a person or group, the time-frame becomes an 
important variable. Similarly, if cross sectional research was looking at stigma relative 
to length of time since diagnosis, participants would need to be reliable in their time 
referenced recall. McDonald et al. (2003), in their discussion of questionnaire design, 
noted that assuming that respondents are able to answer questions relating to their past 
is a mistake, acknowledging that participants may not have access to the information to 
recall, or have the information but cannot recall it from the fixed time reference given. 
The literature highlights that future research with these measures could benefit from 
including greater discussion on the importance of time-frame references, as this could 
have implications for the validity of scales. Although it is important to be aware of 
these limitations, the BADL scale (Bucks et al., 1996) is world-leading for research 
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with people with dementia (Sheehan, 2012), and DEM-QOL (Smith et al., 2005) is 
noted to have ‘comparable psychometric properties to the best available instruments’ 
and is validated with a UK population (Sheehan, 2012:354). Therefore, these tools were 
chosen for this study. 
 
During questionnaires, people often went into great detail about the reasons behind their 
answers, with some expressing frustration that the questionnaires did not always give 
them room to include these experiences. However, they were reassured that the study 
included interviews, whether with them or others. They also appreciated having the 
opportunity to share their stories while doing the questionnaires, even if these stories 
would not be included in the findings data. Further, several people added that they 
appreciated questionnaires being completed in the presence of the researcher. Many had 
experience of postal questionnaires, but had felt frustrated by these as they did not give 
them the opportunity to share their views adequately. It was noted when deciding which 
questionnaires to use in this thesis, that cognitive tests would not be used, as recent 
research emphasises the distress that people with Alzheimer’s disease can experience 
doing these tests (Mograbi et al., 2012). Further, cognitive test scores were not seen as 
being reflective of everyday experiences, compared to scales such as activities of daily 
living, which are more functionally focused (Sheehan, 2012). Not using cognitive tests 
was acknowledged by many participants as something they were pleased about, with 
several participants suggesting more appropriate ways of ‘testing’ the memory 
difficulties they were facing. For example, Lily (SL3), Holly (SL12) and Sophie (SL15) 
all noted that questions such as the cost of bread or handling money would be better 
indicators of the difficulties they are experiencing. Lily and Holly both added how 
Harris (PL3) and Millie (PL12) had ‘sailed through’ their memory assessments when 
seeking a diagnosis, scoring highly on the cognitive tests, despite their memory 
difficulties significantly impacting on everyday life. Importantly, not using cognitive 
assessments does not necessarily mean that participants did not feel ‘tested’ by the other 
questionnaires, which may have led them to answer differently to how they did in 
interview where the format is more conversational. Despite the limitations of 
questionnaires, in particular the fixed-choice answers which may not reflect the 
participants’ underlying concerns, they allow for a structured approach to collecting 
data quickly and give more time for the researcher to focus on getting to know the 
participants and surrounding context, which is particularly useful when building up 
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relationships for multiple-visit research. Questionnaires also allow for direct 
comparisons with previous research and relevant applications to time-pressured clinical 
environments, which is a common feature of health research (Westbrook et al., 2008). 
Finally, although interviews were audio-recorded, on a couple of occasions the 
supporter added comments as the researcher was leaving. This was mainly due to 
wanting to share additional information away from their loved one, for fear of upsetting 
them. With the permission of the supporter, this information was also recorded as part 
of the transcripts whilst noting it was collected without the audio recording.  
 
Data Analysis Procedure 
 
Once all of the data had been collected, the data were analysed using various methods 
based on the measures used. The following outlines the data analysis procedure used to 
address the four research questions this study aimed to explore and answer. An 
overview by question is provided in Table 4, before a more detailed explanation of the 
analysis. This is followed by the findings chapters, presented by research question in 
keeping with the epistemological stance of mixed methods research prioritising the 
research questions over the quantitative or qualitative nature of measures.  
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Table 4. Summary of data analysis process by research question 
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Analysis process 
 
To assist with the data analysis process, two software programmes were used. SPSS 21 
statistics software was used for statistical analysis of questionnaire data, as well as for 
discriminant analysis of group variables. NVivo 10 was used as a data management tool 
for the interview data. NVivo 10 does not analyse the data but contains tools which can 
facilitate the analysis, such as coding matrices. In order to use the software effectively, 
the qualitative analysis procedure had to be chosen beforehand. The type of analysis 
chosen depends on the methodology, the research questions being addressed, and the 
timing of the analysis within the research design. For instance, if an ethnographic 
approach is taken, the data is more likely to be analysed simultaneously with the data 
collection (Marshall and Rossman, 1999), whereas this thesis included sequential 
analysis as part of the mixed-method design. For the purpose of this study, thematic 
analysis was chosen, the reasons for which are discussed in the following section. Other 
similar approaches to analysis were also considered. For example, content analysis, 
which has many overlapping features with thematic analysis (Vaismoradi, 2013), could 
allow for quantification of interview data (Smith, 2000) but would potentially make it 
more challenging to notice unexpected themes in the data, relying more heavily on 
preset codes. Additionally approaches which require a higher level of interpretation 
such as grounded theory were also noted (Vaismoradi, 2013). However, these 
approaches were discounted as the research aimed to limit the level of interpretation put 
on the data by the researcher, so that people’s voices and experiences were not lost. 
A final alternative that could have been used for this type of research is interpretative 
phenomenological analysis. The strength of this approach is that it aims to ‘give voice’ 
to participants, allowing them to tell their story (Smith et al,, 1997) and make sense of 
their concerns (Larkin et al., 2006). Alongside this the approach is interested in how the 
researcher’s interpretation influences the analysis and data (Cassidy et al., 2011). 
Interpretative phenomenological analysis is based upon phenomenological theory, 
interpretation or hermeneutics, and ideography (Smith et al., 2009). The approach is 
concerned with the individual’s perception of a phenomenon (Smith et al., 1997), and 
has been applied to conditions such as dementia (Clare et al., 2008), as well as research 
which sits within a biopsychosocial perspective (Biggerstaff and Thompson, 2008).  
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Despite many positive aspects of interpretative phenomenological analysis, this thesis 
does not take a purely phenomenological approach where the subjective is focused on 
over objective accounts, (Brocki and Wearden, 2006). Instead, the thesis considers 
experiences of Alzheimer’s disease as containing both objective and subjective realities. 
Interpretative phenomenological analysis avoids prior assumptions and explores the 
meaning of experience (Reid et al., 2005). Whereas, this thesis aims to be both 
explanatory and exploratory in terms of stigma and future outlook, and as such the 
interviews are not only acting as a prompt, but are in part prescriptive in answering 
specific questions, which does not fit with interpretative phenomenological analysis 
(Biggerstaff and Thompson, 2008). Further, this thesis is exploring specific aspects of 
the experiences of Alzheimer’s disease, which is more structured than a focus on 
overall lived experiences. Therefore, thematic analysis is more appropriate for this 
thesis, with interpretative phenomenological analysis potentially being more applicable 
to a study exploring experiences more generally. Thematic analysis will now be 
discussed in more detail including the process used in this thesis, before moving onto 
the findings chapters. 
Thematic analysis 
Thematic analysis is “a method of identifying, analysing and reporting patterns within 
data.” (Braun and Clarke, 2006:79). This approach was chosen as the preferred method 
of data analysis in this study for several reasons: firstly, the approach is flexible, 
without needing to be fixed by a particular theory (Braun and Clark, 2006). This is 
useful in the case of this study where the research questions explore an area with novel 
focus. Further as the study used mixed methods, the interview data are more structured, 
based on the need to confirm/refute the evidence collected from the questionnaires.  The 
combination of inductive and deductive coding and theme development has been 
supported by research such as Fereday and Muir-Cochrane (2006), who used the 
approach to understand data from interviews as well as organisational documents.  
Secondly, Braun and Clark (2006) argue that thematic analysis is a useful approach to 
PhD research, given its accessible nature. It is important to be realistic about what can 
be done with the data, given the time and resources available. As such, an accessible 
approach allows for as much time as possible being allocated to analysis, rather than 
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focusing more heavily on the theoretical and technological knowledge (Braun and 
Clarke, 2006).  
Previously, it has been argued that thematic analysis is not an appropriate stand-alone 
approach for analysis, despite the fact is a widely used approach (Spencer et al., 2003). 
The main reason cited for this is a lack of transparency in discussing qualitative data 
analysis (Spencer et al., 2003), with thematic analysis being implied rather than 
explicitly stated. In order to challenge this, the process by which the analysis of this 
study has been done has been kept as clear as possible, enabling others to see how each 
step was reached.  
 
Thematic Analysis Process 
 
The following describes the thematic analysis used in this study in more detail. Firstly, 
all interviews were transcribed by the researcher during the data collection process. 
This made it easier for areas of audio which were harder to transcribe to be remembered 
and accurately recorded. Further, non-verbal communication when appropriate could be 
added. Transcribing as soon as possible after the interview enabled focus on individual 
interviews, and meant that had there been any problems with hearing the audio, 
participants could be contacted fairly easily to confirm answers. All participants 
expressed they would be happy to be contacted for this purpose. The transcriptions were 
written verbatim.  
Following transcription, an initial code book was developed. There are various 
approaches to coding qualitative data: A theoretical approach is a ‘top down’ approach, 
meaning there are predetermined codes to look for based on the theoretical background 
of the study. Comparatively, an inductive approach is data driven, or a ‘bottom-up’ 
approach, where there is not a set coding frame. Such an approach is aimed at removing 
the researcher’s theoretical position before the data have been analysed. However, 
Braun and Clarke (2006) highlight that it is not possible to remove this completely. It is 
important that having an a priori set of codes does not blinker the researcher from 
considering conflicting or miscellaneous data (King, 2004). Despite the concerns raised 
about having a priori codes, an initial code book was chosen over open coding as there 
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were already set questions asked in each interview. These reflected the research 
questions of the study, and were informed by previous research literature. It was felt 
that by acknowledging that these codes would be there, additional codes were more 
likely to be noticed.  
The initial code book was made up of 11 codes, based on the interview schedule: 
Family relationship changes, friend relationship changes, public perception of 
Alzheimer’s disease, reaction to diagnosis, information received, support services, 
advance care planning, changing futures, hopes, fears, and coping. These were not 
meant as fixed codes, but as starting points for looking through the data. Following the 
transcription, additional codes were added to cover areas which had emerged 
throughout the interviews. Acknowledging that such codes had already formed for the 
researcher while transcribing, keeps the process transparent. A summary of codes can 
be seen in Appendix 13. 
The next stage was to read through each script twice and write a summary of the 
interview in order to facilitate being fully immersed in the data, as well as correct any 
typing errors. The interview scripts were then separated into people with early and late-
onset Alzheimer’s disease to allow for more exploration of possible age differences. 
Each script was taken one at a time and initial coding took place. This included noting 
the codes previously outlined as well as any additional codes. Some data was assigned 
multiple codes. Some of these were allocated a singular code upon further revision; 
others were kept across multiple codes. Further, during revisions the key statements 
within larger chunks of coded text were highlighted. 
Following the generation of initial codes, potential themes were considered based on 
the collation of codes, as discussed by Braun and Clarke (2006). The themes were then 
reviewed to reflect both the chunks of data and the entire data set. Once themes had 
been identified and refined, they were named and prepared for reporting (Braun and 
Clarke, 2006). These themes have been separated into the research questions which they 
answer, and are discussed in more detail within the findings. Finally, throughout the 
analysis process PhD supervisors reviewed samples of transcripts and the assigned 
codes. Group discussions strengthened the overall analysis, increasing the validity of 
the process and findings. The remainder of the chapter focuses on how the discussed 
analysis has been applied to the individual research questions. 
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Do people with Alzheimer’s disease and their supporters experience stigma? 
 
Several research measures were used to explore whether people with Alzheimer’s 
disease and their supporters experienced stigma.  Firstly, the mean scores from the 
Stigma Impact Scale for each person within the four groups were generated (people 
with early and late-onset Alzheimer’s disease, and supporters of people with early and 
late-onset Alzheimer’s disease). These scores were compared to previous studies scores 
on perceived stigma to consider similarity of findings. Descriptive statistics were 
brought together with demographic information to consider possible interactions. These 
interactions were explored using a covariate analysis (ANCOVA), a frequently used 
method for research designs when there are variables which could not be controlled, but 
may impact on the outcomes (Rutherford, 2001). ANCOVAs allow for the possible 
influence of the additional measures taken on Stigma Impact Scale scores including: 
demographic information, quality of life and insight. As discussed within study 
measures, mean scores of the Stigma Impact Scale alone do not provide a 
comprehensive picture of stigma using this measure. As such, a multivariate analysis of 
covariance (MANCOVA), an extension of ANCOVA, was conducted to compare the 
experiences of people with Alzheimer’s disease and their supporters across the four 
subcategories of the Stigma Impact Scale.  
 
As well as the questionnaire measures and subsequent analyses, thematic analysis of the 
interviews explored experiences of stigma. Several of the topic guide ideas related 
specifically to stigma including reaction of family and friends to diagnosis, and 
experiences of Alzheimer’s disease. The guide allowed for several codes to be made 
before open coding. A full list of codes is available in Appendix 13. Interview data 
were synthesised to reflect experiences of stigma, as well as provide examples to 
illustrate the stigma categories of the Stigma Impact Scale.   
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How do people with Alzheimer’s disease view and plan for the future? 
 
Semi-structured interviews explored how people look to the future. Accordingly, a level 
of analysis which allows for greater understanding theoretically, whilst preserving the 
voices of people affected was preferred. Thematic analysis was therefore the primary 
route to understanding how people with Alzheimer’s disease view and plan for the 
future. Preliminary codes were created from the literature, and additional codes were 
formed following data collection, as shown in Appendix 13.  
Is there an association between levels of perceived stigma and how a person views and 
plans for the future: for both people with Alzheimer’s disease and their supporters? 
Analysis of this research question required bringing together the data from 
questionnaires and interviews discussed in the previous questions. The scores on the 
Stigma Impact Scale and the stigma reporting at interviews were  looked at to see if 
there was any correlation with how a person views and plans for the future. 
 
Are there differences in experiences, in terms of both stigma and future outlook, for 
people experiencing early-onset Alzheimer’s disease and late-onset Alzheimer’s 
disease? 
 
Finally, the fourth research question aimed to get an overall picture of age-based 
differences in perceptions of stigma, and future outlook. Stigma Impact Scale scores 
(mean and subcategory scores) were compared for people with early and late-onset 
Alzheimer’s disease, and for supporters of people with early and late-onset Alzheimer’s 
disease. This included t-tests, multiple regression analysis, and ANOVAs. Notably, 
there was limited statistical power due to difficulties in recruiting the desired sample 
size. Therefore, the generalizability of the significance of age-based questionnaire 
results should be treated cautiously. As with the questionnaire measures, interview data 
were also explored for age-related similarities and differences between experiences 
people shared for stigma and future outlook. 
 
118 | P a g e  
 
Analysis Chapters Overview 
 
The findings chapters have been structured according to the first three research 
questions, with age-based differences presented across the three findings chapters to 
show how they weave through experiences as a whole. Importantly, it was preferable to 
have quantitative data presented with qualitative data, as numbers alone can 
depersonalise the findings. Further it reflects the discussions in chapter 4, which support 
prioritisation of research questions over research paradigms.  
As it was central to the research to hear the voices of those affected, maintaining a 
sense of the person across methods was key. Table 5 provides an overview of 
characteristics for people with Alzheimer’s disease and their supporters, with summary 
scores presented in the analysis. All of the participants’ names were changed to protect 
their privacy and anonymity. Further, during transcription of interviews some of the 
details were changed if they were identifiable. Table 5 also presents the pseudonyms of 
all of the participants who took part in the study. Identifiers were attached to data for 
example PE5 and SE5, or PL5 and SL5, with ‘P’ referring to person with Alzheimer’s 
disease and ‘S’ referring to supporter. ‘E’ identifies early-onset Alzheimer’s disease, 
and ‘L’ identifies late-onset Alzheimer’s disease. Participants in bold took part in both 
questionnaires and interviews. All other participants completed questionnaires only.  
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People affected by late-onset Alzheimer’s disease People affected by early-onset Alzheimer’s 
disease 
Pseudonyms and 
ID 
Age Gender Time 
living 
with 
diagnosis 
/years 
SIMD 
score 
Pseudonyms 
and ID 
Age Gender Time 
living 
with 
diagnosis 
/years 
SIMD 
score 
David (PL1) 74 M 8 10 James 
(PE1) 
60 M 1 9 
Poppy (SL1) 66 F Eva (SE1) 61 F 
Grace (PL2) 73 F 8 9 Stewart 
(PE2) 
67 M 7 8 
Michael (SL2) 74 M Jean (SE2) 67 F 
Harris (PL3) 87 M 8 7 Toby (PE3) 69 M 8 3 
Lily (SL3) 58 F 8 Katie (SE3) 55 F 
Isla (PL4) 77 F 2 6 Charlie 
(PE4) 
66 M 2 8 
Hamish (SL4) 77 M Emma 
(SE4) 
66 F 
Oliver (PL5) 80 M 8 3 Murray 
(PE5) 
66 M 2 10 
Isobel (SL5) 56 F 5 Lucy (SE5) 60 F 
Bernie (PL6) 86 M 6 8 Jack (PE6) 52 M 1 4 
Janice (SL6) 82 F Olivia 
(SE6) 
47 F 
Alfie (PL7) 77 M 5 8 Matthew 
(PE7) 
63 M 4 5 
Theresa (SL7) 77 F Olivia 
(SE7) 
60 F 
Graham (PL8) 91 M 1 6  
Morag (SL8) 64 F 
Archibald (PL9) 83 M 2 3 
Edith (SL9) 78 F 
Emily (PL10) 80 F 9 7 
Cameron (SL10) 77 M 
Morag (PL11) 88 F 11 6 
Nigel (SL11) 88 M 
Millie (PL12) 89 F 5 9 
Holly (SL12) 53 F 10 
Dorothy (PL14) 85 F 4 10 
Stephen (SL14) 83 M 
Angus (PL15) 80 M 6 10 
Sophie (SL15) 82 F 
Douglas (PL16) 80 M 2 10 
Ginny (SL16) 75 F 
 
Table 5. Summary of all participants from the study including age, gender, time 
living with diagnosis, and socioeconomic status shown by SIMD score. 
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As well as providing demographic information that could be recorded quantitatively as 
shown in Table 5, short biographies of people interviewed are presented in Table 6 to 
increase their salience throughout the following analysis chapters.  
David and Poppy (L1) 
 
David and Poppy are husband and wife. Their faith is very important to them, and they 
are very active members in their community. Poppy has managed many of the 
challenges associated with Alzheimer’s disease by empowering herself to take on new 
skills. 
Grace and Michael (L2) 
 
Grace and Michael are husband and wife. Grace enjoys painting and takes great pride in 
sharing her work. Michael is very independent and hardworking, with traditional values 
for his family. He was very keen to know lots of information and be well informed.  
Harris and Lily (L3) 
 
Harris and Lily are father and daughter. Harris is described as a ‘family man’, who 
cares a lot about being a good father and making sure those around him are happy. Lily 
enjoys socialising with friends, and supports both her mother and father.  
Isla and Hamish (L4) 
 
Isla and Hamish are husband and wife. They like to be actively involved in the 
community and the groups available in their area. They have had experience of social 
discrimination in the past, and as such have built up a lot of resilience to the challenges 
they now face.  
Oliver and Isobel (L5) 
 
Oliver and Isobel are father and daughter. They are from a very close-knit family and 
work together to support each other. Isobel is very protective of Oliver and finding 
activities which make him happy. Oliver likes to be the person people ask for advice, 
and likes to stay well informed.  
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Emily and Cameron (L10) 
 
Emily and Cameron are husband and wife. They are a very independent couple. 
Cameron is very practical, and enjoys gardening and golf. Emily enjoys painting, as 
well as activities such as tennis and swimming.  
Millie and Holly (L12) 
 
Millie and Holly are mother and daughter. They have a strong sense of family values 
and responsibility. They both have a strong faith which has given them strength 
throughout the challenges they have faced.   
Angus and Sophie (L15) 
 
Angus and Sophie are husband and wife. They are very driven by their faith, and 
actively engage in charitable opportunities. Although they had different avenues of 
support, they prefer to do things ‘their way’.  
Eva and James (E1) 
 
Eva and James are husband and wife. They were very keen to show how people can 
continue to ‘live well with dementia’. James likes to stay active, and prefers one-to-one 
activities. Eva and James enjoy travelling, and go on holiday as much as possible. 
Toby and Katie (E3) 
 
Katie and Toby are husband and wife. Katie has used many of the challenges she and 
Toby have faced to empower herself as much as possible. Both Katie and Toby adore 
their pets, who have acted as a great source of comfort through the difficult times.  
Emma and Charlie (E4) 
 
Emma and Charlie are husband and wife. Emma enjoys spending time with a close 
group of friends, meeting up for tea and coffee on a regular basis. Charlie finds his 
reduced independence very difficult as he is a very active independent man, who is very 
proud of his sporting achievements.  
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Murray and Lucy (E5) 
 
Murray and Lucy are husband and wife. Murray enjoys entertaining, and being in front 
of an audience. Lucy and Murray have focused on what they can do despite the 
condition, both having a ‘bucket list’ of things they hope to do.  
Jack and Olivia (E6) 
 
Jack and Olivia are recently married. They have shown a lot of strength and resilience, 
having to face multiple hurdles in a short space of time. Jack was very proud of his 
work, and the camaraderie that comes with it. Both Olivia and Jack were keen to 
change stereotypes of what it meant to live with dementia.  
Matthew and Jennie (E7) 
 
Matthew and Jennie are husband and wife. They both find humour is very important in 
managing their situation. Both chose to focus on the positives in their situation, and 
grounded themselves with their faith. There was a strong sense of partnership between 
them, and working together to make the best of things.   
Table 6. Summary of interviewed participants’ biographies 
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Chapter 6- Do people with Alzheimer’s disease and their supporters experience 
stigma? 
 
The following chapter presents findings from the study relating to experiences of 
stigma. As described in the data analysis overview (chapter 5), a range of statistical 
tests were completed using SPSS 21 software. SPSS outputs can be found in Appendix 
14. Questionnaire answers were then explored in combination with interview data, 
before a broader thematic analysis of interview data in relation to stigma. 
Table 7 provides a summary of Stigma Impact Scale scores for people with Alzheimer’s 
disease and their supporters. Scores are presented alongside mean scores and standard 
deviations for the covariates used in the subsequent analysis.  Measures explored 
perceived stigma, quality of life, insight, and activities of daily living. The choice of 
covariates and their supporting literature can be seen in chapter 5. 
 Perceived 
Stigma 
/Mean 
stigma 
impact 
score 
Insight  
MARS-MFS/ mean scores 
Quality of Life/ 
mean scores 
Bristol 
Activities 
of Daily 
Living/ 
mean 
scores 
Person with 
Alzheimer’s 
disease 
(Self-
Report) 
Supporter 
(Informant) 
Discrepancy DEM-
QOL 
Zarit 
Burden 
Interview 
People with 
Alzheimer’s 
Disease 
38.36 
(SD 6.41) 
30.41 
(SD 10.69) 
- 18.72 
(SD 11.58) 
97.73 
(SD 
11.18) 
- - 
Supporters 29.45 
(SD 15.70) 
- 15.14 
(SD 12.15) 
18.72 
(SD 11.58) 
- 17.00 
(SD 8.73) 
23.86  
(SD 
12.23) 
Table 7. Summary scores for people with Alzheimer’s disease and their supporters 
used for multiple regression analysis of Stigma Impact Scale scores. 
 
Firstly, comparative analysis of perceived stigma for people with Alzheimer’s disease 
and their supporters was conducted.  When comparing the two groups, they could be 
viewed as independent or matched based on the relationship they share, therefore it was 
deemed appropriate to include ‘independent-sample’ and ‘matched-sample’ analyses for 
the initial comparison. A correlation analysis for people with Alzheimer’s disease and 
their supporters suggested a significant correlation between Stigma Impact Scale scores 
124 | P a g e  
 
(r(42) = -0.355, p = 0.018). The scores were considered in more detail with t-test 
analyses.  
A matched-sample t-test found significantly different results between people with 
Alzheimer’s disease and their supporters, t(21)= 2.643, p=0.015. This significance 
remained when the two groups were considered separately with an independent-samples 
t-test, t(42)= 2.464, p=0.007.  The t-tests suggest that there is a significant difference 
between the amount of stigma reported on the Stigma Impact Scale by people with 
Alzheimer’s disease and their supporters, when viewed independently and as matched 
pairs. For the remainder of the analyses the people with Alzheimer’s disease and their 
supporters have been considered as independent groups. This was viewed as the most 
suitable option as different questionnaires were completed for covariates such as quality 
of life, and perceived stigma reflected their own experiences of stigma, as opposed to 
their view of their loved one being stigmatised. Further, a discriminant analysis of the 
demographic variables for people with Alzheimer’s disease and their supporters was 
carried out.  Variables age, gender, and socioeconomic status were included in the 
analysis.  The overall Chi-square test was significant (N= 44, Wilks λ = 0.701, Chi-
square = 14.372, df = 3, Canonical correlation = 0.547, p = 0.002), suggesting that the 
two groups can be viewed independently.   
Table 8 presents the variables which were included in an analysis of covariance 
(ANCOVA) for comparing Stigma Impact Scale scores of people with Alzheimer’s 
disease and supporters. This test explored whether the significant difference observed in 
the t-tests remained when possible covariates (age, socioeconomic status, and gender) 
were included. ANCOVA produced significant results, F (1, 39)= 2.895, p=0.034, with 
an observed power of 0.729.  The findings suggest people with Alzheimer’s disease 
reported higher levels of stigma than their supporters. Further, this difference is not 
explained by age, socioeconomic status or gender. These findings match the direction of 
difference in previous research (Batsch and Mittleman, 2012; Werner and Heinik, 
2008).   
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 Mean Stigma 
Impact Scale 
score 
Mean 
Age 
/Years 
Mean 
socioeconomic 
status 
/ SIMD Decile 
Gender 
Ratio/ 
Male: 
Female 
People with 
Alzheimer’s 
disease 
38.36  
(SD 6.41) 
76.05 7.23 16:6 
Supporters 29.45  
(SD 15.70) 
68.45 7.41 5:17 
Table 8. Mean scores for people with Alzheimer’s disease and their supporters 
used for ANCOVA of Stigma Impact Scale scores. 
 
Perceived stigma and age-based experiences 
 
Age-based differences in mean stigma impact scores were explored for people with 
Alzheimer’s disease and supporters, before looking at questionnaire scores in more 
depth. Table 9 presents the summary scores on the Stigma Impact Scale by age 
category. However, conclusions from this analysis should be taken with caution given 
the sample size and difference between group numbers.  
 Mean Stigma Impact Scale score Standard deviation  
People with Alzheimer’s disease 38.36 6.41 
Early-onset 37.86 10.45 
Late-onset 38.60 3.83 
Supporters 29.45 15.70 
Early-onset 36.29 11.87 
Late-onset 26.20 14.48 
Table 9. Summary scores of Stigma Impact Scale, for people with early and late-
onset Alzheimer’s disease and their supporters.  
 
An independent-samples t-test suggested significant differences in perceived stigma 
reported by people with early and late-onset Alzheimer’s disease (t(20)= -0.247, p= 
0.005). This suggests higher reporting of stigma for people with late-onset Alzheimer’s 
disease. The comparison was explored more robustly through the inclusion of possible 
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covariates. As discussed within study measures in chapter 5, several variables have 
been identified as potentially influencing stigma reporting. Therefore, scores from the 
covariate questionnaires were included in a regression model to observe whether the 
significant difference between people with early and late-onset Alzheimer’s disease 
remained.  
Perceived stigma, measured by Stigma Impact Scale mean score was the dependent 
variable, with insight scores (self-report and discrepancy), quality of life, 
socioeconomic status, gender, time since diagnosis in years, age, and activities of daily 
living included as variables.  A significant association was found for socioeconomic 
status measured by SIMD decile, and quality of life measured by DEMQOL score, 
F(8,13) = 3.146, p=0.033, R
2
= 0.659. The direction of the coefficients in the regression 
model suggests that as socioeconomic status decreases, indicating increased levels of 
deprivation, perceived stigma reporting increases (β = -0.511, p=0.030). Similarly, as 
quality of life decreased, perceived stigma reporting increased (β == -0.526, p=0.041). 
The multiple regression analysis for people with Alzheimer’s disease suggests that 
perceived stigma is influenced by socioeconomic status and quality of life. Further, age 
was not significantly associated with stigma reporting in this model (β = 0.051, p= 
0.795).  
These findings suggest that although the t-test produced significant results between the 
two age groups, stigma reporting is associated more with the quality of life and 
socioeconomic status of participants over age itself. Figure 5 illustrates that people with 
late-onset Alzheimer’s disease had higher scores on average for quality of life (Mean= 
98.67, SD=9.62) than people with early-onset Alzheimer’s disease (Mean= 95.74, 
SD=14.66). Further, people with late-onset Alzheimer’s disease had higher 
socioeconomic status scores (Mean= 7.47, SD=2.36) as shown by SIMD decile, 
compared to people with early-onset Alzheimer’s disease (Mean= 6.71, SD=2.69). 
Overall the findings suggest that the difference in perceived stigma reporting on the 
Stigma Impact Scale for people with Alzheimer’s disease is based on quality of life and 
socioeconomic status.  
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Figure 5. Average quality of life and socioeconomic status scores for people with 
early and late-onset Alzheimer’s disease.  
 
The previous analyses were repeated for supporters’ data. An independent sample t-test 
produced non-significant differences for perceived stigma, measured by Stigma Impact 
Scores, for supporters of people with early and late-onset Alzheimer’s disease (t (20)= 
1.428, p=0.420). This was followed by a multiple regression with the variables age, 
socioeconomic status, gender, quality of life, time since diagnosis in years, activities of 
daily living, and insight (informant and discrepancy), considered in relation to 
perceived stigma. The multiple regression analysis showed significant results overall, 
F(8,13) = 2.705, p=0.05, R
2
= 0.625 (see appendix 14 for SPSS outputs). The difference 
in significance between the t-test and regression analysis can be explained through 
inclusion of quality of life scores, as this was the only significant variable within the 
model (β = 0.512, p=0.026). Increased quality of life measured by the Zarit Burden 
Interview, was associated with a reduction in Stigma Impact Scale scores, reflecting 
perceived stigma. This supports the pattern seen for people with Alzheimer’s disease. 
Overall, the findings suggest there were not significant differences in the amount of 
stigma reported by supporters of people with early and late-onset Alzheimer’s disease 
based on age.   
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Finally, in order to draw conclusions from the mean results presented, scores were 
compared to previous literature. Mean Stigma Impact Scale scores for people with 
Alzheimer’s disease and their supporters are presented in Table 10, alongside mean 
scores obtained from previous research using the Stigma Impact Scale in this area. For 
people with Alzheimer’s disease, mean Stigma Impact Scale scores from the literature 
were 42.7, 39.93, and 39.94, with standard deviations of 9.0, 10.33 and 9.89 
respectively. Mean scores from the Burgener and Berger (2008) and Riley (2012) 
papers suggest similar results to this study. Similarly, scores for supporters of people 
with Alzheimer’s disease were compared to those obtained by Liu (2011), showing 
mean scores differing by 0.13.  The similarity of the study findings to those in previous 
literature support the validity of conclusions that people with Alzheimer’s disease and 
their supporters experience stigma.   
 
 Number of 
participants 
Mean Stigma 
Impact Scale score 
Standard 
deviation 
People with Alzheimer’s disease 
This study 22 38.36 6.41 
Burgener and Berger (2008)  26 42.70 9.0 
Riley (2012) 
(Mean scores for two study 
visits) 
43 39.93 10.33 
39.94 9.89 
Supporters of people with Alzheimer’s disease  
This study 22 29.45 15.70 
Liu (2011) 51 29.58 10.83 
Table 10. Summary of mean scores and standard deviations of study against scores 
from the literature. 
 
Although the mean responses appear similar across studies, the interpretation has to be 
taken with caution. Burgener and Berger (2008) discuss the mean score of people with 
Alzheimer’s disease relative to the score of people with Parkinson’s disease. Similarly, 
Riley (2012) and Liu (2011) discuss how Stigma Impact Scale scores correlate with 
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other variables. However, there has not been clear discussion on the score threshold for 
experiencing stigma. For instance, if the mean results are considered on their own, they 
could be interpreted as reflecting low levels of stigma.  As discussed within study 
measures (chapter 5), the Stigma Impact Scale is made up of 24 questions, with 5 
responses: not applicable (scores 0), strongly disagree (scores 1), disagree (scores 2), 
agree (scores 3), and strongly agree (scores 4). The highest score is 96, which indicates 
that people have strongly agreed with all statements, and therefore reported the highest 
amount of stigma. If the threshold is considered as the majority of answers reflecting 
experiences of stigma, the minimum score for  agreeing to more questions than 
disagreeing would be 50 (13 agree, scoring 3 each, and 11 disagreeing, scoring 1 each). 
This presents an inconsistent picture given that the mean scores for all of the studies 
presented were below 50. If stigma reporting was high, it would be conceivable to 
expect a higher mean. This does not mean that the conclusions drawn from previous 
studies are incorrect. Rather it suggests a need for clearer guidelines on the 
interpretation of scores. In order to explore this further, the subcategories of the scale 
were looked at, including an exploratory analysis of the answers through inclusion of 
interview data. 
 
Subcategories of the Stigma Impact Scale 
 
To understand the meaning behind the subcategories of the Stigma Impact Scale, 
examples from interview data have been selected for illustrative purposes. Firstly, 
‘social rejection’ refers to people feeling discriminated against, particularly in terms of 
assumptions of competence, or people avoiding being around them (Fife and Wright, 
2000).  For example, Isla (PL4) felt that friends were treating her as incompetent: 
“Short of saying ‘get your hand off me’ you know? You’ve got to just go along 
with it.”  
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Other participants such as Jack (PE6), describe experiences where symptoms of 
Alzheimer’s disease, in this case speech difficulties, have led to being treated 
negatively,  
“...couldn’t get the words out and then that lass started laughing, another one 
started laughing, I’m saying what’s going on?” 
The second category, ‘financial instability’ refers to the consequences of job or 
financial insecurity as a result of the condition (Fife and Wright, 2000). Financial 
worries can be seen across the journey of Alzheimer’s disease, particularly in terms of 
funding care. For example, Emma (SE4) shared her concerns over future costs,  
“…it’s expensive, there’s private care, I don’t know if I would get help locally, 
and personal care for him when the time comes...”  
Similarly, Poppy (SL1) shared financial concerns,  
“I did panic at one stage because there was all this talk about care homes and 
funding, and as I say I would hope very much wouldn’t have to happen.”  
Previous literature focuses on financial concerns as more relevant to younger people 
with dementia (Chaston, 2010), whereas interview data highlights it may be a concern 
across age groups, particularly in relation to futures.   
‘Internalised shame’ focuses on how experiences such as social rejection and financial 
insecurity affect the way a person views themselves (Fife and Wright, 2000). These 
experiences are associated with blame and fear of disclosing a diagnosis. Examples 
include, Oliver (PL5) who Isobel (SL5) describes as avoiding accepting the condition 
due to pride, and fear of its meaning, 
 “And it was so hard because he wasn’t really telling you, he was hiding, and if 
you brought it up he would change the subject, he was so awkward.” 
 Similarly, Katie (SE3) discusses regularly reassuring Toby (PE3) and challenging his 
feelings of stupidity, 
 “…something that Toby kept saying to me at the beginning was, he kept saying 
I’m, I feel so stupid, I’m stupid, I wish I wasn’t stupid.” 
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The final subcategory, ‘social isolation’, incorporates feelings of loneliness, and 
inequality in relationships (Fife and Wright, 2000).  Sophie (SL15) discusses that some 
of this loneliness is a result of people not being able to understand the situation if they 
have not lived through it,   
“unless you’re really dealing with it 24 hours a day, I don’t think anybody can 
really do an awful lot.”  
Further, Lucy (SE5) highlights feelings of inequality in relationships when discussing 
her relationship with Murray (PE5), 
 “…for quite some time now I’ve accepted on the whole Murray’s world 
revolves around Murray, and although we still enjoy being a couple in most 
ways, obviously Murray is fixated on what’s going on in his head.”  
This change in experiences can therefore lead to feelings of isolation. The subcategories 
of the Stigma Impact Scale were explored in more detail through quantitative analysis. 
A detailed breakdown of subcategories by questions and subsequent score ranges are 
presented in Appendix 4a-c with the adapted scale.  
Exploratory analysis of the scores within the subcategories took place for people with 
Alzheimer’s disease and supporters. Table 11 presents a summary of scores by 
subcategories, with the number of items and score ranges presented to illustrate the 
unequal weighting of mean scores.   
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Subcategory 
of Stigma 
Impact 
Scale 
Number of 
items 
within 
subcategory 
Range of 
possible 
scores for 
each 
subcategory 
People with 
Alzheimer’s 
disease 
Supporters 
Mean Standard 
Deviation 
Mean Standard 
Deviation 
Social 
Rejection 
9 0-36 15.72 3.67 11.05 6.21 
Early-onset Alzheimer’s Disease 14.14 5.70 13.13 4.42 
Late-onset Alzheimer’s Disease 15.33 1.40 10.40 7.57 
Financial 
Insecurity 
3 0-12 1.27 1.93 1.73 2.21 
Early-onset Alzheimer’s Disease 3.14 2.34 2.88 2.75 
Late-onset Alzheimer’s Disease 0.40 0.83 1.60 2.56 
Internalised 
Shame 
5 0-20 8.36 1.89 5.90 3.35 
Early-onset Alzheimer’s Disease 7.14 2.19 6.75 2.05 
Late-onset Alzheimer’s Disease 9.07 1.87 6.33 3.96 
Social 
Isolation 
7 0-28 13.00 2.47 10.77 5.89 
Early-onset Alzheimer’s Disease 13.43 3.60 12.75 3.99 
Late-onset Alzheimer’s Disease 13.80 1.90 9.93 6.45 
Total 24 0-96  
Table 11. Summary scores by subcategory for people with early and late-onset 
Alzheimer’s disease and their supporters. 
 
The results from comparing mean scores on the Stigma Impact Scale suggested that 
people with Alzheimer’s disease report significantly more stigma than their supporters. 
A multiple analysis of variance (MANOVA) was computed to compare people with 
Alzheimer’s disease and their supporters across the four subcategories. Significant 
differences between people with Alzheimer’s disease and their supporters were 
highlighted across subcategories, F(4, 39)= 3.605, p=0.014, Wilk's Λ = 0.730, partial 
η2 = 0.270. Figure 6 illustrates the average percentage scores for the four subcategories. 
Percentage scores are presented over raw scores, as the unequal weighting of 
subcategories could lead to a skewed picture of results. 
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Figure 6. Percentage scores for People with Alzheimer’s disease and their 
supporters for subcategories of the Stigma Impact Scales 
 
Significant differences were found between people with Alzheimer’s disease and their 
supporters for social rejection, F(1,42)= 9.246, p= 0.004 and internalised shame, 
F(1,42)= 8.953, p= 0.005. This suggests that people with Alzheimer’s disease report 
higher levels of stigma than their supporters, in relation to social rejection and 
internalised shame, but not social isolation (F(1,42)= 2.672, p= 0.110) and financial 
instability (F (1,42)= 0.528, p=0.471).  The difference in subcategories may be linked 
to the impact of the symptoms of Alzheimer’s disease itself on social reactions and self-
stigma, compared to everyday experiences which may affect people with Alzheimer’s 
disease and their supporter together such as financial concerns, and mutual isolation. 
Across subcategories, social isolation was highest for people with Alzheimer’s disease 
and supporters of people with Alzheimer’s disease. This supports earlier discussion 
within the study protocol (chapter 5), that people affected by Alzheimer’s disease are 
likely to experience high levels of social isolation (Alzheimer’s Australia, 2014). 
It should be noted that these results support the pattern of answers, but are not 
necessarily indicative of high or low stigma. Across the subcategories, people with 
Alzheimer’s disease answered ‘disagree’ or ‘strongly disagree’ 66.8% of the time, with 
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supporters ‘disagreeing or strongly disagreeing’ 57.3% of the time. Comparatively, 
levels of agreement with statements were 9.3% for people with Alzheimer’s disease and 
11.1% for Supporters. These results suggest stigma reporting using the Stigma Impact 
Scale is low overall.  
 
Covariate Questionnaires and Stigma Impact Scale Subcategories 
 
The subcategory analysis between people with Alzheimer’s disease and their supporters 
suggests a more complex picture of stigma can be seen across patterns of reporting. To 
build on this further, subcategory analysis within-groups have been explored. Previous 
regression models for mean Stigma Impact Scale scores suggested that quality of life 
and socioeconomic status were significantly associated with stigma for people with 
Alzheimer’s disease , F(7,14) = 3.85, p=0.015, R2= 0.658. As levels of deprivation 
decreased, levels of perceived stigma decreased. As quality of life increased, perceived 
stigma scores decreased.  The significance of these covariate questionnaires supports 
their inclusion in an analysis of variance with Stigma Impact Scale subcategories.  
Quality of life scores for people with Alzheimer’s disease produced near significant 
results for internalised shame (F (15, 6)= 3.89, p=0.051) but did not significantly 
predict the other three subcategories. As quality of life scores increased, scores for 
internalised shame decreased.  The findings suggest that decreased quality of life is 
associated with increased stigma for people with Alzheimer’s disease. This is supported 
by studies such as Burgener et al. (2013) who found quality of life to be significantly 
associated with stigma for three of the four subcategories of the Stigma Impact Scale: 
Social rejection, social isolation, and internalised shame. The difference in number of 
subcategories associated with quality of life between Burgener et al. (2013) and the 
current study may be the use of 8 different measures of quality of life in the Burgener et 
al. (2013) research, compared to the single scale (DEM-QOL) in this study. Further, 
there may be ceiling effects: quality of life scores on DEM-QOL can range from 28-
112, with higher scores indicating higher quality of life. Within this study, people with 
Alzheimer’s disease scores ranged from 74 to 110, with a mean score of 97.7.  A 
sample with greater diversity with respect to quality of life ratings may have produced 
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significant results in the additional subcategories of the Stigma Impact Scale shown by 
Burgener et al. (2013).   
For socioeconomic status, as measured by SIMD decile,  ANOVA results found 
socioeconomic status  significantly predicted financial instability for people with 
Alzheimer’s disease (F (7, 14)= 5.78, p=0.03). Higher levels of deprivation were 
associated with higher scores for financial instability but not the remaining three 
subcategories.  The significance of socioeconomic status and financial instability is 
supported by the overlap in focus of the two measures.  
For supporters, multiple regression analysis of perceived stigma scores produced 
significant results for the quality of life, but not for the additional covariate 
questionnaires, F(8,13) = 2.705, p=0.05, R
2
= 0.625. As with people with Alzheimer’s 
disease, data collected from supporters were explored across the subcategories of the 
Stigma Impact Scale.  Supporters’ quality of life, as measured by Zarit Burden 
Interview was found to be a significant predictor of scores for Social Rejection (F=6.04, 
p= 0.01), Internalised Shame (F=17.19, p= 0.01), and Social Isolation (F= 4.60, 
p=0.03). These results suggest that supporters’ quality of life could influence how much 
stigma is reported. Decreased quality of life was associated with greater stigma 
reporting across the three subcategories.  These findings are supported by previous 
research literature, where higher stigma has been associated with increased ‘caregiver 
burden’ (Werner et al., 2012), which is often used with reference to supporters’ quality 
of life.  
 
Age and Stigma Impact Scale subcategories 
 
As well as subcategory differences between people with Alzheimer’s disease and their 
supporters, age-based differences in Stigma Impact Scale subcategory scores were 
explored as age is a variable of interest throughout the study. The results have been 
illustrated in the following bar graphs.  As with previous figures, percentage scores 
were chosen over raw scores as the unequal weighting of subcategories could lead to a 
skewed picture of results.  
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Firstly people with early and late-onset Alzheimer’s disease were compared by Stigma 
Impact Scale subcategory scores. Figure 7 illustrates that financial instability scored the 
least for people with Alzheimer’s disease. For people with early-onset Alzheimer’s 
disease, social isolation yielded the highest percentage score (48.0%), followed by 
social rejection (39.3%). People with late-onset Alzheimer’s disease showed the same 
pattern, with social rejection and social isolation both producing average percentage of 
45.7%.   
Analysis of variance between groups produced a significant difference in scores for 
people with early and late-onset Alzheimer’s disease for financial instability and 
internalised shame. People with early-onset Alzheimer’s disease scored significantly 
higher than people with late-onset Alzheimer’s disease for financial instability, as 
shown by a significant analysis of variance,  F(1,20) = 16.9, p = .001. This is supportive 
of previous literature on age based differences (see chapter 2), which suggests younger 
people are more likely to be affected by financial difficulties following diagnosis of 
Alzheimer’s disease (Chaston, 2010). People with late-onset Alzheimer’s disease 
scored significantly higher than people with early-onset Alzheimer’s disease for 
internalised shame, F(1,20)= 5.12, p=0.035. This may reflect the accumulated self-
stigma of older adult stereotypes and Alzheimer’s disease stereotypes as suggested in 
previous literature (Scodellaro and Pin, 2011). As noted previously, it is difficult to 
draw firm conclusions from the data given the sample size. However, the pattern of 
results suggests it would be interesting to follow-up with a larger sample to see whether 
the significance remains. Further, the inclusion of interview data later in the chapter 
adds support for the conclusions made. 
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 Figure 7. People with Alzheimer’s disease percentage scores for subcategories on 
the Stigma Impact Scale 
 
The pattern of results for supporters of people with early and late-onset Alzheimer’s 
disease is illustrated in Figure 8.  Scores are given as a percentage of the total score for 
each subcategory. Supporters of people with early-onset Alzheimer’s disease had the 
highest percentage score (45.95%) for social isolation followed by social rejection 
(39.7%).  Similarly, social isolation was the highest for supporters of people with late-
onset Alzheimer’s disease (35.0%). This is followed by internalised shame at 29.3%.  
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Figure 8. Supporters of People with Alzheimer’s disease percentage scores for 
subcategories on the Stigma Impact Scale 
 
Supporters of people with late Alzheimer’s disease scored lower across the 4 
subcategories than supporters of people with early-onset Alzheimer’s disease. This 
suggests that supporters of people with late-onset Alzheimer’s disease report less 
stigma than supporters of people with early-onset Alzheimer’s disease. As with people 
with Alzheimer’s disease, scores for financial instability were significantly different 
between supporters, with scores for supporters of people with late-onset Alzheimer’s 
disease scoring significantly lower (F(1,20) = 5.03, p = .036).This provides further 
empirical evidence for people affected by early-onset Alzheimer’s disease experiencing 
greater financial consequences (Chaston, 2010).  
The answers given by both people with Alzheimer’s disease and their supporters 
suggests that stigma reporting is low, however, a criterion is not available to determine 
a threshold between reporting stigma and not reporting stigma.  The analysis of 
subcategories emphasises that stigma is multifaceted, with mean scores from the Stigma 
Impact Scale not necessarily reflecting people’s experiences of stigma. For example, 
the low scores for financial instability would bring the overall mean down. Results have 
been consistent with the numbers reported in previous literature, particularly with 
increased levels of agreement for social isolation, for both supporters and people with 
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Alzheimer’s disease (Alzheimer’s Australia, 2014). Further, a significant difference 
between the scores of people with Alzheimer’s disease and their supporters is also 
supported by the literature, with supporters reporting lower stigma than the person with 
Alzheimer’s disease (Batsch and Mittelman, 2012). 
The pattern of results supports the hypothesis that people with Alzheimer’s disease and 
their supporters experience stigma. However, results from the Stigma Impact Scale 
itself do not present a clear answer to whether people experience stigma, due to the lack 
of clarification over a threshold. Across the literature using the scale, mean scores 
appear relatively low (Burgener and Burger, 2008; Liu, 2011; Riley, 2012). Despite the 
low mean scores, stigma surrounding Alzheimer’s disease is present in a range of 
research literature (Burgener and Berger, 2008 and 2013; Vernooij-Dassen et al., 2005; 
Werner et al., 2012; Batsch and Mittelman, 2012).  Further the statistical tests, 
particularly those which explore age-based differences should be taken with caution, 
given the limit in sample size, and the non-significance of age within multiple 
regression models. Therefore in order to increase understanding and draw conclusions 
for the research questions, it is important to explore the data in more depth for both 
experiences of stigma, and possible age-based similarities and differences.  
 
Experiences of stigma- Interviews 
 
Interview data provide a more comprehensive understanding of stigma from the 
perspectives of those involved in this study.  Themes which emerged from the 
experiences of stigma are discussed within this chapter, with the consequences being 
explored in more depth within chapter 8. As noted within the data analysis overview in 
chapter 5, the interviews contained topics specifically aimed at understanding stigma 
including, reaction of family and friends to diagnosis. Researcher prompt questions 
included people being asked whether their relationships with people had changed, and 
how they felt about this (see Appendix 5 and 6).  
During thematic analysis, examples which related to experiences of Alzheimer’s 
disease and stigma were identified. Experiences of stigma were mixed and 
unpredictable. People’s experiences differed across relationship groups, including 
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family and friends, public perceptions and healthcare experiences. The presence of self-
stigma draws attention to the inaccuracy of stigma-fuelled misconceptions surrounding 
Alzheimer’s disease which imply that people do not have insight into their experiences.  
Additionally, the mixture of responses emphasises the heterogeneity of the group and 
the subjectivity of experiences.  
Previous research on stigma and Alzheimer’s disease has a tendency to focus on 
whether stigma is present in society, rather than the experience of this for the person 
with the condition. Interview data supports this presence of stigma within society. 
Matthew (PE7) discussed how the public hold misconceptions about how somebody 
with Alzheimer’s is expected to act,  
“They expect you to be all… [Imitates vegetative state]”  
Further, Jennie (SE7) highlights that this may be linked to a lack of accurate knowledge 
about the condition among the general public, 
 “…I think it’s just been left in the dark too long, and now suddenly there’s all 
this rush, it’s splashed over the telly and the papers…there’s very few facts, 
sadly, but there’s plenty of speculation.”  
The lack of facts is argued to lead to ignorance, which the majority of people cite as the 
underlying cause of stigma, evidenced by Eva (SE1) who points out that Alzheimer’s 
disease is an ‘invisible illness’ which makes it harder for people to recognise and 
understand. However, increased visibility of the condition may also increase exposure 
to stigma (Goffman, 1963).  Rather, increasing accurate understanding of the condition 
may be of most benefit.  
Although the examples suggest that a lack of knowledge among the public is associated 
with increased stigma, experiences with healthcare professionals suggests that 
knowledge itself does not always negate stigma. Within current services in the UK, 
people with dementia are likely to receive support from psychiatry and/or psychology 
(Alzheimer’s Society, 2013). However, despite the increased dementia-related 
knowledge among people in this field, experiences are not always positive. For 
example, Poppy (SL1) describes experiences of hospital appointments with David 
(PL1), 
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“… ironically enough the only occasions I‘ve felt not quite so happy has been at 
hospital appointments…and I’ve actually said that to one of the staff that I find 
it really ironic…”  
Experiences such as this led to anger and frustration, feeling that people in this position 
should know better. Similarly, Eva (SE1) and James (PE1) discuss the delivery of 
diagnosis,  
“… The doctor who delivered the diagnosis was very blunt and umm all he said 
to James after looking at scans on his computer was ‘so has anybody else in 
your family got dementia?’” 
 Such blunt delivery of a diagnosis emphasises the stigma-fuelled assumption that 
people do not have insight into their experiences. Further, experiences of stigma from 
healthcare professionals, who are assumed to be more informed, may add to self-stigma 
and anticipated-stigma from others.  
Self-stigma fuelled by healthcare experiences can be seen from people with 
Alzheimer’s disease’s discussion of appointments and memory assessments. Several 
people spoke about feeling stupid and a failure. Others said they were not bothered by 
their difficulties, however, supporters reported significant physiological and 
psychological stress at the time. For example, Emma (SE4) and Charlie (PE4) discussed 
memory testing and its impact,  
“You said to her right away, I know I’m going to be no use at this.” (Emma). “I 
just tell them that I can’t do it and that’s it, not worried about it.” (Charlie). 
“Yeah, but deep down you are...although he was smiling and saying I can’t do 
it, and it’s not bothering me, I could see” (Emma).   
Overall there was agreement that memory testing not only failed to accurately reflect 
their experiences of Alzheimer’s disease but fuelled self-stigmatisation.  
There are also examples in the interview data that self-stigma may be one of the earliest 
experiences relating to stigma and Alzheimer’s disease. This is based on how 
anticipated stigma may make it difficult for people to share their symptoms. For 
example, Isobel (SL5) discussed how Oliver (PL5) tried to hide symptoms of 
Alzheimer’s disease for quite some time,  
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“I think at the start dad tried to cover up and hide it, and he was very stressed 
about it…I think it was affecting his pride, and he was trying to cover up.”  
Isobel went on to discuss how Oliver always tried to look after his health and was 
particularly aware of memory,  
“He always said was look after your brain, and I don’t know why, his whole life, 
he did all these memory and brain books, puzzles and games…”  
Fear of developing memory problems and their consequences highlights the 
pervasiveness of public understandings of Alzheimer’s disease, and how these can go 
onto to influence people who develop the condition. Similarly to Oliver, Holly (SL12) 
discussed how Millie’s (PL12) fear of dementia made it very difficult to use the term 
Alzheimer’s disease around her for fear of the self-stigmatisation it would cause,  
“She used to say if I go like that, shoot me. It was always her worst nightmare.”  
The complex relationship between stigma, terminology, and identity emerging from 
examples like Oliver and Millie illustrates how people can be reluctant to seek a 
diagnosis, and take on an identity of ‘person with Alzheimer’s disease’ for fear of its 
consequences. However, others in the study were more willing to take on the label, 
seeing it as a way of explaining their difficulties. Jack (PE6) exemplifies this adoption 
of Alzheimer’s disease identity following negative experiences of stigma from the 
public.  Jack has early-onset Alzheimer’s disease, and a prominent symptom of the 
condition for him is speech difficulties (known as aphasia). Jack describes a situation 
where he was laughed at whilst using a petrol station,  
“…they don’t do tokens anymore but they couldn’t tell me that and I’m 
saying…[stammers]...couldn’t get the words out and then that lass started 
laughing, another one started laughing, I’m saying what’s going on??” (Jack).  
Experiences such as this led to Jack carrying around information cards with him,  
“My name is Jack, I have an illness called dementia. I would appreciate your 
help and understanding…I like to be independent, but sometimes I need help. 
Here’s how you can help: Be patient and try to understand me. Ask how you can 
help me. If I seem very confused or distressed, contact Olivia.”  
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Having these cards on him increased Jack’s confidence, particularly in public situations. 
Without the information he was concerned that people would think he was drunk and 
act negatively towards him.  Across the interview with Jack and Olivia (SE6) it 
appeared that public stigma was more prevalent than stigma experienced through family 
and friends.  
Overall, the discussion highlights that participants felt that there was stigma relating to 
Alzheimer’s disease. Stigma was prevalent within society, and explained by participants 
as the public misunderstanding what it meant to have the condition. This stigma 
impacted on how people viewed themselves and how they reacted to Alzheimer’s 
disease. Experiences of stigma from other sources are considered in the following 
section, before revisiting age-based similarities and differences. 
 
Sources of Stigma- Family and Friends  
 
A lot of research focuses on experiences of stigma from a more public perspective; 
however interview data suggest that there was generally higher reporting of stigma 
among family and friends. Although this is not to say that quantitatively there is more 
stigma from these groups, it may be that the impact of experiencing stigma from people 
closer to you is greater. This hypothesis is in-keeping with previous literature (Benbow 
and Jolley, 2012) presented in chapter 2. Further, theories such as socioemotional 
selectivity theory discuss how our social networks become smaller and more emotion-
focused across the life course (Carstensen, 1991). As such, stigma from people within 
these networks is likely to have a greater impact. This is not to undermine the negative 
experiences of public stigma; rather if multiple experiences of stigma have taken place, 
family and friend stigma may be reported more.  
Despite there being a lower amount of research which looks at stigma perpetrated by 
family and friends, compared to the general public, interview data included several 
examples of such experiences. In addition, the reactions of family and friends 
exemplified the unpredictable nature of responses.  Jennie (SE7) and Matthew’s (PE7) 
discussion typifies this,  
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“The people that we expected to offer support…disappeared off the face of the 
earth, and the people that we had, I would say we weren’t close friends with but 
we were friends, they are the people that I’ve…” (Jennie) “They’ve come 
through and we see a lot more of” (Matthew).  
 Jennie and Matthew (PE7) , Katie (SE3), and Michael (SL2) all shared examples of 
how very close friends, who they would expect to be supportive had treated them 
negatively. For example, Katie talks about a friend of nearly 30 years who “was kind of 
like a sister” had stopped coming to visit or getting in touch, 
“she just stays very close, within walking distance, and I thought right well I’ve 
been along a couple of times, I’ve phoned every day nearly, I’ve text, right I’ll 
just see what happens, I’ve never heard from her since.”  
Further Katie added that she was not given an explanation for this social rejection. 
Michael shared a similar experience,    
“our bridesmaid who was on the phone maybe 3, 4, 5 times in the year, umm 
she hasn’t phoned at all, the same with the people who [possible identifier 
removed] used to come and stay with us here, they’ve gone, I’ve had to phone 
them three times in a row over a period of 4, 5, months, but there’s no coming, 
no phone call back to us.” 
The examples highlight how people have been socially rejected as a result of living with 
Alzheimer’s disease, without the reasons being made clear.  
Additionally there were examples where family and friends were supportive, but their 
lack of understanding of the condition potentially fuelled self-stigma. For example, Isla 
(PL4) and Hamish (SL4) discuss how although there was a lot of social support, people 
didn’t always know how to help, which led to avoidance from some, and ‘overly 
fussing’ from others,  
“Sometimes you actually complain about support…Isla says ‘they’re treating 
me like an idiot’…some of the friends don’t know how to deal with it so they 
say nothing…others overreact, like mother hen.” (Hamish) “Short of saying ‘get 
your hands off me’ you know? You’ve got to go along with it.” (Isla) “She 
meets her friend every [weekday], she’ll come in sometimes…with steam 
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coming out of her ears [Isla laughs] and it’s simply because her friend is trying 
to be helpful.”(Hamish).  
Generally, families were described as supportive as Harris (PL3) exemplifies,  
“I have an exceptionally good family.”  
Further, families can provide support to both the person with Alzheimer’s disease and 
their supporter in different ways, as Lucy (SE5) highlights, 
“my kids are great, they love Murray, they’re very fond of Murray, and do 
everything they can to keep everything, you know… he’s [son] often around, it 
means that sometimes, in fact quite often he has been there when I’ve been 
really upset on odd occasions.” 
There was variation across groups as to whether families were local or more spread out 
geographically, although there did not appear to be a clear correlation between 
geographical proximity and family-based stigma towards Alzheimer’s disease. For 
instance, Isobel (SL5) talks about how,  
“There’s always family members that have stepped in… as a family we would 
try and work our way around every problem individually as long as we could.”  
Comparatively, people like Cameron (SL10) and Emily (PL10), and Michael (SL2) and 
Grace (PL2) had family close by, but they would rather do things on their own. For 
example Cameron notes,  
“…one of the sons is married with the two grandchildren, and daughter in law, 
but both sons work, and I’m not, I’m not looking for support from them you 
know? I like to be independent, I like to do my own thing, on behalf of Emily I 
do things…” 
Similarly, Michael describes having local family but still being fairly isolated,  
“I mean we have a daughter who lives less than a mile away, and she’d be lucky 
if she comes and sees her mum once a week.”   
The examples presented highlight the mixed experiences of both stigma, and support 
from family and friends. Further, the interactions between people affected by 
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Alzheimer’s disease and those around them are not passive. Both the amount of support 
available and the willingness to accept support vary.  This reinforces the subjectivity in 
experiences, even when similarities are present. 
 
Possible age related differences  
 
Thus far, age-related differences have not been specified from interview data. However, 
several possible differences between age groups emerged related to experiences of 
stigma. As previously highlighted, self-stigma may influence whether people identify 
themselves as being a ‘person with Alzheimer’s disease’. Interviews suggested that 
people with early-onset Alzheimer’s disease were more likely to adopt the label of 
Alzheimer’s disease than people with late-onset Alzheimer’s disease. By identifying 
themselves as having an illness, people were arguably able to see the condition outwith 
their control. People such as Jack (PE6) wanted others to know exactly what condition 
he had, carrying around a card to notify people of Alzheimer’s disease. Similarly, 
Matthew (PE7) and Murray (PE5) were very open about their condition and felt it was 
important for people to understand the symptoms so that their behaviour could be 
explained if necessary. In these scenarios they have identified themselves as people 
with Alzheimer’s disease in order to make their interactions with others easier. 
Comparatively, for people with late-onset Alzheimer’s disease such as Millie (PL12) 
and Oliver (PL5), their fears of developing such a condition influenced the terminology 
they used. Oliver spent a long time trying to hide his symptoms, and tried to do 
everything he could to prevent getting dementia. Similarly, Isla (PL4) saw the condition 
as something she should try to conquer,  
“I think there’s an element of denial in it, you know? I don’t really have, or I 
have this but I’m going to conquer it [Isla agrees]” (Hamish) “Is that not a good 
idea?” (Isla). 
Not being able to ‘beat the condition’ led to significant frustration, 
 “She feels a failure, that I think is one of the main trigger points for the 
frustration.” (Hamish).   
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People with late-onset Alzheimer’s disease appeared to be more reluctant of the term 
‘Alzheimer’s disease’, preferring to use ‘memory problems’, Holly (SL12) explains 
Millie’s experience (PL12) and her avoidance of terms,  
“… she thinks oh I’m in my 80s I’m bound to have a bad memory and that’s ok, 
and I think that goes with a lot of them, and because they’ve got dementia they 
don’t remember, so each time you mention them having dementia, it’s like 
you’re hitting them straight again.”  
Although these examples suggest possible age differences, this difference is not 
consistent. For example, supporters such as Michael (SL2) and Cameron (SL10) 
repeatedly referred to Grace (PL2) and Emily (PL10) as ‘patients’ with Alzheimer’s 
disease. This is more consistent with the illness identities adopted by many of the 
people with early-onset Alzheimer’s disease. Further, they appeared to adopt the 
‘caregiver’ identity. For example, Cameron discusses one of the support groups he 
attends with Emily (PL10),  
“…we break up half way through, the carers go out and have a coffee… and the 
patients stay.”  
Similarly, when Michael (SL2) asked a question, 
 “Experience of living with Alzheimer’s disease, is that from the patient’s point 
of view or carers?”  
This use is despite the terms not being on the information sheets provided, which 
suggests a general adoption of the ‘patient/carer’ identity. Although other participants 
used the term ‘carer’ they did so more reluctantly, including Poppy (PL1) who 
acknowledges that she uses the term because she feels she has to,  
“Primarily I still am his wife but I suppose I do care for him, it’s just a silly 
label [laughs].”  
Further, their choice of terminology varied in terms of how much it reflects their role, 
as Michael talks about his role as a ‘carer’ in line with that of paid/formal carers, 
focusing on the very practical aspects of care; whereas others spoke more about their 
relationship as husband/wife/daughter/son. It is possible that the choice of term reflects 
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particular coping styles. For example, Michael expressed concerns that Grace was no 
longer aware of their relationship, 
 “She’s actually forgotten for the last fortnight to a month, it’s gradually come 
in, she’s actually asked, who are you?”  
The use of the term ‘patient’ may therefore emphasise the caring role, whilst separating 
from the husband relationship and accompanying sense of loss.  
Additional age-based differences emerging in relation to stigma were age-based 
expectations of Alzheimer’s disease. For example, people affected by early-onset 
Alzheimer’s disease highlighted that there was public ignorance around ‘being too 
young to have an older person’s disease’. Jennie (SE7) exemplifies this when 
describing disclosing Matthew’s (PE7) condition to others,  
“Although quite honestly, quite a lot of people expect, you know, they say ‘what 
does your husband do?’ I say oh he’s retired, he, he has Alzheimer’s disease, 
‘oh, he’s much older than you?’”  
Similarly, Olivia (SE6) discusses public misunderstandings,  
“It’s for older people, people don’t realise that people as young as Jack can get 
that.” 
However, these differences do not necessarily mean that younger people experience 
more stigma than older people. Alternatively, it may be that the types of stigma differ. 
For example the discussed evidence suggests older people may be more exposed to self-
stigmatisation, compared with younger people who are more likely to experience public 
stigma.  
The synthesis of answers from the interviews with people with Alzheimer’s disease and 
their supporters suggest that they have experienced stigma from a range of sources, 
whether that be public understanding, family and friends’ reactions, or experiences of 
healthcare. Further, for the majority of people this stigma had been internalised to some 
extent. This led to feelings of stupidity and frustration. Although supporters of people 
with Alzheimer’s disease give examples of social rejection and isolation, the examples 
focus on the stigma being directed at the person with Alzheimer’s disease more so than 
themselves. This supports the questionnaire findings of significantly lower stigma 
149 | P a g e  
 
reported by supporters than people with Alzheimer’s disease. However, although the 
stigma may be directed at the person with Alzheimer’s disease, it is felt as a couple, 
impacting on both identities.  
 
Synthesising questionnaires and interviews- Perceived stigma 
 
The data collected during interviews would predict higher scores on the Stigma Impact 
Scale questionnaires; however reporting stigma using this measure was relatively low. 
The pattern of scores for those interviewed has been considered in the following 
figures. Firstly, people with early-onset Alzheimer’s disease who were selected for 
interview are shown in Figure 9. The four subcategories of the Stigma Impact Scale are 
shown, with the percentage scores given for ease of comparison across subcategories. 
As with mean scores, there is not a clear threshold which indicates high or low stigma, 
however percentage scores allow for a visual representation with over 50% conceivably 
indicating higher rates of stigma.  
 
Figure 9.   Percentage scores for the four subcategories of the Stigma Impact Scale, 
for people with early-onset Alzheimer’s disease selected for interview 
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Toby (PE3) had the highest percentage scores for social isolation, and joint highest 
score for internalised shame with Charlie (PE4). Toby (PE3) was unable to take part in 
the interview due to transitioning into a care home between study visits. However, the 
pattern of his responses fits the experiences discussed by Katie (SE3) within the 
interview. Toby (PE3) had experienced a lot of social isolation (which was scored as 
the highest of the four subcategories) due to limited mobility excluding him from 
activities and group support. Further, Katie (SE3) discussed having to repeatedly tell 
Toby he wasn’t stupid when he got frustrated by his condition, which is mirrored in the 
highest internalised shame score, 
 “Something that Toby kept saying to me at the beginning was, he kept saying 
I’m, I feel so stupid, I’m stupid, I wish I wasn’t stupid, you know? I used to 
have to keep saying to him, you’re not stupid, you’re ill”.  
Interestingly, Charlie had the joint highest score for internalised shame, despite 
repeatedly saying to Emma (SE4) that his circumstances didn’t affect him, 
“It doesn’t bother me Emma, honestly, it doesn’t bother me at all… I don’t care 
a damn, that’s how I feel, because I know I can do this, I know it like it is” 
(Charlie)….  “Deep down you are” (Emma). 
Therefore, potentially supporting Emma’s belief that it does bother Charlie underneath. 
Financial instability was previously noted as the subcategory which did not show 
significant differences between people with Alzheimer’s disease and their supporters. 
Across all participants bar Jack (PE6) and Olivia (SE6) it was the lowest subcategory. 
Whereas, for Jack and Olivia financial instability was highest, this is reflected in 
interview data,  
“See what other people are doing, I could have been doing with that when I had 
nae money, I had to get my sisters, my sisters came and did my mortgage and 
that for me.” (Jack).  
The couple talk about the number of forms they have had to fill in and the difficulty 
they have had with people understanding Jack’s situation, as he developed Alzheimer’s 
disease young,  
“Fighting all the time ain’t we? We should go and see them again ey?” (Jack). 
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Further, Jack scored the highest for social rejection, which may be explained by 
experiences of the general public relating to Alzheimer’s disease, particularly relating to 
his communication difficulties, as discussed previously. 
For James (PE1), Toby (PE3), and Murray (PE5) social isolation was the highest of 
their four subcategories. Lucy (SE5) discusses how Murray initially isolated himself 
from friends and colleagues after the diagnosis, but reengaged over time,  
“I mean first you missed it for a few months, once the diagnosis you didn’t want 
to go, you thought it was the end of all of that sort of thing, and then gradually 
your colleagues were saying why don’t you come back Murray?”   
James and Toby’s high scores appear to be less associated with initial withdrawal and 
more linked to the limited support services available to fit their preferences. For 
example, Eva (SE1) discusses the group activities James has tried, 
“He didn’t like it, and I think that became obvious after a couple of visits, 
remember you went to that wee group? I took you over on a [weekday] or 
something, and it was mostly ladies and the idea was very good but it’s just not 
James’s cup of tea.”  
As a result James and Eva tended to spend the majority of their time doing things 
together or with a support worker, rather than group activities.  
Finally, Matthew (PE7) scored highest on social rejection, relative to the other 3 
subcategories, as did his wife Jennie (SE7). This is in keeping with their interview, 
where they talked about experiencing very mixed reactions from people. For instance, 
Jennie discussed how some friends started treating Matthew,  
“almost like you [Matthew] were contagious.”  
Whereas, other friends have been increasingly supportive,  
“They’ve been much much more supportive. (Matthew)” … “Which I wasn’t 
expecting ‘cus I didn’t know them well.” (Jennie).  
The inclusion of questionnaire answers with interview answers supports a similar 
pattern of responses, even if the degree to which this is reported varied across measures. 
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The discrepancy between the amount of stigma reported at interview and with 
questionnaires will be discussed in more detail towards the end of the chapter.  
 
Figure 10. Percentage scores for the four subcategories of the Stigma Impact Scale, 
for supporters of people with early-onset Alzheimer’s disease selected for 
interview. 
NB: Eva(SE1) and Jennie (SE7) scored 0= non-applicable to all questions relating to financial 
instability. 
 
Supporters of people with early-onset Alzheimer’s disease showed similar patterns of 
responses to the person they support, as shown in Figure 10. Katie (SE3) had the 
highest scores for three out of the four subcategories, with Olivia (SE6) having the 
highest score for financial instability. Katie (SE3) scored particularly high for Social 
Isolation (20 out of 28) and Social Rejection (24 out of 36). This pattern was strongly 
reflected in her interview, with her circumstances leading to a loss of friends and 
family, as well as limited support services which met her and Toby’s (PE3) needs. This 
isolation was particularly evident following Toby’s transition into a care home,  
“I mean it’s like a bereavement, but he’s still there, and there’s days that you 
don’t see anybody, which is why I’ve kept busy, because some of these groups 
could have made a bit more effort.” (Katie, SE3).   
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Social Isolation was also the highest subcategory for Eva (SE1) and Emma (SE4), 
although they scored 12 and 9 out of 36 respectively, which suggests that they do not 
feel significant social isolation. This is supported by discussion in interview, where they 
both talk about maintaining social groups as much as possible,  
“I’ll just phone around, round robin, and say anybody free for coffee? And see 
who can come over.” (Emma, SE4).  
Interestingly, although Lucy (SE5) showed consistently low percentage scores in  the 
questionnaire, the interview data suggest fear of social rejection. This fear resulted in 
avoidance of being open with people early on,  
“…’cus I suppose initially for me, one of my main feelings as you said before, I 
didn’t want people feeling sorry for us, I really didn’t, I just wanted us to be as 
normal as possible for as long as possible” (Lucy).  
Further, Lucy discusses how she has benefited from being able to continue in work, and 
maintain her social connections.  The fact her work and social life had been largely 
uninterrupted compared to some of the other supporters may contribute to overall lower 
scores for Lucy. As with the data presented for people with early-onset Alzheimer’s 
disease, there is a need to consider the difference in reporting across measures when 
drawing overall conclusions. Further, the discrepancy adds support for using multiple 
research measures to build a comprehensive picture of experiences.  
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Figure 11. Percentage scores for the four subcategories of the Stigma Impact Scale, 
for people with late-onset Alzheimer’s disease selected for interview 
NB: Grace (PL2), Oliver (PL5), Emily (PL10), Millie (PL12) and Angus (PL15) scored 0= non-
applicable to all questions relating to financial instability. 
 
Questionnaire scores for people with late-onset Alzheimer’s disease invited to interview 
can be seen in Figure 11.  Unlike people with early-onset Alzheimer’s disease, only 2 of 
the 8 people with late-onset Alzheimer’s disease saw questions on financial instability 
as applicable. Additionally, the scores for David (PL1) and Isla (PL4) were still low, 
both scoring 2 out of 12, which suggests they didn’t agree to any of the statements.  
For 5 of the 8 participants with late-onset Alzheimer’s disease, internalised shame was 
the highest scoring subcategory, scoring 10 out of 20. This may be reflected in their 
fears of developing a condition like Alzheimer’s disease, with Holly (SL11) describing 
how Millie (PL11) felt about dementia,  
“it was always her worst nightmare, she says I could cope with heart, stroke, 
cancer anything...”  
Similarly, Isobel (SL5) notes that for Oliver (PL5),  
“it was the one thing he feared and didn’t want.”  
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Emily (PL10) expressed internalised shame through a reduction in confidence, with 
Cameron (SL10) commenting on how she no longer feels able to paint, despite it 
previously being a much loved hobby.  
Isla (PL4) scored highest across participants with late-onset Alzheimer’s disease for 
social rejection and social isolation. In interview, both Isla and Hamish (SL4) expressed 
concerns over social isolation in terms of care within the community and residential 
care,  
“I think care in the community is condemning an awful lot of people to a life of 
isolation and loneliness and poor level of support.” (Hamish).  
Although Isla scored higher within these subcategories than others, when talking to her, 
the majority of her frustration stems from wanting to be able to ‘beat’ the condition, and 
feeling the symptoms of Alzheimer’s disease such as memory loss have affected how 
she views herself and her abilities, which does not come across in the questionnaire 
scores alone.  
 
Figure 12. Percentage scores for the four subcategories of the Stigma Impact Scale, 
for supporters of people with late-onset Alzheimer’s disease selected for interview 
NB: Lily (SL3 and Hamish (SL4) scored 0= non-applicable to all questions relating to financial 
instability. Cameron (SL10) and Sophie (SL15) scored 0= non-applicable to all questions on the Stigma 
Impact Scale. 
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Finally, supporters of people with late-onset Alzheimer’s disease showed quite a 
distinct pattern, as illustrated in Figure 12, to that displayed in Figures 9-11. This is due 
to Cameron (SL10) and Sophie (SL15) scoring zero across all subcategories. A score of 
zero indicates that Cameron and Sophie felt that the questions on the Stigma Impact 
Scale were not applicable to them. A possible similarity between the two of them, 
which may explain their scores, is in the strong sense of independence and 
responsibility within their supporting role. Cameron notes, 
“I’m not looking for support from them you know, I like to be independent, I 
like to do my own thing, on behalf of Emily I do things…”  
Similarly, Sophie spoke about her frustration of other people being involved and 
making suggestions, 
 “… I’ve been married 60 years surely, sometimes that kind of thing, I want to 
say don’t tell me.”  
There is a sense from them both that they are separated from any possible stigma by 
focusing on themselves and the person they support, and not focusing on how others 
react, with Sophie adding,  
“Unless you’re really dealing with it 24 hours a day, I don’t think anybody can 
really do an awful lot.” 
It should be noted that scoring ‘non-applicable’ across questions does not mean that 
they did not believe Alzheimer’s disease was a stigmatised condition, rather that they 
did not feel it affected them in ways that the questionnaire reflects. 
Out of the 6 supporters who did score on the scale, 5 of them had social isolation as the 
highest scoring subcategory. For Michael (SL2), internalised shame was highest, 
followed by social isolation. Michael scored higher than other supporters of people with 
late-onset Alzheimer’s disease across all four categories. There are several examples 
within the interview which help to contextualise this. Michael has very limited contact 
with support from family, friends, or support groups,  
“I mean I don’t really, I mean we’ve all got our problems but I don’t think 
sharing this problem would be of any help to me.”  
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Further, he sees the support he provides Grace (PL2) with as part of his role as a 
husband,  
“Don’t feel sorry for me, umm, because that’s what I’ve got to do, that’s what 
I’m doing”.   
The higher score on financial instability is likely to be linked to the money he puts 
towards helping care for Grace, and his avoidance of accessing public money if he 
doesn’t have to,  
“I don’t really need hand-outs, and yet I should have it, you know?”  
Social isolation and rejection were also highest for Michael, which is reflected in his 
experiences of friends no longer contacting or visiting,   
“I have a cousin who hasn’t phoned up for 8, 9 months to find out how Grace is; 
I’ve got a sister who hasn’t phoned me to find out how Grace is…” 
For the other 4 supporters social isolation was highest of the subcategories, with a 
mixture of possible explanations. Lily (SL3) and Isobel (SL5) were generally positive 
about the reactions of family and friends, and the support available for groups and 
activities. Part of the isolation they experienced may be a result of being adult-child 
supporters, rather than spousal supporters. As such, they are balancing their own home 
lives with that of the person with Alzheimer’s disease they support. Further Lily gave 
up work to help look after Harris (SL3). Despite the prevalence of supporters being 
adult-children of people with dementia (Brodaty and Donkin, 2009), only 3 of the 22 
supporters in this study were (Lily, Isobel, and Holly). Isobel noted that challenging 
Oliver’s (PL5) behaviour early on was difficult, and conflicting with her role as 
daughter,  
“but I think you don’t have the confidence to challenge your parent initially and 
things have to get to a stage where you think no, before you do it.”  
The difficulty Isobel felt may also be linked with her having the second highest score of 
internalised shame. 
Holly and Poppy (SL1) also scored highly on social isolation, relative to their other 
scores. For Holly, much of this could be linked to her own health, where she 
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experiences significant anxiety, which limits her activities.  For Poppy, social isolation 
may be linked more to her avoidance of groups relating to Alzheimer’s disease, she 
explained her fears in relation to worrying about the future,  
“I just feel that groups, I feel personally that that would depress me… I can see 
the benefit and some …but I also feel too that people are obviously going to be 
at different stages… I think I could start to panic, and really worry about the 
future, about things that might never happen.” 
Overall the pattern of results on the Stigma Impact Scale appears to mirror much of the 
interview data for people with Alzheimer’s disease and their supporters. Considering 
interview data along with the Stigma Impact Scale scores allowed for the more complex 
picture of stigma to be captured, with patterns between subcategories reflecting the 
experiences of participants more accurately than the mean score and quantitative data 
alone.  
In addition, the discussed findings highlight an interesting discrepancy between the 
extent of stigma reporting on questionnaires and interviews. The questionnaire scores 
alone would suggest that stigma is low, with people with Alzheimer’s disease agreeing 
or strongly agreeing to 9.3% of statements on the Stigma Impact Scale, and supporters 
agreeing or strongly agreeing 11.1% of the time. However, interview data show 
multiple examples of stigma being experienced, including public awareness, family and 
friends’ reactions, experiences of healthcare, and self-stigma. Possible reasons behind 
such a discrepancy will be discussed before addressing the second research question in 
chapter 7, which explores people’s future outlook.  
 
Exploring the discrepancy between reporting of stigma in questionnaires and interviews 
 
The methodology within the research literature relating to stigma and Alzheimer’s 
disease is mixed, including questionnaires (Burgener and Burger, 2008), focus groups 
(Vernooij-Dassen et al., 2005), and interviews (Werner et al., 2012). However, as has 
been discussed previously, scales such as the Stigma Impact Scale (Burgener and 
Burger, 2008) did not present a clear answer as to whether people experience stigma. 
Across the literature using the scale, mean scores appear relatively low (Burgener and 
159 | P a g e  
 
Burger (2008); Liu (2011); Riley (2012)). However, other studies have shown higher 
response to stigma, for example, Alzheimer’s Disease International (Batsch and 
Mittelman, 2012) surveyed 127 people with dementia and 1716 supporters of people 
with dementia, across 54 countries, with 75% of people with dementia answering ‘yes’ 
to “in your opinion, do you think there are negative associations (i.e. stigma) about 
people who have dementia in the country where you live?” (Batsch and Mittelman, 
2012:28). Similarly, 64% of supporters believed that there was stigma surrounding 
dementia, although when asked about stigma related to being a supporter, 60% of 
supporters within the English survey did not feel there were negative associations 
(Batsch and Mittelman, 2012).  
It is possible that this difference in reporting is based on differing sample characteristics 
and size. However, an alternative hypothesis is that the difference is due to whether the 
question contains ‘the self’. People with Alzheimer’s in the Batsch and Mittelman 
(2012) survey, were asked their views about whether people with dementia are 
stigmatised. Whereas, the Stigma Impact Scale is worded from the person’s perspective, 
for example, “I feel I have been treated with less respect than usual.” (Question 5, 
Stigma Impact Scale, Appendix 4a). As a result, the person with Alzheimer’s disease 
may be more, or less, able to separate themselves from the situation. This is further 
supported when Batsch and Mittleman’s (2012) data are looked at more closely. 
Questions where the person with dementia was asked to report their experiences, for 
example, “Have you concealed or hidden the diagnosis of dementia from others?” and 
“Have you been avoided or treated differently because of the diagnosis?” yielded 
agreement of 24% and 40% respectively. Further suggesting people with dementia will 
report lower stigma when they are answering about themselves compared to others with 
dementia. This phenomenon has been more widely explored within social psychology, 
as discussed within personal/group discrimination discrepancy theory (Taylor et al., 
1990). As noted within chapter 2, the theory suggests that people acknowledge higher 
levels of stigma towards the group ‘people with Alzheimer’s disease’ compared to their 
own experiences. The minimisation of personal stigma is a way of managing and 
avoiding the negative consequences of stigma.  
Additional explanations for low stigma reporting include a bias in responding when 
having to make a choice between a positive or negative answer, if only one answer can 
be given. As discussed in field notes, participants were keen to elaborate on 
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questionnaires with stories to support them, and noted frustration at times where 
multiple answers would have been appropriate. For example, if asked whether family 
members have treated them differently, some participants commented that they wanted 
to respond ‘disagree and agree’. Where both answers were appropriate, participants 
favoured disagree over agree answers. This direction of effects is discussed in more 
detail as part of the theoretical considerations. As the literature review (chapter 3) 
highlighted, the presence of a positivity bias in the way people process information has 
been discussed across several disciplines. For instance, Berntsen et al. (2011) suggest 
that positive events are more central to older adults’ life story and identity and increase 
in salience over time, whereas negative events are less central and decrease over time. 
As such, the findings support that people with Alzheimer’s disease and their supporters 
are more likely to focus on positive reactions of those around them, with the strength of 
this increasing over time, compared to the negative experiences they have experienced. 
As interviews were less structured, negative experiences were given the space to be 
shared, leading to the discrepancy in stigma reporting. 
Research suggests that as people get older, they show a preference for processing 
positive memories, and show better recall of positive stimuli, relative to their younger 
counterparts (Mather and Carstensen, 2005). This would suggest that people affected by 
late-onset Alzheimer’s disease would report lower stigma in the questionnaires than 
people with early-onset Alzheimer’s disease. This is interesting as the direct 
comparison of age categories suggested higher reporting of stigma for people with late-
onset Alzheimer’s disease, with further exploration suggesting that age differences were 
non-significant compared to covariates such as quality of life and socioeconomic status.  
The non-significance of age when considered within multiple regression analysis 
suggests a similarity in the way people affected by early and late-onset Alzheimer’s 
disease report stigma. As introduced within socioemotional selectivity theory (chapter 
3), people facing ‘time-limiting’ conditions may equally be influenced by the positivity 
bias. The relatively low reporting of stigma on the Stigma Impact Scale for both age 
groups provides contradictory evidence to Reed and Carstensen (2011) who concluded 
that age-related positivity bias is less likely to be seen in people with cognitive 
impairment, as it is an active process requiring cognitive resources. Rather, it supports 
that people with Alzheimer’s disease choose to focus their attention on the positive 
stimuli as much as possible (consciously or unconsciously).  
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Possible explanations for the discrepancy between questionnaires and interviews may 
also include the design and corresponding protocols which differ between the two. For 
instance, first study visits were the questionnaire visits with people with Alzheimer’s 
disease and their supporters. For people who were interviewed, there was increased 
familiarity with the researcher as it was the second meeting. Seeing participants more 
than once has been evidenced as an important part of building up relationships 
(McKillop and Wilkinson, 2004). Therefore, interviews may have revealed higher 
reports of stigma due to people feeling better able to share their difficulties. 
Additionally, all interviews were with people with Alzheimer’s disease and their 
supporter, which may have increased feelings of comfort and familiarity (Wilkinson, 
2002) as well as aiding with memory retrieval cues.  
In addition, differences between questionnaire scores and interviews may be due to 
participants not feeling their experiences of stigma were included on the Stigma Impact 
Scale. Such experiences could include negative interactions with healthcare 
professionals, which are not currently included as a topic on the scale. The feeling that 
questionnaires cannot accurately reflect their situation may also explain why Sophie 
(SL15) and Cameron (SL10) scored non-applicable to all questions from the Stigma 
Impact Scale, given that in interview many of the elements the Stigma Impact Scale 
aims to pick up on were evident.  
A final consideration for the discrepancy between questionnaire scores and interview 
answers is the inclusion of a time-frame reference in questionnaires, discussed in 
chapter 5, that is not present at interview. The DEM-QOL, Stigma Impact Scale, and 
Bristol activities of daily living, all have time-frames to which people are to base their 
answers. For example: In the last week have you felt cheerful? (DEM-QOL question 1). 
Smith et al. (2005) acknowledged that some people with dementia felt they were unable 
to provide reliable information within the time-frame, suggesting that data would be 
unreliable for these participants. However, Smith et al. (2005) argued that the time-
reference was important for those who could visualise time in this way, whereas, 
McDonald et al. (2003) noted that assuming that respondents are able to answer 
questions relating to their past is a mistake. They suggest acknowledging that people 
may not have access to the information to recall, or have the information but cannot 
recall it from the fixed time-reference given. Further, recent events are more likely to be 
recalled (McDonald et al., 2003) which could potentially skew the results relating to 
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stigma reporting. However, if time-frame references were having a significant impact 
on results, the time since diagnosis would have been more likely to produce significant 
results when included as a covariate. Further, the accuracy of time-based recall may 
also affect interviews. Therefore, the discrepancy between questionnaires and 
interviews appears to be underpinned by a range of factors, rather than specific to the 
measures themselves.  
Finally, regardless of the reason for the discrepancy, it is important to consider the 
implications for stigma reporting in practice. If interview data reports high levels of 
stigma but the Stigma Impact Scale is not reflecting this, it may suggest a more 
effective questionnaire is needed to measure stigma. For instance, during clinical 
assessments a short tool which captures experiences may be preferable over completing 
a more in-depth interview. At present, if the Stigma Impact Scale was used for this 
purpose it may suggest stigma is low, rather than acknowledging that had the questions 
been worded differently or focused on other aspects of stigma, reporting may have been 
higher.  
 
Conclusions 
 
Overall the findings presented in this chapter support the conclusion that people with 
Alzheimer’s disease and their supporters experience stigma. The extent of this stigma 
varies across participants, as well as within individual circumstances. For some, stigma 
was more evident in public reactions. For others, negative reactions of family and/or 
friends were more prevalent.  
Statistical analysis evidenced a higher reporting of stigma by people with Alzheimer’s 
disease compared to their supporters. Further, these differences remained across 
subcategories of the Stigma Impact Scale. Possible age-based differences emerged 
relating to financial instability, and internalised shame. People affected by early-onset 
Alzheimer’s disease scored higher for financial instability, reflecting previous literature 
on financial concerns of younger people with dementia (Chaston, 2010). People 
affected by late-onset Alzheimer’s disease reported higher internalised shame which 
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would support a ‘double stigma’ of ageing and Alzheimer’s disease (Scodellaro and 
Pin, 2011).  
Interview and questionnaire data complimented each other in terms of pattern of 
responses. However reporting during questionnaires was substantially lower. A range of 
possible reasons for this discrepancy have been discussed. These include ease of 
responding during interviews, based on flexibility of answers, and increased familiarity 
with the researcher. Further, bias processing of positive information, and dissociating 
with the group identity may skew questionnaire results. The findings reinforce the 
benefits of including multiple methods to answer the research questions, as the 
discrepancy seen between questionnaires and interviews provides interesting insights 
for how people report their experiences. 
Despite the range of negative experiences reported, people generally remained very 
positive. The possible age-based differences in stigma appeared to be reduced when 
considered in the context of how people manage their experiences. Both older and 
younger participants showed shared motivations to focus on the positive aspects of their 
experiences. For instance, people focused on considering the friends and family who 
remain supportive. Such mechanisms will be discussed in more detail when looking at 
the consequences of stigma on looking to the future in chapter 8.  
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Chapter 7- How do people with Alzheimer’s disease and their supporters view and 
plan for the future? 
 
The question of how people with Alzheimer’s disease and their supporters view and 
plan for the future, was a largely unexplored topic outside of advance care planning. 
Therefore, unlike with the stigma-focused questions, there were not appropriate 
quantitative measures to look at future outlook more generally. As such, a range of 
topic guide questions were used to ground answers in what was already known, and 
address the gaps in knowledge to broaden understandings.  
As advance care planning and end of life care have received greater focus than looking 
to the future more broadly, these topics were included with several interview schedule 
questions including: Have you been involved in advance care planning? Have you 
thought about future care?  It was important to keep these questions given that much of 
the drive behind early diagnosis of Alzheimer’s disease, and the subsequent exposure to 
stigma is justified through advance care planning. Further, it would allow a baseline in 
literature for similarities and differences in findings to emerge. The focus was then 
widened to include hopes and fears about the future, and how Alzheimer’s disease may 
influence future outlook. For example, Have your thoughts about the future changed 
since having Alzheimer’s disease? (full topic guide in Appendix 6).  By moving beyond 
end of life care, it brings to light the ongoing future thoughts which can influence 
people across the journey of Alzheimer’s disease. Similarly, by seeing Alzheimer’s 
disease as a journey it highlights how future outlook can influence people’s experiences 
pre-diagnosis, through to learning to manage their condition.  
Thematic analysis was used to synthesise answers relating to looking to the future. 
Across people with Alzheimer’s disease and their supporters two key themes emerged: 
Focusing on ‘one day at a time’ and maintaining a positive outlook. These themes 
overlap where the focus on ‘one day at a time’ is a way of managing their concerns 
about the future and thereby remaining positive. The following discussion brings 
together examples from the interview data to demonstrate how people in this study 
looked to the future. These experiences have been considered in relation to research 
literature, before being brought together with stigma-related findings in chapter 8. 
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What do we do now? 
 
Following the diagnosis of Alzheimer’s disease, all participants expressed a feeling of 
‘What now?’ Getting over the initial shock and distress of diagnosis was the first 
hurdle. This is exemplified by Eva (SE1) describing the moments following diagnosis,  
“…had a cup of coffee in the hospital cafe and thought what do we, what do we 
do? Where do we go from here?”  
The presence of uncertain futures early on in the journey of Alzheimer’s disease 
contributes to the need to move beyond an end of life focus. However, several 
participants asked, ‘why do people need to know the diagnosis?’ Following initial 
adjustment almost all participants expressed that they were glad to know in order to 
move forward with their lives. As Poppy (SL1) highlights,  
“Actually it was a relief that there was an explanation, I mean you know, very 
sad about the diagnosis, but a lot of close friends and family had been concerned 
because there was obviously something wrong.” 
These extracts support previous literature which discusses how distress from diagnosis 
reduces over time, as people adjust to the situation (Robinson et al., 2011).  
Across participants there was varying amounts of previous experience of Alzheimer’s 
disease, with some families having several family members being diagnosed with the 
condition at some point, and other families having never spent much time with 
somebody who has the condition.  This did not appear to impact on whether participants 
felt they knew what to do next or what was ahead of them. This was largely explained 
by viewing the condition as unique and unpredictable. For example, Isobel (SL5) notes 
that Oliver’s (PL5) aunt had dementia, 
 “It was the one thing he feared and didn’t want, I think he had an aunt …” 
(Isobel)…“So he had an idea of what it would mean?”(Researcher)…“Yes, I 
think it was her who possibly, who, uh huh...” (Isobel) 
Isobel goes on to add that the trajectory is unique,  
166 | P a g e  
 
“And it’s different for everyone when it comes, it doesn’t necessarily, because 
aunt went downhill quite quickly.”  
Separating experiences based on their unique nature may suggest that future outlook is 
not being affected by knowing others with the condition. However, there may be more 
indirect mechanisms around fear of what has been observed in others and what may be 
influencing views. For instance, Emma (SE4) notes that previous experiences may have 
led to avoidance,  
“His mother had it you see, so I don’t think, you know the alarm bells were 
there, maybe chose to ignore them for a bit …” 
Similarly, Sophie (SL15) highlights the general view of participants, that whether you 
have seen others living with Alzheimer’s disease or not, you hope it would be different 
when you have to deal with it,  
“Well his mum had it, and all her family had it… Well you can’t really prepare 
yourself for it, just have to hope it’s not going to happen…” 
Even if people had not had direct experience of people with Alzheimer’s disease 
beforehand, their discussions mirror those who had. For instance Poppy (SL1) and 
Cameron (SL10) discussed reading books about another supporter’s experience of 
living with Alzheimer’s disease to learn more. They conclude with a similar acceptance 
of unpredictability seen in previous quotes, as Poppy explains, 
“by the time it came to the end I thought maybe I shouldn’t have read this…, 
sometimes I think you have to shut your mind off to things because I had to 
think well that might not happen, just the way she’d [book reference] gone, that 
might not necessarily happen so really there is no point dwelling on that.”  
Overall, participants did not appear to be heavily influenced by having had previous 
family members with the condition, as their responses were much the same as those 
without previous experience. However, as Kristiansen et al. (2015) note, it may have 
influenced feared futures which could change the way people manage their experience.  
Initial future outlook revolved around lifestyle changes which needed to be 
implemented as a result of symptoms, such as loss of driving licenses and job roles. For 
all of those who had to make these changes, there was a clear sense of loss and 
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uncertainty about how this would affect their lives, noting both the change in 
independence and the boredom of not being busy.  Such differences appeared to have 
age-related differences, with previous research suggesting that loss of driving licences 
can affect younger people more than older people (Taylor and Tripodes, 2001). 
Although, this does not mean older people will not be affected by a loss of license (Carr 
and Ott, 2010). All but one of the participants with early-onset Alzheimer’s disease 
discussed the loss of their driving license and the impact this had on their confidence 
and feelings of independence. Both Matthew (PE7) and Jack (PE6) talked about how 
they had been driving all of their lives, and having this taken away had caused 
significant distress as highlighted in the conversation between Jack and Olivia (SE6), 
“I’ve drived all my life and then…” (Jack)… “Aye, but he dinnae feel confident 
to drive” (Olivia).  
This discussion also highlights how it is not necessarily the symptoms themselves that 
have an impact, but how they are understood and managed. For example, studies have 
shown that psychometric profiles of people with Alzheimer’s disease who continued to 
drive, or had stopped driving did not significantly differ (Carr et al., 2005). This 
suggests that factors such as confidence levels, discussed by Olivia and Jack, have a 
greater impact than the physical changes.   
Unlike the other participants with early-onset Alzheimer’s disease, at the time of 
interview Murray (PE5) was still driving but waiting to find out if his license was to be 
renewed. Discussing the impact of this possibility further illustrated how much these 
participants saw driving as part of who they are, and a symbol of their independence. 
Comparatively, driving was very rarely mentioned in the interviews with people 
affected by late-onset Alzheimer’s disease, other than references from supporters 
highlighting that they appreciated still being able to drive. For example, Poppy notes 
how her ability to drive kept her optimistic,  
“A lot of friends can’t drive, and that would be awful, and I thought right you 
can drive and that’s a positive from there.”  
All of the participants with Alzheimer’s disease were no longer in employment, as were 
the majority of supporters. As with driving, changes in employment were largely 
discussed by people with early-onset Alzheimer’s disease. These changes had clear 
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impacts on how they viewed themselves and considered their plans for the future. Both 
Jack (PE6) and Murray (PE5) talked about how they had to leave work due to fears 
such as burdening colleagues, or no longer being as capable of maintaining the standard 
necessary. It was particularly evident for Murray and Jack how important colleagues’ 
reactions to their diagnosis were to them, particularly in treating them the same,  
“...there’s 18 years in my work, and when they found out about it, they come up 
and shook my arms, worst of luck, wee laugh, wee joke, come on Jack, so I was 
always Jack…”   
Being out of work was something which caused concerns over the future, both 
financially and through fear of boredom as Olivia (SE6) and Jack’s (PE6) discussion 
highlights,  
“I mean you’ve never ever been out of work, never” (Olivia). “Nah, this is new 
to me, know what I mean? What’s gonna happen in winter? … financially I 
panic, don’t I?” (Jack).  
The impact of changes in employment was also evident from the supporters, for 
instance, Lily (SL3) had given up work to support Harris (PL3) more,  
“Well I was working before…I took early retirement with a view to getting a 
part-time job … but I don’t have time for that.” (Lily, SL3). 
Interestingly, Michael (SL2) refers to his role as similar to that of being in employment, 
comparing the time he gets off to formal support workers,  
“They allow me 2 weeks holiday in a year, or 2 weeks respite but the workers 
get 5…” 
Noting that he gets very little time to himself,  
“While we were away on holiday I was able to have a lot of time on my own 
because [formal support] was there all the time with Grace, whereas when I’m 
here I’m with Grace all the time so. I think that that’s probably the most difficult 
part of it, apart from the number of hours I’ve got to put in every day…” 
Several other supporters mirrored Michael’s discussion over lack of time to themselves; 
with Cameron (SL10) describing how doing things for himself was self-centred, 
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recounting how fitting in activities he wanted to do on the same day as Emily (PL10) 
had appointments was “selfish me.” 
Emma (SE4) and Lucy (SE5) also discussed the need for time to themselves, and the 
change that Charlie (PE4) and Murray’s (SE5) employment had on the relationship 
dynamics. Charlie had previously worked away from home for periods of time, and 
adjusting to being home full-time was difficult for both of them. It should be noted that 
Charlie retired prior to the onset of Alzheimer’s disease, something which in hindsight 
they both appreciated as it gave him some time being retired without the condition. This 
may have meant he was protected from some of the distress experienced by the likes of 
Matthew (PE7) and Jack (PE6) by having to leave before they were ready. However, his 
greater distress was related to now feeling he was capable of returning to work, and 
Emma (SE4) disagreeing.  
“You wouldn’t have had a great retirement, because you finished work 
early…you’ve had a good few years…I doubt if you could of [carried on 
working] now could you? You couldn’t wire up tools and use a 
computer?”(Emma)...”Oh well, I don’t know” (Charlie, PE4)… “Be honest 
Charlie, I mean, I know you would like to.” (Emma)… “I would have a go at it 
anyway…I was a [job title] for goodness sake, I used to do that every day” 
(Charlie).   
This dialogue highlights the challenges faced by Emma and Charlie, particularly in 
terms of differing views over capability and the loss of work roles. This challenge was 
also noted by Lily (SL3) when explaining that Harris (PL3) sometimes thought he 
should be working, and that it could be difficult to explain that he was retired now. 
Others, such as Matthew (PE7) and Jennie (PE7), used the situation to focus on finding 
new ways of using their time together, considering volunteering as a way of filling the 
gap of employment. As well as the change in the person with Alzheimer’s disease’s 
employment status, supporters such as Katie (SE3), Lily (SL3) and Poppy (SL1) had 
given up work to look after Toby (PE3), Harris (PL3), and David (PL1). Lily had taken 
early retirement and planned to work part-time but was unable to do this given the 
circumstances. For both Katie and Lily, losing this employee role had a clear impact, 
affecting their confidence and feelings of connection. However, Poppy (SL1) tried to 
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focus on what she was now able to do with the time when she would have been 
working, 
“…because I can’t do that [work] now, but that’s the other thing, things fill the 
gaps and you don’t sit thinking oh I used to be [working], I sometimes think oh 
gosh I would have been [working], I wouldn’t have been able to do such and 
such…” 
 
Unlike the other supporters, Lucy (SE5) was still in employment, and it was evident 
how important maintaining this for as long as possible was for her, as shown by the 
following extract,   
“I would hate at this point in time to be retired and with Murray 24/7, because 
we would drive each other mad, I, I currently still need my job, I still enjoy 
working, most of my, my colleagues who are my age have gone, so I’m one of 
the most senior ones there now….”  
The interviews highlighted that following the diagnosis of Alzheimer’s disease, people 
had to adapt to the losses associated with the condition. This process was particularly 
evident for people affected by early-onset Alzheimer’s disease, as they were more 
likely to have been in employment prior to disease onset. Examples such as Poppy 
(SL1), Matthew (PE7) and Jennie (SE7) looking into volunteering roles, highlight a 
general preference to focus on the positive, and what is still possible. This supports the 
theoretical framework discussed in the literature review (chapter 3), where people are 
motivated to remain positive as a way of managing challenging circumstances (Walker 
et al., 2003).  
Part of the push for early-diagnosis of Alzheimer’s disease is to allow people with 
dementia and their families to plan for the future (Luengo-Fernandez et al., 2010). In 
terms of planning, timing was paramount. When should people start planning for the 
future? And how can you know what the time scale will be? For example, Jack (PE6) 
points out, 
“I’ve not done it yet, know what I mean, I’ve still two arms, two legs.”  
He went on to talk about waiting for the dementia to “kick in”. Other participants 
expressed similar views to Jack, talking about preferring to deal with things as they 
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come. As Isobel (SL5) discusses, it wasn’t until Oliver (PL5) started going “downhill” 
that they started to think about help and making plans. These shared experiences fit well 
with previous literature on help-seeking, and waiting for a ‘crisis point’ situation 
(Adams, 2008). At this point, people are less likely or able to avoid the situation, and 
therefore override the preference for positive information.  
Knowing when something may happen was another issue discussed across interviews, 
as Holly (SL12) exemplifies,  
“You haven’t got a timescale to know whether they’re going to go downhill 
weekly, monthly, annually, so there’s no way you can predict.”  
This uncertainty was mirrored across participants, feeling that planning was difficult to 
do as you never know what might happen. Uncertainty around Alzheimer’s disease 
progression has also been evidenced in challenges to advance care planning in the 
research literature (Sampson et al., 2011; Dening et al., 2012; Poppe et al., 2013; Davies 
et al., 2014b). Further, Katie discussed how the unpredictability of the condition makes 
it harder to predict over time so she learned to stop planning what her and Toby (PE3) 
would do,  
“You really couldn’t plan too far ahead, especially, maybe at the beginning you 
could plan a little bit more, but nearer the end you just couldn’t because things 
change so rapidly.” 
These discussions suggest that participants were generally reluctant to initiate planning 
for the future. Instead, they chose to focus more on specific changes to everyday life. 
Age-based differences may be present in terms of what the initial changes made were, 
however age itself was not salient to future planning.  
 
Can we continue normally? 
 
Although there was a general avoidance of planning across people with Alzheimer’s 
disease and their supporters, more immediate plans were discussed, such as, continuing 
with activities, staying active and busy, and having a routine. For Cameron (SL10), 
routine had become a significant feature in their everyday lives. He discussed how 
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Emily (PL10) always wanted to know what was happening next, and that he had to keep 
a plan of the day in his head to make sure that they were always aware of what they had 
left to do; as evidenced in the following quote from Cameron (SL10), 
“It hasn’t changed from the question, what are we doing tomorrow? Have you 
any idea? Have you any plans? What are we going to do tomorrow?” 
Questions over everyday activities, or what they will do tomorrow, highlights how 
looking to the future does not need to be a distant future. Rather, it can be near future 
planning which is evident in thinking about how to continue ‘normally’.  
Eva (SE1), Poppy (SL1), and Sophie (SL15) also talked about how they did not feel the 
need to be involved in a lot of the local dementia support groups, as they currently did a 
lot of the activities offered as part of their normal routine. For example, Poppy notes,  
“…we’re fortunate we can do these things ourselves, and that’s what we enjoy, 
going out for coffees, lunches, town, you know? So we can do that, you know?”  
However, other supporters, such as Holly (SL12) and Emma (SE4), mentioned how 
difficult it can be to keep busy, particularly if Millie (PL12) and Charlie (PE4) do not 
feel motivated to do activities, or know what they would like to be doing. As Holly 
notes,  
“…. [they] all seem to have this, I can’t be bothered attitude, you try and 
encourage them to do things and they just think, ‘I can’t be bothered’...”  
The lack of engagement expressed by Holly and Emma may add to the challenges of 
planning for the future, particularly if the decision-making is one sided.  
Generally, in terms of looking to the future and finding ways to continue normally, 
most of the time everyday lives were much the same as they were previously. Over time 
there was an introduction of gradual changes to make things easier. These included the 
supporter doing the shopping, or introducing day-care services and groups to keep busy. 
However, there was a separation over how the gradual changes were discussed, 
compared  to the more practical but greater-scale changes towards planning a future 
with Alzheimer’s disease. These will be described in the following sections. The 
reasons behind differences in the smaller to large-scale changes appear mostly down to 
learning to manage the condition. 
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What changes will I need to make? 
 
Throughout the study, participants highlighted that they focused on one day at a time, 
choosing to avoid thinking about the future. It was viewed as both unpredictable and 
distressing to consider the possible outcomes. However, despite this approach many had 
made practical changes. Interestingly, when these changes were discussed they were 
still qualified with statements about unpredictability. Hoyle and Sherrill (2006) support 
the use of these qualifiers by highlighting that nobody knows what is going to happen in 
the future; therefore making predictions is not necessarily realistic.  
Despite the condition being unpredictable and unique, Alzheimer’s disease does limit 
people’s future (Kristiansen et al., 2015), and therefore changes will inevitably be made 
at some point. The main changes discussed for the future included home-based 
adaptations, and securing their financial situations. All but two participants talked about 
their desire to stay at home, with their first answer to looking to the future regularly 
emphasising this preference. For example, Lily (SL3) stated, 
 “I want dad to be able to stay at home, but there needs to be the right support 
for this.”   
In order to make it easier to stay where they were several participants had made 
changes to their homes. Sophie (SL15) had moved their bedroom downstairs, although 
she talked frankly about how hard this was to do, due to the restricted space and the 
emotional impact of having to leave the bedroom herself and Angus have always shared 
together,  
“I was saying to one of the ladies I was thinking of moving the bedroom 
downstairs…but there was an awful lot against us moving downstairs, for a start 
the bedrooms tiny, can’t take our bed down. “  
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Her continued discussion highlights how much the bedroom is more than just a room, 
“You’ve more or less had everything in those drawers from when the kids were 
little, they needed space in there as well, but you get so used to everything, 
Angus’s shirts hanging in the wardrobe and trousers hanging in the next bit… 
there’s an awful lot of things folk don’t understand unless you’re actually 
working with others, nobody can say what you can and can’t do.” 
 It was evident that such changes made it harder for participants like Sophie (SL15) to 
avoid the increased needs of the person they support. Lucy (SE5) had renovated the 
kitchen, noting how much she had tried to keep it similar to before to reduce 
disorientation for Murray (PE5). As well as this they spoke about removing Murray’s 
office and making the space more open plan to avoid him secluding himself. In 
addition, Lucy (SE5) and Murray (PE5) had bought a summer house to allow Lucy 
(SE5) her own space, whilst knowing that Murray (PE5) was happy in the familiar 
environment of the home. Similarly, Michael (SL2) spoke about renovating an unused 
space to become a self-contained studio for ‘formal carers’ to stay when Grace (PL2) 
needed more continuous care. These bigger changes showed awareness of the potential 
challenges that could happen in the future, and finding practical ways to deal with them. 
However, there was a lot more detachment from these discussions to the rest of the 
interviews, with conversation returning back to the idea of ‘it could be worse’ or ‘it 
might not be necessary’. 
In terms of lifestyle changes, the most frequent example was the reduction in holidays, 
or the shorter distance and duration that holidays now took, although, many participants 
still went away fairly regularly. Michael (SL2) talked about how much more he would 
like to go away but there were many practical limitations to this. Similarly, Emma 
(SE4) expressed sadness and regret over missing the opportunity to go away when they 
were more able to,   
“Going away for a weekend I think the downside of it outweighs the benefits, 
it’s easier not to do it, so, no I wouldn’t say the future’s looking rosy, I just, 
there’s a lot of regrets, and opportunities lost I think, that’s the way I look at it.”   
Comparatively, Murray (PE5) and Lucy (SE5), and Eva (SE1) and James (PE1) talked 
about going on more holidays following the diagnosis of Alzheimer’s disease, as a way 
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of making the most of life. Murray and Lucy’s bucket list exemplifies this focus, having 
chosen to visit all of the places they wished to see following Murray’s diagnosis, 
 “…this bucket list that started all that in the first place… because it suddenly 
took me away from what I was…” (Murray).  
Both Murray and Lucy discuss the various holidays they have managed across the 
world in recent years,  
“So we’ve done a good bucket list and we’ve filled a lot of bucket!” (Murray).  
As with previous discussions, timing was important to the variation in experiences, with 
all participants talking about changes in opportunity and type of holiday across time. 
There were also concerns over future holidays, feeling that it was safer to plan trips that 
were nearby or with other people for additional support. Hamish’s (SL4) discussion 
highlights these changes, 
“Our holiday taking pattern changed because we used to do a lot of travelling, 
that has stopped because we weren’t going on package holidays, we were just 
taking off travelling around, and I suddenly realised that we can’t do that 
anymore.”  
Many supporters expressed concerns over how the person with Alzheimer’s disease 
would cope with any unforeseen problems. Lucy (SE5) shares these fears about 
travelling,  
“I’ve always watched and waited, and usually a couple evolve that I feel, you 
know what I can tell you, just in case anything happens to me, that’s always my 
fear, if something happens to me, Murray would be lost, he absolutely wouldn’t 
know what to do”.  
Despite changes in the type of holiday people go on, the ability to go away has helped 
people like Eva (SE1) and James (PE1) look to the future and feel they are ‘living well’. 
Further, they acknowledge that they are lucky to be able to do this. This reinforces how 
positive comparisons can help in managing their situation,  
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“We’re lucky in many ways, we’re in a position to be able to do these things, 
because there are lots of people who, who obviously can’t and, perhaps if you’re 
not in a position to be able to, to go on nice holidays and you’re kind of stuck in 
worrying about things, that makes things worse…” 
It should be noted that not all of the participants were in a financial position to go on 
such holidays. Financial concerns were discussed further by participants when thinking 
about the future, with some participants such as Jack (PE6) and Olivia (SE6) discussing 
their immediate concerns over financial instability and the complications they have 
faced over support for Jack who had to leave work early due to his condition. Other 
people’s financial fears were discussed much more in relation to the prospect of 
increased care and moving to a care home in the future. Emma (SE4) describes these 
fears for the future,  
“I don’t think physically we’d be able to afford it, I worry about the finances of 
let’s say Charlie going into care, because I’m physically not able to cope with 
him, you know you hear about people having to sell their homes to finance, that 
bothers me.” 
Implicit within the changes made is a need to make decisions based on the new 
situation and the related consequences. Making these decisions was challenging for 
people over time, particularly due to the reduction in shared decision-making between 
people with Alzheimer’s disease and their supporters. Increased dependency on 
supporters to make decisions was seen fairly early on in people’s journey with 
Alzheimer’s disease, with Hamish (SL4) stating that it was one of the first changes he 
noticed in Isla (PL4). Further, changes in decision-making can have a marked effect on 
the person they support. Poppy (SL1) discusses these changes,  
“One of the most tiring things in a way, sometimes, is the fact that I know that 
every decision has to be mine, absolutely everything, and sometimes that’s fine, 
most of the time, but I, sometimes I think you know I’m really tired of that, 
because even the arrangement for [upcoming event]… it’s all my decision, but, I 
suppose it has its advantages as well I get what I want [laughter] so sometimes I 
do think well, look at it that way…but just the fact there’s nobody to refer to, 
and I do miss sometimes, things I would quite like to run past, decisions about 
things, or what to do about silly things…” 
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Emma (SE4) shares similar experiences and the impact of this in more detail, 
highlighting how she had previously been a very decisive person, but not being able to 
share decisions with Charlie (PE4) led to avoidance,   
“I don’t like it, you know, you tend not to make a decision because you’re not 
sure what the other person would do about it, so it’s easy to put it off, and that’s, 
that goes against the grain because I was never that type of person, I always 
dealt with things as they came along, now I’m very aware I bury my head in the 
sand.”  
The apparent disinterest Charlie shows over decisions fuels Emma’s feelings of 
loneliness within their relationship, a feeling mirrored by Lucy (SE5). The challenges 
expressed here related to decision-making and understanding the needs of both the 
person with Alzheimer’s disease and their supporters have been explored in more detail 
within research such as Livingston et al. (2010). Similar observations are noted, such as 
the challenge of decision-making from onset of Alzheimer’s disease through to end of 
life care (Livingston et al., 2010), reiterating the on-going challenges people may face. 
There were also examples of where the preferences of the person with Alzheimer’s 
disease and their supporter differed. This was highlighted by Lucy (SE5) and Murray’s 
(PE5) experience of a clinical trial. During the trial Murray decided he wanted to stop 
due to the side effects. This caused great upset to Lucy, who felt that the trial was a 
lifeline to them. Such hope for clinical trials, and emotions attached to their 
involvement is mirrored in literature which explores motivations to be involved in 
research more generally (Black et al., 2013; Karlawish et al., 2001; Sugarman et al., 
2001). Lucy felt that had Murray had a different condition, he would have made a 
different decision. Despite his reservations, Murray decided to continue the trial, putting 
his change in decision down to seeing himself as part of a family as well as an 
individual,  
“The thing again… which finally made a big thing in there… yes [identifier 
removed] pills and everything else but what I forgot, or didn’t fathom out, that 
it’s not just me but it is us and therefore it’s not just about me, there’s a wife 
who also has to be part and parcel.” 
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For Lucy, this provided a moment of Murray seeing himself as a husband, a feeling 
which she felt was being lost. It also demonstrated much of the challenges faced by 
people when having to make decisions while accounting for what people currently wish 
for, and what they may have wanted prior to the condition.  
If people are facing a scenario which as a pair they have not anticipated or discussed, or 
their previous discussions could not be implemented, people may become increasingly 
avoidant of making decisions. A supporter’s fear  over making a decision which 
accurately reflects the wishes of the person they support is exemplified in Emma’s 
(SE4) earlier quote, where she acknowledges ‘burying her head in the sand’.  This can 
be seen in avoidance of advance care planning literature, where people worry that the 
person’s prior decisions are being honoured, whilst also balancing their current 
preferences. This contributed to the ‘take a day at a time’ focus seen throughout the 
interviews for this study, and within research literature (Van der Steen et al., 2014; 
Black et al., 2009; Dickinson et al., 2013) as discussed in chapter 3. 
 
Can we manage? 
 
Underlying how people with Alzheimer’s disease and their supporters look to the future 
is how they manage the challenges faced. As Poppy (SL1) exemplifies,  
“I think it’s just a question of, you know, taking it as it comes, and just hoping 
that, you know, you can still cope with it.”  
Although there is repeated reference to the unpredictable and unique nature of the 
condition, this does not mean people are in denial over the potential difficulties. This 
can be seen by the practical changes participants have made to their daily lives and their 
futures. However, despite awareness of what may happen, there are many examples of 
avoidance of thinking too much about it, therefore avoiding thinking too far ahead. As 
Jennie (SE7) states, 
 “You know we tend to kind of think ahead so far, but obviously, none of us can 
tell, we can get run down by a bus tomorrow…”  
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This philosophy was evident across all participants. There is a clear acknowledgement 
and fear towards the future, and therefore in their everyday lives people focused on 
dealing with each day at a time. As noted, this does not mean people cannot look to the 
future, as hypothesised by some of the neurobiological literature (Addis et al., 2010). 
Rather, due to awareness of what the future could hold or fear of such circumstances, 
people chose not to.  
Due to the lack of control participants felt over their futures, they tried not to worry 
about what could lie ahead. Many participants talked about how you could easily get 
overly worried and panicked about the future. Focusing on the present moment helped 
people to manage the lack of control. This is shown by Isobel (SL5) when discussing 
potential changes in Oliver’s (PL5) condition, 
 “I think once you accept it and stop worrying and imagining what it could be, 
you just have to take it as it comes.” 
The ‘day at a time’ way of coping with Alzheimer’s disease further reinforces the 
preference for gradual change. Participants talked about their preference for receiving 
information slowly, and adapting to situations as they happen. As Jennie (SE7) 
explains, 
 “I mean we know that eventually things will change, but for the moment…”  
Jennie adds that they know where to go if they need more information and support. This 
is reflected in other people’s stories, such as Eva (SE1) and Poppy (SL1) who have an 
information drawer/folder which they can go to when needed. Thus emphasising the 
importance of knowing what is available, but not necessarily accessing it at that 
particular time. Further, Eva (SE1) was avoidant of James (PE1) being exposed to too 
much unfiltered information without sufficient time to process their situation. She 
discusses ‘banning’ James searching ‘Alzheimer’s disease’ after a while reasoning that, 
 “There’s so much out there and you are maybe not always reading the right 
thing.” 
 This is supported by previous literature, which emphasises knowledge can lead to 
increased anxieties (Proctor et al., 2002) and fears for future selves (Kristiansen et al., 
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2015). Further, health-related information can compromise positive emotional states 
(Lockenstoff and Carstensen, 2004).  
Focusing on a day at a time also made it easier to manage plans changing unexpectedly. 
Holly (SL12) discussed how no matter how much you plan, you never know whether 
that plan will end up in place or whether the circumstances will change. Further, Katie 
(SE3) talked about how she used to make plans but felt this was problematic in 
hindsight, 
 “I used to often say to myself, one day at a time, one day at a time, and just try 
and, I mean I did make some mistakes in maybe forward planning holidays and 
things that didn’t occur, because you really couldn’t plan too far ahead.”  
Understandably there were several incidences where people feared whether they could 
manage their circumstances. This fear led to avoidance of situations where they may 
have to think about or plan for such a time.  For instance Poppy (SL1), Emma (SE4) 
and Lucy (SE5) avoided support groups, fearing meeting people who may have 
advanced symptoms of Alzheimer’s disease. Emma explains, 
 “There’s different types, and people are at different stages, and it can be if 
you’re in with a poorer group, oh lord is this what’s in front of me? I don’t want 
to be like that, you know?”  
This sentiment is mirrored by Poppy,  
“I just feel that groups, I feel personally that that would depress me, I really, I’m 
not saying, I never like to say never, but I just, I can see the benefit and some 
people can find great comfort and support and all the rest of it from that, but I 
also feel too that people are obviously going to be at different stages, and also 
everyone’s different, I think I could start to panic, and really worry about the 
future about things that might never happen.”  
Poppy’s discussion supports theories of positivity bias, and the need to maintain 
positive emotional states, therefore minimising exposure to negative information 
(Carstensen et al., 2003). Further, it reiterates people’s fears of the ‘advanced stages’ of 
Alzheimer’s disease, reflecting the interaction between stigma and future outlook.  
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Katie (SE3) also discussed her difficulty with thinking ahead, and exemplifies how 
participants managed this,  
“I tried not to look too far ahead, cos if you do look too far ahead it becomes too 
difficult, so you tend to try and deal with what you’re dealing with at the time”.  
Similarly, Cameron (SL10) found it frustrating and distressing when members of the 
group he attended continually asked him whether he had made plans,  
“They say, ‘what have you done? Have you organised a maid? Someone to 
come in?’ …Give it a rest, please don’t, they’re always ‘you should do this’…”  
Cameron, Poppy, and Emma talked openly and frankly about their fears over not coping 
with thinking about the future, and wanting to keep their situation at a level they could 
handle. They believed that thinking about a time where things may be worse would lead 
them to anxiety/depression very quickly, as supported by previous literature 
surrounding salience of the situation and feared futures (Szpunar and Schacter, 2013). 
Emma (SE4) summarises the feelings shared by herself, Poppy, and Cameron,  
“I couldn’t cope with it, literally, you know, our situation just now is at a level I 
can just handle, you know? I don’t know what’s going to happen if it gets 
worse… I just have to take it day by day, week by week, otherwise I’m, I’m 
sure I would get depressed…not just down in the dumps, I think I could get 
really, yeah genuinely upset and not able to cope.”  
As well as not feeling able to cope with thoughts of the future, others expressed fears 
about how they would manage the changes expected in the future. Michael’s (SL2) 
statement exemplifies this fear when talking about Grace’s (PL2) care needs increasing,  
“There may be a time comes when I can’t do it, and I fear that day… the fact 
that maybe I won’t be able to do it, and that will be a sad day”.  
Similarly, Katie (SE3) talks retrospectively about Toby (PE3) transitioning to a care 
home and how she had never thought that would have to happen. Katie goes on to add 
how difficult it has been to manage this change, and how limited, or in some cases non-
existent, the support has been in helping cope and prepare for this transition. These 
discussions highlight how people with Alzheimer’s disease and their supporters’ fears 
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of the future both need considering. Further, it is important to consider how people 
manage these fears if they are being encouraged to think ahead by others.  
 
Advance care planning 
 
Despite the heavy focus on advance care planning within the research literature 
compared to broader thoughts about the future, advance care planning was 
unrecognised by participants. Most said that they had not heard of the term, and very 
few had spoken with healthcare professionals or other informants about potential care 
needs. Plans were identified more in terms of having a will and whether or not the 
supporter had power of attorney. Further, many reinforced the fact they had wills and 
other such documentation but this was irrespective of having Alzheimer’s disease, and 
was more to do with securing theirs and their families’ futures. Not all supporters had 
power of attorney, for Jack (PE6) completion was not necessary whilst he still had “two 
arms, two legs” but  he did see the importance of it in the future for Olivia (SE6) to be 
‘his voice’. Again, the timing of this was mentioned with some participants feeling 
there was no need to rush into such formalities, particularly as it takes a lot of work and 
costs.  
As discussed in terms of making changes to their homes, the main aspect of advance 
care planning highlighted was a preference to stay at home as long as possible. Oliver 
(PL5) and Millie (PL12) were already living in supported accommodation, with their 
daughters Isobel (SL5) and Holly (SL12) acting as their main supporters. Isobel and 
Holly generally felt that advance care planning was taken care of in the sense that they 
could increase the care support their parents received if and when they needed to. Both 
expressed a wish for them not to have to move again, although this would be dependent 
on the support available where they currently lived.  
Many reasons were given for the preference of both people with Alzheimer’s disease 
and supporters wishing to remain in their own homes, largely based around care home 
stigma. This stigma may be a key reason for avoiding future care planning. People 
worried that the level of care would never be as good as more individualised care within 
their own homes, as well as the inevitable impact on their identity and roles. All but one 
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participant disliked the idea of going into a residential care home if their needs 
increased, and their fears of this were given as reasons to not consider future 
possibilities. Reasons behind the stigma included previous experiences of care homes, 
stories heard in the media, and fears over how they would be treated by care home staff. 
Matthew (PE7) highlighted that if he got to a stage where he needed a care home, he 
hoped to have no awareness of the fact it had happened. Similarly, Isobel (SL5) ponders 
Oliver’s (PL5) awareness of future changes, 
 “I’m quite hopeful that really he can finish out his days in his own home and 
not have to go anywhere…my sister keeps saying it would only ever happen if 
he went downhill so badly that he wouldn’t know where he was anyway, but I 
do still think they do no matter, I don’t know though.” 
Although there didn’t appear to be an age difference in attitudes towards care homes, 
for younger participants, the age range of people using care homes was mentioned. 
People such as Emma (SE4) expressed fears that people using care homes would be 
older and sedentary, suggesting younger people need more stimulation. Emma’s 
statement exemplifies this,  
“These people are in their 80s and 90s, we’re not that age, you know, they don’t 
have ones for younger people, I mean, I would die if I had to go into somewhere 
like that.”  
Unlike the rest of the participants, Hamish (SL4) felt expressively more positive 
towards care homes. He spoke in depth about his dislike of ‘care in the community’ and 
how if there was ever a time where he or Isla (PL4) needed more help, they would want 
to move into a care home.  
Generally discussion of what life would be like following transitions into care homes 
was very limited, with participants often diverting the conversation back by focusing on 
the unpredictability of the situation. However, Katie (SE3) and Michael (SL2) spoke in 
more detail about their futures aside from living with Alzheimer’s disease. For instance, 
Michael talked about whether he would have a future where he wasn’t caring for Grace 
(PL2), noting that there were many things he wished he could do. He shared these 
thoughts and the sadness that they bring,  
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“Well I often think, believe it or not, that is this it? Is this all I can expect out of 
my life for the next, I don’t know how many years I might have… Can I slip 
away and enjoy what’s left of my life, since I’ve already devoted a lot of years 
to her? And can I slip away and just live the way I want to do?”  
Following this, Michael goes on to discuss how despite these thoughts he is not sure he 
could cope with a life where he was not with Grace, they are “inseparable”.  
For one of the couples, Katie (SE3) and Toby (PE3), the transitional period into a care 
home facility happened between study visits. Katie stressed how difficult it is to think 
about the future, and how it feels just as uncertain as before. Although she now has 
more control over what she does, Katie emphasises how difficult it is to think about 
moving forward. She expresses the guilt that comes from considering a future away 
from Toby, or being involved in things which Toby was unable to do,  
“I’ve not had a great deal of pleasure since Toby went into the home, but if I’m 
doing something that I am enjoying a bit, I feel, that’s when I’ll maybe feel 
guilty, I’ve booked, I was going on a break…I feel guilty that I’m looking, in a 
way I’m looking forward to going to somewhere I’ve not been, I do feel guilty 
because we never went there together and there’s one or two places that we still 
wanted to go…”  
This excerpt highlights the opposite end of the spectrum in the journey of Alzheimer’s 
disease and looking to the future. 
 Current focus on advance care planning does not take into account the complexity of 
the situation for both the person with the condition and their supporter.  
“I’ve lost it all… I’ve not got an identity… then I was able to say well I’m 
looking after Toby, I’m a carer, what do I say now?” (Katie, SE3).  
Much more research is needed into how people manage the transition from being a 
supporter to building a different identity following such a transition. Overall these 
examples highlight that the avoidance of looking to the future doesn’t have a clear end 
point but continues across the journey of dementia. Within the literature there is 
acknowledgement of the challenges supporters may face following a loved one’s 
transition in a care home (Milligan, 2005; Davies and Nolan, 2004; Nolan and 
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Dellasega, 2001; Cronin et al., 2015; Mullin et al., 2011). However, Katie’s experiences 
suggest that the research literature is not currently impacting on lived experiences, such 
as increased support options available. 
 
Age-based differences in looking to the future 
 
Finally, age-based differences relating to future outlook seem to emerged from the 
interview data. However, the pattern was not unidirectional. There were mixed 
responses for how the situation was for the age group people were in compared to the 
opposite age group. This emphasises the subjectivity of experiences, over age itself. For 
example, there were instances of people affected by early-onset Alzheimer’s disease 
suggesting their futures had been ‘snatched away’, but this loss of future was also 
present for some affected by late-onset Alzheimer’s disease. Olivia (SE6) states, 
 “Your future’s been snatched away, your plans have grandly altered, and where 
the elderly, the over 75s, they’ve had that time”(Olivia)…“We’re nowhere near 
it yet.” (Matthew, PE7). 
 Similarly, Holly (SL12) talking about how much harder it must be for people 
diagnosed young, seeing memory problems as understandable “ once they come to a 
certain age”. She continues to say, 
 “If you or I were diagnosed it would be absolutely devastating, but at that age, I 
don’t know, the thing is, different people are diagnosed at different points.”  
However, there were also cases where people affected by late-onset Alzheimer’s 
disease felt their future had been lost. Michael (SL2) represents this view, 
“Well I often think, believe it or not, that is this it? Is this all I can expect out of 
my life for the next, I don’t know how many years I might have.”  
Lucy (SE5) agrees with the increased difficulty for people such as Michael, arguing that 
the scenario is easier to manage for younger people. She states,  
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“I think we’re maybe one of the lucky ones, ‘cus what I thought at the 
beginning, it’s awful that we’re young and it’s happening, but imagine if you’re 
old and it’s happening, how much harder is that to handle, how much harder for 
a carer, the whole thing  must be a nightmare.”  
The presence of similar challenges across age groups suggests overarching themes, 
rather than being reduced to age-specific experiences. Importantly, across age groups 
there appears to be a shared method of managing the situation: focusing on one day at a 
time. As with previous discussions, the similarities seen across age groups add further 
support to theories such as socioemotional selectivity theory (Carstensen, 1991).As 
explained in chapter 3, the theory suggests that people affected by ‘time-limiting’ 
conditions, in this case Alzheimer’s disease, will have a similar sense of time being 
restricted. If Alzheimer’s disease were not present, older participants would be expected 
to have a different view of time to younger participants (Carstensen et al., 1999). The 
change in perception of time experienced by people affected by the condition, leads to a 
shift in focus from knowledge-focused to emotion-focused goals. Overall, this can be 
seen to influence how people affected by early and late-onset Alzheimer’s disease 
manage their experiences, and will be discussed further in the following chapter. 
 
Conclusions 
 
Synthesis of interview data demonstrates the continuous nature of looking to the future. 
Participants were seen to think about their immediate futures, and small practical 
changes, over looking ahead to an ‘end point’. Their discussions highlighted that future 
outlook is not restricted to focusing on ‘care’. Rather, it can be seen as something that is 
fluid and changing throughout people’s life-course. How people look to the future can 
therefore influence the whole journey of dementia, from pre-diagnosis and fears about 
anticipated futures, through to continuing ‘normally’ and making the most of the 
situation you are in.  
Age-related differences were present but bi-directional, with people affected by early 
and late-onset Alzheimer’s disease arguing that the future looked better/worse for their 
group, or the opposite group highlighting the lack of clear direction. As with the stigma-
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related findings presented in chapter 6, possible differences between age groups were 
overarched by shared methods of managing the situation.  
Future planning from the perspective of current policy and practice was unfamiliar to 
the majority of people. Choosing not to engage in advance care planning did not seem 
to be limited to awareness of its existence, or neurological inability to look ahead 
(Schacter et al., 2013; Addis et al., 2009). Instead consideration of such plans was more 
intertwined with an avoidance of thinking about a feared future. This deliberate 
diverting of attention to positive stimuli and avoidance of negative events is supported 
through the theoretical literature and research evidence (Carstensen, 1991; Kristiensen 
et al., 2015). For instance, looking too far ahead or acknowledging negative information 
led people to worry about the future and what may happen. Worrying was seen as 
unhelpful, particularly as the future was viewed as unpredictable and out of one’s 
control. Therefore, as will be discussed in the following chapter, focusing attention on 
more positive experiences allowed people to maintain a positive emotional state, and 
manage their everyday experiences.   
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Chapter 8- Is there an association between levels of perceived stigma and how a 
person views and plans for the future: for both people with Alzheimer’s disease 
and their supporters? 
 
The final findings chapter brings together what has been learned about stigma 
experiences and future outlook for people with Alzheimer’s disease and their 
supporters. There is particular focus on the overarching themes which have enabled 
people to manage the difficult situations they have faced. Figure 13 provides an 
illustration of the thematic analysis which has guided the findings and how they have 
been presented.  
 
 
Figure 13. Illustration of the key findings from the thematic analysis 
 
The following discusses the findings evidenced so far, before proposing how these 
findings interact with each other. The study results suggest that people with 
Alzheimer’s disease and their supporters experience stigma. The source of the stigma 
ranged from the reaction of the public, healthcare professionals, family, and friends. 
These reactions were unpredictable and mixed. Further, there were many examples of 
the person with Alzheimer’s disease internalising the stigma-driven assumptions of the 
condition. This can affect how they view themselves now and in the future.  
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The findings described in the previous chapter emphasise that future planning is not an 
‘end point’ rather it is an on-going process across people’s journey with Alzheimer’s 
disease. Thoughts about the future are evident from pre-diagnosis through to end of life 
care. The most prominent finding within this is that although people are aware of the 
challenges they may face, there is general avoidance of thinking too far ahead. Across 
all participants there was a preference for taking one day at a time. Small changes may 
have been put into place, but generally changes were downplayed substantially to lessen 
their emotional impact. As the previous chapter notes, some of this avoidance is linked 
to stigma-fuelled fears relating to what the future may hold, such as care home stigma.  
In addition, literature indicates that a loss of future is a widely held stereotypical 
assumption relating to Alzheimer’s disease (McParland et al., 2012). Despite this, there 
is a drive towards early diagnosis as a facilitator of future planning (Luengo-Fernandez 
et al., 2010). It could be argued that the drive towards early diagnosis for future 
planning is challenging the stigma-driven assumptions of ‘no future’. However, as the 
majority of the future planning focus is on advance care planning and end of life care, it 
may inadvertently be reinforcing the stigma-fuelled assumptions.  
Both people with Alzheimer’s disease and their supporters have expressed fear over 
what the future may hold, and therefore chose to avoid situations where they may have 
to confront it, as the following quotes exemplify, 
“… the sleepless nights, or you wake early or something, you can, your mind 
can, you really just try to rein it in and think oh well, nobody knows what’s 
going to happen, so.. but just you know as long as you know what’s available, 
and what’s there and hoping you won’t have to…” (Poppy, SL1) 
This can lead to avoidance of activities, as discussed in chapter 7, or more generally 
choosing not to think about how the future may be,  
“…there’s a great unknown out there, what I do know is there’s a lot of 
variables, and so I could frighten myself to death or not, and I’ve decided not to 
frighten myself to death.” (Lucy, SE5).  
Recent research suggests that fears of the future are likely to be fuelled by stigma 
(Kristiansen et al., 2015).  This supports the interplay between stigma-based 
assumptions and future outlook emerging from this study. Several core strategies were 
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seen across participants for managing these fears and possibilities. Firstly, where 
possible, people tried to maintain a positive focus. This was seen throughout stigma 
reporting, as well as when looking to the future. Secondly, people can be seen to have 
actively separated from the group identity of ‘people with Alzheimer’s disease’. 
Therefore, separating from the stigma and anticipated futures of the group. This is 
evidenced by people seeing their situation as unpredictable and unique. These two 
strategies are discussed in more detail in relation to socioemotional selectivity theory 
(Carstensen et al., 1991) and personal/group discrimination discrepancy (Taylor et al., 
1990). These theories help to ground the thesis’s findings in terms of living with a 
condition like Alzheimer’s disease for both younger and older people, by highlighting 
that the presence of a ‘time-limiting’ condition can minimise the age-based differences 
expected along a ‘typical’ life-course trajectory. Additionally, they offer explanations 
for why people may separate themselves from a group identity, skewing the reporting of 
negative experiences and influencing how they look to the future.  
 
Socioemotional selectivity theory  
 
As discussed in more detail within the literature review (chapter 3), socioemotional 
selectivity theory (Carstensen, 1991) is underpinned by motivational goals.  These goals 
change across the lifespan from knowledge-seeking to emotion-seeking. Knowledge-
seeking in this context refers to engaging in social interactions for the primary purpose 
of acquiring knowledge. Comparatively, emotion-seeking refers to looking for 
interactions to regulate emotional states. This includes avoiding negativity and focusing 
on positive interaction (Carstensen et al., 1999).  
Socioemotional selectivity theory offers compelling evidence for how people affected 
by Alzheimer’s disease manage stigma and future outlook. The underlying principle is 
that people are motivated to maintain a positive emotional state (Carstensen, 1991). As 
a result, social networks are actively narrowed to those that provide positive 
experiences. Therefore, people that react negatively are acknowledged but 
compartmentalised, focusing on those who continue to support them.  Jennie’s (SE7) 
response to stigma from friends highlights this,  
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“It’s their problem; I mean if they can’t deal with it, quite honestly I’d rather 
they stayed away.”  
Similarly, possible negative futures are ‘bracketed off’ (Brown and Graaf, 2013), by 
focusing on one day at a time. Looking further ahead may compromise the positive 
focus, and therefore potentially expose people to significant distress. Examples of this 
can be seen throughout the study data, such as Cameron’s (SL10) fears of looking 
ahead, 
 “See what happens, not in a position mentally to consider that one, or 
emotionally.” 
Despite a range of negative experiences reported in relation to stigma, reporting of this 
was low when making a ‘forced-choice’ in one direction during the questionnaires. For 
example, Katie (SE3) discussed a variety of negative responses from family and friends, 
such as Toby’s (PE3) son,  
“Yes, they’ve detached, and the sad thing is, we did get on fine, we all, we, I 
mean they were really close to him, he was really close to Toby.”  
Despite describing this within the interview, on the questionnaire Katie disagreed with 
the question, ‘Some family members have rejected me because of my contact with 
family member with Alzheimer’s disease’. Similarly, Sophie (SL15) and Angus (PL15) 
talk about how the support they have had from their social group has been largely 
gestures such as sending chocolates at Christmas, rather than spending time visiting. 
Despite this limited contact following Angus’s diagnosis, Sophie scored zero on the 
Stigma Impact Scale and Angus answered disagree or not applicable to 23 out of 24 
questions. These findings suggest a possible bias in reporting when having to decide 
between a positive or negative response. Further, the findings support the strength of 
including multiple measures within the study to capture the complexity of experiences 
and how they may be reported. 
Interestingly, as discussed in chapter 3, there is evidence to suggest that positivity bias 
does not always work for people with cognitive impairments; due to the amount of 
cognitive resources it requires (Reed and Carstensen, 2012). This may explain examples 
such as Toby (PE3) who strongly agreed to ‘some family members have rejected me 
because of my condition.’, whereas, others although having similar experiences of 
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family rejection to Toby, reported lower scores.  For instance, David’s (PL1) brother is 
described as being avoidant following the diagnosis of Alzheimer’s disease,  
“…but David’s brother definitely, I don’t think he can cope with it, think that’s 
the bottom line.” (Poppy, SL1). 
However, both David and Poppy answered ‘strongly disagree’ to the Stigma Impact 
Scale question. Toby may have had greater cognitive impairments than other 
participants, given that he transitioned into a care facility between visits, as well as 
scoring the highest for the Bristol Activities of Daily Living. Therefore, being at a 
slightly more ‘advanced’ stage of his condition may have reduced the presence of the 
bias seen in others. The bias is also less likely in people who are experiencing 
depression and anxiety (Walker et al., 2003; Taylor and Brown, 1988), which may be 
reflected by Toby having the lowest score for quality of life compared to other 
participants with Alzheimer’s disease. These conclusions are limited in that the findings 
should not be generalised from one person, however they suggest an avenue for future 
consideration. Further, the results demonstrate the complexity of separating biological 
and psychosocial factors to draw conclusions, and therefore add further support for the 
use of a biopsychosocial approach. 
 
Age, Stigma, and Future Outlook 
 
The literature review (chapter 2) highlighted several possible directions of age 
differences for stigma and future outlook. Scodellaro and Pin (2013), among others, 
suggested that younger adults with dementia will experience less stigma than older 
adults as they will not be exposed to the stigma of ageing (Milne, 2010; Benbow and 
Reynolds, 2000). Whereas, researchers such as Chaston (2010) reviewed the current 
understandings surrounding younger adults with dementia, and found that stigma was 
resulting in a loss of opportunities and independence (Roach et al., 2008; Ducharme et 
al., 2014).  The literature provided by Chaston (2010) and Scodellaro and Pin (2013) 
suggests that the experience of stigma will be different based on age. Alternatively, 
socioemotional selectivity theory may be a bridge between debates over experiences of 
people with early and late-onset Alzheimer’s disease. According to the theory people 
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who are experiencing ‘time-limiting’ conditions will experience similar views of time 
and the future, compared with people without health conditions (Carstensen et al., 
1999).  
The theory suggests that people with early and late-onset Alzheimer’s disease are likely 
to share similar views, despite possible differences in circumstances. For instance, 
younger participants including Jack (PE6), Matthew (PE7), and Murray (PE5) discussed 
loss of driving licenses and changes in employment status more so than older 
participants. However, despite these differences, the findings presented throughout 
suggest a similar attitude to managing stigma and future outlook. Therefore, although 
there are debates in the literature about stigma and age-based experiences of 
Alzheimer’s disease, the shared experience of the condition across age groups appears 
to override these effects. As discussed within chapter 2, previous research focuses on 
differences between the two age groups, whereas the similarities emerging from this 
study are likely to have been missed by not considering people across age groups 
together. 
  
Managing feared futures 
 
The discussion across the findings chapters has highlighted that generally participants 
avoided negative information, and focused on taking each day at a time. The salience of 
positive memories is seen to be stronger due to the cognitive-processing bias, with 
negative memories appearing further away (Walker et al., 2003). As such, people are 
more likely to recall scenarios where people have responded positively towards them, 
than negatively. This appears to be particularly true when reporting on questionnaires, 
as discussed in the previous section. 
Similarly, people are more likely to avoid situations where they may be exposed to 
negative scenarios, or information that will potentially fuel stigma. Several examples of 
this avoidance are available within the interview data, including accounts of Poppy 
(SL1) and Emma (SE4) who discuss avoiding group activities. Emma exemplifies 
avoidance of groups by people like herself and Poppy,  
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“There’s different types, and people are at different stages, and it can be if 
you’re in with a poorer group, oh lord is this what’s in front of me? I don’t want 
to be like that, you know.”  
Despite the avoidance and negativity associated with the future, people spoke about 
their hopes and how these helped them to manage their fears. These hopes included 
considering what they were still able to do, and goals they hoped to achieve. This is 
exemplified by Murray (PE5) and Lucy’s (SE5) bucket list, and hopes for research 
discussed in the previous chapter. Many participants talked of their hopes for new 
medications and new technology to help people with Alzheimer’s disease now or in the 
future, as Cameron (SL10) explains, 
“…I have faith in technology that something will happen, we will improve, we 
will learn, we’ll experience, and there’s all sorts of people beavering away in 
labs up and down the country.” 
Such hopes contributed to people wanting to be involved in research, with them 
expressing how this helped them maintain a positive outlook for the future. Such 
findings can be seen in similar research literature which considers research participation 
for Alzheimer’s disease and other ‘time-limiting’ conditions (Black et al., 2013; 
Karlawish et al., 2001; Sugarman et al., 2001). Further, Matthew (PE7) and Jennie 
(SE7) discuss how research participation keeps them involved, 
“It brings in other people, and it keeps us abreast with what’s going on…if 
there’s something gonna happen, or something available, somebody in that 
group is gonna tell us.” (Jennie) 
As well as providing hope for the future, even if they won’t directly benefit from 
research outcomes, 
“Got nothing to lose…but it could help somebody else, that’s the thing and the 
future, it might not help me, but it might help.” (Matthew) 
Similarly, as presented in chapter 3, hope enables people to look ahead when facing 
challenging circumstances (Bruininks and Malle, 2005). 
As well as discussing general hopes for the future, there were times where people had to 
acknowledge the future possibilities. For instance, Michael (SL2) and Katie (SE3) 
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shared their fears of a time in the future when they would be separated from the person 
they support, 
 “There may be a time comes when I can’t do it, and I fear that day, that’s the 
only thing I would say about advance care planning, is the fact that maybe I 
won’t be able to do it, and that will be a sad day, because I will never rest, 
because of the attention that Grace needs, and because I’d always be worried 
that people wouldn’t understand what she needs.” (Michael, SL2).  
Despite the challenge of looking ahead, Katie’s (SE3) interview illustrated that avoiding 
thinking about the future does not necessarily help in the long term,  
“I didn’t predict I would feel like this, I didn’t predict I’d be in this situation and 
it isn’t a situation that any family member, partner, carer, you know, none of us 
want to think about this, umm, however, I didn’t think I’d feel as bad as I do, I 
didn’t think I’d be as sad.”  
Katie’s distress reflects the concerns raised by Lockenhoff and Carstensen (2004), who 
note that whilst avoiding negative information can reduce distress in the short-term, it 
may lead to negative long-term outcomes.  Further, interviews such as Katie’s (SE3) 
reinforces how futures of people with Alzheimer’s disease and their supporters are 
entwined. For example, Katie talks about how Toby (PE3) no longer being able to 
participate in the same things as she is doing makes her feel,  
“I feel guilty that…I’m looking forward to going to somewhere I’ve not been, I 
do feel guilty because we never went there together.”  
As a result of their supporting role, many of the supporters’ pursuits had changed, such 
as stopping work (Lily, SL3), or having less time for themselves (Cameron, SL10). To 
focus on this would be maladaptive to emotion regulation. Therefore in order to remain 
positive, the smaller things in life become appreciated (Hicks et al., 2012). Most 
importantly, people focused on the positive relationships with those around them such 
as family and friends (Benbow and Jolley, 2012).  
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Managing unpredictability  
 
The thesis findings emphasise that looking to the future exposed people to their fears 
about what could happen. As a result, people avoided looking ahead as much as 
possible, choosing to focus on their current situation. The unpredictable trajectory of the 
condition encouraged people to see it as out of their control, and avoid worrying as 
much as possible.  As Holly (SL12) notes,  
“You haven’t got a time scale to know whether they’re going to go downhill 
weekly, monthly, annually, so there’s no way you can predict.”  
This sentiment is mirrored across previous literature which considers how people 
manage adverse and unpredictable circumstances (Hoyle and Sherrill, 2006; Dickinson 
et al., 2013).  The need to ‘just get on with it’ was unanimous amongst participants, 
feeling that the only way to manage was to accept it for what it was, and try to focus on 
what they could still do, instead of worrying about what you cannot do now, or in the 
future. This approach was seen across participants, regardless of age.  
The management strategies employed are being increasingly reported, as noted in the 
literature review chapters. The current findings build on this body of literature further 
by highlighting how experiences of people with Alzheimer’s can be similar despite 
affecting a diverse range of people. The acceptance of unpredictability was most 
adaptive for participants, and is supported by motivations to maintain positive 
emotions. However, this process takes time. Participants talked about the gradual 
process of change, and learning to move forward. For instance, Lucy (SE5) notes how 
initially she did not necessarily think people should be diagnosed, whereas she now sees 
the benefits as it led them to create the ‘bucket list’, 
“… if there’s nothing you can do, why do we need to know?, and [doctor’s 
wife] she felt that you know, why tell people when there’s nothing we can do? 
But once we got over that, we decided that actually we were glad that we did 
know, because we could plan.”  
This is supported by research into how people experience their diagnosis (Vernooij-
Dassen et al., 2006). The focus moved from diagnosis to thinking about what they 
enjoyed doing, emphasising how planning in practice was focused on life-goals over 
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‘care’ concerns. Eva (SE1) spoke passionately throughout the interview about this 
viewpoint,  
“Go with the flow; do as much as we can, when we can, live well.”  
For some couples this was continuing activities they had done before, for others it was 
engaging in new activities or services to help support this transition. Similar findings 
have been seen in relation to ‘couplehood’, and preservation of joint activities 
(Hellstrom et al., 2005, 2007; Sorensen et al., 2008).  
The unpredictable nature of Alzheimer’s disease was also used as protection from 
future fears.  Poppy (SL1) highlights this view,  
“I think it’s just a question of, you know, taking it as it comes…certainly 
sometimes something will happen and I really panic and think oh no it’s a 
slippery slope, but then I’ve learnt to realise that that’s not necessarily even 
going to occur… you can’t dwell on it, just hope for the best and keep going.”  
Such feelings were also expressed in terms of the unique nature of the condition, where 
each person is different; therefore unpredictable. This is exemplified by Eva (SE1),  
“Why worry about something that might never happen?...nobody knows, so, you 
I think you just have to get on, and as I say, we concentrate on the positive 
things in life, and what we enjoy doing, and what we can do, and you know, just 
get on with it.” 
The discussion highlights how across age groups people with Alzheimer’s disease and 
their supporters manage unpredictable reactions and fears of the future through focusing 
on each day. Further, within this unpredictability is a sense that each experience is 
unique. As Sophie (SL15) notes,  
“You wouldn’t get two stories the same”  
Poppy (SE1) mirrors this, 
“You could have a dozen people with Alzheimer’s who are all completely 
different…and they might have come across somebody who’s completely 
different to the next.” 
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By separating individual experiences to those expected by the group, people have 
learned to maintain a positive emotional state as much as possible.  The findings have 
been supported throughout by socioemotional selectivity theory for people affected by 
Alzheimer’s disease, irrespective of age. This is explained through a shift in motivation 
towards emotion-focused goals when people face ‘time-limiting’ conditions. The 
unique nature of the condition has also been discussed as a way of helping people 
separate from the group identity, associated stigma, and anticipated futures, as will be 
discussed in the following section.  
 
The personal/group discrimination discrepancy- ‘We’re the lucky ones’ 
 
The separation from the group identity of ‘people with Alzheimer’s disease’ can be 
explained using personal/group discrimination discrepancy theory (Taylor et al., 1990). 
Further, it can be applied to both stigma and future planning, under the framework of 
socioemotional selectivity theory (Carstensen, 1991). The following discussion has 
brought together evidence from this study with the research literature presented in 
chapters 2 and 3, to show how findings build on current understandings of experiences 
of Alzheimer’s disease, and consider how people manage exposure to stigma and the 
consequences to future planning. 
Personal/group discrimination discrepancy, as discussed in more detail within the 
literature review, was developed to explain the emergent finding that people perceived a 
higher level of discrimination towards their group, compared to themselves as an 
individual within the group (Taylor et al., 1990).  By seeing others as worse off, people 
may be able to dissociate themselves from the group norm, thereby protecting their 
identity (Taylor et al., 1990). This allows people to separate from the stigma toward the 
condition and the feared futures, to maintain emotional stability.  
Across interviews, people regularly described themselves as being the ‘lucky ones’. 
When negative events were reported, they were followed by an event which affected 
somebody else, and was perceived as worse. Examples include Sophie (SL15), who 
mentions finding things difficult at times, but follows this by describing her neighbour’s 
circumstances,  
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“Oh I keep it together, Sunday really wasn’t very good, but I just hold it 
together, saw my neighbours, saw my grandchildren…feel sorry for my 
neighbour, I think it’s easier for a female to cope with an illness than a male, 
and neighbour says life is not what it was like when his wife could do it….she 
has an awful lot of health problems…I think, I don’t have that to contend 
with…” 
Other examples to support the discrepancy include, Holly (SL12) and Lucy (SE5). 
Holly talked about how much harder it must be for people diagnosed with Alzheimer’s 
disease when they are younger. Whereas, Lucy felt it was better to be dealing with it 
whilst young and able. Their differing views also emphasise the complexity of age-
based hypotheses relating to experiences of Alzheimer’s disease. Other participants 
compared their situation to health problems other than Alzheimer’s disease. For 
instance, Sophie (SL15) discussed one of her friends,  
“He’s had two heart attacks and also had prostate cancer, so I think we’re lucky, 
when I compare myself, I think we’re ok.”   
In addition, the process of seeing themselves as lucky relative to others may have 
contributed to low reporting of stigma in questionnaires. For example, Jennie (SE7) and 
Matthew (PE7) talk about knowing people with dementia who have “dropped off the 
radar” and ended up very isolated, whereas they didn’t feel that was the case for them. 
Knowing about other people’s experiences may have increased the motivation for 
employing the positivity bias.  If participants had not known of other people’s 
experiences, or focused on these comparisons, reported stigma during questionnaires 
may have been higher. 
Throughout all of the interviews, participants were continually comparing their 
situations to others, both with Alzheimer’s disease and with other health conditions. 
The majority of the time this was to suggest that their situation could be worse. 
Matthew (PE7) exemplifies the positive comparison to other health conditions,  
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“At the end of the day it’s something that happens, it’s not, I’m not the only 
person that’s got it, there’s an awful lot of other people out there that have it as 
well, you know, and there’s a lot of things a lot worse than Alzheimer’s, so you 
know, if you’ve got to have something, I don’t mind because you can forget 
things, it’s convenient you know!”  
However others, such as Millie (PL12) and Oliver (PL5) felt that Alzheimer’s disease 
was the worst condition to be diagnosed with, and others were in easier situations. As 
Holly (SL12) describes,  
“It was always her worst nightmare, she says I could cope with heart, stroke, 
cancer anything...”  
Isobel (SL5) also discusses how Oliver expressed similar feelings,  
“It was the one thing he feared and didn’t want.” (Isobel, SL5). 
These differences in response may link back to previous discussions on stigma and 
labelling of the condition (chapter 2). There may also be age differences, with younger 
participants being more likely to see Alzheimer’s disease as an illness outside of their 
control. Whereas, as the questionnaire data alluded to, older participants may be at more 
risk of internalising the stigma of the condition and therefore expressing greater 
anticipatory fear.  In addition, the experiences may differ due to how Millie and Oliver 
used to talk about the condition before developing it themselves. Whereas, Matthew’s 
response may be a result of seeing the condition differently since the diagnosis, as his 
experiences have challenged the stigmatised view. The range of possible explanations 
highlights the complexity of the topic and suggests future research which considers 
people’s view of Alzheimer’s disease before and after diagnosis may be insightful.  
Participants’ ability to see their situation as better off is captured in the interviews with 
references to being the ‘lucky ones’. The sense of being lucky may contribute to the 
significant difference seen between people with Alzheimer’s disease and their 
supporters in the questionnaires. During the interviews, the shared experience of 
Alzheimer’s disease is evident,  
“‘It didn’t just happen to Matthew, it happened to me too.” (Jennie, SE7).  
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However, in terms of questionnaires relating to stigma, supporters may have felt that 
the level of stigma they have experienced was marginal to that of the person they 
support. Taking account of the possible positivity bias and the sense of being lucky 
relative to others, the experiences of Alzheimer’s disease appear to be affected by how 
people manage their situation. Results may have been different for people who felt that 
they were unable to manage, or did not have the psychological or physical resources to 
do so. For example, if people did not have the resources available to use the positivity 
bias, or they focused on their feared futures, a different picture may have emerged. This 
is reflected in the case studies presented by Kristiansen et al. (2015) who highlighted 
that the participant who focused on the feared future had poorer outcomes overall than 
the participant who was able to focus on maintaining positivity.  
Part of the focus on being the ‘lucky ones’ enabled people to separate themselves from 
the group identity. Weiss and Lang (2012) found that such dissociation could be self-
protective. Early research by Weinstein (1980) found people rated positive future events 
as more likely to happen for themselves than others, and negative future events as less 
likely to happen. This is an attribution bias known as unrealistic optimism. McKay and 
Dennett (2009) note, that although this view of the future can be a misperception, it can 
still be highly adaptive.  In keeping with this, separating from the rest of the group can 
change the way people consider their future. Functional MRI (fMRI) imaging has 
shown people processing less information that challenges their optimistic view 
compared to that which supports it (Sharot, 2011). An example of this from interview 
data can be seen when Lucy is discussing a clinical trial Murray (PE5) is involved in. 
Lucy (SE5) talks about changes which make her hopeful that he is on the active drug, 
although noting that it’s not consistently the case,  
“…sometimes you do things or say things and I think, oh he’s definitely not on 
the tablet, and then there will be something else you’ll think, wow I wasn’t 
expecting that…” (Lucy, SE5).  
By focusing on the potential signs the drug is working, Lucy can direct her hopes 
towards this. Lucy highlights the distress resulting from Murray considering stopping 
the trial, and therefore losing hope of changing their anticipated future,  
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“I was absolutely devastated that Murray couldn’t grasp that it was our only 
hope of a future that was longer, and yes it might not work, but it’s the only 
hope we’ve got.” 
The fMRI research by Sharot (2011) highlighted that as well as a reduction in 
processing challenging information, people showed increased processing of information 
which supports their view. These findings would suggest that people affected by 
Alzheimer’s disease are more likely to process experiences which suggest they are 
managing better than they expected, as shown by Isobel (SL5),  
“We’ve been really pleasantly surprised that dad, after all these years, you 
expect when you get the diagnosis that they’re going to go downhill very 
quickly, but that hasn’t been the case with dad at all, dad’s still very active and 
very, just memory problems.”   
However, across the visits and stories shared, changes in Oliver’s (PL5) abilities were 
evident. The extracts from interviews reinforce the subjective nature of people’s 
experiences, with the need to consider how people appraise their own situations relative 
to their expectations for themselves and others.  
The literature surrounding unrealistic optimism highlights how neurological processes 
can impact on the way people view their situation. Such processes can influence how 
they anticipate their future, relative to their own beliefs, and others’ situations. 
Similarly, it could add further explanation for why people would rate their own 
experiences of stigma as low, given the reduction in negative information processing.  
Overall, personal/group discrimination discrepancy and the attribution biases discussed 
go some way to explaining why people may report less stigma being directed at 
themselves. This does not take away their awareness of stigma towards the group, 
rather it places greater emphasis on others who they feel are more affected, leading 
them to feel the ‘lucky one’. This dissociation is thought to improve people’s ability to 
manage stigma. Acknowledging the group stigma without self-identifying appeared to 
have the best outcomes for people in this study; it allows them to maintain positivity 
whilst not denying the existence of negative circumstances.  
Despite these findings, dissociating with the group may not necessarily be the best 
outcome in the long term. When it comes to looking to the future, such dissociation 
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may be making it harder to acknowledge the changes they may have to face, as 
discussed within socioemotional selectivity theory (Lockenhoff and Carstensen, 2004). 
Generally, a lot more research is needed to consider the current dissonance between 
looking to the future in policy, and in practice (Robinson et al., 2010; Godfrey and 
Hackatt, 2015; Dening et al., 2011), and how to manage the avoidance which has 
protective effects in the moment (Lockenhoff and Carstensen, 2004).  The current 
literature is not conclusive over the benefits of advance care planning (Robinson et al., 
2012) and in line with the current study’s findings, suggests focusing on daily living is 
more optimal (Dickinson et al., 2013). However, if planning ahead can be of benefit, 
findings ways to support this could improve outcomes for people affected by 
Alzheimer’s disease.  
 
Conclusions  
 
Overall, this chapter has brought together the findings relating to stigma and future 
outlook to highlight how they interact and shape people’s experiences of living with 
Alzheimer’s disease. Exposure to stigma can lead to feared futures, with a focus on 
increased ‘care’ and reduction in capabilities. In order to manage the negative 
experiences they had been exposed to and their fears for the future, participants 
employed a range of mechanisms to help manage their situation. These included 
separating from the group identity, and considering themselves as ‘lucky’ relative to 
others. The concept of being ‘lucky’ enabled people to focus on how things could be 
worse, further facilitating the positive focus and the minimising of negative 
experiences. These techniques are considered to be particularly helpful when people are 
faced with unpredictable circumstances that are outside of a person’s control.  
Socioemotional selectivity theory provides a useful lens to explore the interaction 
between stigma and future outlook by highlighting how people are motivated to 
maintain their positive emotional state. As such, participants separated themselves from 
the negative reactions of others and focused on those who remained close to them. 
Further, participants chose to avoid looking far ahead, instead focusing on taking one 
day at a time.  
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Finally, emerging findings brought together with the research literature emphasise how 
age-based differences are minimised when focusing on the interaction between stigma 
and future outlook. The findings suggest that some experiences may differ between age 
groups including, the impact of diagnosis on employment and driving license affecting 
confidence and finances of younger participants, with internalised shame impacting 
more on older participants. Despite these differences, the way people have learned to 
manage a diagnosis of Alzheimer’s disease encompassed all participants. As with 
previous discussions, these findings are supported by shared experiences of people 
living with ‘time-limiting’ conditions, irrespective of age.  
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  Chapter 9-Discussion and Conclusion 
 
The following chapter synthesises what has been discussed across the thesis, and how 
the PhD contributes to wider understandings of living with Alzheimer’s disease. Firstly, 
the study results will be considered in relation to the gaps in the research literature 
discussed within the literature review chapters. The potential for generalisation of 
findings has been noted in terms of replications of the research. Finally, gaps which 
have emerged as a result of the findings will be explored with recommendations for 
future directions of research.  
 
Perceptions of Stigma and Future Outlook 
 
This study explored the experiences of people with Alzheimer’s disease and their 
supporters. The aims and objectives were to consider people’s perceptions of stigma 
and future outlook, including the possible age differences previously unexplored in the 
research literature. The development of Alzheimer’s disease can expose both people 
with the condition and their supporters to stigma, the source of which can range from 
public perceptions through to family, friends, and self-stigmatisation. One of the core 
stigma-driven assumptions explored was that people do not have a future following the 
development of Alzheimer’s disease. This assumption may be fuelled further by current 
understandings of future planning which focus on advance care planning and end of life 
care (Dening et al., 2011; Robinson et al., 2010; Dickinson et al., 2013). 
The results presented across the three findings chapters considered four research 
questions. Firstly, do people with Alzheimer’s disease and their supporters experience 
stigma? Secondly, how do people with Alzheimer’s disease and their supporters view 
and plan for the future? Thirdly, is there an association between levels of perceived 
stigma and how a person views and plans for the future: for both people with 
Alzheimer’s disease and their supporters? Finally, across the findings chapters the 
differences in experiences of stigma and future outlook, for people experiencing early 
and late-onset Alzheimer’s disease were explored. These questions were examined 
through questionnaires and interviews, to give an in-depth account of the complexities 
206 | P a g e  
 
of experiences. Further, theoretical and methodological understandings were considered 
through a biopsychosocial lens, which acknowledged the biological underpinnings of 
the condition whilst focusing on the psychosocial experiences of Alzheimer’s disease.  
The findings presented highlighted that people with Alzheimer’s disease and their 
supporters had various experiences of stigma. These experiences were mixed and 
unpredictable, with inconsistent age differences seen across participants. Questionnaire 
and interview methods produced different outcomes. Stigma reporting in questionnaires 
was generally much lower than that expressed at interview. Several explanations were 
suggested to explain this. The positivity bias, explained with socioemotional selectivity 
theory, highlights how people affected by ‘time-limiting’ conditions are motivated to 
maintain positive emotional states. As such, when making ‘forced choices’ between 
positive and negative answers on questionnaires, people were more likely to focus on 
the positive. The interview data suggest that the Stigma Impact Scale may not be 
accurately capturing people’s experiences of stigma, which is considered in relation to 
whether stigma is being discussed towards oneself or the group ‘people with 
Alzheimer’s disease’.  By separating from the group and seeing other people’s 
situations as worse off, reporting of stigma was lower in questionnaire responses than 
when discussing experiences more broadly in interviews. 
The positivity bias and pursuit of emotion-focused goals can also capture broader 
experiences of living with Alzheimer’s disease and looking to the future. Instead of 
planning post-diagnosis, people chose to focus on one day at a time, and hope for a 
future that was different to that feared through stigma. By comparing themselves to 
others and seeing themselves as unique, people with Alzheimer’s disease and their 
supporters were better able to separate themselves from the ‘typical future’ associated 
with developing the condition. As such, the interaction between stigma and future 
outlook is reinforced. These findings compliment socioemotional selectivity theory, as 
well as various attributional biases which help people to maintain this view (Taylor et 
al., 1990; Shepperd et al., 2013).  
The theoretical literature warns that such attributional biases can lead people to avoid 
thinking about the future when negative events are likely to occur (Lockenhoff and 
Carstensen, 2004).  As a result of this, people avoid information that disturbs their 
positive emotional state. This was evident amongst people with Alzheimer’s disease 
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and their supporters. There was a lot of reluctance to consider a time where care needs 
would increase for the person with Alzheimer’s disease, as well as more generally the 
changes that may take place practically and emotionally. Several participants 
acknowledged that this avoidance was deliberate and necessary to avoid fear and 
anguish. Despite fears of thinking about the future, many participants had begun to 
make more practical changes, such as moving their bedrooms to the ground floor. 
However, these changes were generally segregated from being considered in relation to 
the person with Alzheimer’s disease’s health. These findings are consistent with recent 
work by Dickinson et al. (2013) who found people were reluctant to make plans relating 
to care, but were more likely to consider aspects such as finances.  
Finally, age differences were explored given the lack of research which included people 
with early and late-onset Alzheimer’s disease together. Although differences in 
experiences were evident, particularly in relation to finances and occupational change, 
the differences focused on in previous literature do not seem to accurately reflect the 
overall similarity in experiences of people in this study. Interestingly, people across age 
groups learned to manage their situation in similar ways, which influenced how they 
lived their everyday lives and looked to the future. Participants showed positivity bias 
and pruning of social networks to surround themselves with those who continued to 
support them. Further, although their circumstances differed in the sense of having been 
retired or working before diagnosis, across age groups the ‘day at a time’ perspective 
and avoidance of looking to the future was consistent.  
 
Applying research findings to previous literature 
 
The literature review presented in the earlier chapters of the thesis highlighted several 
gaps within the research, which have been addressed in this study. Firstly, there was 
minimal research in experiences of stigma from the perspective of people with 
Alzheimer’s disease and their supporters. Previous research focused more on public 
understanding of Alzheimer’s disease. This has led to considerable drives to challenge 
the stigma attached to the condition internationally. This is demonstrated by the World 
Health Organisation report on overcoming the stigma of dementia (Batsch and 
Mittleman, 2012).  Within this report is recognition that the voices of people with 
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dementia are often missing in the literature to date; an acknowledgement shared among 
other researchers in the field (McKeown et al., 2010). The findings from the thesis 
support the presence of stigma from the perspective of people with Alzheimer’s disease 
and their supporters. Further, the increased stigma reported in this study by people with 
Alzheimer’s disease compared to their supporters, mirrors the figures from the Batsch 
and Mittleman (2012) survey data. The presence of stigma challenges the stigma-driven 
assumption that people with Alzheimer’s disease will not have insight into their 
circumstances (Bond et al., 2002). Further, the findings support the limited research 
currently available into insight and perceptions of people with Alzheimer’s disease, 
with a focus on stigma (Burgener and Berger, 2008; Riley, 2012). Based on these 
findings, interventions may be needed that target both public awareness and people 
already affected, to reduce internalised stigma.  
The reviewed literature in chapters 2 and 3 suggested several possible directions of 
results relating to age, stigma, and Alzheimer’s disease. Chaston (2010) suggested that 
younger people were likely to experience more stigma than older people affected by 
Alzheimer’s disease. This was hypothesised due to ‘inverse ageism’ and the presence of 
an ‘older person’s’ disease. However, researchers such as Scodellaro and Pin (2013) 
argued that older people are likely to be exposed to greater amounts of stigma due to the 
‘double stigma’ of ageing and Alzheimer’s disease. Despite these opposing views, there 
was very limited research into the psychosocial experiences of the two age groups 
together. Examples of age-based differences have been reported in relation to biological 
differences and symptomology (Toyota et al., 2007), time to diagnosis (Van Vliet et al., 
2013) and supporters’ perspectives on challenging behaviour (Arai et al., 2007), which 
begins to bridge biomedical and psychosocial factors. The findings from the thesis 
highlight that although age may influence aspects of experiences, such as financial 
insecurity and internalised shame, the impact of age was inconsistent in relation to 
stigma and future outlook. Further, the thesis findings emphasise the benefit of 
including both age groups together; 
Other research has included both people with early and late-onset dementia, but without 
noting that participants are classified as having different ages of onset. This has made it 
difficult to separate out possible age based differences. For instance, Caddell and Clare 
(2013) included people with dementia over the age of 60 as one group, despite the 
current diagnostic cut off of age 65 years old for early and late-onset dementia (Koedam 
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et al., 2010). Given that across areas of dementia research, different experiences have 
been evidenced for the two age groups (Tolhurst et al., 2014), it seems an oversight for 
research to not acknowledge when people with early and late-onset diagnoses are 
included, even if the age cut off itself is arbitrary (Woods and Clare, 2015). This thesis 
helped to address the challenges of this by considering the results by age groups, 
separately and together, helping to understand more about age itself as a variable.   
Age differences highlighted through the subcategories of the Stigma Impact Scale 
suggested that people affected by early-onset Alzheimer’s disease were more likely to 
experience financial instability. This is in-keeping with the work of Chaston (2010) and 
discussions of the Alzheimer’s Society (2015b). Comparatively, people with late-onset 
Alzheimer’s disease reported higher stigma than people with early-onset Alzheimer’s 
disease for internalised shame. This is discussed within chapter 6 as a possible 
reflection of self-stigma of older adult stereotypes and Alzheimer’s disease (Scodellaro 
and Pin, 2011), supporting the presence of ‘double stigma’ (Milne, 2010; Benbow and 
Jolley, 2012). Despite the differences seen on the assessment scales, interview data 
highlighted that there were overarching similarities in the way people managed the 
exposure to stigma and its consequences. The findings show support for both sides of 
previous evidence, demonstrating the complexity of the topic area. They also help to 
illustrate the multifaceted nature of stigma, and suggest it cannot be considered as a 
unitary concept. The difference in reporting across measures demonstrates the strength 
of mixed method designs, as will be discussed in the ensuing section. 
Another key gap in the research literature was how people look to the future, 
particularly if they have internalised the stigma-driven assumption that a future is not 
possible. Previous literature has focused almost exclusively on future planning from the 
perspective of advance care planning and end of life care (Robinson et al., 2012; 
Dickinson et al., 2013; Alzheimer’s Disease International, 2014). This thesis aimed to 
move away from this focus and look at how people view and plan for the future across 
the journey of Alzheimer’s disease. The findings presented in chapter 7 highlight that 
looking to the future was not an end point process. Rather, people’s focus fluctuated 
from immediate to more long term futures, depending on how manageable the situation 
felt at the time.  Smaller everyday changes in future planning and outlook were evident 
across participants. Larger changes were sometimes present, but downplayed to 
minimise the emotional impact. This led to people focusing on one day at a time, 
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acknowledging that Alzheimer’s disease is an unpredictable, unique condition, which 
makes looking ahead difficult. Therefore, it is easier to focus on what can be done in the 
moment.  
As well as adding to the psychosocial literature in relation to looking to the future, the 
findings add to the field of neurobiological research. As discussed in the literature 
review, cognitive impairment and ageing have been associated with increased difficulty 
in looking to the future. This has been explained through the additional challenge of 
projecting oneself into the future and reconceptualising past memories to anticipate the 
future (Schacter et al., 2013). Literature such as Mark (2012) sought to explore the 
applicability of socioemotional selectivity theory to people with Alzheimer’s disease. It 
was noted that the symptoms of the condition may make it difficult for people to 
experience the adaptive biases discussed within the theory. Despite the discussions of 
these researchers, the results of this study suggest that such theory is applicable to 
people with Alzheimer’s disease and their supporters. Further, the deliberate focus of 
emotion-focused goals and avoidance of negative information supports that people are 
not unable to look to the future. Rather they are deliberately choosing to avoid this and 
focus on daily living.  
As with the stigma findings, age differences were mentioned in relation to looking to 
the future, but they were not consistent in direction. For example, some people affected 
by early-onset Alzheimer’s disease felt they were worse off, having futures ‘snatched 
away’ whilst older people with the condition had been able to experience longer 
without Alzheimer’s disease. This in in-keeping with theoretical literature discussed in 
chapter 2, where people may be adversely affected by events that appear ‘off time’ to 
the ‘normal’ life span (Heckhausen et al., 1989). Comparatively, there were other 
younger people who felt they were better equipped to deal with the condition due to 
their age. The alternative responses within and between-groups highlight the 
subjectivity of experiences and how age does not necessarily separate people with 
Alzheimer’s disease as much as the previous literature suggests. Instead, there was a 
shared sense of focusing on each day and making the most of the opportunities 
available. The results suggest that although certain age differences may be present, 
these differences are overarched by shared management of the situation, in keeping 
with socioemotional selectivity theory (Carstensen, 1991).  
211 | P a g e  
 
Alternative explanations for findings 
 
The previous section highlights how the findings from this thesis have been interpreted 
using a psychological lens within a biopsychosocial perspective. As noted within the 
literature reviews (chapters 2 and 3), this is not the only perspective that could have 
been taken to understand people’s experiences of living with Alzheimer’s disease. 
Therefore, alternative explanations for the key findings of this thesis have been 
considered in the following section. 
 
Experiences of stigma 
 
The first key finding was that people with Alzheimer’s disease and their supporters 
experience stigma. As noted in the literature review (chapter 2), there was already 
significant evidence to suggest Alzheimer’s disease is a stigmatised illness (Devlin et 
al., 2007; McParland et al., 2012; Mendez and Cummings, 2003). However, less 
research was available from the individual’s perspective. In order to facilitate this focus, 
Modified Labelling Theory (Link, 1987) was used as the conceptual framework. 
Despite its origins in sociology, this framework has been developed and applied as a 
model of stigma in the field of psychology and mental health due to the continued focus 
on the individual within a social context (Olafsdottir, 2013; Yang et al., 2007). It may 
be controversial to apply a theory with its roots in sociology within a thesis where 
‘measurement’ is included, as Scambler (2009) suggests people’s experiences are too 
complex to operationalise. However, Link et al. (2004) assert it is crucial in the field of 
mental health, and the theory has been successfully used to develop stigma scales (see 
chapter 5). 
Alternative psychological stigma theories which centre on models of stigma and mental 
health include Corrigan and Rusch’s (2002) two-factor theory. Within their model, 
stigma is separated into socio-cognitive structures of stereotypes, prejudice, and 
discrimination. Although public and self-stigma follow the same structure they are 
presented independently. Taking this perspective, the extent to which participants 
endorse the stereotypes will influence the consequences of stigma for their everyday 
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lives. For instance, people who believe that Alzheimer’s disease is equivalent to a 
‘social death’ (Kirkman et al., 2006) are more likely to separate from the group identity. 
This could be a useful perspective when considered in light of personal/group 
discrimination discrepancy (Taylor et al., 1990), as discussed in chapter 2. However, 
the findings from this thesis highlighted that stigma is very complex and difficult to 
separate into two components. For instance, public stigma included the attitudes of 
friends, family and the general public, but the impact of stigmatised-responses from 
these groups varied across participants. Furthermore, it could be argued that 
Alzheimer’s disease is not purely a mental health condition (Ticehurst, 2001), and 
therefore is less suited to a framework that does not include the physical and social 
aspects of the condition, as has been considered in this thesis using a socio-cognitive 
model (Corrigan, 2000). 
From the sociological perspective of biographical disruption, it could be expected that 
people living with a chronic condition such as Alzheimer’s disease would focus on the 
positives of their situation, minimising the impact of its effects to maintain a sense of 
hope for the future. This is discussed by Bury (1991) and others as strategic 
mobilisation of resources (Williams, 2000a). A strength of such an approach is that it is 
possible to understand the symbolic nature of the condition as it is expressed 
narratively, and to explore how people manage this through representing disruption or 
continuity in their identity. Some ‘disruptive’ events may actually be anticipated in later 
life, and the extent of adversity is likely to be further mediated by a person’s material 
circumstances (Williams, 2000a) or ‘emotional capital’ (Williams, 2000b). Therefore, 
from this perspective, the experience of stigma would be contextualised through 
understanding dementia as an older person’s condition (Mendez and Cummings, 2003; 
Werner, 2005), with younger participants expected to experience greater biographical 
disruption. This would explain why younger participants felt there was less public 
understanding, and their futures were more disrupted by having been diagnosed at a 
younger age.  However, this approach does not address how younger participants in the 
current study also suggested that they may be better able to cope and had more 
resources to do so, than if they were older; thereby conflicting with literature suggesting 
that older people may be better able to manage stigma, due to repeated exposure to 
disruptive events across the life-course (Pound et al., 1998).   
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Overall, this sociological framework takes a different approach to what has been 
explored within the thesis by exploring how the person constructs the impact of the 
condition on their identity. Taking such an approach would have included identity as an 
explicit and integral characteristic from the outset (Hubbard et al., 2010), whereas this 
thesis focused on the socio-cognitive processes that influence people’s perceptions of 
stigma and future outlook.  
 
Looking to the future 
 
A key reason for exploring the stigma of Alzheimer’s disease was to consider the 
consequences it may have for future outlook. Participants’ future outlook was explained 
using Socioemotional Selectivity Theory (Carstensen, 1991), a psychological 
perspective on the life-course. A weakness of the socio-cognitive approach, in this case 
Socioemotional Selectivity Theory (Carstensen, 1991), is that it focuses on the 
internalised world in terms of a person’s thought processes, compared to understanding 
the sociocultural context framing the individual’s experiences and the impact of this 
context on their identity.  
Alternative theories which consider future outlook, with a particular focus on time, are 
also worth noting. As discussed above in relation to the sociological concept of 
biographical disruption, Alzheimer’s disease acts as a critical event in a person’s 
biography, leading to an awareness of the body, self and social world (Bury, 1982). 
Later work by Bury (2001) suggests that people manage this change by trying to 
maintain their previous lifestyle as much as possible and minimise symptoms, or alter 
their lifestyle to contain the chronic illness (Bury, 2001). This perspective also fits well 
with the work of Keady et al. (2009) who describes how people diagnosed with 
dementia undergo a balancing act between these two approaches of minimising and 
accommodating the condition. From this perspective, actively narrowing social 
networks to include only people who are supportive may enable participants to maintain 
as ‘normal’ a life as possible, minimising the overall disruption.  
The extent to which a chronic illness is biographically disruptive has been argued to be 
based on context and expectations in terms of age and perceived life expectancy 
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(Hubbard et al., 2010), which Williams (2000a) argues the original theory fails to 
account for. This would suggest that older people, who may be more likely to expect 
Alzheimer’s disease based on age-related risk factors, would be less disrupted by the 
condition, supporting the idea of biographical continuity (Williams, 2000a). However, 
the findings of this thesis suggested more similarity than difference in the experiences 
of people with early and late-onset dementia, as will be discussed further below in 
relation to the finding about age-related differences in perceived stigma and future 
outlook.  
Recent research by Reeve et al. (2010) suggests that to understand the impact of a 
terminal illness, the biographical approach should combine the study of the narrative 
and the embodied emotional experience. However, this type of research may be better 
suited to a purely qualitative study with a more interpretive analysis of the lives of the 
participants and their surrounding context. Although such approaches have relevance in 
terms of explaining the subjective experience of chronic illness, this thesis has chosen 
to focus on theory which can explain the association between stigma and future outlook 
observed in terms of socio-cognitive processes (Corrigan, 2000). This provides an 
explanatory framework to understand the potential cognitive biases that influence 
perceptions and experiences, a notable gap in the current literature about stigma and 
future outlook.  
 
Perceptions of stigma and future outlook 
 
The third key finding from this thesis was the interaction between stigma and future 
outlook, which raised the importance of considering the two core topics together. 
Stigma of Alzheimer’s disease and fear of the future led to an active avoidance of 
looking ahead to a time where the stigmatised-future may be realised. To maintain 
focus on positive experiences, social networks were actively ‘pruned’ and exposure to 
others with dementia was often avoided. The findings have previously been discussed 
using a biopsychosocial perspective.  
A socio-political framework, as described in more detail by Bartlett and O’Connor 
(2010), provides an interesting alternative that may also capture the interaction between 
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stigma and future outlook. This perspective focuses on positioning people with 
dementia as ‘active citizens’ shaped by life events and broader socio-political systems 
(Bartlett and O’Connor, 2010). To facilitate citizenship, the Scottish Dementia Strategy 
(Scottish Government, 2013) promotes five ‘pillars’ of support recommended by 
Alzheimer Scotland (Simmons, 2011): planning for future decision making, 
understanding the illness and symptoms, supporting connections in the community, 
planning for future care, and peer support. Despite the suggested value of such support, 
there remain risks to diagnosis (Fox et al., 2013) which may alter the way the condition 
is managed, and the options people living with dementia feel they have. The findings of 
this thesis suggest that the currently cited benefits of future planning may not outweigh 
the negatives of stigma attached to the diagnosis of Alzheimer’s disease. More work is 
needed to enable person-centred support following diagnosis, advancing on the ‘one 
size fits all’ model currently available (Kelly and Innes, 2016), to give people more 
choice (Watts et al., 2013) and to better support ‘active citizenship’ (Bartlett and 
O’Connor, 2010).  
From a socio-political perspective, Clarke and Bailey (2016) discuss how people with 
dementia can be socially excluded but have shown resilience in the face of such 
adversity.  Participants showed awareness of being treated differently, and excluded 
themselves from some situations in order to minimise the risk of others ‘shunning’ them 
(Clarke and Bailey, 2016), mirroring some of the experiences described in this thesis. 
Taking this alternative perspective, the findings of this thesis may be explained through 
stigma disrupting the identity of people living with dementia, and their position within 
society (see Beard and Fox, 2008). People strive to maintain a certain degree of 
‘normality’ despite the changes they face, withdrawing from social circumstances in 
order to minimise personal risk (Clarke and Bailey, 2016; Lee and Craft, 2002). 
Although social withdrawal appears to be a positive approach, correlational evidence 
suggests that it may also lead to lower self-esteem and therefore may not be protective 
in the longer-term (Ilic et al., 2011). From a psychological perspective, this would need 
further exploration in terms of the consequences of withdrawing socially on an 
individual’s perceptions about themselves and those around them. Finally, the potential 
for resilience to facilitate how people manage experiences provides an interesting 
avenue for future research, given how techniques for managing adverse circumstances 
were key to the thesis findings. 
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Age-based differences: Perceived stigma and future outlook 
 
The final key finding explored throughout this thesis was the age-based differences in 
experiences of stigma and future outlook for people with early and late-onset 
Alzheimer’s disease. Socioemotional Selectivity Theory (Carstensen, 1991) explained 
why people with early and late-onset Alzheimer’s disease shared similar experiences. 
The findings present a different picture to previous literature by highlighting that there 
are overarching similarities across age groups that are missed when early and late-onset 
Alzheimer’s disease are separated. As discussed previously, the age category is 
arbitrary and based on a clinical cut-off of older or younger than 65 years old for 
diagnosis of early or late-onset Alzheimer’s disease (Woods and Clare, 2015); 
nonetheless, the separation is used consistently across literature which considers age-
based experiences (e.g. Roach et al., 2008).  
Alternative theoretical perspectives to Socioemotional Selectivity Theory around ageing 
and experiences of Alzheimer’s disease include biographical disruption (Bury, 1982). 
As discussed previously, the theory reflects on the impact of chronic illness on a 
person’s life trajectory. Much of the biographical disruption literature suggests younger 
people may be more affected by the onset of a chronic illness than older people (Pound 
et al., 1998; Sanders et al., 2002), although conflicting research is available (Larsson 
and Jeppsson-Grassman, 2012). This challenges the idea that Alzheimer’s disease itself 
is universally disruptive, and supports the focus on context and timing (Grinyer, 2007; 
Hubbard et al., 2010; Wilson, 2007). Had a biographical disruption approach been 
taken, more pronounced age-based differences may have been expected from 
participants within this thesis. In support of this assumption, Roach et al. (2008) 
highlight that Alzheimer’s disease may be more disruptive to the identity of younger 
people because of their life-stage and family dynamics; however, changes in family 
dynamics more generally (Swartz, 2009) may minimise these age-based differences. 
From this perspective, the similarities seen between younger and older participants in 
this study may be a result of similar family dynamics, or more generally a result of self-
selection bias to research creating a more homogenous participant group. This is an area 
where further research would be helpful to explore these potential explanations. 
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As biographical disruption was not chosen as the theoretical framework, it is not 
possible to draw firm conclusions around the age-based similarities seen within this 
thesis. Grinyer (2007) notes the impact of illness on any age group can present 
profound challenges and is of significance for all age groups, but the specific 
difficulties people face may vary by age.  It may have been that Alzheimer’s disease 
was more disruptive to younger people in this study but they may have been better able 
to adjust their identities, leading to an overall similar level of disruption compared to 
the older participants. Alternatively, Alzheimer’s disease may be equally disruptive for 
both older and younger people living with the condition.  An approach which explicitly 
considered identity and adjustment to chronic illness may be better placed to answer 
this question.  
Overall, the findings of this thesis do not intend to contradict the different experiences 
or potential levels of disruptiveness that a diagnosis of Alzheimer’s disease can create 
based on age. There was evidence from both age groups to support different needs; 
importantly, there was also a need to consider the group similarities where age is one of 
many influential factors. In terms of practice implications, it may be more beneficial to 
separate dementia services from older adult psychiatry, as this may help to reduce the 
impact of age-based stigma (Richeson and Shelton, 2006), confusion around normal 
ageing (Whalley, 2002), as well as mental health stigma (Corrigan and Watson, 2002) 
that could all contribute to the experience of the condition. This separation could also 
ensure access to appropriate services. 
 
Conclusion: Alternative Findings 
 
Across the four findings, several alternative perspectives have been highlighted that 
could have been applied to this thesis, with a particular focus on biographical disruption 
due to its relevance to both stigma and future outlook. The alternatives have been 
discussed in terms of how the findings may have been framed differently had such 
approaches been taken. Of note, had alternative perspectives such as biographical 
disruption been used from the outset, the research questions are likely to have been 
different, particularly in terms of a more explicit consideration of identity. Therefore, 
the findings are interpreted using alternative approaches cautiously, as Hubbard et al. 
(2010) note it can be difficult to distinguish whether something is not relevant to a 
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participant, or whether it has not emerged since it was not raised as a topic during the 
data collection. 
Although offering unique insights, there are strengths and limitations of all perspectives 
which were considered critically when selecting the most relevant approach. 
Socioemotional Selectivity Theory (Carstensen, 1991) was chosen as it explains the 
findings from a psychological perspective, using a socio-cognitive model (Corrigan, 
2000), within a biopsychosocial framework. As discussed across the thesis, this theory 
has allowed for two seemingly separate topics, stigma and future outlook, to be 
considered together to highlight the complexity of the 'benefits and costs of diagnosis' 
debate (Fox et al., 2013)and people’s experiences of Alzheimer's disease. Further, the 
theory helps to address the overarching similarities between age groups which may be 
missed in alternative theories, and is particularly important when considering a 
condition such as Alzheimer’s disease where there is a somewhat tangled relationship 
between age as a risk factor and age as a cause of Alzheimer’s disease, with the added 
complexity of social constructions of age and stigma. The alternative explanations 
discussed above reflect different but relevant theoretical perspectives that merit further 
investigation in future research.   
 
Supporting the use of mixed methods design  
 
In order to generate the findings discussed, a mixed methods design was used. It is 
important to note that this choice of method is not without critics, and therefore the 
strengths and limitations should be acknowledged when drawing conclusions. 
Commonly cited criticisms of mixed methods include, the lack of guidance relating to 
combination of methods and the integration of findings (Ostlund et al., 2011), as well as 
the underlying challenge of possibly opposing paradigms (Guba and Lincoln, 1994), 
considered in more detail within chapter 4.  
The aim of this study was not to debate the use of mixed methods, but to show that they 
could be used effectively when the focus was on the research questions themselves 
(Tashakkori and Teddlie, 2003). Further, one of the issues highlighted in Ostlund et 
al.’s (2011) review of mixed methods research literature is a lack of clarity, particularly 
for the weighting of different methods. As such, this thesis aimed to make the research 
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process as transparent as possible, to support the validity of the research, as well as for 
ease of replicating the research in future. 
Despite the limitations of mixed method designs raised, the results of this study support 
its use to capture the complexity of experiences. This is particularly the case for the 
discrepancy in stigma reporting between questionnaires and interviews. The 
discrepancy had been alluded to in previous literature, but through comparing separate 
studies, as opposed to studies which included both measures. For instance, Werner et al. 
(2012) documented that reported stigma was higher in qualitative studies than 
quantitative studies. This discrepancy remains after methodological differences, such as 
freedom of reporting, have been taken into account (Bergmann et al., 2004; McKillop 
and Wilkinson, 2004). The presence of a discrepancy that cannot be explained by 
measures chosen alone, suggests psychological mechanisms such as personal/group 
discrimination discrepancy may be skewing the responding (Taylor et al., 1990). It 
would not have been possible to observe the discrepancy as clearly had a singular 
approach been used. The discrepancy also suggests a more effective tool for capturing 
perceived stigma in questionnaires may need to be developed. The findings from this 
thesis and previous literature suggest low stigma reporting using the Stigma Impact 
Scale, therefore if the questionnaire had been used alone it would not have accurately 
captured people’s experiences of stigma.  
Finally, mixed methods designs are increasingly encouraged in dementia research as a 
field made up of multiple disciplines and research backgrounds (Robinson et al., 
2011b). This is mirrored in the use of a biopsychosocial perspective. Driscoll et al. 
(2007) note that traditionally, quantitative measures focus more on biophysical features 
and qualitative measures focus on sociocultural data.  In contrast to this view, Robinson 
et al. (2011b) emphasise that understanding well-being involves a holistic approach. 
Therefore there is a need to appreciate the impact of biology, whilst recognising the 
impact of psychosocial variables on people’s everyday experiences. The findings of this 
study support this approach by emphasising that the changes that people have had to 
make, as a result of the symptoms associated with Alzheimer’s disease, have been 
influenced by psychosocial factors. People have chosen to focus as much as possible on 
what their capabilities are and how they can adjust their everyday living to 
accommodate the changes. This process of change and adaptation provides a stark 
contrast to biomedical perspectives on dementia which focus on a journey of 
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deterioration from diagnosis to end of life care (Cuijpers and van Lente, 2015). Further, 
the biomedical explanation alone would not have reflected the experiences shared 
between people with Alzheimer’s disease and their supporters.  
 
Researching with people with Alzheimer’s disease and their supporters 
 
In addition to the gaps which led to research questions, a more general concern for 
dementia research is the limited inclusion of people with Alzheimer’s disease 
(McKeown et al., 2010; Batsch and Mittleman, 2012). This inclusion was prioritised 
across the research process, including within initial design formulation, presenting ideas 
at conferences to people affected by dementia, and study protocol, as discussed within 
chapter 5. There is increasing awareness across the field of dementia that the voices of 
those affected by the condition can provide valuable insight into the experiences people 
face (Hellstrom et al., 2007; de Boer et al., 2007; Hubbard et al., 2003). An ever present 
concern for research which includes people with dementia is considering the additional 
ethical dilemmas that can be faced, which may be less prominent when researching 
other conditions (Higgins, 2013; Sadler et al., 2010; Shaghaghi et al., 2011). These 
concerns include the therapeutic benefits of research and the capacity to consent. 
Discussion relating to capacity to consent to research has been covered in more detail 
within the methodology chapter (chapter 5). Therefore, the remainder of this section 
focuses on the therapeutic benefits of research. Berghmans and Ter Meulen (1995) note 
that for research with other age groups, or more treatable conditions, participants are 
more likely to benefit directly from the research. However, this is not to say that people 
with dementia should not be involved. Rather the focus is on how research participation 
itself can outweigh the potential negative aspects of involvement.   
Psychosocial research tends to have fewer risks, but is associated with less direct 
benefits (Berghmans and Ter Meulen, 1995). The indirect benefits of research for 
people with Alzheimer’s disease and their supporter have been evidenced both in this 
thesis as discussed in chapter 5, and in the research literature (Higgins, 2013; Law et al., 
2014).  Participation in research has not only been shown to benefit people with 
Alzheimer’s disease and their supporters, but may indirectly help to challenge stigma, 
ageism and negative future outlook being explored in this thesis. Research which 
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focuses on strategies to overcome stigma include challenging the stereotypical view 
(Corrigan et al., 2012; Milne, 2010) and increasing social contact (Corrigan et al., 2001; 
Morgan et al., 2002).  Challenging stigma-driven assumptions may increase general 
understanding of the ongoing journey people face with dementia. Assumptions to 
challenge include the view that there is no future post diagnosis, or that people cannot 
be actively engaged in activities such as research. These considerations emphasise the 
importance of disseminating research findings to a wide range of audiences.  
 
Future directions of research 
 
The following section takes account of the discussion across the thesis to consider 
future directions of research based on what has been learned so far. Firstly, the 
discussed limitations in sample suggest that an initial direction of future research would 
be to replicate the study with a more diverse, larger sample size. If more potential 
participants were available, stratified sampling could be used for a more proportionate 
representation of characteristics such as gender, age and socioeconomic status (Teddlie 
and Yu, 2007). As highlighted in the methods chapter, the low numbers of people with 
early-onset Alzheimer’s disease in this study meant that statistical comparisons by age 
group did not have sufficient power. As such, there is greater risk of making a type I or 
type II error whereby the difference between the two age groups for Stigma Impact 
Scale scores may be concluded to be greater than it is or less than it is. For instance, a 
non-significant result between a small group of people with early- and late-onset 
Alzheimer’s disease may become significant when more data is included, resulting in a 
different conclusion about the impact of age and stigma. This is in-part alleviated by the 
inclusion of interviews, as well as consideration of the findings against previous 
literature, but it would still be interesting to see whether the same results between age 
groups can be seen in a larger scale study. 
Additionally, cultural differences were not considered in this study, given that the 
sample was made up of Scottish men and women.  Therefore it would be an interesting 
comparison for future research given that cultural differences are expected in relation to 
stigma, ageing and future outlook (Mackenzie, 2006; La Fontaine et al., 2007; Hinton et 
al., 2005; Downs, 2000; Fung et al., 2008; Mezulis et al., 2004).  
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Scotland has a devolved health system to the rest of the UK. Within this is a national 
strategy which guarantees people diagnosed with dementia one year of post-diagnostic 
support (Scottish Government, 2013). Research suggests that increased support may 
influence perceptions of stigma, as well as potentially increased diagnosis rates and 
future planning strategies (Miller and Kaiser, 2001; Alzheimer’s Disease International, 
2012; MacLeod and Conway, 2005; Prenda and Lachman, 2001). Therefore a UK wide 
replication of this study may produce different findings given that this year of support is 
not currently offered elsewhere in the UK. For example, greater stigma may be 
expected for samples in the other areas of the UK due to the reduced post-diagnostic 
support. Alternatively, findings may not differ significantly given that the pattern of 
results found in this study has mirrored much of the similar literature in other countries 
such as America (Burgener and Burger, 2008; 2013). Further, although the increased 
rates of diagnosis and support may suggest greater future planning in Scotland 
compared to the rest of the UK, the results from this study suggest people are not 
utilising future planning, therefore differences may not be expected. The variety of 
potential findings when considered from a UK-wide context highlights an important 
future research opportunity, whilst also suggesting that any generalisation of results 
should proceed with caution.  Further research would be needed to see whether the 
findings were similar or different to the outcomes of this thesis. 
When considering the replication of research on a wider scale, it is worth considering 
the use of the Stigma Impact Scale itself. The scale developed by Fife and Wright 
(2000) and adapted for use with people with Alzheimer’s disease by Burgener and 
Berger (2008) has produced conflicting findings when triangulated with the interview 
data. In practice this means that people with Alzheimer’s disease may be reporting low 
levels of stigma when in fact they are experiencing much higher levels. Literature 
discussed in the literature review (chapter 2) and findings presented across chapters 6-8 
highlight that stigma has negative consequences for the person affected, including loss 
of family and friends, lower self-esteem, and increased isolation.  
Given the negative consequences of stigma, it is important in practice for those working 
within the field of dementia to be able to accurately capture the experiences of people 
with dementia in an efficient way. Questionnaires remain a suitable method for 
capturing information quickly, with the increased structure allowing for faster analysis 
(Zohrabi, 2013). In a clinical environment, healthcare professionals face significant 
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time pressure (Westbrook et al., 2008); as such, a questionnaire into perceived stigma 
may be particularly helpful, but the options available do not necessarily reflect key 
experiences of people with dementia, based on the data from this thesis. Therefore, 
further research could develop a new scale which is able to measure perceived stigma 
that would be consistent with levels reported using other methods. 
As well as replication of this research on a wider scale, the findings of the study suggest 
multiple avenues of research which could be explored. Firstly, the study findings 
suggest that age differences expected based on the age-associated nature of Alzheimer’s 
disease are overarched by shared methods of managing the situation. As was 
highlighted in the methodology, there was minimal research found to reflect similar 
age-associated patterns in other health conditions. Emlet (2006) considered experiences 
of older people with HIV, who were seen as ‘too old’ to have the condition, and 
acknowledged both age-related and illness-related stigma. However, this study did not 
directly compare experiences with younger people with the condition. Therefore, it 
would be interesting to see whether conditions which are associated with younger 
people are experienced in similar ways for older adults, when both groups are 
considered in the same study. The results of this thesis would suggest similar 
experiences of stigma and future outlook if the condition is ‘time-limiting’, regardless 
of the age of onset. Further, the findings indicate the relevance of this thesis to broader 
understandings of living with a chronic health condition. 
 
Secondly, the findings suggest more research is needed into the diagnosis of 
Alzheimer’s disease and the assumed future planning resulting from early diagnosis. It 
is widely recognised that a diagnosis can expose people with Alzheimer’s disease to 
stigma (Bunn et al., 2012; Iliffe et al., 2003; Milne, 2010). This is supported by the 
findings of this thesis, with both people with Alzheimer’s disease and their supporters 
sharing a number of experiences relating to stigma. Currently, one of the motivators 
behind diagnosis is the opportunity to plan for the future (Luengo-Fernandez et al., 
2010). However, as the findings of this thesis show, people do not necessarily wish to 
engage in future planning. Instead the focus is on focusing on each day at a time, which 
has been discussed throughout the findings chapters as a way of maintaining a positive 
emotional state. This is supported by recent work into the impact of diagnosis and 
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avoidance of information about the future (Bunn et al., 2012; Lockenhoff and 
Carstensen, 2004).    
Given these findings, future research is needed to explore ways of helping people to 
manage both exposure to stigma and planning for the future, whilst focusing on daily 
living. This is particularly advisable as despite the exposure to stigma, research 
highlights that the majority of people still wish to know their diagnosis (Pinner and 
Bouman, 2003, Robinson et al., 2011; Robinson et al., 2014). These conclusions may be 
biased, as people who are most fearful of the condition and its anticipated future 
trajectory may engage less with research; a limitation discussed in more detail within 
sampling (chapter 4). Current research which looks more specifically at future planning 
suggests that people benefit most from health care professionals instigating the 
discussion and supporting them through the decision-making processes (Engelhardt et 
al., 2006; Poppe et al., 2013). This may be particularly true for people affected by 
dementia who already face challenges with the shift in decision-making processes 
(Robinson et al., 2013). Therefore, shared responsibility relating to future planning may 
reduce avoidance.    
The literature often assumes that both receiving a diagnosis of Alzheimer’s disease and 
having the opportunity to plan for the future can be beneficial. The thesis findings of 
both perceived stigma and avoidance of future planning do not intend to contradict this. 
Rather, they illustrate that there remains a gap between policy recommendations and 
how people are managing their condition. The Scottish Dementia Strategy includes 
commitment to improving the rates of dementia diagnosis and access to a minimum one 
year post-diagnostic support (Scottish Government, 2013). The commitment is 
supported by Alzheimer’s Scotland’s “5 Pillar Model” (Scottish Government, 2013:7). 
Two of the five ‘pillars’ focus on future outlook: ‘planning for future care’ and 
‘planning for future decision-making’ (Simmons, 2011). The results of this thesis 
suggest that while it is important to begin making changes, future research should aim 
to move beyond planning from the perspective of ‘care’. The thesis illustrates that 
future outlook is an on-going, fluctuating process which is happening across the life 
course.  
It should be noted that this thesis did not aim to focus on advance care planning; 
therefore the recommendations in terms of advance care planning and policy should be 
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taken with caution. Although the findings of this thesis suggest it may not be beneficial 
for people to look ahead due to the potentially negative futures they perceive, 
Lockenhoff and Carstensen (2004) warn that this can lead to potential difficulties in the 
long term. Therefore, future research which explores advance care planning in terms of 
long term benefits, as suggested by Robinson et al. (2012), would provide further 
context to these recommendations and the relevance of advance care planning in future 
outlook. 
Considering a time where ‘care’ needs will increase exposes people to significant 
distress and activities such as group support are avoided, through fear of seeing people 
at more ‘advanced stages’ of their condition. As such, support services should be aware 
of the challenges people face in engaging in future planning and find ways of helping 
people to make appropriate plans whilst not compromising their emotional state. 
Recognising that the view of ‘no future’ is a stigma-driven assumption (Devlin et al., 
2007) may help to reduce fear of looking ahead. Post-diagnostic support should be 
tailored to help people acknowledge that it is possible to live well and have a future 
which is not dominated by ‘care’, whilst not taking away from the challenges people 
face in learning to live with a condition like Alzheimer’s disease. 
Finally, future research could explore possible therapeutic interventions to support 
people to maintain a positive focus and take one day at a time. ‘Mindfulness’ is one 
such intervention to help people develop and maintain this focus. Originating from 
Buddhist traditions (Whitebird et al., 2012) mindfulness is increasingly recognised as a 
way of improving health and wellbeing (Robertson, 2015) and refers to “the awareness 
that emerges through paying attention on purpose, in the present moment, and 
nonjudgmentally to the unfolding of experience moment by moment” (Kabat-Zinn, 
2003:145). The evidence surrounding mindfulness interventions is generally positive, 
although there remains a need for a more rigorous approach to evaluation (Robertson, 
2015). Previous literature highlights that such interventions may improve the 
experience of supporters (Hurley et al., 2014; Mackenzie and Pulin, 2013) and people 
with dementia (Larouche et al., 2015; Paller et al., 2015). The findings of this thesis, in 
particular the positive impact of maintaining a day at a time perspective, may support 
further research into mindfulness-based interventions for both people with dementia and 
their supporters. Although, as with the discussions surrounding cognitive resources for 
implementing the positivity bias (Mark, 2012), it may be that for some, the ability to 
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direct and engage attention makes it difficult to benefit from mindfulness-based 
interventions. Further research is needed in order to draw conclusions regarding this 
issue. 
Overall Conclusions 
 
The thesis sought to explore the experiences of people affected by early and late-onset 
Alzheimer’s disease, with a particular focus on how stigma and future outlook interact.  
People with Alzheimer’s disease and their supporters experienced a range of stigma. 
The reporting of stigma varied by research measure and begins to highlight the 
management of the condition, as participants actively chose not to identify with the 
stigmatised group as much as possible. One of the consequences of stigma is people 
being highly fearful of their future with Alzheimer’s disease and what may happen. In 
order to manage fears, people chose to focus on one day at a time, deliberately avoiding 
planning or looking too far ahead. Alzheimer’s disease was viewed by participants as 
unpredictable and unique, which helped them to manage the lack of control over the 
condition and to see themselves as ‘lucky’ relative to others. Across findings, age 
differences, such as financial concerns and internalised stigma, were minimised by a 
shared focus on preserving positive emotional states. The findings for both stigma and 
future outlook are supported by socioemotional selectivity theory and a range of 
attributional biases which help people to maintain the positive focus.  Overall, there is a 
need to consider how best to explore the complex nature of future outlook in practice 
and policy, alongside managing stigma and its consequences. Of key importance is how 
to help people affected by Alzheimer’s disease remain positive in the face of adversity. 
In the current context, taking ‘one day at a time’ appears to be the most adaptive 
strategy for managing everyday life with Alzheimer’s disease, and minimising exposure 
to stigma-fuelled fears of the future. 
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Appendix 2- SASS Risk Assessment 
 
 
Risk Assessment                School of Applied Social Science, University of Stirling  
 
All those doing the work must be involved in the completion of this form. Complete all 
sections, marking clearly those that are not applicable. The form must be signed by all 
involved, and copies made for each person. Hard copies of the completed form, with 
original signatures, must be sent by the principal investigator to the School 
Administrator within 3 months of the start date of the project, or prior to the 
commencement of fieldwork, whichever is the sooner. 
 
Head of School Professor Alison Bowes 
School Administrator Mrs. Morag Crawford 
University Safety Advisor Mr. David Duckett 
Completed by Rosalie Ashworth 
Date 13/11/13 
Contact in Emergency, 
name & telephone 
number 
Professor Alison Bowes,01786 467795 
Dr Fiona Kelly, 01786 466332 
 
Research Activity 
 
Dates of activity: 01/10/2013-01/10/2015 
Activity: Give title and 
briefly summarise 
PhD fieldwork- “A comparison of the perceived stigma 
experienced by people with early-onset Alzheimer’s disease, late-
onset Alzheimer’s disease, and their supporters: stigma and future 
planning” 
Visiting people with dementia and their supporters in their homes 
(or in the University of Stirling if they request). I will be 
completing questionnaires and interviews, across multiple visits.  
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People involved:  
Give individual name(s)  
 
PhD Student- Rosalie Ashworth 
Supervisors- Professor Alison Bowes and Dr Fiona Kelly 
Location(s) of the 
activity: Give specific 
locations,  
e.g. name of hospital, or 
town 
People will be seen in their own homes or the University of 
Stirling, School of Applied Social Science.  
Peoples’ homes will be across the central belt of Scotland: Forth 
Valley, Glasgow, Tayside, Lanarkshire and Lothian.  
 
 Hazard(s) Control Measures Severity of 
risk 
Likelihood 
of risk 
Overall 
Risk 
Working in a 
dangerous 
area: e.g. high 
crime area, area 
of civil unrest. 
Give contact 
details and 
measures in 
case of 
emergency  
People will be seen 
at their homes the 
majority of the 
time: they may live 
in high crime areas 
etc.  
 
 
 
 
 
The address of the 
visit will be given to 
supervisors prior to 
visits if the area is 
high risk, based on 
address given. The 
researcher will let the 
supervisors know 
when arriving/leaving 
the visit. Emergency 
contact details will be 
on the work phone of 
the researcher, and all 
visits will be done by 
car, with a Sat-Nav 
and breakdown cover 
with GreenFlag. 
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
Working in an 
isolated 
geographical 
area: Give 
contact details 
and measures in 
case of 
emergency 
As above, peoples’ 
homes may be in an 
isolated area. 
 
 
 
 
 
 
The address of the 
visit will be given to 
supervisors prior to 
visits if the area is 
isolated. The 
researcher will let the 
supervisors know 
when arriving/leaving 
the visit. Emergency 
contact details will be 
on the work phone of 
the researcher, and all 
visits will be done by 
car, with a Sat-Nav 
and breakdown cover 
with GreenFlag.  
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
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Lone working: 
Give contact 
details and 
measures in 
case of 
emergency  
The research 
involves lone 
working. 
 
As above, the 
supervisors will be 
regularly contacted to 
ensure safety. The 
researcher will 
always have a 
charged work mobile 
phone, a Sat-Nav and 
breakdown cover on 
their car. 
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
Working with 
Equipment: 
Risks associated 
 
N/A 
 
 
 
 
 
  
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
Environmental 
hazards: e.g. 
weather, terrain, 
animals, plants, 
earthquake, 
water quality 
 
 
Weather 
 
 
 
 
Weather conditions 
may affect driving: 
high winds. Snow 
etc. If the researcher 
feels that this is a risk 
the visit will be 
rearranged, 
particularly where 
people live in isolated 
areas where there is a 
greater risk of being 
affected by road 
conditions. 
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
Chemical & 
Biological 
Hazards: e.g. 
laboratory 
chemicals, crop 
spraying, 
diseases 
 
N/A 
 
 
 
  
High    
 
Med    
 
 
High    
 
Med    
 
 
High    
 
Med    
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Low    Low    Low    
Manual 
Handling: 
e.g. loading and 
unloading 
equipment 
 
 
N/A 
 
 
 
 
  
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
Emotional 
Risks: 
e.g. Sensitive 
research 
 
The nature of the 
research is 
sensitive- 
discussing 
experiences of 
living with 
Alzheimer’s disease 
  
 
 
 
The researcher has 
regular experience 
working with people 
with dementia and 
their families, and 
listening to their 
experiences of 
dementia. In terms of 
support for the 
researcher, the 
university supervisors 
are always available 
and highly 
supportive, as well as 
social support from 
the Postgraduate 
Society at the 
University of Stirling.  
 
In terms of all of the 
participants, they will 
be made fully aware 
of the nature of the 
research and the fact 
that it will be 
covering sensitive 
topics. The researcher 
will be sensitive to 
the participant’s 
situation at all time, 
with visits being 
allocated additional 
time for general 
conversation, as well 
as going at the pace 
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
 
High    
 
Med    
 
Low    
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of the participants, so 
they feel they can 
pause or stop at any 
time.  
 
 
Legal compliance: Are there any 
specific standards relevant to the 
research activities? 
Informed consent will be obtained from all participants, and this will be 
continually monitored across visits. People who do not have the capacity to 
consent will not be included in the research. People who lose their capacity 
during the study will not continue in the study- data collected so far will be kept 
unless they have not consented to this initially. 
Training: Has special training 
been given for fieldwork activities 
in relation to safety? 
The researcher is working as a Clinical Studies Officer for the Scottish Dementia 
Clinical Researcher Network; this role involves regular visits to the homes of 
people with dementia and their families. This involves lone working, in 
potentially isolated areas and areas of high risk. As will be done for the research 
study, a phone is used with emergency contacts, and the researcher will use their 
own car which has insurance and breakdown cover. 
 
Supervision: What level of 
supervision is required, and are 
there sufficient supervisors for 
research? 
The PhD supervisors, Professor Alison Bowes and Dr Fiona Kelly will be 
regularly involved throughout the fieldwork in keeping in touch with the 
researcher and being updated on progress. Both of the supervisors have 
experience with similar research projects and working with the target population. 
Medical conditions/allergies: 
This information is to be kept 
confidential.   
Participants are asked to make a declaration that they are not knowingly in a 
condition that could compromise their health and safety (or the safety of 
others) during the proposed research activities 
First Aid: Will a First Aid box be 
available? 
If research involves a group, name 
the First Aider(s) 
The researcher is not first aid trained, any injury that cannot be self-managed will 
be reported to supervisors or appropriate services. 
If the researcher is injured in any way they will seek appropriate action. 
Disabled persons: Detail any 
special arrangements required 
The researcher will be aware of any arrangements based on the information for 
each participant collected on the Scottish Dementia Clinical Research Network 
Register, where participants will be recruited from.  
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Insurance: Are all activities 
covered by University insurance? 
Provide confirmation that this has 
been checked and approved.  
Give details of any additional 
personal insurance. 
Attached is confirmation of University Insurance, contact Daniela Bolle. 
 
Risk assessment:    Overall LOW   MEDIUM    HIGH   
 
Safe system of work procedure (to be completed by research team on basis of above 
information. Continue on separate sheet if necessary) 
 
Safety System: The researcher will complete a risk assessment and review this with the PhD 
supervisors. Following on from this, the steps given throughout the assessment will be implemented 
for each participant visit- getting the address and directions; making supervisors aware of where the 
researcher will be; maintaining awareness of the areas that will be visited and the weather conditions 
etc. Throughout the study, the researcher will keep a work phone on them, and be contactable at all 
times.  
 
Throughout the study, the researcher will maintain contact with supervisors and support network of 
friends for wellbeing. If at any point the researcher feels the situation has changed/become a higher 
risk/or is having adverse effects, the supervisors will be contacted.  
 
The safety of participants will be maintained at all times, through following the set out guidelines 
above, as well as this, NHS ethical approval is being sought for the study before it begins; this ensures 
that the researcher will act in the best interests of the participants, and that possible ethical 
considerations have been dealt with and acting on accordingly. The researcher will be continually 
aware of the health and wellbeing of the participants and any concerns for their safety will be raised 
with the supervisors (as outlined in participant consent forms).  
 
 
Date:…………13/11/13…………………………………… 
 
Agreed date for review…NHS Ethical Review 20th November…… 
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Appendix 3- SDCRN Research Register figures 
 
The number of people on the SDCRN research register based on 2014 figures. Numbers are presented by age of onset, type of dementia, 
gender, and health board.  
Area Gender 
Number of people with early- 
onset Alzheimer’s disease 
Number of people with 
late- onset Alzheimer’s 
disease 
People with 
other types of 
dementia Total 
 Percentage of males and 
females on the register 
/% 
Register 
Male 50  235 342 627 58.60 
Female 39 240 164 443 41.40 
  89 475 506 1070   
Forth 
Valley 
Male 1 9 16 26 72.22 
Female 0 3 7 10 27.78 
  1 12 23 36   
Tayside 
Male 6 58 41 105 51.98 
Female 6 64 27 97 48.02 
  12 122 68 202   
Grampian 
Male 8 17 26 51 41.46 
Female 11 25 36 72 58.54 
  19 42 62 123   
Lothian 
Male 11 35 46 92 48.17 
Female 4 56 39 99 51.83 
  15 91 85 191   
Glasgow 
Male 6 25 20 51 62.20 
Female 2 20 9 31 37.80 
  8 45 29 82   
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Appendix 4a- Adapted Stigma Impact Scale- People with Alzheimer’s disease 
Stigma Impact Scale 
DIRECTIONS:  Alzheimer’s disease can affect many areas of a person’s life. Please tick the response for each item 
that best describes your recent experiences (within the past 3 to 4 weeks). 
  NOT 
APPLICABLE 
STRONGLY 
DISAGREE 
DISAGREE AGREE STRONGLY 
AGREE 
1 I have experienced financial 
hardship that has affected how I 
feel about myself 
     
2 My job security has been affected 
by my condition 
     
3 My employer/co-workers have 
discriminated against me 
 
     
4 I have experienced financial 
hardship that has affected my 
relationship with others 
     
5 Some people act as though I am 
less competent than usual 
     
6 I feel I have been treated with less 
respect than usual by others 
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  NOT 
APPLICABLE 
STRONGLY 
DISAGREE 
DISAGREE AGREE STRONGLY 
AGREE 
 
7 I feel set apart from others who 
are well 
     
8 I feel others are concerned they 
could “catch” Alzheimer’s disease 
through contact like a handshake 
or eating food I prepare 
 
     
9 I feel others avoid me because of 
my condition 
     
10 Some family members have 
rejected me because of my 
condition 
 
     
11 I feel others think I am to blame 
for my condition 
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  NOT 
APPLICABLE 
STRONGLY 
DISAGREE 
DISAGREE AGREE STRONGLY 
AGREE 
12 I do not feel I can be open with 
others about my condition 
     
13 I fear someone telling others 
about my condition without my 
permission 
     
14 I feel I need to keep my condition 
a secret 
 
     
15 I feel some friends have rejected 
me because of my condition 
 
     
16 I have a greater need than usual 
for reassurance that others care 
about me 
 
     
17 I feel lonely more often than usual      
18 Due to my condition I have a 
sense of being unequal in my 
relationship with others 
     
30/08/2015 
307 | P a g e  
 
  NOT 
APPLICABLE 
STRONGLY 
DISAGREE 
DISAGREE AGREE STRONGLY 
AGREE 
 
19 I feel I am at least partially to 
blame for my condition 
     
20 I feel less competent than I did 
before my condition 
 
     
21 I encounter embarrassing 
situations as a result of my 
condition 
     
22 Due to my condition others seem 
to feel awkward and tense why 
they are around me 
 
     
23 Due to my condition, I sometimes 
feel useless 
 
     
24 Changes in my appearance have 
affected my social relationships 
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Appendix 4b- Adapted Stigma Impact Scale- Supporters 
Stigma Impact Scale 
DIRECTIONS:  Alzheimer’s disease can affect many areas of a person’s life. Please tick the response that best 
describes your recent experiences (within the past 3 to 4 weeks) in relation to the person you support with Alzheimer’s 
disease. 
  NOT 
APPLICABLE 
STRONGLY 
DISAGREE 
DISAGREE AGREE STRONGLY 
AGREE 
1 I have experienced financial 
hardship that has affected how I 
feel about myself 
 
     
2 My job security has been affected 
by my family member’s condition 
     
3 My employer/co-workers have 
discriminated against me 
 
     
4 I have experienced financial 
hardship that has affected my 
relationship with others 
     
5 I feel I have been treated with less 
respect than usual by others 
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  NOT 
APPLICABLE 
STRONGLY 
DISAGREE 
DISAGREE AGREE STRONGLY 
AGREE 
6 I feel set apart from others whose 
family members are well 
     
7 I feel others are concerned they 
could “catch” Alzheimer’s disease 
through contact like a handshake 
or eating food I prepare 
 
     
8 I feel others avoid me because of 
my family member’s condition 
     
9 Some family members have 
rejected me because of my contact 
with my family member with 
Alzheimer’s disease 
 
     
10 I feel others think I am to blame 
for my family member’s condition 
 
     
11 I do not feel I can be open with 
others about my family member’s 
condition 
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  NOT 
APPLICABLE 
STRONGLY 
DISAGREE 
DISAGREE AGREE STRONGLY 
AGREE 
12 I fear someone telling others  
about my family member’s 
condition without my permission 
     
13 I feel I need to keep my family 
member’s condition a secret 
 
     
14 I feel some friends have rejected 
me because of my family 
member’s condition  
 
     
15 I have a greater need than usual 
for reassurance that others care 
about me 
 
 
     
16 I feel lonely more often than usual  
 
     
17 Due to my family member’s 
condition I have a sense of being 
unequal in my relationship with 
others 
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  NOT 
APPLICABLE 
STRONGLY 
DISAGREE 
DISAGREE AGREE STRONGLY 
AGREE 
 
18 I feel I am at least partially to 
blame for my family members 
condition 
 
     
19 I feel less competent than I did 
before my family member’s 
condition 
 
     
20 I encounter embarrassing 
situations as a result of my family 
member’s condition  
 
 
     
21 Due to my family member’s 
condition others seem to feel 
awkward and tense why they are 
around me 
     
22 Some people act as though I am 
less competent than usual 
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  NOT 
APPLICABLE 
STRONGLY 
DISAGREE 
DISAGREE AGREE STRONGLY 
AGREE 
23 Due to my family member’s 
condition, I sometimes feel 
useless 
 
     
24 Changes in the appearance of my 
family member with Alzheimer’s 
disease have affected my social 
relationships 
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Appendix 4c-Questions and Score Ranges for Subcategories of the Stigma Impact Scale 
 
Subcategory of Stigma 
Impact Scale 
Number of items within 
subcategory 
Range of possible scores for 
each subcategory 
Social Rejection 9 0-36 
 
My employer/ co-workers have discriminated against me. 
Some people act as though I am less competent than usual. 
I feel I have been treated with less respect than usual by others. 
I feel others are concerned they could “catch” my condition through contact like a 
handshake or eating food I prepare. 
I feel others avoid me because of my condition. 
Some family members have rejected my because of my condition.  
I feel some friends have rejected me because of my condition. 
I encounter embarrassing situations as a result of my condition.  
Due to my illness others seem to feel awkward and tense when they are around me.  
Financial Insecurity 3 0-12 
 
I have experienced financial hardship that has affected how I feel about myself. 
My job security has been affected by my condition. 
I have experienced financial hardship that has affected my relationship with others.  
Internalised Shame 5 0-20 
 
I feel others think I am to blame for my condition.  
I do not feel I can be open with others about my condition.  
I fear someone telling others about my condition without my permission.  
I feel I need to keep my condition a secret. 
I feel I am at least partially to blame for my condition.  
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Subcategory of Stigma 
Impact Scale 
Number of items within 
subcategory 
Range of possible scores for 
each subcategory 
Social Isolation 7 0-28 
 
I feel set apart from others who are well. 
I have a greater need than usual for reassurance that others acre about me.  
I feel lonely more often than usual.  
Due to my condition, I have a sense of being unequal in my relationships with others.  
I feel less competent than I did before my condition. 
Due to my condition, I sometimes feel useless.  
Changes in my appearance have affected my social relationships.  
Total 24 0-96 
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Appendix 5- Interview topic guide 
 
      
 
Interview Topics 
Below is a list of some of the things we will be talking about in 
the interviews. You are welcome throughout the interview to 
bring up anything you feel is important to you or your 
experiences of Alzheimer’s disease. If at any point you feel 
uncomfortable or would like to stop the interview, please do say. 
The interview can also be stopped and restarted at another time if 
you wish.  
 
 Experience of living with Alzheimer’s disease 
 Reactions of Family and Friends to Diagnosis 
 Amount and type of information received about 
Alzheimer’s disease 
 Use of Support services 
 Feelings of control 
 Advance Care Planning 
 Thoughts about  the future  
 Hopes and Fears 
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Appendix 6- Interview Schedule 
 
      
 
Interview  
 Experience of living with Alzheimer’s disease 
o Has your life changed? 
 If so, can you explain how? 
o What challenges do you face? 
o How do you feel about Alzheimer’s disease? 
 Reactions of Family and Friends to Diagnosis 
o Have your relationships changed? 
 In what way have they changed? If they haven’t changed, what do 
you think is the reason for this? 
o How do you feel about others’ reactions to yourself and/or your diagnosis 
of Alzheimer’s disease? 
 Amount and type of information received about Alzheimer’s disease 
o Have you received information about Alzheimer’s disease? 
o What sources of information have you used? 
o What type of information has been most useful? 
o Is there information that you would like but haven’t received? 
 Use of Support services 
o Do you currently use any support services? 
o Which ones? 
o What made you chose/discount particular services? 
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o How do you feel about receiving these services? 
 Feelings of control 
o How do you feel about managing Alzheimer’s disease? 
o What kind of support or help have you received to help you manage 
Alzheimer’s disease? 
 Has this been useful? Could you explain why/why not? 
 Advance Care Planning 
o Have you been involved in ACP? 
o Have you thought about future care? 
o Is ACP something you would like to do? 
 Thoughts about  the future  
o How do you view the future with Alzheimer’s disease 
o Do you have future goals? 
o Have your thoughts about the future changed since having Alzheimer’s 
disease 
o What helps/hinders you looking to the future? 
 Hopes and Fears 
o Do you have any particular hopes and fears about Alzheimer’s disease and 
the future? 
o What factors influence your thoughts about the future with Alzheimer’s 
disease? 
 Any other thoughts? 
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Appendix 7- Initial contact letter 
      
 
Participant Name 
Participant Address 
Date 
 
 
 
 
Dear ____________________________ 
 
Involvement in a research study 
 
I am writing to invite you to be included in a research study. The Scottish Dementia 
Clinical Research Network have given permission for you to be contacted, as the 
information you provided for the research register suggests you are eligible for this study. 
The study has ethical approval through the NHS ethics committee.  
 
The study is looking into people’s experiences of Alzheimer’s disease, and looking to the 
future. It will involve completing a selection of questionnaires, and possibly an interview.  
 
If you are interested in receiving more information or taking part, please get in touch 
using either the telephone numbers provided below or by filling in the response slip and 
sending it back in the stamped address envelope provided.  
 
Many thanks for your time, 
 
Yours sincerely 
 
Rosalie Ashworth 
 
Postgraduate Researcher- University of Stirling 
Clinical Studies Officer- SDCRN 
 
Email: rosalie.ashworth@stir.ac.uk 
 
Tel: 01786 467728  
 
Mob: 07816067066 
 
 
 
 
Name: _________________________________ 
 
I would like to be contacted with further information about this study. 
 
If you have a preference over how best to contact you or the most suitable time to 
contact you please write in the space below: 
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Appendix 8a- Information Sheet for Person with Alzheimer’s disease 
 
      
Information Sheet for Person With Alzheimer’s Disease 
 
Experiences of Alzheimer’s disease: Looking to the future. 
The purpose of the study 
The purpose of the study is to look at people’s experiences with 
Alzheimer’s disease, and the possible consequences of the 
condition. The study aims to understand more about the effect of 
Alzheimer’s disease on your life, and to help people affected by 
Alzheimer’s disease have their voices heard. 
The study has two core aims: 
1. To explore how people with Alzheimer’s disease and their 
supporters experience living with the condition 
2. To explore how people with Alzheimer’s disease and their 
supporters look to the future 
Why have you been contacted? 
The study is looking to learn more from people who have been 
diagnosed with Alzheimer’s disease, and supporters of people 
with Alzheimer’s disease. You have been identified as someone 
who may be eligible to take part in this study, if you wish.  
Do I have to take part? 
No, taking part in this study is completely voluntary. 
 If you choose to take part in this study you will be asked to sign a 
consent form to show you have given your permission to be 
involved. Your GP will be notified that you are taking part in a 
study.  
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What will I be asked to do? 
 You will be asked to complete three questionnaires with the 
researcher, asking about yourself and your experience of 
Alzheimer’s disease. 
 Some people will be invited to take part in an interview. 
You will be asked whether you would like to take part in 
this.   
 The interview would be with the researcher, and you will be 
asked about your experiences of Alzheimer’s disease and 
your views about the future.  
o This interview can be done with your supporter or on 
your own 
o This interview can be done within your home or at the 
University of Stirling. 
o The interview will take place over one to three visits 
to make sure that you do not have to talk for too long 
at any one meeting.  
o All interviews will be audio recorded 
What if I agree to take part, and change my mind? 
If at any time during the study you wish to stop taking part, or 
you are unable to continue, all of the information collected about 
you up to that point will be retained unless you opt out of this on 
the consent form, in which case all information up to that point 
will be removed and destroyed. Withdrawing from the study will 
not affect your care or access to services in any way.  
You can withdraw from the study, by asking the researcher to 
stop the study; or by contacting one of the other contacts linked to 
the research, as shown at the end of this document.  
What will happen to information I give? 
All information collected as part of the study will remain 
confidential. When the information is written up, your answers 
will not be identifiable: you will be given a pseudo-name.  All 
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information will be kept securely at the University of Stirling, in a 
locked cabinet; audiotaped recordings will be stored in a 
password protected file, on a password protected computer to 
which only the researcher will have access.  
If the researcher is concerned that you may harm yourself or 
others, confidentiality will need to be broken, the researcher will 
inform and the study supervisors, Professor Alison Bowes, and 
Dr Fiona Kelly, of the concerns; your GP will also be contacted. 
This means they will be able to contact you to check on your 
safety and wellbeing.  
What will happen to the results of the study? 
The results of the study will be written up as part of a PhD thesis 
at the University of Stirling. You will not be personally 
identifiable in any of the write up.  The results may also be 
presented at conferences, as well as published in an academic 
journal. A summary of results will also be available for you if you 
would like to have a copy.  
What is there is a problem during the study? 
If you have any concerns at any point during the study, you can 
talk to the researcher who will do their best to answer any 
problems you may have. A list of other possible contacts has also 
been provided.  
Who is funding this research? 
The research is being funding by the University of Stirling, and 
the Scottish Dementia Clinical Research Network (SDCRN). It is 
being funded as part of a PhD at the University of Stirling. 
 
Thank you for reading this information sheet. Contact details 
for all those involved in the study are provided on the next 
page.  
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Contact Details 
Rosalie Ashworth 
PhD Student (University of Stirling) and Clinical Studies 
Officer (SDCRN) 
Email: rosalie.ashworth@stir.ac.uk 
Tel: 01786 467728  
Mob: 07816067066 
Address: Room 3S29, School of Applied Social Sciences, 
Colin Bell Building, University of Stirling, Stirling. FK9 4LA 
Professor Alison Bowes 
PhD Supervisor 
Head of School of Applied Social Sciences 
Email: a.m.bowes@stir.ac.uk 
Tel: 01786 467709 
 
Dr Fiona Kelly 
PhD Supervisor 
Lecturer in Dementia Studies 
Email: fiona.kelly@stir.ac.uk 
Tel: 01786 466322 
Emma Law 
SDCRN Manager 
Email: emma.law@nhs.net 
Tel: 01738 562322 
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Appendix 8b- Information Sheet for Supporter 
 
      
Information Sheet for Supporters 
 
Experiences of Alzheimer’s disease: Looking to the future. 
The purpose of the study 
The purpose of the study is to look at people’s experiences with 
Alzheimer’s disease, and the possible consequences of the 
condition. The study aims to understand more about the effect of 
Alzheimer’s disease on your life, and to help people affected by 
Alzheimer’s disease have their voices heard. 
The study has two core aims: 
3. To explore how people with Alzheimer’s disease and their 
supporters experience living with the condition 
4. To explore how people with Alzheimer’s disease and their 
supporters look to the future 
Why have you been contacted? 
The study is looking to learn more from people who have been 
diagnosed with Alzheimer’s disease, and supporters of people 
with Alzheimer’s disease. You have been identified as someone 
who may be eligible to take part in this study, if you wish.  
Do I have to take part? 
No, taking part in this study is completely voluntary. 
 If you choose to take part in this study you will be asked to sign a 
consent form to show you have given your permission to be 
involved. 
  
30/08/2015 
324 | P a g e  
 
What will I be asked to do? 
 
 You will be asked to complete five questionnaires about 
yourself and the person you support. 
 Some people will be invited to take part in an interview. 
You will be asked whether you would like to take part in 
this.   
 The interview is about your experiences of Alzheimer’s 
disease and your views about the future.  
o This interview can be done on your own or with the 
person you support 
o This interview can be done within your home or at the 
University of Stirling. 
o The interview will take place over one to three visits 
to make sure that you do not have to talk for too long 
at any one meeting.  
o All interviews will be audio recorded 
What if I agree to take part, and change my mind? 
If at any time during the study you wish to stop taking part, all of 
the information collected about you up to that point will be 
retained unless you opt out of this on the consent form, in which 
case all information up to that point will be removed and 
destroyed. Withdrawing from the study will not affect your care 
or access to services in any way.  
You can withdraw from the study, by asking the researcher to 
stop the study; or by contacting one of the other contacts linked to 
the research, as shown at the end of this document.  
What will happen to information I give? 
All information collected as part of the study will remain 
confidential. When the information is written up, your answers 
will not be identifiable: you will be given a pseudo-name.  All 
information will be kept securely at the University of Stirling, in a 
locked cabinet; audiotaped recordings will be stored in a 
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password protected file, on a password protected computer to 
which only the researcher will have access.  
If the researcher is concerned that you may harm yourself or 
others, confidentiality will need to be broken, the researcher will 
inform and the study supervisors, Professor Alison Bowes, and 
Dr Fiona Kelly, of the concerns; your GP may also be contacted. 
This means they will be able to contact you to check on your 
safety and wellbeing. 
What will happen to the results of the study? 
The results of the study will be written up as part of a PhD thesis 
at the University of Stirling. You will not be personally 
identifiable in any of the write up.  The results may also be 
presented at conferences, as well as published in an academic 
journal. A summary of results will also be available for you if you 
would like to have a copy.  
What is there is a problem during the study? 
If you have any concerns at any point during the study, you can 
talk to the researcher who will do their best to answer any 
problems you may have. A list of other possible contacts has also 
been provided.  
Who is funding this research? 
The research is being funding by the University of Stirling, and 
the Scottish Dementia Clinical Research Network (SDCRN). It is 
being funded as part of a PhD at the University of Stirling. 
 
Thank you for reading this information sheet. Contact details 
for all those involved in the study are provided on the next 
page.  
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Contact Details 
Rosalie Ashworth 
PhD Student (University of Stirling) and Clinical Studies 
Officer (SDCRN) 
Email: rosalie.ashworth@stir.ac.uk 
Tel: 01786 467728  
Mob: 07816067066 
Address: Room 3S29, School of Applied Social Sciences, 
Colin Bell Building, University of Stirling, Stirling. FK9 4LA 
Professor Alison Bowes 
PhD Supervisor 
Head of School of Applied Social Sciences 
Email: a.m.bowes@stir.ac.uk 
Tel: 01786 467709 
 
Dr Fiona Kelly 
PhD Supervisor 
Lecturer in Dementia Studies 
Email: fiona.kelly@stir.ac.uk 
Tel: 01786 466322 
Emma Law 
SDCRN Manager 
Email: emma.law@nhs.net 
Tel: 01738 562322 
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Appendix 9- Consent Form 
      
Consent Form 
Title of project: Experiences of Alzheimer’s disease: 
Looking to the future. 
Researcher: Rosalie Ashworth, University of Stirling / SDCRN 
 
1. I have read and understood the information 
sheet dated November, 2013 (version 2) for 
the above study. I have had the opportunity 
to consider the, information, ask questions 
and have had these answered satisfactorily.  
 
2. I understand that my participation is 
voluntary and that I am free to withdraw at 
any time without giving any reason, without 
my medical care or legal rights being 
affected.  
 
3. I understand that the relevant sections of my 
medical notes and data collected during the 
study may be looked at by individuals from 
the University of Stirling, from regulatory 
authorities or from the NHSTrust, where it is 
relevant to my taking part in this research, I 
give permission for these individuals to have 
access to my records.  
 
 
 
Please Initial Box 
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__________________________ ________________  __________________________  
Name    Date   Signature  
 
 
 
 
________________________ ________________ 
 __________________________  
Name of Person   Date   Signature  
taking consent  
 
  
4. I agree to my GP being informed of my 
participation in the study 
 
 
5. I agree that interviews can be audio-recorded 
 
 
 
6. I understand that all information about me 
will be confidential and kept securely. My 
answers will be anonymised and not be 
identifiable to others 
 
7. I agree to take part in the above study 
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Appendix 10- Debrief Letter 
      
Debrief Letter 
Experiences of Alzheimer’s disease: Looking to the 
future. 
Thank You 
Thank you for taking the time to take part in this study on the 
experience and consequences of stigma on your life.  
The study is looking at experiences of Alzheimer’s disease, for 
people of various ages, and whether their experiences affect how 
they plan for the future. At the heart of the study is making sure 
that people with Alzheimer’s disease and their supporters have 
their voices heard. By being part of this study, you have helped to 
do this. 
A summary of the results will be sent to you when the study is 
complete.  
If you have any questions, please get in touch on the below 
contact details: 
Rosalie Ashworth 
PhD Student (University of Stirling) and Clinical 
Studies Officer (SDCRN) 
Email: rosalie.ashworth@stir.ac.uk 
Telephone: 01786 467728  
Mobile: 07816067066 
Address: Room 3S29, School of Applied Social 
Science, Colin Bell Building, University of Stirling, 
Stirling FK9 4LA 
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Appendix 11- Useful Contacts 
 
 
30/08/2015 
331 | P a g e  
 
Appendix 12- Summary of results 
 
         
  
Dear ____________________________ 
Experiences of Alzheimer’s disease: Looking to the Future 
Thank you once again for taking part in the research study conducted by 
myself last year. The stories you shared and the time generously given was 
incredibly helpful in allowing me to understand your experiences better, 
and hopefully the experiences of others in similar situations.  
I have included a summary of the results for your interest. The results are 
currently being written up as part of the PhD thesis, with the intention of 
publishing the results as soon as possible so that other people will have the 
opportunity to learn from what you have shared.  
If you have any questions about the study or its findings please feel free to 
get in touch.  
It was lovely to meet you, and I am very grateful that you shared your 
experiences for this research. 
Yours sincerely, 
Rosalie Ashworth. 
Postgraduate Researcher- University of Stirling 
Clinical Studies Officer- SDCRN 
Email: rosalie.ashworth@stir.ac.uk 
Tel: 01786 467728 / Mob: 07816067066. 
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Summary of Results  
 
Living with Alzheimer’s disease involves a range of experiences for both the 
person with the condition and their supporter (often referred to as a carer). 
The study focused on two main topics: Stigma and Looking to the Future.  
 
Stigma refers to the negative attitudes of others relating to Alzheimer’s 
disease. This was explored and compared between people with early and 
late-onset Alzheimer’s disease and their supporters. The study went on to 
look at whether negative attitudes about what it is like to have Alzheimer’s 
disease influenced how people look to the future.  
 
All participants took part in questionnaires about their experiences, and a 
selection of people went on to be interviewed, where experiences were 
discussed in more depth. In particular interviews considered examples of 
how others have responded to the diagnosis of Alzheimer’s disease, and 
explored how people view the future.  
 
The results from the questionnaires suggested that people with Alzheimer’s 
disease have experienced more negative attitudes towards their condition 
than supporters. Participants discussed that people’s reactions could be 
unpredictable, with examples of friends, family members, health care 
professionals, and the general public treating them differently. Although all 
participants highlighted that they had experienced a mixture of both 
positive and negative experiences.  
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Although there were some differences in everyday lives for people with 
early and late-onset Alzheimer’s disease, there were many similarities in 
the way people managed the condition and chose to deal with the reactions 
of others. People discussed how it was important to focus on the people 
who had supported them, and to not dwell on those who had reacted 
negatively.  
Despite the negative experiences shared, people often saw themselves as 
the ‘lucky ones’ and thought about how their situation could be worse. 
People chose to focus as much as possible on what they could still do, 
staying positive, and trying not to think too far ahead. People tried to think 
about one day at a time, as the future is very hard to predict or control and 
many different things could happen. Therefore, thinking too much about 
possible changes was not helpful so changes in circumstances were dealt 
with as they arose.  
The findings of this study suggest that greater support is needed to help 
people plan for the future, if that is what they wish to do. This support 
should reflect the unique nature of living with Alzheimer’s disease, and 
personal preferences for how much information people want to take on 
board.  
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Appendix 13- Summary of codes 
 
Initial Codes 
Interview Schedule codes- 
 Family Relationship changes 
 Friend Relationship changes 
 Public perception of AD 
 Reaction to diagnosis 
 Information received 
 Support services 
 ACP 
 Changing futures 
 Hopes 
 Fears 
 Coping 
Additional codes following interviews and transcription 
 Day-at-a-time approach 
 Planning 
 Comparison with others situations 
 Unique experience 
 Decision making 
 Capability vs Inability 
 Holidays 
 Positive experiences of Healthcare 
 Negative experiences of Healthcare 
 Media 
 Research 
 Identity 
 Role change 
 Supporter and People with Alzheimer’s disease relationship 
 Terminology 
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NVivo Codes 
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Appendix 14- SPSS Outputs 
 
Discriminant Analysis of Sampled Population- People with late-onset Alzheimer’s 
disease 
 
Analysis Case Processing Summary 
Unweighted Cases N Percent 
Valid 111 92.5 
Excluded Missing or out-of-range group codes 
0 .0 
At least one missing discriminating 
variable 
9 7.5 
Both missing or out-of-range group 
codes and at least one missing 
discriminating variable 
0 .0 
Total 9 7.5 
Total 120 100.0 
 
 
Group Statistics 
Contacted 
Valid N (listwise) 
Unweighted Weighted 
YES Age 77 77.000 
SIMD 77 77.000 
Time_diagnosis 77 77.000 
MMSE 77 77.000 
NO Age 34 34.000 
SIMD 34 34.000 
Time_diagnosis 34 34.000 
MMSE 34 34.000 
Total Age 111 111.000 
SIMD 111 111.000 
Time_diagnosis 111 111.000 
MMSE 111 111.000 
 
Eigenvalues 
Function Eigenvalue % of Variance Cumulative % 
Canonical 
Correlation 
1 .085
a
 100.0 100.0 .280 
a. First 1 canonical discriminant functions were used in the analysis. 
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Wilks' Lambda 
Test of Function(s) Wilks' Lambda Chi-square df Sig. 
1 .921 8.767 4 .067 
 
Discriminant Analysis of People with late-onset Alzheimer’s disease who completed 
questionnaires 
 
Group Statistics 
Interviewed Mean Std. Deviation 
Valid N (listwise) 
Unweighted Weighted 
yes SIMD 7.6250 2.38672 8 8.000 
Time_diagnosis 6.7500 2.31455 8 8.000 
Age 80.0000 5.65685 8 8.000 
Gender 1.5000 .53452 8 8.000 
SIS 38.8750 4.42194 8 8.000 
DEMQOL 100.8750 10.73629 8 8.000 
MFS 13.0000 10.71714 8 8.000 
MFSD 24.2500 15.78200 8 8.000 
no SIMD 7.2857 2.49762 7 7.000 
Time_diagnosis 4.4286 3.40867 7 7.000 
Age 84.2857 4.75094 7 7.000 
Gender 1.2857 .48795 7 7.000 
SIS 38.2857 3.35233 7 7.000 
DEMQOL 96.1429 8.21439 7 7.000 
MFS 13.5714 16.81128 7 7.000 
MFSD 19.7143 7.13476 7 7.000 
Total SIMD 7.4667 2.35635 15 15.000 
Time_diagnosis 5.6667 3.01583 15 15.000 
Age 82.0000 5.52914 15 15.000 
Gender 1.4000 .50709 15 15.000 
SIS 38.6000 3.83219 15 15.000 
DEMQOL 98.6667 9.61893 15 15.000 
MFS 13.2667 13.36556 15 15.000 
MFSD 22.1333 12.32226 15 15.000 
 
 
Eigenvalues 
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Function Eigenvalue % of Variance Cumulative % 
Canonical 
Correlation 
1 .910
a
 100.0 100.0 .690 
a. First 1 canonical discriminant functions were used in the analysis. 
 
 
Wilks' Lambda 
Test of Function(s) Wilks' Lambda Chi-square df Sig. 
1 .524 5.822 8 .667 
 
Discriminant Analysis of Supporters of people with late-onset Alzheimer’s disease who 
completed both questionnaires and interviews 
 
 
Group Statistics 
Interviewed Mean Std. Deviation 
Valid N (listwise) 
Unweighted Weighted 
yes Age 67.8750 11.12831 8 8.000 
SIMD 8.2500 1.98206 8 8.000 
Time_diagnosis 6.7500 2.31455 8 8.000 
Gender 1.6250 .51755 8 8.000 
SIS 26.0000 19.13113 8 8.000 
MFSS 37.2500 11.37353 8 8.000 
MFSD 24.2500 15.78200 8 8.000 
Zarit 16.6250 5.09727 8 8.000 
BADL 24.2500 10.41633 8 8.000 
no Age 78.1429 7.60326 7 7.000 
SIMD 7.2857 2.49762 7 7.000 
Time_diagnosis 4.4286 3.40867 7 7.000 
Gender 1.7143 .48795 7 7.000 
SIS 27.2857 7.84675 7 7.000 
MFSS 27.2857 7.84675 7 7.000 
MFSD 19.7143 7.13476 7 7.000 
Zarit 15.5714 10.90653 7 7.000 
BADL 25.2857 12.20265 7 7.000 
Total Age 72.6667 10.71492 15 15.000 
SIMD 7.8000 2.21037 15 15.000 
Time_diagnosis 5.6667 3.01583 15 15.000 
Gender 1.6667 .48795 15 15.000 
SIS 26.6000 14.48546 15 15.000 
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MFSS 32.6000 10.84172 15 15.000 
MFSD 22.1333 12.32226 15 15.000 
Zarit 16.1333 8.01665 15 15.000 
BADL 24.7333 10.87899 15 15.000 
 
 
Eigenvalues 
Function Eigenvalue % of Variance Cumulative % 
Canonical 
Correlation 
1 3.012
a
 100.0 100.0 .866 
a. First 1 canonical discriminant functions were used in the analysis. 
 
 
Wilks' Lambda 
Test of Function(s) Wilks' Lambda Chi-square df Sig. 
1 .249 11.809 9 .224 
 
 
Descriptive Statistics- People with Alzheimer’s disease (Questionnaires and Interviews) 
 
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
MARSMFS 22 12.00 50.00 30.4091 10.68893 
MARSD 22 4.00 50.00 18.7273 11.58892 
Age 22 52.00 91.00 76.0455 10.46298 
SIMD 22 3.00 10.00 7.2273 2.42864 
Time_Diag 22 1.00 11.00 5.0000 3.07060 
Gender 22 1.00 2.00 1.2727 .45584 
SIS 22 25.00 54.00 38.3636 6.41089 
SR 22 8.00 21.00 15.7273 3.67983 
FI 22 .00 8.00 1.2727 1.93174 
IS 22 5.00 11.00 8.3636 1.89097 
SI 22 9.00 20.00 13.0000 2.46885 
DEMQOL 22 74.00 110.00 97.7273 11.18324 
BADL 22 4.00 54.00 23.8636 12.22525 
Valid N (listwise) 22     
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Descriptive Statistics- Supporters of people with Alzheimer’s disease (Questionnaires 
and Interviews) 
 
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
Age 22 47.00 88.00 68.4545 11.38390 
SIMD 22 3.00 10.00 7.4545 2.36497 
Time_Diag 22 1.00 11.00 5.0000 3.07060 
Gender 22 1.00 2.00 1.7727 .42893 
SIS 22 .00 58.00 29.4545 15.70177 
SR 22 .00 24.00 11.0455 6.21425 
FI 22 .00 8.00 1.7273 2.20782 
IS 22 .00 14.00 5.9091 3.35104 
SI 22 .00 20.00 10.7727 5.89537 
Zarit 22 .00 38.00 17.0000 8.72872 
MARS_MFS 22 .00 42.00 15.1364 12.15493 
MARSD 22 4.00 50.00 18.7273 11.58892 
BADL 22 4.00 54.00 23.8636 12.22525 
Valid N (listwise) 22     
 
 
 
Discriminant Analysis- People with Alzheimer’s disease and their supporters 
Category: Person with Alzheimer’s disease or Supporter 
Variables: Age, SIMD, and Gender 
Group Statistics 
PwAD_S Mean Std. Deviation 
Valid N (listwise) 
Unweighted Weighted 
PwAD Age 76.0455 10.46298 22 22.000 
SIMD 7.2273 2.42864 22 22.000 
Gender 1.2727 .45584 22 22.000 
Supporter Age 68.4545 11.38390 22 22.000 
SIMD 7.4545 2.36497 22 22.000 
Gender 1.7727 .42893 22 22.000 
Total Age 72.2500 11.46709 44 44.000 
SIMD 7.3409 2.37176 44 44.000 
Gender 1.5227 .50526 44 44.000 
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Eigenvalues 
Function Eigenvalue % of Variance Cumulative % Canonical Correlation 
1 .426
a
 100.0 100.0 .547 
a. First 1 canonical discriminant functions were used in the analysis. 
 
Wilks' Lambda 
Test of Function(s) Wilks' Lambda Chi-square df Sig. 
1 .701 14.372 3 .002 
 
 
Correlation of Stigma Impact Scores for people with Alzheimer’s disease and their supporters  
 
Descriptive Statistics 
 Mean Std. Deviation N 
PwAD_S 1.5000 .50578 44 
SIS 33.9091 12.67999 44 
 
 
 
 PwAD_S SIS 
PwAD_S Pearson Correlation 1 -.355* 
Sig. (2-tailed)  .018 
N 44 44 
SIS Pearson Correlation -.355* 1 
Sig. (2-tailed) .018  
N 44 44 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
Matched-sample t-test of Stigma Impact Scores for people with Alzheimer’s disease and their 
supporters  
Paired Samples Statistics 
 Mean N Std. Deviation Std. Error Mean 
Pair 1 PWAD 38.3636 22 6.41089 1.36681 
S 29.4545 22 15.70177 3.34763 
Paired Samples Test 
 Paired Differences t df Sig. (2-
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Mean 
Std. 
Deviation 
Std. Error 
Mean 
95% Confidence Interval of 
the Difference 
tailed) 
Lower Upper 
Pair 1 PWAD - 
S 
8.90909 15.80810 3.37030 1.90017 15.91801 2.643 21 .015 
 
Independent-sample t-test of Stigma Impact Scores for people with Alzheimer’s disease and 
their supporters  
 
Group Statistics 
 PwAD_S N Mean Std. Deviation Std. Error Mean 
SIS PwAD 22 38.3636 6.41089 1.36681 
Supporter 22 29.4545 15.70177 3.34763 
 
 
 
 
Independent Samples Test 
 
Levene's Test for 
Equality of 
Variances t-test for Equality of Means 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
SIS Equal 
variances 
assumed 
7.898 .007 2.464 42 .018 8.90909 3.61591 1.61190 16.20628 
Equal 
variances not 
assumed 
  
2.464 27.812 .020 8.90909 3.61591 1.49999 16.31819 
 
 
Analysis of covariance (ANCOVA): Stigma Impact Scale scores of People with Alzheimer’s 
disease and their supporters 
 
Descriptive Statistics 
Dependent Variable:   SIS   
PwAD_S Mean Std. Deviation N 
PwAD 38.3636 6.41089 22 
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Supporter 29.4545 15.70177 22 
Total 33.9091 12.67999 44 
Tests of Between-Subjects Effects 
Dependent Variable:   SIS   
Source 
Type III 
Sum of 
Squares df 
Mean 
Square F Sig. 
Partial Eta 
Squared 
Noncent. 
Parameter 
Observed 
Power
b
 
Corrected 
Model 
1582.840
a
 4 395.710 2.895 .034 .229 11.580 .729 
Intercept 1525.615 1 1525.615 11.161 .002 .223 11.161 .903 
Age 159.248 1 159.248 1.165 .287 .029 1.165 .183 
SIMD 300.580 1 300.580 2.199 .146 .053 2.199 .304 
Gender 159.800 1 159.800 1.169 .286 .029 1.169 .184 
PwAD_S 1157.793 1 1157.793 8.470 .006 .178 8.470 .810 
Error 5330.796 39 136.687      
Total 57506.000 44       
Corrected 
Total 
6913.636 43 
      
a. R Squared = .229 (Adjusted R Squared = .150) b. Computed using alpha = .05 
 
 
Multiple Regression – People with Alzheimer’s disease 
Dependent Variable: Stigma Impact Scale score (SIS) 
Variables: Age, Socioeconomic status measured by SIMD decile, Time since diagnosis in years, 
Quality of Life measured by DEMQOL, Insight (self-report and discrepancy) reported through 
MARS-MFS, and Activities of daily living measured by BADL score.  
Model Summary 
Model 
R 
R Square Adjusted R Square 
Std. Error of the 
Estimate 
PwAD_S =  PwAD 
(Selected) 
1 .812
a
 .659 .450 4.75547 
a. Predictors: (Constant), BADL, MARS_D, Gender, SIMD, Age, QOL, Time_Diagnosis, MARS_MFS 
 
ANOVA
a,b
 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 569.102 8 71.138 3.146 .033
c
 
Residual 293.989 13 22.615   
Total 863.091 21    
a. Dependent Variable: SIS 
b. Selecting only cases for which PwAD_S =  PwAD 
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c. Predictors: (Constant), BADL, MARS_D, Gender, SIMD, Age, QOL, Time_Diagnosis, MARS_MFS 
 
Coefficients
a,b
 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) 68.228 12.862  5.305 .000 
Age .031 .117 .051 .266 .795 
SIMD -1.350 .553 -.511 -2.440 .030 
Time_Diagnosis -.213 .550 -.102 -.387 .705 
Gender 4.305 2.799 .306 1.538 .148 
QOL -.301 .133 -.526 -2.271 .041 
MARS_MFS -.032 .166 -.053 -.192 .851 
MARS_D .153 .145 .276 1.053 .312 
BADL .028 .139 .054 .203 .842 
a. Dependent Variable: SIS  b. Selecting only cases for which PwAD_S =  PwAD 
 
 
Independent Samples t-test: Stigma Impact Scale scores (SIS) for people with early and late-
onset Alzheimer’s disease 
Group Statistics 
 EL N Mean Std. Deviation Std. Error Mean 
SIS Early 7 37.8571 10.44715 3.94865 
Late 15 38.6000 3.83219 .98947 
 
 
Independent Samples Test 
 
Levene's Test for 
Equality of 
Variances t-test for Equality of Means 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
SIS Equal variances 
assumed 
9.756 .005 -.247 20 .807 -.74286 3.00238 -7.00572 5.52001 
Equal variances 
not assumed 
  
-.182 6.766 .861 -.74286 4.07074 
-
10.43660 
8.95088 
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Independent Samples t-test: Stigma Impact Scale scores (SIS) for supporters of people with 
early and late-onset Alzheimer’s disease 
Group Statistics 
 EL N Mean Std. Deviation Std. Error Mean 
SIS_S Early 7 36.2857 11.87033 4.48656 
Late 15 26.2667 16.58944 4.28338 
 
Independent Samples Test 
 
Levene's Test for 
Equality of 
Variances t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
SIS_S Equal 
variances 
assumed 
.677 .420 1.428 20 .169 10.01905 7.01576 
-
4.61558 
24.65367 
Equal 
variances not 
assumed 
  
1.615 16.166 .126 10.01905 6.20295 
-
3.11962 
23.15772 
 
Multiple Regression – Supporters 
Dependent Variable: Stigma Impact Scale score (SIS) 
Variables: Age, Socioeconomic status measured by SIMD decile, Time since diagnosis in years, 
Quality of Life measured by Zarit Burden Interview, Insight (informant and discrepancy) 
reported through MARS-MFS, and activities of daily living measured by BADLs. 
Model Summary 
Model 
R 
R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
PwAD_S =  
Supporter 
(Selected) 
1 .790a .625 .394 12.22606 
a. Predictors: (Constant), BADL, MARS_D, Age, QOL, SIMD, Gender, 
Time_Diagnosis, MARS_MFS 
 
ANOVAa,b 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 3234.260 8 404.283 2.705 .054c 
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Residual 1943.194 13 149.476   
Total 5177.455 21    
a. Dependent Variable: SIS 
b. Selecting only cases for which PwAD_S =  Supporter 
c. Predictors: (Constant), BADL, MARS_D, Age, QOL, SIMD, Gender, Time Diagnosis, MARS_MFS 
 
Coefficientsa,b 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) 30.122 39.848  .756 .463 
Age -.350 .298 -.254 -1.178 .260 
SIMD .520 1.351 .078 .385 .706 
Time Diagnosis -.759 1.353 -.148 -.561 .584 
Gender 2.572 8.997 .070 .286 .780 
QOL .920 .366 .512 2.513 .026 
MARS_MFS -.201 .395 -.156 -.510 .619 
MARS_D -.228 .330 -.168 -.690 .502 
BADL .434 .441 .338 .983 .344 
a. Dependent Variable: SIS  b. Selecting only cases for which PwAD_S =  Supporter 
 
 
Multiple Analysis of Variance (MANOVA): Stigma Impact Scale subcategory scores people 
with Alzheimer’s disease and their supporters. 
Key:  
PwAD- Person with Alzheimer’s disease, S= Supporter 
SR= Social Rejection, FI= Financial Instability, IS= Internalised Shame, SI= Social Isolation 
 
Multivariate Testsa 
Effect Value F 
Hypothesis 
df Error df Sig. 
Partial Eta 
Squared 
Noncent. 
Parameter 
Observed 
Powerc 
Intercept Pillai's Trace .899 86.800b 4.000 39.000 .000 .899 347.201 1.000 
Wilks' 
Lambda 
.101 86.800b 4.000 39.000 .000 .899 347.201 1.000 
Hotelling's 
Trace 
8.903 86.800b 4.000 39.000 .000 .899 347.201 1.000 
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Roy's Largest 
Root 
8.903 86.800b 4.000 39.000 .000 .899 347.201 1.000 
PwAD_
S 
Pillai's Trace .270 3.605b 4.000 39.000 .014 .270 14.421 .830 
Wilks' 
Lambda 
.730 3.605b 4.000 39.000 .014 .270 14.421 .830 
Hotelling's 
Trace 
.370 3.605b 4.000 39.000 .014 .270 14.421 .830 
Roy's Largest 
Root 
.370 3.605b 4.000 39.000 .014 .270 14.421 .830 
a. Design: Intercept + PwAD_S  b. Exact statistic c. Computed using alpha = .05 
 
 
Levene's Test of Equality of Error Variancesa 
 F df1 df2 Sig. 
SR 3.264 1 42 .078 
FI 1.011 1 42 .320 
IS 2.223 1 42 .143 
SI 11.210 1 42 .002 
Tests the null hypothesis that the error variance of the dependent 
variable is equal across groups. 
a. Design: Intercept + PwAD_S 
 
 
 
Tests of Between-Subjects Effects 
Source 
Dependent 
Variable 
Type III 
Sum of 
Squares df 
Mean 
Square F Sig. 
Partial 
Eta 
Squared 
Noncent. 
Parameter 
Observed 
Powere 
Corrected 
Model 
SR 241.114a 1 241.114 9.246 .004 .180 9.246 .844 
FI 2.273b 1 2.273 .528 .471 .012 .528 .109 
IS 66.273c 1 66.273 8.953 .005 .176 8.953 .832 
SI 54.568d 1 54.568 2.672 .110 .060 2.672 .359 
Intercept SR 7884.568 1 7884.568 302.334 .000 .878 302.334 1.000 
FI 99.000 1 99.000 23.007 .000 .354 23.007 .997 
IS 2240.818 1 2240.818 302.707 .000 .878 302.707 1.000 
SI 6216.568 1 6216.568 304.356 .000 .879 304.356 1.000 
PwAD_S SR 241.114 1 241.114 9.246 .004 .180 9.246 .844 
FI 2.273 1 2.273 .528 .471 .012 .528 .109 
IS 66.273 1 66.273 8.953 .005 .176 8.953 .832 
SI 54.568 1 54.568 2.672 .110 .060 2.672 .359 
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Error SR 1095.318 42 26.079 
     
FI 180.727 42 4.303      
IS 310.909 42 7.403      
SI 857.864 42 20.425      
Total SR 9221.000 44 
      
FI 282.000 44       
IS 2618.000 44       
SI 7129.000 44       
Corrected 
Total 
SR 1336.432 43 
      
FI 183.000 43       
IS 377.182 43       
SI 912.432 43       
a. R Squared = .180 (Adjusted R Squared = .161) 
b. R Squared = .012 (Adjusted R Squared = -.011) 
c. R Squared = .176 (Adjusted R Squared = .156) 
d. R Squared = .060 (Adjusted R Squared = .037) 
e. Computed using alpha = .05 
 
 
ANOVA- Quality of Life scores measured by DEMQOL for people with Alzheimer’s disease 
across the four subcategories of the Stigma Impact Scale 
 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
SR Between Groups 235.864 15 15.724 1.945 .211 
Within Groups 48.500 6 8.083   
Total 284.364 21    
FI Between Groups 67.864 15 4.524 2.585 .124 
Within Groups 10.500 6 1.750   
Total 78.364 21    
IS Between Groups 68.091 15 4.539 3.891 .051 
Within Groups 7.000 6 1.167   
Total 75.091 21    
SI Between Groups 100.500 15 6.700 1.462 .335 
Within Groups 27.500 6 4.583   
Total 128.000 21    
 
ANOVA- Socioeconomic status measured by SIMD decile for people with Alzheimer’s disease 
across the four subcategories of the Stigma Impact Scale 
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ANOVA 
 Sum of Squares df Mean Square F Sig. 
SR Between Groups 81.330 7 11.619 .801 .600 
Within Groups 203.033 14 14.502   
Total 284.364 21    
FI Between Groups 58.230 7 8.319 5.784 .003 
Within Groups 20.133 14 1.438   
Total 78.364 21    
IS Between Groups 27.424 7 3.918 1.151 .388 
Within Groups 47.667 14 3.405   
Total 75.091 21    
SI Between Groups 60.717 7 8.674 1.805 .164 
Within Groups 67.283 14 4.806   
Total 128.000 21    
 
 
ANOVA- Quality of life measured by Zarit Burden Interview-short form for supporters of 
people with Alzheimer’s disease across the four subcategories of the Stigma Impact Scale 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
SR Between Groups 748.955 14 53.497 6.040 .012 
Within Groups 62.000 7 8.857   
Total 810.955 21    
FI Between Groups 65.864 14 4.705 .902 .590 
Within Groups 36.500 7 5.214   
Total 102.364 21    
IS Between Groups 229.152 14 16.368 17.186 .000 
Within Groups 6.667 7 .952   
Total 235.818 21    
SI Between Groups 658.197 14 47.014 4.592 .025 
Within Groups 71.667 7 10.238   
Total 729.864 21    
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ANOVA- People with early and late-onset Alzheimer’s disease scores across the four 
subcategories of the Stigma Impact Scale 
 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
SR Between Groups 25.773 1 25.773 1.993 .173 
Within Groups 258.590 20 12.930   
Total 284.364 21    
FI Between Groups 35.906 1 35.906 16.914 .001 
Within Groups 42.457 20 2.123   
Total 78.364 21    
IS Between Groups 15.300 1 15.300 5.118 .035 
Within Groups 59.790 20 2.990   
Total 75.091 21    
SI Between Groups 1.886 1 1.886 .299 .591 
Within Groups 126.114 20 6.306   
Total 128.000 21    
 
 
 
ANOVA- Supporters of people with early and late-onset Alzheimer’s disease scores across the 
four subcategories of the Stigma Impact Scale 
 
ANOVA 
 Sum of Squares df Mean Square F Sig. 
SR Between Groups 107.793 1 107.793 3.066 .095 
Within Groups 703.162 20 35.158   
Total 810.955 21    
FI Between Groups 20.573 1 20.573 5.031 .036 
Within Groups 81.790 20 4.090   
Total 102.364 21    
IS Between Groups .085 1 .085 .007 .933 
Within Groups 235.733 20 11.787   
Total 235.818 21    
SI Between Groups 44.606 1 44.606 1.302 .267 
Within Groups 685.257 20 34.263   
Total 729.864 21    
 
